ss_strn,src_ss_d,ss_rgnsm,rltnshp_tp,src_d,ss_sbclllr_frctn,ss_ctgr,b_frmt,ss_tss,ss_tp,ss_cll_tp,td,crtd_b,cll_d,dc_d,ss_tx_d,vrnt_d,ss_d,chmbl_d,dscrptn,ss_tst_tp,cnfdnc_scr,tss_d
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7524,CHEMBL618647,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7525,CHEMBL618648,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7526,CHEMBL618649,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7527,CHEMBL618650,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7528,CHEMBL618651,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7529,CHEMBL876497,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9866,10116.0,,7530,CHEMBL618652,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9866,10116.0,,7531,CHEMBL618653,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9866,10116.0,,7532,CHEMBL618654,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6351,10116.0,,7533,CHEMBL618655,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1465,10116.0,,7534,CHEMBL618656,Compound was tested for solubility in water,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Intermediate,,5182,,,7535,CHEMBL618657,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17847,10116.0,,7536,CHEMBL618658,Solubility was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15339,10116.0,,7537,CHEMBL618659,solubility in water (ug/mL) at 37 degree C.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5202,10116.0,,7538,CHEMBL618660,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1088,10116.0,,7539,CHEMBL618661,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,7540,CHEMBL873807,Half life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5353,10116.0,,7541,CHEMBL618662,Half life in Dawley rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2864,10116.0,,7542,CHEMBL618663,Half life period after 3 mg/kg iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2864,10116.0,,7543,CHEMBL618664,Half life period after 3 mg/kg iv administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2864,10116.0,,7544,CHEMBL618665,Half life period after 3 mg/kg iv administration in the rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6362,10116.0,,7545,CHEMBL876498,Half life period in female Sprague-Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6249,10116.0,,7546,CHEMBL618666,Half life period in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,7547,CHEMBL620440,Half-life in rats was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,7548,CHEMBL620441,Half-life in rats with metabolic oxidation,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,7549,CHEMBL620442,Half-life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7550,CHEMBL620443,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7551,CHEMBL620444,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7552,CHEMBL620445,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7553,CHEMBL620446,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2879,10116.0,,7554,CHEMBL620447,Biological half-life measured in plasma of rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2879,10116.0,,7555,CHEMBL621129,Biological half-life measured in plasma of rat; 22-25,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2879,10116.0,,7556,CHEMBL621130,Biological half-life measured in plasma of rat; 9-16,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3184,10116.0,,7557,CHEMBL873808,Compound was evaluated for its half life when administered intravenously in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4891,10116.0,,7558,CHEMBL876598,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,7559,CHEMBL621131,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,7560,CHEMBL621132,Half life (T1/2) after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4413,10116.0,,7561,CHEMBL621133,Half life of compound after iv administration of 20 mg/kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,7562,CHEMBL621312,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17267,10116.0,,7563,CHEMBL621313,Half life of compound was determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,4727,10116.0,,7564,CHEMBL621314,Half life of compound was determined in rat blood,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17651,10116.0,,7565,CHEMBL621315,Half life at 1 mg/kg was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17651,10116.0,,7566,CHEMBL621316,Half life at 10 mg/kg was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,401,10116.0,,7567,CHEMBL621317,Half life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4942,10116.0,,7568,CHEMBL621318,Half life in rats in hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17735,10116.0,,7569,CHEMBL621319,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6056,10116.0,,7570,CHEMBL621377,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5213,10116.0,,7571,CHEMBL621378,Half life was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6616,10116.0,,7572,CHEMBL876599,Half life after i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5937,10116.0,,7573,CHEMBL621379,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5819,10116.0,,7574,CHEMBL621380,Half life in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5819,10116.0,,7575,CHEMBL621381,Half life in rat plasma; Not detected,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6803,10116.0,,7576,CHEMBL618515,Half life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,7577,CHEMBL618516,Half life period of compound was determined after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,7578,CHEMBL618517,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5948,10116.0,,7579,CHEMBL618518,Half life period in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1916,10116.0,,7580,CHEMBL618519,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1916,10116.0,,7581,CHEMBL618698,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1916,10116.0,,7582,CHEMBL618862,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4890,10116.0,,7583,CHEMBL618863,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,7584,CHEMBL618864,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,7585,CHEMBL618865,Half life time in rat the dose of 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,7586,CHEMBL618866,Half-life 24 hr after 10 mg/kg iv administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,7587,CHEMBL618867,Half-life 24 hr after 2 mg/kg iv administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6597,10116.0,,7588,CHEMBL875828,Half-life consistent with the observed metabolic steady state in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17735,10116.0,,7589,CHEMBL618868,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6597,10116.0,,7590,CHEMBL618869,Half-life for oxidative metabolic stability was determined using male human,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17670,10116.0,,7591,CHEMBL618870,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1696,10116.0,,7592,CHEMBL618871,Half-life in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1742,10116.0,,7593,CHEMBL618872,Half-life in rat plasma was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17800,10116.0,,7594,CHEMBL873816,Half-life in rats was determined,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12923,,,7595,CHEMBL618873,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11954,,,7596,CHEMBL621602,Area under curve after oral dose of 0.1 mg//kg,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,7597,CHEMBL621603,Area under curve after oral dose of 0.3 mg/kg,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,7598,CHEMBL621604,Area under curve after oral dose of 1 mg/kg,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,7599,CHEMBL621605,Area under curve after oral dose of 10 mg/kg,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,7600,CHEMBL621606,Area under curve after oral dose of 23.4 mg/kg,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,7601,CHEMBL621607,Area under curve after oral dose of 3 mg/kg,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,7602,CHEMBL621608,Area under curve after oral dose of 3.87 mg/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5237,,,7603,CHEMBL621609,Area under curve was determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4026,,,7604,CHEMBL621610,Area under curve at a dose of 10 mg/kg,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5237,10116.0,,7605,CHEMBL621611,Area under curve was determined; ND=No data,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7606,CHEMBL621612,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7607,CHEMBL622308,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7608,CHEMBL622309,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7609,CHEMBL622310,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7610,CHEMBL622311,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7611,CHEMBL622312,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7612,CHEMBL622931,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,7613,CHEMBL622932,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7614,CHEMBL622736,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7615,CHEMBL622737,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7616,CHEMBL622738,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7617,CHEMBL622739,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7618,CHEMBL622740,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7619,CHEMBL622741,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7620,CHEMBL622742,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,7621,CHEMBL622743,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,11637,10090.0,,7622,CHEMBL622744,AUC in mice,,1,1969.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11149,,,7623,CHEMBL624134,Area under curve was measured from the graph obtained from concentration Vs time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10016,,,7624,CHEMBL624135,Area under curve value of compound per hour after oral administration,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,7625,CHEMBL624136,Area under curve was determined after oral administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,7626,CHEMBL624137,Area under curve was determined after oral administration in rats; No data,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,7627,CHEMBL624320,Area under curve was determined after oral administration in rats;No data,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12923,9615.0,,7628,CHEMBL624321,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7629,CHEMBL624322,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7630,CHEMBL624323,Area under curve was determined for the compound after iv dose of 5.06 in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7631,CHEMBL624324,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7632,CHEMBL624325,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7633,CHEMBL624326,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7634,CHEMBL624327,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,7635,CHEMBL624328,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14169,9615.0,,7636,CHEMBL627848,Area under curve was determined in Dogs after peroral administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14169,10116.0,,7637,CHEMBL627849,Area under curve was determined in Rats after peroral administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14258,10116.0,,7638,CHEMBL627850,Area under curve was determined in carotid blood of rat when administered intradermally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14258,10116.0,,7639,CHEMBL627851,Area under curve was determined in portal blood of rat when administered intradermally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7640,CHEMBL627852,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7641,CHEMBL627853,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7642,CHEMBL627854,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7643,CHEMBL627855,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7644,CHEMBL627856,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7645,CHEMBL875339,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7646,CHEMBL627857,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11195,10116.0,,7647,CHEMBL627858,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10130,10116.0,,7648,CHEMBL627859,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10130,10116.0,,7649,CHEMBL627860,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,10130,10116.0,,7650,CHEMBL627019,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10130,10116.0,,7651,CHEMBL627020,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10130,10116.0,,7652,CHEMBL627021,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10130,10116.0,,7653,CHEMBL627022,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10130,10116.0,,7654,CHEMBL627023,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10130,10116.0,,7655,CHEMBL627024,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10130,10116.0,,7656,CHEMBL627025,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10130,10116.0,,7657,CHEMBL627026,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10130,10116.0,,7658,CHEMBL627027,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10130,10116.0,,7659,CHEMBL627028,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,10130,10116.0,,7660,CHEMBL627029,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10130,10116.0,,7661,CHEMBL627030,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10130,10116.0,,7662,CHEMBL627031,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10130,10116.0,,7663,CHEMBL627032,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10130,10116.0,,7664,CHEMBL627033,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10130,10116.0,,7665,CHEMBL627034,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10130,10116.0,,7666,CHEMBL627035,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10130,10116.0,,7667,CHEMBL627036,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10130,10116.0,,7668,CHEMBL875340,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,10130,10116.0,,7669,CHEMBL627037,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10130,10116.0,,7670,CHEMBL627038,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10130,10116.0,,7671,CHEMBL627039,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10130,10116.0,,7672,CHEMBL627040,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10130,10116.0,,7673,CHEMBL624663,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10130,10116.0,,7674,CHEMBL625963,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10130,10116.0,,7675,CHEMBL876799,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10130,10116.0,,7676,CHEMBL626133,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10130,10116.0,,7677,CHEMBL626134,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6295,10116.0,,7678,CHEMBL626135,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6296,10116.0,,7679,CHEMBL626136,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6296,10116.0,,7680,CHEMBL626137,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6295,10116.0,,7681,CHEMBL626138,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6296,10116.0,,7682,CHEMBL626139,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7683,CHEMBL626140,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7684,CHEMBL626141,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,7685,CHEMBL626142,C24h in rat p.o. at 20 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,7686,CHEMBL627930,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,7687,CHEMBL627931,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,7688,CHEMBL627932,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,7689,CHEMBL627933,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,7690,CHEMBL627934,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,7691,CHEMBL627935,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7692,CHEMBL627936,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7693,CHEMBL627937,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7694,CHEMBL627938,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7695,CHEMBL627939,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7696,CHEMBL627940,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7697,CHEMBL627941,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7698,CHEMBL876800,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7699,CHEMBL627942,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7700,CHEMBL627943,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7701,CHEMBL627944,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7702,CHEMBL627945,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7703,CHEMBL628584,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7704,CHEMBL628585,Biodistribution in rat blood in the presence of GdDTPA at 15 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7705,CHEMBL628586,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7706,CHEMBL628587,Biodistribution in rat blood in the presence of GdDTPA at 30 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7707,CHEMBL628588,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7708,CHEMBL628589,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7709,CHEMBL625304,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7710,CHEMBL625305,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7711,CHEMBL625306,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7712,CHEMBL625307,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7713,CHEMBL625308,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7714,CHEMBL627740,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7715,CHEMBL627741,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7716,CHEMBL627742,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7717,CHEMBL627743,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9866,10116.0,,7718,CHEMBL627744,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7719,CHEMBL627745,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7720,CHEMBL627746,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7721,CHEMBL627747,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7722,CHEMBL876810,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7723,CHEMBL627748,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7724,CHEMBL627749,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7725,CHEMBL627750,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7726,CHEMBL618728,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7727,CHEMBL618729,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7728,CHEMBL618730,Biodistribution in rat bone in the presence of GdDTPA at 15 min,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7729,CHEMBL618731,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7730,CHEMBL618732,Biodistribution in rat bone in the presence of GdDTPA at 30 min,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7731,CHEMBL618733,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7732,CHEMBL618734,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7733,CHEMBL618735,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7734,CHEMBL876602,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7735,CHEMBL618736,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7736,CHEMBL618737,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7737,CHEMBL618738,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7738,CHEMBL618739,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7739,CHEMBL618740,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7740,CHEMBL618741,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7741,CHEMBL618742,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,9866,10116.0,,7742,CHEMBL618743,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17752,10116.0,,7743,CHEMBL618744,Half-life from rat plasma at a single oral dose of 25 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5610,10116.0,,7744,CHEMBL618745,Half-life in male rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,7745,CHEMBL620479,Half-life in rat after peroral administration at 10 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,7746,CHEMBL620480,Half-life in rat after peroral administration at 5 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17771,10116.0,,7747,CHEMBL620481,Half-life in rat at a dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1974,10116.0,,7748,CHEMBL620482,Half-life was evaluated in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4239,10116.0,,7749,CHEMBL876603,Half-life was measured in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6681,10116.0,,7750,CHEMBL620483,Half-life period for the compound was determined in rats at 50 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17752,10116.0,,7751,CHEMBL620484,Half-life period in rats after intravenous administration at 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6046,10116.0,,7752,CHEMBL620485,Half-life period in rat at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,7753,CHEMBL620486,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,7754,CHEMBL620487,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,7755,CHEMBL620488,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,7756,CHEMBL620489,Half-life time in rat the dose of 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1088,10116.0,,7757,CHEMBL620490,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5610,10116.0,,7758,CHEMBL620491,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3032,10116.0,,7759,CHEMBL876604,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5199,10116.0,,7760,CHEMBL620492,Oral half life was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,7761,CHEMBL620493,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4408,10116.0,,7762,CHEMBL620494,Pharmacokinetic property (t1/2) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2552,10116.0,,7763,CHEMBL620495,Plasma elimination half-life was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5199,10116.0,,7764,CHEMBL620496,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,7765,CHEMBL620497,Plasma half life was observed after intravenous administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1465,10116.0,,7766,CHEMBL620498,Plasma half-life was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1446,10116.0,,7767,CHEMBL620499,Plasma half-life following oral administration in Fisher rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6824,10116.0,,7768,CHEMBL620500,Plasma half-life in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17533,10116.0,,7769,CHEMBL873809,Plasmatic Half-life after intravenous administration to rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5979,10116.0,,7770,CHEMBL620501,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,7771,CHEMBL620502,Terminal half life after intravenous administration (1 mg/kg) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,7772,CHEMBL620503,Terminal half life in Rat at a oral dose of 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2463,10116.0,,7773,CHEMBL620504,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,7774,CHEMBL876605,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,7775,CHEMBL620505,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,7776,CHEMBL873811,plasma half life was observed after intravenous administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,7777,CHEMBL624016,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,7778,CHEMBL624017,Half life of compound determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,7779,CHEMBL624018,Mean residence time determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,7780,CHEMBL624019,Plasma half life determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,4910,10116.0,,7781,CHEMBL624020,Compound was evaluated for Tmax in brain after intravenous administration in male rats,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4891,10116.0,,7782,CHEMBL624201,Compound was evaluated for pharmacokinetic parameter maximum time period,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,7783,CHEMBL872528,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,7784,CHEMBL624202,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,7785,CHEMBL624203,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,7786,CHEMBL624350,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,7787,CHEMBL621320,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,7788,CHEMBL621321,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,7789,CHEMBL621322,Maximum time (Tmax) required to reach Cmax in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4890,10116.0,,7790,CHEMBL621323,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6571,10116.0,,7791,CHEMBL621324,Maximum time of clearance of compound in rats after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,7792,CHEMBL621325,Maximum time at the dose of 2 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17651,10116.0,,7793,CHEMBL875837,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17651,10116.0,,7794,CHEMBL621326,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14465,10116.0,,7795,CHEMBL621327,Tmax in Guinea pig (PO dose),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,7796,CHEMBL621328,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5960,10116.0,,7797,CHEMBL621329,Pharmacokinetic parameter (Tmax) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5022,10116.0,,7798,CHEMBL621330,Pharmacokinetic parameter (Tmax) was estimated,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4408,10116.0,,7799,CHEMBL621331,Pharmacokinetic property (Tmax) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5983,10116.0,,7800,CHEMBL621332,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,7801,CHEMBL621333,T max in Rat at a oral dose of 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,7802,CHEMBL621334,T max was determined at 10 mg/kg po dose in rats,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,7803,CHEMBL621335,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14180,9615.0,,7804,CHEMBL621336,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14180,10116.0,,7805,CHEMBL621337,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,7806,CHEMBL621338,Area under curve was measured after i.v. administration into Beagle dog.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,7807,CHEMBL875838,Area under curve was measured after iv administration into Beagle dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,7808,CHEMBL621339,Area under curve was measured after po administration into Beagle dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,7809,CHEMBL621340,Area under curve was measured after po administration into Beagle dog.,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15675,,,7810,CHEMBL621341,Area under curve was measured at peroral dose of 3 mg/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12706,,,7811,CHEMBL621342,Area under curve was measured by using concentration Vs time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12706,,,7812,CHEMBL621343,Area under curve was measured by using concentration Vs time; not tested,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9750,10090.0,,7813,CHEMBL621344,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9750,10090.0,,7814,CHEMBL621345,Area under curve(AUC) was measured in mice after oral administration.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14691,,,7815,CHEMBL621346,Area under curve(AUC) value of the compound,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14691,,,7816,CHEMBL621347,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14691,9615.0,,7817,CHEMBL621348,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,1,
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,2939,,,7818,CHEMBL621349,Area under curve(carotid artery) was determined by the availability in blood,,0,178.0
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,2939,,,7819,CHEMBL621350,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,0,178.0
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,2939,,,7820,CHEMBL875839,Area under curve(carotid artery) was determined by the availability in blood; No data,,0,178.0
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,2939,,,7821,CHEMBL620211,Area under curve(portal vein) was determined by the availability in blood,,0,178.0
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,2939,,,7822,CHEMBL620212,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,0,178.0
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,2939,,,7823,CHEMBL620213,Area under curve(portal vein) was determined by the availability in blood; No data,,0,178.0
,,Macaca mulatta,N,1,,,BAO_0000218,Plasma,A,,50797,Intermediate,,9552,9544.0,,7824,CHEMBL620214,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,1,1969.0
,,Macaca mulatta,N,1,,,BAO_0000218,Plasma,A,,50797,Intermediate,,9552,9544.0,,7825,CHEMBL620215,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,1,1969.0
,,Macaca mulatta,N,1,,,BAO_0000218,Plasma,A,,50797,Intermediate,,9552,9544.0,,7826,CHEMBL620216,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,9552,9615.0,,7827,CHEMBL620888,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,9552,9615.0,,7828,CHEMBL620889,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,1,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,9552,,,7829,CHEMBL620890,Area under plasma concentration vs time curve observed in rats for 0-3 h,,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,11911,10116.0,,7830,CHEMBL620891,Area under plasma time curve determined in male rat,,1,1969.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,16618,,,7831,CHEMBL620892,Area under the MAP curve measured over 5 min.,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14387,10090.0,,7832,CHEMBL621079,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14387,10090.0,,7833,CHEMBL621080,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12836,9615.0,,7834,CHEMBL621081,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,12836,10026.0,,7835,CHEMBL621082,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12836,10116.0,,7836,CHEMBL621083,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14339,9615.0,,7837,CHEMBL621084,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14339,9615.0,,7838,CHEMBL621085,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14339,9615.0,,7839,CHEMBL621086,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,10524,9615.0,,7840,CHEMBL621087,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9994,9615.0,,7841,CHEMBL622607,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,11325,9615.0,,7842,CHEMBL622608,Serum AUC in marmosets (IV dose),,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12536,,,7843,CHEMBL624481,Area under the curve after intravenous administration at a dose of 10 umol/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12536,,,7844,CHEMBL624482,Area under the curve after intravenous administration at a dose of 2 umol/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12536,,,7845,CHEMBL624483,Area under the curve after intravenous administration at a dose of 4 umol/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12536,,,7846,CHEMBL624484,Area under the curve after intravenous administration at a dose of 40 umol/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12536,,,7847,CHEMBL624485,Area under the curve after intravenous administration at a dose of 5 umol/kg,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15556,10116.0,,7848,CHEMBL624486,Area under the curve for fumarate salt was evaluated in F344 Rats.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2809,,,7849,CHEMBL624487,Area under the curve for the compound was calculated.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9511,,,7850,CHEMBL624488,Area under the curve in concentration/ time,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12818,10116.0,,7851,CHEMBL624489,Area under the curve administered intraintestinal in rats.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12818,10116.0,,7852,CHEMBL625184,Area under the curve administered intravenously in rats.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15118,,,7853,CHEMBL625185,Area under the curve during intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15118,,,7854,CHEMBL875954,Area under the curve during intravenous administration; Not determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15118,,,7855,CHEMBL625186,Area under the curve during systemic administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15118,,,7856,CHEMBL625187,Area under the curve during systemic administration; Not determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2632,,,7857,CHEMBL625188,Area under the curve was calculated for the compound.,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14346,9615.0,,7858,CHEMBL625189,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14346,9615.0,,7859,CHEMBL625190,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,7860,CHEMBL621733,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,7861,CHEMBL621734,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11149,10116.0,,7862,CHEMBL621735,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17796,10116.0,,7863,CHEMBL621736,Clearance of the drug was measured in the plasma of rat; No data,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5247,10116.0,,7864,CHEMBL621737,The pharmacokinetic parameter plasma clearance in vivo in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,7865,CHEMBL621738,Plasma clearance at the dose of 2 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,7866,CHEMBL622806,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,7867,CHEMBL623519,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,7868,CHEMBL623520,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17065,10116.0,,7869,CHEMBL623521,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17671,10116.0,,7870,CHEMBL623522,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6672,10116.0,,7871,CHEMBL623523,Clearance rate in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6673,10116.0,,7872,CHEMBL623690,Clearance rate in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,7873,CHEMBL623691,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,7874,CHEMBL623692,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,7875,CHEMBL623693,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,7876,CHEMBL623694,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4413,10116.0,,7877,CHEMBL623695,Clearance of compound after iv administration of 20 mg/kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,7878,CHEMBL623696,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,7879,CHEMBL623697,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,1,
,,Macaca mulatta,U,1,,,BAO_0000218,Plasma,A,,22224,Intermediate,,5005,9544.0,,7880,CHEMBL623698,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,0,1969.0
,,Rattus norvegicus,U,1,,,BAO_0000218,Plasma,A,,22224,Intermediate,,5005,10116.0,,7881,CHEMBL623699,Compound was tested for its plasma clearance rate in Sprague Dawley rats,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,7882,CHEMBL623700,Mean (%CV) PK parameters for CL(mL/min/kg).,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3747,10116.0,,7883,CHEMBL623701,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16366,10116.0,,7884,CHEMBL623702,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,7885,CHEMBL623703,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17267,10116.0,,7886,CHEMBL623704,Plasma clearance in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,7887,CHEMBL623705,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,7888,CHEMBL623706,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,7889,CHEMBL623707,Plasma clearance was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5960,10116.0,,7890,CHEMBL623708,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5937,10116.0,,7891,CHEMBL623709,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5871,10116.0,,7892,CHEMBL623710,Plasma clearance in rat by iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5874,10116.0,,7893,CHEMBL623711,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6504,10116.0,,7894,CHEMBL623712,Plasma clearance in rat p.o.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6803,10116.0,,7895,CHEMBL623713,Plasma clearance in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,7896,CHEMBL623714,Plasma clearance was determined; ND denotes no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,7897,CHEMBL623715,Plasma clearance was determined; ND denotes not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1916,10116.0,,7898,CHEMBL623716,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5199,10116.0,,7899,CHEMBL622980,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,7900,CHEMBL622981,Plasma administration to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6362,10116.0,,7901,CHEMBL622982,Plasma clearance of the compound in female Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,7902,CHEMBL622983,Plasma clearance was observed after intravenous administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6215,10116.0,,7903,CHEMBL622984,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1466,10116.0,,7904,CHEMBL622985,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,7905,CHEMBL623631,plasma clearance was observed after intravenous administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,7906,CHEMBL623632,In vivo CL/F determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2792,10116.0,,7907,CHEMBL623633,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2792,10116.0,,7908,CHEMBL623634,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5213,10116.0,,7909,CHEMBL623635,Compound was tested for the lower blood clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4687,10116.0,,7910,CHEMBL621195,Evaluated for the low clearance in rat (in vivo),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3371,10116.0,,7911,CHEMBL621196,Pharmacokinetic property (CLb)of the compound was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4690,10116.0,,7912,CHEMBL875287,Rapid clearance after intravenous administration in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5702,10116.0,,7913,CHEMBL621197,Clearance measured in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,740,10116.0,,7914,CHEMBL621198,Compound was evaluated for plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4853,10116.0,,7915,CHEMBL621199,Low plasma clearance was calculated in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5789,10116.0,,7916,CHEMBL621200,Pharmacokinetic property (Clp) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,7917,CHEMBL621201,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,7918,CHEMBL621202,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,7919,CHEMBL621203,Plasma clearance after IV dosing at 0.5 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,7920,CHEMBL621204,Plasma clearance after IV dosing at 1 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7921,CHEMBL621205,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7922,CHEMBL621206,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7923,CHEMBL621207,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7924,CHEMBL621208,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7925,CHEMBL621209,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7926,CHEMBL876484,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7927,CHEMBL621210,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7928,CHEMBL621211,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7929,CHEMBL621212,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7930,CHEMBL621213,Biodistribution in rat heart in the presence of GdDTPA at 15 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7931,CHEMBL621214,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7932,CHEMBL621215,Biodistribution in rat heart in the presence of GdDTPA at 30 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7933,CHEMBL621216,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7934,CHEMBL621217,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7935,CHEMBL621218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7936,CHEMBL621219,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7937,CHEMBL621220,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7938,CHEMBL621221,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7939,CHEMBL621222,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7940,CHEMBL621223,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7941,CHEMBL876485,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7942,CHEMBL621224,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7943,CHEMBL621225,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9866,10116.0,,7944,CHEMBL621226,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7945,CHEMBL621227,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7946,CHEMBL621228,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7947,CHEMBL621229,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7948,CHEMBL621230,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7949,CHEMBL621231,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7950,CHEMBL621232,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7951,CHEMBL621233,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7952,CHEMBL621234,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7953,CHEMBL621235,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7954,CHEMBL621236,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7955,CHEMBL621237,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9866,10116.0,,7956,CHEMBL876486,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,9866,10116.0,,7957,CHEMBL622436,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,9866,10116.0,,7958,CHEMBL622437,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,9866,10116.0,,7959,CHEMBL622438,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7960,CHEMBL622439,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7961,CHEMBL622440,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7962,CHEMBL622441,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7963,CHEMBL622442,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7964,CHEMBL622443,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7965,CHEMBL622444,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7966,CHEMBL622445,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7967,CHEMBL622446,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7968,CHEMBL622447,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7969,CHEMBL622448,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7970,CHEMBL622449,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7971,CHEMBL622450,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7972,CHEMBL622451,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7973,CHEMBL622452,Biodistribution in rat liver in the presence of GdDTPA at 15 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7974,CHEMBL622453,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7975,CHEMBL622454,Biodistribution in rat liver in the presence of GdDTPA at 30 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7976,CHEMBL622455,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,7977,CHEMBL876024,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,7978,CHEMBL622456,T max was determined at 3 mg/kg po dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,7979,CHEMBL622457,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,7980,CHEMBL622458,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,7981,CHEMBL622459,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,7982,CHEMBL873343,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,7983,CHEMBL622460,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4576,10116.0,,7984,CHEMBL622461,Time for maximum plasma concentration determined in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6681,10116.0,,7985,CHEMBL622462,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,7986,CHEMBL622463,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,7987,CHEMBL622464,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,7988,CHEMBL622465,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,7989,CHEMBL622466,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,7990,CHEMBL622467,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6824,10116.0,,7991,CHEMBL622468,Time of maximum plasma concentration in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6685,10116.0,,7992,CHEMBL876025,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6685,10116.0,,7993,CHEMBL622469,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6685,10116.0,,7994,CHEMBL622470,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,7995,CHEMBL622471,Time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1742,10116.0,,7996,CHEMBL622472,Time required to reach maximum concentration in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2774,10116.0,,7997,CHEMBL622473,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5199,10116.0,,7998,CHEMBL624282,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,7999,CHEMBL624283,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,8000,CHEMBL624284,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1916,10116.0,,8001,CHEMBL624285,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,8002,CHEMBL624286,Time to reach Cmax after oral administration to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16366,10116.0,,8003,CHEMBL624287,Time to reach Cmax when a dose of 1 mg/kg is administered orally,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,216,10116.0,,8004,CHEMBL624288,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6410,10116.0,,8005,CHEMBL624289,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6410,10116.0,,8006,CHEMBL873344,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6215,10116.0,,8007,CHEMBL619623,Tmax after peroral administration (10 mg/kg) was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,8008,CHEMBL621399,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,8009,CHEMBL621400,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17670,10116.0,,8010,CHEMBL621401,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1465,10116.0,,8011,CHEMBL621402,Tmax was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2552,10116.0,,8012,CHEMBL621403,Tmax was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,8013,CHEMBL621121,Tmax after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,8014,CHEMBL872525,Tmax after peroral administration in rats at 2.4 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5610,10116.0,,8015,CHEMBL621122,Tmax in male rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6046,10116.0,,8016,CHEMBL621123,Tmax in rat at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5874,10116.0,,8017,CHEMBL621124,Tmax in rat by po administration at a dose of 40 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17596,10116.0,,8018,CHEMBL621125,Tmax in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,8019,CHEMBL621126,Tmax was measured in rats after peroral administration at 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1908,10116.0,,8020,CHEMBL621127,Tmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2959,10116.0,,8021,CHEMBL621128,Tmax value after administration of 20 mg/Kg oral dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,8022,CHEMBL618263,Tmax value at a dose of 10 mg/kg in male SD rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,8023,CHEMBL618264,Tmax value at a dose of 100 mg/kg in male SD rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,8024,CHEMBL618265,Tmax value at a dose of 50 mg/kg in male SD rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4186,10116.0,,8025,CHEMBL618266,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,8026,CHEMBL618267,time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,429,10116.0,,8027,CHEMBL618450,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,429,10116.0,,8028,CHEMBL618451,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5546,10116.0,,8029,CHEMBL618452,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,3173,10116.0,,8030,CHEMBL618453,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,3173,10116.0,,8031,CHEMBL618454,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,3173,10116.0,,8032,CHEMBL618455,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4257,10116.0,,8033,CHEMBL618456,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6011,10116.0,,8034,CHEMBL618457,Compound distribution in rat tissues was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,8035,CHEMBL618458,Volume of distribution was evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8036,CHEMBL618459,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8037,CHEMBL876733,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14346,9615.0,,8038,CHEMBL618460,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8039,CHEMBL618461,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15469,,,8040,CHEMBL618462,Area under the curve was determined after oral administration (300 uM/Kg),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8041,CHEMBL618463,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8042,CHEMBL618464,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8043,CHEMBL618465,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8044,CHEMBL618466,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,8045,CHEMBL618467,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,8046,CHEMBL618468,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,12935,9615.0,,8047,CHEMBL618469,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,12935,9615.0,,8048,CHEMBL618470,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,1,1969.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14813,,,8049,CHEMBL618471,Plasma drug AUC in rat (PO dose),,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15792,10090.0,,8050,CHEMBL618472,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3579,,,8051,CHEMBL618473,Area under was determined at a dose of 30 mg/kg,,0,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,12487,9669.0,,8052,CHEMBL621699,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12487,10116.0,,8053,CHEMBL621700,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12487,10116.0,,8054,CHEMBL621701,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,12487,9669.0,,8055,CHEMBL621702,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12487,9615.0,,8056,CHEMBL621703,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12487,9615.0,,8057,CHEMBL621704,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8058,CHEMBL624259,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8059,CHEMBL624260,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8060,CHEMBL624430,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8061,CHEMBL624431,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8062,CHEMBL624432,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8063,CHEMBL624433,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8064,CHEMBL624434,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,8065,CHEMBL624435,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8066,CHEMBL618570,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8067,CHEMBL618571,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8068,CHEMBL618572,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8069,CHEMBL618573,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8070,CHEMBL619267,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8071,CHEMBL619431,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8072,CHEMBL619432,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,8073,CHEMBL619433,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,1,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13298,,,8074,CHEMBL619434,AUC in mice after oral dose (50 mg/kg),,0,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Serum,A,,50594,Intermediate,,12226,10090.0,,8075,CHEMBL619435,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,1,1977.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,12634,,,8076,CHEMBL619436,AUC (0-4 hr) ug/ml/h,,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14810,10116.0,,8077,CHEMBL619437,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13889,,,8078,CHEMBL619438,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10018,10090.0,,8079,CHEMBL619439,Compound was evaluated for Area under curve in mice,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8758,10116.0,,8080,CHEMBL619440,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,1,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,8758,,,8081,CHEMBL619441,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8758,10116.0,,8082,CHEMBL619442,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2249,,,8083,CHEMBL875156,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2249,,,8084,CHEMBL619443,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2249,,,8085,CHEMBL619444,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2249,,,8086,CHEMBL623464,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15115,10090.0,,8087,CHEMBL623465,Compound was evaluated for area under curve when administered through oral route in mouse,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,8088,CHEMBL623466,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,8089,CHEMBL623467,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6249,10116.0,,8090,CHEMBL623468,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2463,10116.0,,8091,CHEMBL622660,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4969,10116.0,,8092,CHEMBL622661,Plasma clearance rate in Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,17720,10116.0,,8093,CHEMBL622662,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3457,10116.0,,8094,CHEMBL622663,Pharmacokinetic property (total body clearance) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5983,10116.0,,8095,CHEMBL622664,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6295,10116.0,,8096,CHEMBL622665,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6296,10116.0,,8097,CHEMBL622666,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,8098,CHEMBL621615,Cl in rat i.v. at 2 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,8099,CHEMBL621616,Clearance of compound after intravenous administration in rats at 24 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5503,10116.0,,8100,CHEMBL621617,Clearance was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4368,10116.0,,8101,CHEMBL621618,Clearance by intravenous administration of 3.4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6005,10116.0,,8102,CHEMBL621619,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5031,10116.0,,8103,CHEMBL621620,Clearance rate after i.v. administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4890,10116.0,,8104,CHEMBL621786,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,8105,CHEMBL621787,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5979,10116.0,,8106,CHEMBL621788,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,8107,CHEMBL621789,Clearance (Cl) after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,8108,CHEMBL621790,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4839,10116.0,,8109,CHEMBL621791,Compound was tested for plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,Microsomes,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,8110,CHEMBL621792,In vitro microsome metabolism clearance in rat was determined,In vitro,1,
,,Rattus norvegicus,N,1,Microsomes,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,8111,CHEMBL621793,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8112,CHEMBL621794,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5496,10116.0,,8113,CHEMBL621795,In vivo plasma clearance was determined,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5739,10116.0,,8114,CHEMBL621796,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,Hepatocyte,50597,Intermediate,401.0,5676,10116.0,,8115,CHEMBL621797,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4239,10116.0,,8116,CHEMBL621798,Pharmacokinetic property (Plasma clearance) was measured in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5676,10116.0,,8117,CHEMBL621799,Pharmacokinetic property (clearance) in rat i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1918,10116.0,,8118,CHEMBL621800,"Plasma Clearance was evaluated in rats, iv",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17800,10116.0,,8119,CHEMBL621801,Plasma clearance (in vivo) in rats was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6056,10116.0,,8120,CHEMBL621802,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5496,10116.0,,8121,CHEMBL618596,Plasma clearance was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,8122,CHEMBL618597,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,8123,CHEMBL618598,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17752,10116.0,,8124,CHEMBL618599,Plasma clearance in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,8125,CHEMBL618600,Plasma clearance rate determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6011,10116.0,,8126,CHEMBL618601,Plasma clearance was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,8127,CHEMBL618602,Plasma clearance was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5948,10116.0,,8128,CHEMBL618603,Plasma clearance value in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6125,10116.0,,8129,CHEMBL618604,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4839,10116.0,,8130,CHEMBL618605,Clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,8131,CHEMBL618606,Total body clearance in rat i.v. at 2 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6571,10116.0,,8132,CHEMBL618607,Clearance of compound in rats after intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3364,10116.0,,8133,CHEMBL618608,Clearance after iv administration to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8134,CHEMBL618609,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8135,CHEMBL618610,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8136,CHEMBL618611,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8137,CHEMBL618612,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8138,CHEMBL618613,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8139,CHEMBL621076,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8140,CHEMBL621077,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17670,10116.0,,8141,CHEMBL621078,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5970,10116.0,,8142,CHEMBL621251,Clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,8143,CHEMBL621252,Clearance in rat after oral administration at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4590,10116.0,,8144,CHEMBL621253,Clearance in rat.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6193,10116.0,,8145,CHEMBL621254,Clearance rate following an oral dose of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2832,10116.0,,8146,CHEMBL621255,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1052,10116.0,,8147,CHEMBL621256,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8148,CHEMBL621257,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8149,CHEMBL621258,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8150,CHEMBL621259,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8151,CHEMBL621260,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8152,CHEMBL876494,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8153,CHEMBL621261,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8154,CHEMBL621262,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8155,CHEMBL621263,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9866,10116.0,,8156,CHEMBL621264,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8157,CHEMBL621265,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8158,CHEMBL621266,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8159,CHEMBL621267,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8160,CHEMBL621268,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8161,CHEMBL621269,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8162,CHEMBL621270,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8163,CHEMBL621271,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8164,CHEMBL621272,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8165,CHEMBL621273,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8166,CHEMBL621274,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8167,CHEMBL876495,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8168,CHEMBL621275,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8169,CHEMBL621276,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9866,10116.0,,8170,CHEMBL621277,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,9866,10116.0,,8171,CHEMBL621278,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,9866,10116.0,,8172,CHEMBL621279,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,9866,10116.0,,8173,CHEMBL621280,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8174,CHEMBL621281,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8175,CHEMBL621282,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8176,CHEMBL621283,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8177,CHEMBL621284,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8178,CHEMBL621285,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8179,CHEMBL621286,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8180,CHEMBL623220,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8181,CHEMBL623221,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9866,10116.0,,8182,CHEMBL876029,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,9866,10116.0,,8183,CHEMBL623222,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,9866,10116.0,,8184,CHEMBL623223,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,9866,10116.0,,8185,CHEMBL621445,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13950,10116.0,,8186,CHEMBL621446,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13950,10116.0,,8187,CHEMBL621447,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13950,10116.0,,8188,CHEMBL619681,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13950,10116.0,,8189,CHEMBL619682,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13950,10116.0,,8190,CHEMBL619683,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13950,10116.0,,8191,CHEMBL619684,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13950,10116.0,,8192,CHEMBL619685,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13950,10116.0,,8193,CHEMBL619686,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13950,10116.0,,8194,CHEMBL619687,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13950,10116.0,,8195,CHEMBL619688,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13950,10116.0,,8196,CHEMBL619689,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13950,10116.0,,8197,CHEMBL619690,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13950,10116.0,,8198,CHEMBL619691,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6062,10116.0,,8199,CHEMBL619692,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,8200,CHEMBL619693,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1908,10116.0,,8201,CHEMBL619694,Vc value after IV dose at a dose of 5 mg/kg in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17596,10116.0,,8202,CHEMBL619695,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4891,10116.0,,8203,CHEMBL619696,Compound was evaluated for pharmacokinetic parameter volume of distribution,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,740,10116.0,,8204,CHEMBL619697,Compound was evaluated for volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16366,10116.0,,8205,CHEMBL619698,Steady state volume distribution was determined; steady state(ss),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3364,10116.0,,8206,CHEMBL619699,Steady state volume of distribution after iv administration to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2552,10116.0,,8207,CHEMBL619700,Steady state volume of distribution dosing at 3 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,406,10116.0,,8208,CHEMBL619701,The compound was evaluated for volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12500,10116.0,,8209,CHEMBL619702,The compound was tested for volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12500,10116.0,,8210,CHEMBL620335,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,8211,CHEMBL620336,Volume distribution (VD) after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17671,10116.0,,8212,CHEMBL620337,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1094,10116.0,,8213,CHEMBL620520,Volume distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5833,10116.0,,8214,CHEMBL620521,Volume distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,8215,CHEMBL875825,Volume distribution in rat after peroral administration at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,8216,CHEMBL620522,Volume distribution in rat after peroral administration at 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6005,10116.0,,8217,CHEMBL620523,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1696,10116.0,,8218,CHEMBL620524,Volume of distribution in rat.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6672,10116.0,,8219,CHEMBL620525,Volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6673,10116.0,,8220,CHEMBL620526,Volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5871,10116.0,,8221,CHEMBL620527,Volume of distribution in rat by iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6803,10116.0,,8222,CHEMBL620528,Volume of distribution in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5199,10116.0,,8223,CHEMBL620529,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,8224,CHEMBL620530,Volume distribution at the dose of 2 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,8225,CHEMBL620531,Steady state volume of distribution was determined,In vivo,1,
,,Macaca mulatta,U,1,,,BAO_0000218,,A,,22224,Intermediate,,5005,9544.0,,8226,CHEMBL620532,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,5005,10116.0,,8227,CHEMBL620533,Compound was tested for its plasma volume distribution in Sprague Dawley rats,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,5005,10116.0,,8228,CHEMBL620534,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,8229,CHEMBL620535,Mean (%CV) PK parameters for Vdss(mL/kg).,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,8230,CHEMBL875826,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,8231,CHEMBL620536,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8232,CHEMBL620537,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8233,CHEMBL618526,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5739,10116.0,,8234,CHEMBL618527,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5789,10116.0,,8235,CHEMBL618528,Pharmacokinetic property (Vdss) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4239,10116.0,,8236,CHEMBL618529,Pharmacokinetic property (vdss) was measured in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4709,10116.0,,8237,CHEMBL618530,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6642,10116.0,,8238,CHEMBL618531,Volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5247,10116.0,,8239,CHEMBL618532,The pharmacokinetic parameter volume of distribution in vivo in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,17720,10116.0,,8240,CHEMBL618533,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,8241,CHEMBL618534,Vdss in rat i.v. at 2 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,8242,CHEMBL618535,Volume distribution after intravenous administration (1 mg/kg) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,8243,CHEMBL618536,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,8244,CHEMBL618537,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,8245,CHEMBL618538,Volume distribution at a dose of 10 uM/kg in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4521,10116.0,,8246,CHEMBL618539,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,8247,CHEMBL618540,Volume distribution was calculated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,8248,CHEMBL618541,Volume distribution was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2938,10116.0,,8249,CHEMBL618542,Volume of distribution after intravenous administration was evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6679,10116.0,,8250,CHEMBL622544,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,8251,CHEMBL622545,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,8252,CHEMBL622546,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,8253,CHEMBL622547,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5145,10116.0,,8254,CHEMBL622548,Volume of distribution in steady state was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6467,10116.0,,8255,CHEMBL622549,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6467,10116.0,,8256,CHEMBL622550,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15115,10090.0,,8257,CHEMBL622551,Compound was evaluated for area under curve when administered through oral route to mouse,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8758,10116.0,,8258,CHEMBL622552,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8758,10116.0,,8259,CHEMBL622553,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,1,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,8267,,,8260,CHEMBL622554,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8267,9615.0,,8261,CHEMBL622555,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14239,10090.0,,8262,CHEMBL622556,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14239,10090.0,,8263,CHEMBL622557,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,8264,CHEMBL622558,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,8265,CHEMBL622559,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,10754,9615.0,,8266,CHEMBL622560,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14681,10116.0,,8267,CHEMBL622561,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14681,10116.0,,8268,CHEMBL622562,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14681,10116.0,,8269,CHEMBL622563,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,8270,CHEMBL622564,Concentration of compound in Central nervous system,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,8271,CHEMBL622565,Concentration of compound in Central nervous system; Not detectable,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13318,10090.0,,8272,CHEMBL622566,"Concentration of diester in the blood, following oral administration in mice",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13318,10090.0,,8273,CHEMBL624515,"Concentration of monoester in the blood, following oral administration in mice",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13318,10090.0,,8274,CHEMBL624516,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15692,,,8275,CHEMBL624517,Evaluated for Pharmacokinetic property: Area under the curve,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8276,CHEMBL624518,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8277,CHEMBL624519,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8278,CHEMBL624520,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8279,CHEMBL624521,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8280,CHEMBL624522,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8281,CHEMBL624523,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8282,CHEMBL624409,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8283,CHEMBL624410,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8284,CHEMBL624411,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8285,CHEMBL623531,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8286,CHEMBL623532,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8287,CHEMBL623533,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,8288,CHEMBL623534,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8289,CHEMBL623535,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8290,CHEMBL623536,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8291,CHEMBL623537,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8292,CHEMBL623538,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8293,CHEMBL623539,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8294,CHEMBL623540,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8295,CHEMBL623541,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8296,CHEMBL623542,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8297,CHEMBL623543,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8298,CHEMBL623544,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8299,CHEMBL623545,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,8300,CHEMBL623546,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5408,10116.0,,8301,CHEMBL623547,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6827,10116.0,,8302,CHEMBL623548,High i.v. clearance in Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,Microsomes,,BAO_0000218,Liver,A,,50597,Intermediate,,17538,10116.0,,8303,CHEMBL623549,In vitro clearance in rat liver microsomes,In vitro,1,2107.0
,,Rattus norvegicus,N,1,Microsomes,,BAO_0000218,Liver,A,,50597,Intermediate,,6331,10116.0,,8304,CHEMBL623550,Intrinsic clearance in rat liver microsomes was determined,In vitro,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,Hepatocyte,50597,Intermediate,401.0,5948,10116.0,,8305,CHEMBL875276,Intrinsic clearance in rat hepatocytes was determined,In vitro,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,8306,CHEMBL621872,Plasma Clearance was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6647,10116.0,,8307,CHEMBL621873,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1696,10116.0,,8308,CHEMBL621874,Plasma clearance in rat.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6597,10116.0,,8309,CHEMBL621875,Plasma clearance in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,347,10116.0,,8310,CHEMBL621876,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,8311,CHEMBL621877,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2879,10116.0,,8312,CHEMBL621878,Plasma clearance was measured in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,8313,CHEMBL621879,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5328,10116.0,,8314,CHEMBL621880,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5160,10116.0,,8315,CHEMBL621881,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,8316,CHEMBL621882,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17651,10116.0,,8317,CHEMBL875283,Total clearance at 1 mg/kg was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17651,10116.0,,8318,CHEMBL621883,Total clearance at 10 mg/kg was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6596,10116.0,,8319,CHEMBL621884,Clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4796,10116.0,,8320,CHEMBL621885,Plasma clearance rate determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6850,10116.0,,8321,CHEMBL621886,Clearance of compound in rat was evaluated,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5932,10116.0,,8322,CHEMBL621887,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3371,10116.0,,8323,CHEMBL621888,Pharmacokinetic property (blood clearance) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2083,10116.0,,8324,CHEMBL621889,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4942,10116.0,,8325,CHEMBL621890,Plasma clearance in rats,In vivo,1,
,,Rattus norvegicus,N,1,Microsomes,,BAO_0000218,Liver,A,,50597,Intermediate,,6838,10116.0,,8326,CHEMBL621891,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,In vitro,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5353,10116.0,,8327,CHEMBL621892,Clearance in Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,8328,CHEMBL621893,Clearance rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,8329,CHEMBL621894,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,8330,CHEMBL621895,Clearance rat; Not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,8331,CHEMBL875284,Clearance rate was determined in rat at a dose of 1 mpk i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,8332,CHEMBL618699,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,8333,CHEMBL618700,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6211,10116.0,,8334,CHEMBL618701,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,8335,CHEMBL876600,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,8336,CHEMBL618702,Clearance of compound in rat after 1 mg/kg i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3341,10116.0,,8337,CHEMBL618703,Compound was evaluated for Hepatic clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4891,10116.0,,8338,CHEMBL618704,In vivo clearance after 5 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1094,10116.0,,8339,CHEMBL618705,Compound was tested for plasma clearance in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2938,10116.0,,8340,CHEMBL618706,Hepatic clearance after intravenous administration was evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17853,10116.0,,8341,CHEMBL618707,Lower clearance in rat (i.v.) at 0.5 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6049,10116.0,,8342,CHEMBL618708,Pharmacokinetic parameter expressed as plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5789,10116.0,,8343,CHEMBL618709,Pharmacokinetic property (Clp) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4514,10116.0,,8344,CHEMBL618710,Plasma clearance in Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6448,10116.0,,8345,CHEMBL618711,Plasma clearance (Clp) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6062,10116.0,,8346,CHEMBL618712,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5710,10116.0,,8347,CHEMBL618713,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4709,10116.0,,8348,CHEMBL618714,Plasma clearance after intravenous administration of 1 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4521,10116.0,,8349,CHEMBL618715,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1742,10116.0,,8350,CHEMBL618716,Plasma clearance in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,8351,CHEMBL876601,Plasma clearance measured in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,8352,CHEMBL618717,Plasma clearance was calculated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5145,10116.0,,8353,CHEMBL618718,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5833,10116.0,,8354,CHEMBL618719,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6453,10116.0,,8355,CHEMBL618720,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,8356,CHEMBL618721,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6305,10116.0,,8357,CHEMBL621477,Plasma clearance in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6642,10116.0,,8358,CHEMBL621478,Plasma clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,8359,CHEMBL621479,Plasma clearance was evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,8360,CHEMBL621480,Plasma clearance was evaluated in rat; Not tested,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5144,10116.0,,8361,CHEMBL621481,Plasma clearance rate was determined for the compound in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,8362,CHEMBL621482,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,8363,CHEMBL621483,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,8364,CHEMBL621484,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13950,10116.0,,8365,CHEMBL621485,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13950,10116.0,,8366,CHEMBL621486,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,13950,10116.0,,8367,CHEMBL621487,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,13950,10116.0,,8368,CHEMBL621488,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,13950,10116.0,,8369,CHEMBL621489,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,13950,10116.0,,8370,CHEMBL621490,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,13950,10116.0,,8371,CHEMBL621491,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13950,10116.0,,8372,CHEMBL621492,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13950,10116.0,,8373,CHEMBL621493,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13950,10116.0,,8374,CHEMBL621494,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13950,10116.0,,8375,CHEMBL621495,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13950,10116.0,,8376,CHEMBL621496,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13950,10116.0,,8377,CHEMBL621497,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13950,10116.0,,8378,CHEMBL621498,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13950,10116.0,,8379,CHEMBL621499,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13950,10116.0,,8380,CHEMBL618634,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13950,10116.0,,8381,CHEMBL618635,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13950,10116.0,,8382,CHEMBL618636,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13950,10116.0,,8383,CHEMBL619737,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13950,10116.0,,8384,CHEMBL619738,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13950,10116.0,,8385,CHEMBL624329,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13950,10116.0,,8386,CHEMBL624330,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13950,10116.0,,8387,CHEMBL624331,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13950,10116.0,,8388,CHEMBL624332,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13950,10116.0,,8389,CHEMBL624333,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13950,10116.0,,8390,CHEMBL624334,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13950,10116.0,,8391,CHEMBL624335,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13950,10116.0,,8392,CHEMBL620016,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13950,10116.0,,8393,CHEMBL620169,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13950,10116.0,,8394,CHEMBL620170,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13950,10116.0,,8395,CHEMBL620171,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13950,10116.0,,8396,CHEMBL620172,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,13950,10116.0,,8397,CHEMBL620173,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,13950,10116.0,,8398,CHEMBL620174,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,13950,10116.0,,8399,CHEMBL620175,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,13950,10116.0,,8400,CHEMBL620176,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,13950,10116.0,,8401,CHEMBL620177,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13950,10116.0,,8402,CHEMBL620178,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13950,10116.0,,8403,CHEMBL620179,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13950,10116.0,,8404,CHEMBL620180,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,8405,CHEMBL620181,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6571,10116.0,,8406,CHEMBL620182,Volume of distribution of compound in rats after intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6453,10116.0,,8407,CHEMBL620183,Volume of distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,8408,CHEMBL620184,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,8409,CHEMBL620185,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,8410,CHEMBL620186,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5353,10116.0,,8411,CHEMBL620187,Volume of distribution was determined in Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8412,CHEMBL620188,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8413,CHEMBL620189,Volume of distribution was reported in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,8414,CHEMBL620190,Volumes of distribution in rat after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,8415,CHEMBL620191,Volumes of distribution in rat after po administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,8416,CHEMBL620192,Volumes of distribution in rat after po administration; Not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5676,10116.0,,8417,CHEMBL620193,Pharmacokinetic property (Volume) in rat i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,8418,CHEMBL620194,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17670,10116.0,,8419,CHEMBL876730,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,8420,CHEMBL620195,Volume distribution in rat after oral administration at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5408,10116.0,,8421,CHEMBL620196,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,8422,CHEMBL620197,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6647,10116.0,,8423,CHEMBL620198,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,8424,CHEMBL620199,Volume of distribution in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,8425,CHEMBL620200,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,8426,CHEMBL620201,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8427,CHEMBL620202,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8428,CHEMBL620203,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8429,CHEMBL620204,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8430,CHEMBL620205,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5960,10116.0,,8431,CHEMBL624664,Pharmacokinetic parameter (Vss) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5676,10116.0,,8432,CHEMBL624665,Pharmacokinetic property (Volume) in rat i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5948,10116.0,,8433,CHEMBL624666,Pharmacokinetic property (Vss) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5979,10116.0,,8434,CHEMBL624667,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,8435,CHEMBL624668,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,8436,CHEMBL624669,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,8437,CHEMBL624670,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,8438,CHEMBL624671,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6448,10116.0,,8439,CHEMBL624672,Steady state volume distribution in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,8440,CHEMBL624673,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,8441,CHEMBL624674,Steady state volume of distribution determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,8442,CHEMBL624675,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1466,10116.0,,8443,CHEMBL621728,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,8444,CHEMBL621729,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,8445,CHEMBL621730,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,8446,CHEMBL621731,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,8447,CHEMBL621732,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,8448,CHEMBL621908,Volume in steady state distribution value was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,8449,CHEMBL875347,Volume in steady state distribution value was determined; ND denotes no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,8450,CHEMBL621909,Volume in steady state distribution value was determined; ND denotes not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17065,10116.0,,8451,CHEMBL621910,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6597,10116.0,,8452,CHEMBL621911,Volume of distribution at steady state was evaluated in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,8453,CHEMBL621912,Volume of distribution at steady state was observed after intravenous administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6485,10116.0,,8454,CHEMBL621913,Volume of distribution in steady state was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17655,10116.0,,8455,CHEMBL621914,Volume of distribution in steady state was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6616,10116.0,,8456,CHEMBL621915,Volume of distribution after i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1916,10116.0,,8457,CHEMBL621916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,16438,10090.0,,8458,CHEMBL621917,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,16438,10090.0,,8459,CHEMBL621918,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8460,CHEMBL621919,Biodistribution of compound (oxidized form) in spleen tissue,In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8461,CHEMBL621920,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8462,CHEMBL621921,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8463,CHEMBL622401,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8464,CHEMBL875348,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8465,CHEMBL622402,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,16438,10090.0,,8466,CHEMBL622403,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,16438,10090.0,,8467,CHEMBL622404,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,16438,10090.0,,8468,CHEMBL622405,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,16438,10090.0,,8469,CHEMBL622406,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,16438,10090.0,,8470,CHEMBL622407,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,16438,10090.0,,8471,CHEMBL622408,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,16438,10090.0,,8472,CHEMBL622409,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,16438,10090.0,,8473,CHEMBL622410,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,16438,10090.0,,8474,CHEMBL622411,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,16438,10090.0,,8475,CHEMBL627864,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,16438,10090.0,,8476,CHEMBL627865,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,16438,10090.0,,8477,CHEMBL627866,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,16438,10090.0,,8478,CHEMBL627751,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8479,CHEMBL627752,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8480,CHEMBL627753,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,16438,10090.0,,8481,CHEMBL627754,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12467,10090.0,,8482,CHEMBL627755,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,17208,10090.0,,8483,CHEMBL627756,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,17208,10090.0,,8484,CHEMBL627757,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,17208,10090.0,,8485,CHEMBL627758,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,17208,10090.0,,8486,CHEMBL627759,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,17208,10090.0,,8487,CHEMBL627760,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,17208,10090.0,,8488,CHEMBL627761,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,17208,10090.0,,8489,CHEMBL876811,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,17208,10090.0,,8490,CHEMBL627762,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,17208,10090.0,,8491,CHEMBL627763,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,17208,10090.0,,8492,CHEMBL627764,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,17208,10090.0,,8493,CHEMBL627765,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,17208,10090.0,,8494,CHEMBL627766,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,17208,10090.0,,8495,CHEMBL627767,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,17208,10090.0,,8496,CHEMBL627768,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,17208,10090.0,,8497,CHEMBL628422,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,17208,10090.0,,8498,CHEMBL628423,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5089,10116.0,,8499,CHEMBL628424,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5089,10116.0,,8500,CHEMBL628425,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4257,10116.0,,8501,CHEMBL628426,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6679,10116.0,,8502,CHEMBL628427,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5546,10116.0,,8503,CHEMBL626938,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6141,10116.0,,8504,CHEMBL626939,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8505,CHEMBL626940,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8506,CHEMBL626941,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,8507,CHEMBL626942,Plasma clearance was reported in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,8508,CHEMBL876812,Plasma clearance after intravenous administration (1 mg/kg) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6848,10116.0,,8509,CHEMBL626943,Plasma clearance of compound in rats was evaluated,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6848,10116.0,,8510,CHEMBL626944,Plasma clearance of compound in rats was evaluated; ND indicates not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6467,10116.0,,8511,CHEMBL626945,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6467,10116.0,,8512,CHEMBL626946,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4956,10116.0,,8513,CHEMBL626856,Plasma clearance rate in Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5529,10116.0,,8514,CHEMBL626857,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,406,10116.0,,8515,CHEMBL626858,The compound was evaluated for plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17655,10116.0,,8516,CHEMBL627018,Total plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,3293,10116.0,,8517,CHEMBL625331,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,4075,10116.0,,8518,CHEMBL625332,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,8519,CHEMBL877590,C max was determined at 10 mg/kg po dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,8520,CHEMBL625333,C max was determined at 3 mg/kg po dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17594,10116.0,,8521,CHEMBL625334,Cmax after repeated oral dose of compound at 1 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17594,10116.0,,8522,CHEMBL625335,Cmax after single intravenous bolus of 1 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4762,10116.0,,8523,CHEMBL625336,Cmax of compound at 5 mg/kg after po administration was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,8524,CHEMBL625337,Cmax 24 hr after 10 mg/kg oral administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,8525,CHEMBL625338,Cmax 24 hr after 2 mg/kg oral administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1466,10116.0,,8526,CHEMBL625339,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,8527,CHEMBL625340,Cmax in rat after administration of 2 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,8528,CHEMBL625341,Cmax in rat after administration of 2 mg/kg iv,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,8529,CHEMBL622687,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6515,10116.0,,8530,CHEMBL622688,Cmax wa determined in rat plasma at 30 mg/kg after po administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11149,10116.0,,8531,CHEMBL622689,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11149,10116.0,,8532,CHEMBL620295,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17858,10116.0,,8533,CHEMBL620296,Cmax after 10 mg/kg oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,8534,CHEMBL620297,Cmax after IV dosing at 0.5 mg/kg in rat; no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,8535,CHEMBL620298,Cmax after IV dosing at 1 mg/kg in rat; no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,8536,CHEMBL620299,Cmax after oral administration at 20 mpk in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,8537,CHEMBL620300,Cmax after oral administration at 20 mpk in rats; Not performed.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,8538,CHEMBL620301,Cmax after oral administration at 20 mpk in rats d; Not performed.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,8539,CHEMBL620302,Cmax after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,8540,CHEMBL620303,Cmax after oral administration at a dose of 2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,8541,CHEMBL620304,Cmax after oral administration at a dose of 4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6113,10116.0,,8542,CHEMBL620305,Cmax in rats after 20 mg/kg oral dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,8543,CHEMBL620306,Cmax after peroral administration in rats at 2.4 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,8544,CHEMBL620307,Cmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,8545,CHEMBL620308,Cmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6402,10116.0,,8546,CHEMBL620309,Cmax by administering at 20 mg/kg p.o. in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5610,10116.0,,8547,CHEMBL620310,Cmax in male rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5207,10116.0,,8548,CHEMBL620311,Cmax in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6011,10116.0,,8549,CHEMBL620312,Cmax in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6504,10116.0,,8550,CHEMBL620313,Cmax in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6046,10116.0,,8551,CHEMBL620314,Cmax in rat at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6504,10116.0,,8552,CHEMBL620315,Cmax in rat at the dose of 1 mg/kg i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5874,10116.0,,8553,CHEMBL620316,Cmax in rat by po administration at a dose of 40 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,8554,CHEMBL620317,Cmax in rat p.o. at 20 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5836,10116.0,,8555,CHEMBL620318,Cmax in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17596,10116.0,,8556,CHEMBL620319,Cmax in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,8557,CHEMBL620320,Cmax was evaluated after 20 uM/kg of peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,8558,CHEMBL620321,Cmax was measured in rats after peroral administration at 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1908,10116.0,,8559,CHEMBL620322,Cmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13950,10116.0,,8560,CHEMBL620323,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Frontal cortex,A,,50597,Intermediate,,13950,10116.0,,8561,CHEMBL620324,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,1870.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Frontal cortex,A,,50597,Intermediate,,13950,10116.0,,8562,CHEMBL620325,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,1870.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13950,10116.0,,8563,CHEMBL620326,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13950,10116.0,,8564,CHEMBL620327,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13950,10116.0,,8565,CHEMBL620328,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13950,10116.0,,8566,CHEMBL620329,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Midbrain,A,,50597,Intermediate,,13950,10116.0,,8567,CHEMBL620330,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,1891.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Midbrain,A,,50597,Intermediate,,13950,10116.0,,8568,CHEMBL875286,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,1891.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13950,10116.0,,8569,CHEMBL620331,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13950,10116.0,,8570,CHEMBL620332,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13950,10116.0,,8571,CHEMBL620333,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13950,10116.0,,8572,CHEMBL620334,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8573,CHEMBL621015,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8574,CHEMBL621016,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8575,CHEMBL621191,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8576,CHEMBL621192,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8577,CHEMBL621193,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8578,CHEMBL621194,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8579,CHEMBL624204,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8580,CHEMBL624205,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8581,CHEMBL624206,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8582,CHEMBL624207,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8583,CHEMBL624208,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8584,CHEMBL624209,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8585,CHEMBL624210,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8586,CHEMBL624211,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8587,CHEMBL624212,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8588,CHEMBL624213,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8589,CHEMBL876611,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8590,CHEMBL624214,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16434,10116.0,,8591,CHEMBL624215,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8592,CHEMBL624216,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8593,CHEMBL624217,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8594,CHEMBL624218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8595,CHEMBL624219,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8596,CHEMBL624220,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,16435,10116.0,,8597,CHEMBL624221,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8598,CHEMBL624222,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8599,CHEMBL624223,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8600,CHEMBL624224,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8601,CHEMBL624225,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,8602,CHEMBL622420,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5031,10116.0,,8603,CHEMBL622421,Volume of steady state distribution after i.v. administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6215,10116.0,,8604,CHEMBL622422,Vss after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17671,10116.0,,8605,CHEMBL622423,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17752,10116.0,,8606,CHEMBL622424,Vss was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6596,10116.0,,8607,CHEMBL622425,Vss in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,8608,CHEMBL876612,Vss was evaluated after 10 uM/kg of intra arterial administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,8609,CHEMBL622426,volume of distribution at steady state was observed after intravenous administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6062,10116.0,,8610,CHEMBL622427,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5874,10116.0,,8611,CHEMBL622428,Pharmacokinetic (PK) parameter Vz in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4942,10116.0,,8612,CHEMBL622429,Volume distribution in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,8613,CHEMBL622430,Volume of distribution in rat; No data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4890,10116.0,,8614,CHEMBL622431,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Ileum,A,,50597,Intermediate,,15765,10116.0,,8615,CHEMBL622432,% absorption predicted from in vitro rat ileum transport studies,,1,2116.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8616,CHEMBL622433,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8617,CHEMBL622434,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8618,CHEMBL622435,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8619,CHEMBL618748,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8620,CHEMBL618749,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8621,CHEMBL618750,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8622,CHEMBL618751,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13569,10116.0,,8623,CHEMBL618752,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,8624,CHEMBL618753,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,750,10116.0,,8625,CHEMBL618754,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,750,10116.0,,8626,CHEMBL618755,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4590,10116.0,,8627,CHEMBL618756,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1716,10116.0,,8628,CHEMBL618757,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1974,10116.0,,8629,CHEMBL618758,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4502,10116.0,,8630,CHEMBL621088,Oral bioavailability in rat (dose 30 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3371,10116.0,,8631,CHEMBL621089,Pharmacokinetic property (cLogP) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,F,,50597,Intermediate,,9099,10116.0,,8632,CHEMBL621090,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,F,,50597,Intermediate,,9099,10116.0,,8633,CHEMBL621091,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4590,10116.0,,8634,CHEMBL876731,Clearance in rat.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3184,10116.0,,8635,CHEMBL621092,Compound was evaluated for its clearance when administered intravenously in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16456,10116.0,,8636,CHEMBL621093,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,8637,CHEMBL621094,Blood: Brain distribution ratio is determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,8638,CHEMBL621095,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,8639,CHEMBL621096,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8677,10116.0,,8640,CHEMBL621097,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,8641,CHEMBL621098,Percent dose excreted in 0-48 hours administered ip to male rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,11977,10116.0,,8642,CHEMBL621099,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,11977,10116.0,,8643,CHEMBL621100,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,11977,10116.0,,8644,CHEMBL621101,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,11977,10116.0,,8645,CHEMBL621102,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,11977,10116.0,,8646,CHEMBL876732,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8647,CHEMBL621103,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8648,CHEMBL621104,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8649,CHEMBL621105,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8650,CHEMBL621106,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8651,CHEMBL621107,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8652,CHEMBL621108,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8653,CHEMBL621109,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,17208,10090.0,,8654,CHEMBL621110,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,17208,10090.0,,8655,CHEMBL621111,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,17208,10090.0,,8656,CHEMBL622541,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,17208,10090.0,,8657,CHEMBL622542,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,17208,10090.0,,8658,CHEMBL622543,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,17208,10090.0,,8659,CHEMBL624412,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,17208,10090.0,,8660,CHEMBL624413,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,17208,10090.0,,8661,CHEMBL624414,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,17208,10090.0,,8662,CHEMBL624415,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,17208,10090.0,,8663,CHEMBL624416,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,17208,10090.0,,8664,CHEMBL624417,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,17208,10090.0,,8665,CHEMBL624418,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,17208,10090.0,,8666,CHEMBL624419,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,17208,10090.0,,8667,CHEMBL624420,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,17208,10090.0,,8668,CHEMBL624421,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,17208,10090.0,,8669,CHEMBL624422,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,17208,10090.0,,8670,CHEMBL624423,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,17208,10090.0,,8671,CHEMBL625123,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,17208,10090.0,,8672,CHEMBL625124,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,17208,10090.0,,8673,CHEMBL625125,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,17208,10090.0,,8674,CHEMBL625126,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,17208,10090.0,,8675,CHEMBL626947,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,17208,10090.0,,8676,CHEMBL626948,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,17208,10090.0,,8677,CHEMBL626949,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,17208,10090.0,,8678,CHEMBL626950,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,17208,10090.0,,8679,CHEMBL626951,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,17208,10090.0,,8680,CHEMBL626952,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,17208,10090.0,,8681,CHEMBL626953,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,17208,10090.0,,8682,CHEMBL626954,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,17208,10090.0,,8683,CHEMBL626955,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,17208,10090.0,,8684,CHEMBL626956,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,17208,10090.0,,8685,CHEMBL626957,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,17208,10090.0,,8686,CHEMBL626958,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,17208,10090.0,,8687,CHEMBL626959,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,17208,10090.0,,8688,CHEMBL626960,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,17208,10090.0,,8689,CHEMBL626961,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,17208,10090.0,,8690,CHEMBL627589,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,17208,10090.0,,8691,CHEMBL627590,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,3132,10090.0,,8692,CHEMBL627591,Time taken for EC90 was determined when tested in mouse,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,3132,10090.0,,8693,CHEMBL627592,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,16597,10090.0,,8694,CHEMBL627593,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5727,10090.0,,8695,CHEMBL627594,Half life in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5302,10090.0,,8696,CHEMBL876813,Half life period in mouse after 10 mg/Kg dose,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5302,10090.0,,8697,CHEMBL627595,Half life period in mouse after 10 mg/kg dose,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,6348,10090.0,,8698,CHEMBL627596,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5964,10116.0,,8699,CHEMBL627597,Cmax value at 5 mg/kg po was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,8700,CHEMBL627598,Cmax value evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,5206,10116.0,,8701,CHEMBL627599,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2959,10116.0,,8702,CHEMBL627600,Cmax value after administration of 20 mg/Kg oral dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5964,10116.0,,8703,CHEMBL627601,Cmax value at 1 mg/kg po in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5964,10116.0,,8704,CHEMBL627776,Cmax value at 5 mg/kg po in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,8705,CHEMBL627777,Cmax value at a dose of 10 mg/kg in male SD rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,8706,CHEMBL627778,Cmax value at a dose of 100 mg/kg in male SD rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,8707,CHEMBL627779,Cmax value at a dose of 50 mg/kg in male SD rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17617,10116.0,,8708,CHEMBL876814,Cmax value in rats at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1445,10116.0,,8709,CHEMBL627780,Cmax value was evaluated in rats at a dose of 20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6082,10116.0,,8710,CHEMBL627781,Cmax value was determined after peroral administration of 20 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1446,10116.0,,8711,CHEMBL627782,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5407,10116.0,,8712,CHEMBL627783,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2690,10116.0,,8713,CHEMBL627784,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,8714,CHEMBL627785,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,8715,CHEMBL627786,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4891,10116.0,,8716,CHEMBL627787,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2807,10116.0,,8717,CHEMBL627788,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2807,10116.0,,8718,CHEMBL626579,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2807,10116.0,,8719,CHEMBL626580,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3634,10116.0,,8720,CHEMBL876815,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1881,10116.0,,8721,CHEMBL626581,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1881,10116.0,,8722,CHEMBL626582,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,8723,CHEMBL626583,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8724,CHEMBL626205,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8725,CHEMBL626206,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8726,CHEMBL626207,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,8727,CHEMBL623882,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,8728,CHEMBL623883,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,8729,CHEMBL623884,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3032,10116.0,,8730,CHEMBL623885,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6295,10116.0,,8731,CHEMBL623886,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6619,10116.0,,8732,CHEMBL623887,Maximal concentration in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6616,10116.0,,8733,CHEMBL623888,Maximal concentration after i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3249,10116.0,,8734,CHEMBL623889,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17791,10116.0,,8735,CHEMBL623890,Maximal plasma concentration in rat after oral administration at 50 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17791,10116.0,,8736,CHEMBL623891,Cmax in rat plasma after oral dose (50 mg/Kg),In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1360,10116.0,,8737,CHEMBL623892,Maximal plasma concentration was determined.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2552,10116.0,,8738,CHEMBL623893,Maximal plasma drug concentration was determined,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6571,10116.0,,8739,CHEMBL877616,Maximal concentration in rats after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,8740,CHEMBL623894,Maximum concentration in rat after 2 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6567,10116.0,,8741,CHEMBL623895,Maximum concentration in rat plasma after 5 mg/kg oral gavage,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3031,10116.0,,8742,CHEMBL623896,Maximum concentration of compound in rat was evaluated.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3436,10116.0,,8743,CHEMBL623897,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3436,10116.0,,8744,CHEMBL623898,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2083,10116.0,,8745,CHEMBL623899,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3436,10116.0,,8746,CHEMBL623900,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,8747,CHEMBL623901,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1974,10116.0,,8748,CHEMBL623902,Maximum concentration was evaluated in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebrospinal fluid,A,,50597,Intermediate,,3307,10116.0,,8749,CHEMBL623903,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,1,1359.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3307,10116.0,,8750,CHEMBL623904,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1916,10116.0,,8751,CHEMBL877617,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1500,10116.0,,8752,CHEMBL623905,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1500,10116.0,,8753,CHEMBL623906,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4186,10116.0,,8754,CHEMBL623907,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8755,CHEMBL623908,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8756,CHEMBL623909,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8757,CHEMBL623910,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8758,CHEMBL623911,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8759,CHEMBL623912,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8760,CHEMBL624616,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8761,CHEMBL624617,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8762,CHEMBL624618,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8763,CHEMBL624619,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8764,CHEMBL624794,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8765,CHEMBL624795,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8766,CHEMBL623921,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8767,CHEMBL623922,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8768,CHEMBL623923,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,8769,CHEMBL623924,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8770,CHEMBL623925,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8771,CHEMBL623926,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8772,CHEMBL623927,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8773,CHEMBL623928,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8774,CHEMBL623929,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,8775,CHEMBL623930,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8776,CHEMBL623931,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8777,CHEMBL622165,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8778,CHEMBL621249,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8779,CHEMBL621250,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8780,CHEMBL621448,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8781,CHEMBL621449,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8782,CHEMBL621450,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8783,CHEMBL621451,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8784,CHEMBL621452,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8785,CHEMBL621453,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8786,CHEMBL621454,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8787,CHEMBL621455,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8788,CHEMBL621456,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8789,CHEMBL625145,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8790,CHEMBL875847,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8791,CHEMBL625146,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8792,CHEMBL625147,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8793,CHEMBL625148,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16434,10116.0,,8794,CHEMBL625149,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8795,CHEMBL625150,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8796,CHEMBL625151,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8797,CHEMBL625152,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8798,CHEMBL625153,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8799,CHEMBL625154,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,16435,10116.0,,8800,CHEMBL625155,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8801,CHEMBL625156,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,8802,CHEMBL624354,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,11977,10116.0,,8803,CHEMBL624355,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,11977,10116.0,,8804,CHEMBL624356,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,11977,10116.0,,8805,CHEMBL624357,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,11977,10116.0,,8806,CHEMBL624358,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,11977,10116.0,,8807,CHEMBL624359,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,11977,10116.0,,8808,CHEMBL624360,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,11977,10116.0,,8809,CHEMBL624361,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,11977,10116.0,,8810,CHEMBL624362,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,11977,10116.0,,8811,CHEMBL624363,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11977,10116.0,,8812,CHEMBL624364,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11977,10116.0,,8813,CHEMBL624365,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11977,10116.0,,8814,CHEMBL624366,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11977,10116.0,,8815,CHEMBL624367,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11977,10116.0,,8816,CHEMBL624368,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11977,10116.0,,8817,CHEMBL624369,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11977,10116.0,,8818,CHEMBL624370,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11977,10116.0,,8819,CHEMBL625069,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11977,10116.0,,8820,CHEMBL625070,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11977,10116.0,,8821,CHEMBL626051,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11977,10116.0,,8822,CHEMBL626052,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11977,10116.0,,8823,CHEMBL626053,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11977,10116.0,,8824,CHEMBL626054,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11977,10116.0,,8825,CHEMBL626055,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11977,10116.0,,8826,CHEMBL626056,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11977,10116.0,,8827,CHEMBL626057,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11977,10116.0,,8828,CHEMBL625193,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11977,10116.0,,8829,CHEMBL625194,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11977,10116.0,,8830,CHEMBL625195,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11977,10116.0,,8831,CHEMBL625196,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11977,10116.0,,8832,CHEMBL625197,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11977,10116.0,,8833,CHEMBL625198,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11977,10116.0,,8834,CHEMBL627929,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11977,10116.0,,8835,CHEMBL627074,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11977,10116.0,,8836,CHEMBL627075,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11977,10116.0,,8837,CHEMBL627076,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11977,10116.0,,8838,CHEMBL627077,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11977,10116.0,,8839,CHEMBL627078,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11977,10116.0,,8840,CHEMBL627079,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,4573,10090.0,,8841,CHEMBL873824,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,3132,10090.0,,8842,CHEMBL627080,Half life in mouse plasma was determined at dose 25 mg/kg,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17718,10090.0,,8843,CHEMBL627081,Half life was determined,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17728,10090.0,,8844,CHEMBL627082,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5961,10090.0,,8845,CHEMBL627083,Half-life in male mice after 1 mg/kg intravenous dose,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,17731,10090.0,,8847,CHEMBL627085,Half life in mice plasma,,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17592,10090.0,,8848,CHEMBL627086,Half life in mouse,,1,
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,3132,10090.0,,8849,CHEMBL627087,Half life in mouse plasma at dose 25 mg/kg,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17729,10090.0,,8850,CHEMBL627088,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17729,10090.0,,8851,CHEMBL627089,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17729,10090.0,,8852,CHEMBL627090,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,3277,10090.0,,8853,CHEMBL627091,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,3760,10090.0,,8854,CHEMBL627092,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,3760,10090.0,,8855,CHEMBL876785,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,2862,10090.0,,8856,CHEMBL627093,Half-life by iv administration in mouse,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,2862,10090.0,,8857,CHEMBL627094,Half-life by oral administration in mouse,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5980,10090.0,,8858,CHEMBL627095,Half-life in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,6159,10090.0,,8859,CHEMBL627096,Half-life using mouse brain homogenate,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,6254,10090.0,,8860,CHEMBL627097,Half-life was measured in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,6062,10090.0,,8861,CHEMBL627098,Half-life was measured in mouse after an iv dose of 1 mg/kg,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,1574,10090.0,,8862,CHEMBL627099,Half-life period was determined in mouse blood,,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,56,10090.0,,8863,CHEMBL627100,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,993,10090.0,,8864,CHEMBL627101,Plasma half life in mouse,,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,6652,10090.0,,8865,CHEMBL627102,Stability of the peptide in the presence of mouse serum,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17852,10090.0,,8866,CHEMBL627103,Terminal half life of compound was determined in mouse,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,2675,10090.0,,8867,CHEMBL627104,Terminal half life was evaluated in mice after intravenous administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,2675,10090.0,,8868,CHEMBL627105,Terminal half life was evaluated in mice after oral administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,499,10090.0,,8869,CHEMBL876786,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,499,10090.0,,8870,CHEMBL873825,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,499,10090.0,,8871,CHEMBL627106,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14239,10090.0,,8872,CHEMBL626336,half life period is evaluated by administering intravenously at 25 mg/kg in mice,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5506,10090.0,,8873,CHEMBL877462,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,5506,10090.0,,8874,CHEMBL626337,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17734,10090.0,,8875,CHEMBL626338,Half life after intraperitoneal administration of 100 mg/kg in mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17728,10090.0,,8876,CHEMBL626339,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17728,10090.0,,8877,CHEMBL626340,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17728,10090.0,,8878,CHEMBL625377,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17728,10090.0,,8879,CHEMBL625378,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,17728,10090.0,,8880,CHEMBL625379,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,In vivo,1,
,,Sus scrofa,U,1,Microsomes,,BAO_0000251,,A,,22224,Autocuration,,14294,9823.0,,8881,CHEMBL625380,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,0,
,,Sus scrofa,U,1,Microsomes,,BAO_0000251,,A,,22224,Autocuration,,14294,9823.0,,8882,CHEMBL625381,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,0,
,,Sus scrofa,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6056,9823.0,,8883,CHEMBL625382,Stability to porcine renal DHP-I,,0,
,,Sus scrofa,U,1,,,BAO_0000218,,A,,22224,Autocuration,,1317,9823.0,,8884,CHEMBL873828,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,In vivo,0,
,,Sus scrofa,U,1,,,BAO_0000218,,A,,22224,Autocuration,,1317,9823.0,,8885,CHEMBL625383,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,In vivo,0,
,,Sus scrofa,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5229,9823.0,,8886,CHEMBL625384,Half-life of the parent prodrug in porcine esterase solution,,0,
,,Sus scrofa,U,1,,,BAO_0000019,,A,,22224,Autocuration,,4231,9823.0,,8887,CHEMBL625385,"First order rate constant, k was determined in in pig liver Esterase",,0,
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,4231,9823.0,,8888,CHEMBL625386,Half life of the in pig liver Esterase,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,5318,9823.0,,8889,CHEMBL623571,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,5318,9823.0,,8890,CHEMBL623572,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,5318,9823.0,,8891,CHEMBL623573,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,3305,9823.0,,8892,CHEMBL623574,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,3305,9823.0,,8893,CHEMBL623575,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,2842,9823.0,,8894,CHEMBL623749,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,2842,9823.0,,8895,CHEMBL623750,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,889,9823.0,,8896,CHEMBL623751,Half-life in vitro in pig liver,In vitro,0,2107.0
,,Sus scrofa,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,1904,9823.0,,8897,CHEMBL623752,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,0,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4186,10116.0,,8898,CHEMBL623753,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2774,10116.0,,8899,CHEMBL623754,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1742,10116.0,,8900,CHEMBL623755,Maximum concentration in rat plasma was determined,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,8901,CHEMBL623756,Maximum concentration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,8902,CHEMBL623757,Maximum concentration in rats at 1-2 hours,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2081,10116.0,,8903,CHEMBL623758,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,3307,10116.0,,8904,CHEMBL623759,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,8905,CHEMBL623760,Maximum concentration at the dose of 2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6597,10116.0,,8906,CHEMBL623761,Maximum concentration was evaluated in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16365,10116.0,,8907,CHEMBL623762,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16365,10116.0,,8908,CHEMBL877594,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16365,10116.0,,8909,CHEMBL623763,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16365,10116.0,,8910,CHEMBL623764,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16365,10116.0,,8911,CHEMBL623765,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,2591,10116.0,,8912,CHEMBL623766,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,2591,10116.0,,8913,CHEMBL623767,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,2591,10116.0,,8914,CHEMBL623768,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8915,CHEMBL623769,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8916,CHEMBL623770,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8917,CHEMBL623771,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8918,CHEMBL623772,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8919,CHEMBL623773,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8920,CHEMBL623774,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5978,10116.0,,8921,CHEMBL623775,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14465,10116.0,,8922,CHEMBL623776,Cmax in rat (PO dose),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4723,10116.0,,8923,CHEMBL622191,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4723,10116.0,,8924,CHEMBL622192,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4576,10116.0,,8925,CHEMBL622193,Maximum plasma concentration determined in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,8926,CHEMBL622194,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,8927,CHEMBL622195,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6824,10116.0,,8928,CHEMBL622196,Maximum plasma concentration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17065,10116.0,,8929,CHEMBL622197,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2932,10116.0,,8930,CHEMBL622198,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2932,10116.0,,8931,CHEMBL622199,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2879,10116.0,,8932,CHEMBL622200,Maximum plasma concentration of compound was measured in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2864,10116.0,,8933,CHEMBL622201,Maximum plasma concentration after 20 mg/kg oral administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16367,10116.0,,8934,CHEMBL623990,Maximum plasma concentration after oral administration to rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17717,10116.0,,8935,CHEMBL623991,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17717,10116.0,,8936,CHEMBL623992,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17717,10116.0,,8937,CHEMBL623993,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17717,10116.0,,8938,CHEMBL623994,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,F,,50597,Intermediate,,17720,10116.0,,8939,CHEMBL623995,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,F,,50597,Intermediate,,17720,10116.0,,8940,CHEMBL623996,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,F,,50597,Intermediate,,17720,10116.0,,8941,CHEMBL623997,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4516,10116.0,,8942,CHEMBL623998,Maximum plasma concentration dosed orally in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4516,10116.0,,8943,CHEMBL623999,Maximum plasma concentration dosed orally in rats after 6 hours,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4516,10116.0,,8944,CHEMBL624000,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5199,10116.0,,8945,CHEMBL624001,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17538,10116.0,,8946,CHEMBL624002,Maximum plasma concentration in rat after po administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6685,10116.0,,8947,CHEMBL624003,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6685,10116.0,,8948,CHEMBL624004,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8949,CHEMBL624005,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8950,CHEMBL624006,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8951,CHEMBL624007,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8952,CHEMBL624008,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8953,CHEMBL624009,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8954,CHEMBL874387,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8955,CHEMBL624010,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8956,CHEMBL624011,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8957,CHEMBL624012,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8958,CHEMBL624013,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8959,CHEMBL624736,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8960,CHEMBL624737,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8961,CHEMBL624738,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8962,CHEMBL624739,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16434,10116.0,,8963,CHEMBL624740,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8964,CHEMBL624896,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8965,CHEMBL624897,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8966,CHEMBL624108,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8967,CHEMBL624109,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8968,CHEMBL624110,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8969,CHEMBL624111,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8970,CHEMBL624112,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8971,CHEMBL624113,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8972,CHEMBL619709,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,16435,10116.0,,8973,CHEMBL619710,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8974,CHEMBL619711,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8975,CHEMBL619712,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8976,CHEMBL619713,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8977,CHEMBL619714,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8978,CHEMBL619715,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8979,CHEMBL619716,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8980,CHEMBL619717,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8981,CHEMBL619718,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8982,CHEMBL619719,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8983,CHEMBL875329,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8984,CHEMBL619720,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8985,CHEMBL619721,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8986,CHEMBL619722,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8987,CHEMBL619723,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8988,CHEMBL619724,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8989,CHEMBL619725,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8990,CHEMBL619726,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8991,CHEMBL619727,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16434,10116.0,,8992,CHEMBL619728,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,8993,CHEMBL619729,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11977,10116.0,,8994,CHEMBL619730,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11977,10116.0,,8995,CHEMBL619731,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11977,10116.0,,8996,CHEMBL619732,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11977,10116.0,,8997,CHEMBL619733,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11977,10116.0,,8998,CHEMBL619734,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11977,10116.0,,8999,CHEMBL619735,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11977,10116.0,,9000,CHEMBL875330,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11977,10116.0,,9001,CHEMBL628465,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11977,10116.0,,9002,CHEMBL628466,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11977,10116.0,,9003,CHEMBL628467,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11977,10116.0,,9004,CHEMBL628468,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11977,10116.0,,9005,CHEMBL628469,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11977,10116.0,,9006,CHEMBL628470,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11977,10116.0,,9007,CHEMBL628471,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11977,10116.0,,9008,CHEMBL628472,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11977,10116.0,,9009,CHEMBL625191,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11977,10116.0,,9010,CHEMBL625192,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11977,10116.0,,9011,CHEMBL875337,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11977,10116.0,,9012,CHEMBL626341,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11977,10116.0,,9013,CHEMBL626342,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11977,10116.0,,9014,CHEMBL621943,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3748,10116.0,,9015,CHEMBL621944,Half life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,9016,CHEMBL621945,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4871,10116.0,,9017,CHEMBL621946,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4871,10116.0,,9018,CHEMBL621947,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4872,10116.0,,9019,CHEMBL621948,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4872,10116.0,,9020,CHEMBL621949,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5413,10116.0,,9021,CHEMBL621950,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5413,10116.0,,9022,CHEMBL621951,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,15272,10116.0,,9023,CHEMBL621952,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,4689,10116.0,,9024,CHEMBL621953,Stability (%) in rat liver microsomes,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,9025,CHEMBL621954,Area under curve was calculated after intravenous administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,9026,CHEMBL621955,Area under the curve was calculated after iv administration in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,9027,CHEMBL621956,Area under the curve was calculated in rat after peroral administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6211,10116.0,,9028,CHEMBL621957,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5710,10116.0,,9029,CHEMBL621958,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5710,10116.0,,9030,CHEMBL621959,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17853,10116.0,,9031,CHEMBL621960,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17853,10116.0,,9032,CHEMBL621961,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,9033,CHEMBL621962,p value of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,15765,10116.0,,9034,CHEMBL876787,p value of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,9035,CHEMBL621963,p value of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9036,CHEMBL622637,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9037,CHEMBL622638,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9038,CHEMBL626561,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000019,,F,,22224,Autocuration,,7991,9986.0,,9039,CHEMBL626562,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,429,9986.0,,9040,CHEMBL626563,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,429,9986.0,,9041,CHEMBL626564,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6253,9986.0,,9042,CHEMBL626565,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6253,9986.0,,9043,CHEMBL626566,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3615,9986.0,,9044,CHEMBL626567,Clearance rate in rabbits,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4059,9986.0,,9045,CHEMBL626568,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5124,9986.0,,9046,CHEMBL626569,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5124,9986.0,,9047,CHEMBL626570,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5124,9986.0,,9048,CHEMBL626571,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,429,9986.0,,9049,CHEMBL626572,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,4059,9986.0,,9050,CHEMBL626573,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,0,1969.0
,,Oryctolagus cuniculus,U,1,Microsomes,,BAO_0000251,Liver,A,,22224,Autocuration,,9659,9986.0,,9051,CHEMBL626574,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,0,2107.0
,,Oryctolagus cuniculus,U,1,Microsomes,,BAO_0000251,Liver,A,,22224,Autocuration,,9659,9986.0,,9052,CHEMBL626575,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,0,2107.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3639,9986.0,,9053,CHEMBL626576,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3639,9986.0,,9054,CHEMBL626577,Dose at which bioavailability of perorally administered compound was tested in rabbit,,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3639,9986.0,,9055,CHEMBL626578,The compound was tested for its bioavailability in rabbit (by oral dosage).,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5124,9986.0,,9056,CHEMBL625263,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5124,9986.0,,9057,CHEMBL625264,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5124,9986.0,,9058,CHEMBL625265,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,Microsomes,,BAO_0000251,,A,,22224,Autocuration,,14294,9986.0,,9059,CHEMBL625266,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,0,
,,Oryctolagus cuniculus,U,1,Microsomes,,BAO_0000251,,A,,22224,Autocuration,,14294,9986.0,,9060,CHEMBL876796,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,429,9986.0,,9061,CHEMBL625267,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,5124,9986.0,,9062,CHEMBL625268,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,0,1969.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,5124,9986.0,,9063,CHEMBL625269,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,0,1969.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,5124,9986.0,,9064,CHEMBL624689,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,0,1969.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,429,9986.0,,9065,CHEMBL624690,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,429,9986.0,,9066,CHEMBL624691,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,0,1088.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,429,9986.0,,9067,CHEMBL624692,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,0,1088.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4059,9986.0,,9068,CHEMBL624693,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4137,9986.0,,9069,CHEMBL624694,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,In vivo,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000221,,A,,22224,Autocuration,,11672,9986.0,,9070,CHEMBL877596,In vitro Biological half-life in crude homogenate of rabbit renal cortex,In vitro,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12886,9986.0,,9071,CHEMBL624695,Time within which only 10% of the drug was degraded,,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000221,Liver,A,,22224,Autocuration,,3853,9986.0,,9072,CHEMBL624696,Half life period in rabbit liver homogenate,,0,2107.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3615,9986.0,,9073,CHEMBL624697,Half life value in rabbits,,0,
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,6253,9986.0,,9074,CHEMBL624698,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,0,178.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,6253,9986.0,,9075,CHEMBL624699,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,0,178.0
,,Oryctolagus cuniculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6077,9986.0,,9076,CHEMBL624700,Half-life period in rabbits following intravenous administration at 2 mg/kg,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17617,10116.0,,9077,CHEMBL622903,AUC 0-8 hr value in rats at 10 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17594,10116.0,,9078,CHEMBL622904,AUC after administration at 2000 mg/kg/day in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6149,10116.0,,9079,CHEMBL622905,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17260,10116.0,,9080,CHEMBL622906,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17260,10116.0,,9081,CHEMBL622907,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6644,10116.0,,9082,CHEMBL622908,AUC in rat after oral administration at 10.5 mg/kg dose,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6644,10116.0,,9083,CHEMBL622909,AUC in rat after oral administration at 11.2 mg/kg dose,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6644,10116.0,,9084,CHEMBL622910,AUC in rat after oral administration at 9.7 mg/kg dose,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,6495,10116.0,,9085,CHEMBL622911,AUC in rat brain after oral administration at 10 mg/kg,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6504,10116.0,,9086,CHEMBL622912,AUC in rat p.o.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17686,10116.0,,9087,CHEMBL622913,AUC in rat p.o. at 20 mg/kg concentration,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6495,10116.0,,9088,CHEMBL622914,AUC in rat plasma after oral administration at 10 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,216,10116.0,,9089,CHEMBL622915,AUC in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1908,10116.0,,9090,CHEMBL622916,AUC value after IV dose at a dose of 5 mg/kg in rats.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1908,10116.0,,9091,CHEMBL622917,AUC value after oral dose at a dose of 10 mg/kg in rats.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6685,10116.0,,9092,CHEMBL622918,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,216,10116.0,,9093,CHEMBL622919,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6049,10116.0,,9094,CHEMBL622920,Maximum plasma concentration was evaluated in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2463,10116.0,,9095,CHEMBL622921,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6679,10116.0,,9096,CHEMBL622922,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6681,10116.0,,9097,CHEMBL622923,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4890,10116.0,,9098,CHEMBL877604,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6410,10116.0,,9099,CHEMBL622924,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6410,10116.0,,9100,CHEMBL622925,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16366,10116.0,,9101,CHEMBL622926,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6227,10116.0,,9102,CHEMBL623625,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Expert,,3598,10116.0,,9103,CHEMBL623626,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1465,10116.0,,9104,CHEMBL623627,Maximum plasma drug concentration was determined,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4368,10116.0,,9105,CHEMBL623628,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,9106,CHEMBL623629,Mean peak plasma concentration was observed after intravenous administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,9107,CHEMBL623630,Mean peak plasma concentration was observed after oral administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9108,CHEMBL623804,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9109,CHEMBL623805,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1567,10116.0,,9110,CHEMBL623806,Peak oral plasma concentration was determined in rats by oral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4026,10116.0,,9111,CHEMBL623807,Peak plasma concentration (Cmax) was determined,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6193,10116.0,,9112,CHEMBL623808,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4026,10116.0,,9113,CHEMBL623809,Peak plasma concentration (Cmax) in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6485,10116.0,,9114,CHEMBL623810,Peak plasma concentration at 1 mg/kg peroral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17655,10116.0,,9115,CHEMBL623811,Peak plasma concentration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14941,10116.0,,9116,CHEMBL623812,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5394,10116.0,,9117,CHEMBL877605,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4408,10116.0,,9118,CHEMBL623813,Pharmacokinetic property (Cmax) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5983,10116.0,,9119,CHEMBL623814,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4878,10116.0,,9120,CHEMBL623815,Cmax in rat after 3mg/kg oral dose,In vivo,1,
Sprague-Dawley,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5862,10116.0,,9121,CHEMBL623816,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4517,10116.0,,9122,CHEMBL623145,Cmax in rats after 20 mg/kg oral dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5932,10116.0,,9123,CHEMBL623146,Cmax in rat plasma after 30mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5436,10116.0,,9124,CHEMBL623147,Plasma concentration after oral administration of 100 mg/kg to rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,4910,10116.0,,9125,CHEMBL623042,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4950,10116.0,,9126,CHEMBL623043,Tested for the Cmax in rat at 10 mg/kg per orally,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9127,CHEMBL623044,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9128,CHEMBL623045,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3360,10116.0,,9129,CHEMBL623046,Bioavailability as oral Cmax in rats at 30 mins,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3360,10116.0,,9130,CHEMBL623226,Bioavailability as oral Cmax in rats at 6hr,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,9131,CHEMBL623227,The maximum concentration of compound was measured at the dose of 100 umol/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,9132,CHEMBL623228,The maximum concentration of compound was measured at the dose of 300 umol/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,9133,CHEMBL623229,The maximum concentration of compound was measured at the dose of 30 umol/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5160,10116.0,,9134,CHEMBL623230,The maximum plasma levels for the compounds were determined by LC-MS.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,9135,CHEMBL623231,mean peak plasma concentration was observed after intravenous administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15662,10116.0,,9136,CHEMBL623232,mean peak plasma concentration was observed after oral administration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4709,10116.0,,9137,CHEMBL623233,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3535,10116.0,,9138,CHEMBL623234,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3535,10116.0,,9139,CHEMBL623235,Concentration in plasma (portal) following oral dose in rats at 1 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3535,10116.0,,9140,CHEMBL623236,Concentration in plasma (portal) following oral dose in rats at 2 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3535,10116.0,,9141,CHEMBL623237,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3535,10116.0,,9142,CHEMBL623238,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3535,10116.0,,9143,CHEMBL623239,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,Plasma,A,,22224,Intermediate,,5005,10116.0,,9144,CHEMBL623240,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,6326,10116.0,,9145,CHEMBL623241,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,6326,10116.0,,9146,CHEMBL623242,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6326,10116.0,,9147,CHEMBL874394,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6326,10116.0,,9148,CHEMBL623243,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9149,CHEMBL623244,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,9150,CHEMBL623245,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,9151,CHEMBL623246,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,9152,CHEMBL623247,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,9153,CHEMBL623248,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,16435,10116.0,,9154,CHEMBL623249,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9155,CHEMBL625072,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9156,CHEMBL625073,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9157,CHEMBL625074,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9158,CHEMBL625075,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9159,CHEMBL625076,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9160,CHEMBL625077,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9161,CHEMBL625078,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9162,CHEMBL874395,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9163,CHEMBL625079,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9164,CHEMBL625080,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9165,CHEMBL625081,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9166,CHEMBL625082,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9167,CHEMBL625083,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9168,CHEMBL625084,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9169,CHEMBL625085,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9170,CHEMBL625086,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9171,CHEMBL625087,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9172,CHEMBL625088,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16434,10116.0,,9173,CHEMBL622205,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9174,CHEMBL622206,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9175,CHEMBL622207,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9176,CHEMBL622366,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9177,CHEMBL622367,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9178,CHEMBL875331,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,16435,10116.0,,9179,CHEMBL622368,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9180,CHEMBL622369,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9181,CHEMBL622370,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9182,CHEMBL622371,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9183,CHEMBL622372,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9184,CHEMBL622373,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9185,CHEMBL622374,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9186,CHEMBL622375,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9187,CHEMBL622376,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9188,CHEMBL622377,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9189,CHEMBL622378,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9190,CHEMBL622379,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9191,CHEMBL622380,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9192,CHEMBL622381,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9193,CHEMBL622382,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9194,CHEMBL622383,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9195,CHEMBL875332,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9196,CHEMBL622384,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9197,CHEMBL622385,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,6175,10116.0,,9198,CHEMBL622386,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10839,10116.0,,9199,CHEMBL622387,The compound was tested for the plasma binding in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16459,10116.0,,9200,CHEMBL622388,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16459,10116.0,,9201,CHEMBL622389,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16459,10116.0,,9202,CHEMBL622390,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16459,10116.0,,9203,CHEMBL622391,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16459,10116.0,,9204,CHEMBL622392,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16459,10116.0,,9205,CHEMBL622393,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3278,10116.0,,9206,CHEMBL622394,Plasma level at 2 hr after administration of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3278,10116.0,,9207,CHEMBL622395,plasma level at 2 hr after administration of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9208,CHEMBL622396,Stability in rat serum measured as % recovery at 1 min,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9209,CHEMBL624894,Stability in rat serum measured as % recovery at 10 min,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9210,CHEMBL624895,Stability in rat serum measured as % recovery at 10 mins,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9211,CHEMBL624058,Stability in rat serum measured as % recovery at 2 hr,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9212,CHEMBL624059,Stability in rat serum measured as % recovery at 3 min,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9213,CHEMBL624060,Stability in rat serum measured as % recovery at 3 mins,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9214,CHEMBL624061,Stability in rat serum measured as % recovery at 5 min,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,4684,10116.0,,9215,CHEMBL624062,Stability in rat serum measured as % recovery at 5 mins,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16456,10116.0,,9216,CHEMBL624063,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16456,10116.0,,9217,CHEMBL624064,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,723,10116.0,,9218,CHEMBL624065,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,723,10116.0,,9219,CHEMBL624066,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5160,10116.0,,9220,CHEMBL877490,Half life tested in mature male rat at a dose of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4709,10116.0,,9221,CHEMBL874442,Half life after intravenous administration of 1 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5633,10116.0,,9222,CHEMBL626890,Half life period after administration (30 mg/kg) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5302,10116.0,,9223,CHEMBL626891,Half life period in rat after 5 mg/Kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5302,10116.0,,9224,CHEMBL626892,Half life period in rat after 5 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9225,CHEMBL626893,Half life period was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9226,CHEMBL626894,Half life period was evaluated in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9227,CHEMBL626895,Half life period was evaluated in rat; 0.5-1.0,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9228,CHEMBL626896,Half life period was evaluated in rat; 5.9-7.5,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14512,10116.0,,9229,CHEMBL626897,Half-life in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6230,10116.0,,9230,CHEMBL626898,Half-life time in rat was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3364,10116.0,,9231,CHEMBL626899,Terminal half-life after iv administration to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6874,10116.0,,9232,CHEMBL626900,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,857,10116.0,,9233,CHEMBL626901,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,858,10116.0,,9234,CHEMBL626902,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,858,10116.0,,9235,CHEMBL626903,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9236,CHEMBL874443,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9237,CHEMBL626904,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6305,10116.0,,9238,CHEMBL626905,Half life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13501,10116.0,,9239,CHEMBL873830,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17594,10116.0,,9240,CHEMBL626906,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4186,10116.0,,9241,CHEMBL631076,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2932,10116.0,,9242,CHEMBL631077,Biological half-life was measured in plasma of rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17065,10116.0,,9243,CHEMBL631078,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,9244,CHEMBL631079,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2713,10116.0,,9245,CHEMBL631080,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,9246,CHEMBL631081,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,9247,CHEMBL631239,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,740,10116.0,,9248,CHEMBL631240,Compound was evaluated for plasma half life in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6597,10116.0,,9249,CHEMBL631241,AUC value at a dose of 5 mg/kg (p.o.) in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2959,10116.0,,9250,CHEMBL631242,AUC value after administration of 20 mg/Kg oral dose in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17594,10116.0,,9251,CHEMBL631243,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17596,10116.0,,9252,CHEMBL874444,AUC0-96 after administration at 50 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17594,10116.0,,9253,CHEMBL631244,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3293,10116.0,,9254,CHEMBL631245,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,9255,CHEMBL627162,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,9256,CHEMBL627163,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6757,10116.0,,9257,CHEMBL627164,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,5979,10116.0,,9258,CHEMBL627165,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5979,10116.0,,9259,CHEMBL627166,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5979,10116.0,,9260,CHEMBL627167,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,9261,CHEMBL627822,Area under curve (AUC) at a dose of 30 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9262,CHEMBL627823,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9263,CHEMBL627824,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5355,10116.0,,9264,CHEMBL627825,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5633,10116.0,,9265,CHEMBL627826,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1716,10116.0,,9266,CHEMBL627827,Area under curve (Pharmacokinetic property) was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1716,10116.0,,9267,CHEMBL627828,Area under curve (Pharmacokinetic property) of the compound; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,9268,CHEMBL627829,Area under curve after intravenous administration (1 mg/kg) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,9269,CHEMBL627830,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,9270,CHEMBL627831,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,9271,CHEMBL627832,Area under curve in male SD rats was observed after oral administration in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4413,10116.0,,9272,CHEMBL627833,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,9273,CHEMBL627834,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,9274,CHEMBL628004,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5964,10116.0,,9275,CHEMBL628005,Area under curve at 5 mg/kg po was determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,9276,CHEMBL628006,Area under curve in Rat at a oral dose of 5 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4186,10116.0,,9277,CHEMBL628007,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,9278,CHEMBL625676,Area under curve was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17858,10116.0,,9279,CHEMBL631309,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,9280,CHEMBL631310,Area under curve after intravenous administration at 3 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6106,10116.0,,9281,CHEMBL631311,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5964,10116.0,,9282,CHEMBL631312,Area under curve at 4 hr in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,9283,CHEMBL631313,Area under curve at a dose of 30 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,9284,CHEMBL631314,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,9285,CHEMBL631315,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5862,10116.0,,9286,CHEMBL631316,Area under curve for a 2-mpk po dose in SD rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5862,10116.0,,9287,CHEMBL631317,Area under curve in SD rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,9288,CHEMBL874471,Area under curve in rat after oral administration at 13 mg/kg dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5871,10116.0,,9289,CHEMBL631318,Area under curve in rat by po administration at 0-24 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5919,10116.0,,9290,CHEMBL631319,Area under curve in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,9291,CHEMBL631320,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,9292,CHEMBL631321,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10,10116.0,,9293,CHEMBL631322,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11149,10116.0,,9294,CHEMBL631323,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5302,10116.0,,9295,CHEMBL631324,Area under curve value in rat at a dose of 5 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,9296,CHEMBL631325,Area under curve was determined after oral administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4890,10116.0,,9297,CHEMBL631326,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6011,10116.0,,9298,CHEMBL631327,Area under curve was determined after peroral administration in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5375,10116.0,,9299,CHEMBL631328,Area under curve was determined at a dose 30 mpk administered orally.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,9300,CHEMBL631329,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4368,10116.0,,9301,CHEMBL627217,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5610,10116.0,,9302,CHEMBL626352,Area under curve was determined in male rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5833,10116.0,,9303,CHEMBL626353,Area under curve was determined in rat after PO administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4257,10116.0,,9304,CHEMBL626354,Area under curve was determined in rat after a 3 mg/kg of oral dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5937,10116.0,,9305,CHEMBL626355,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5932,10116.0,,9306,CHEMBL626356,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5932,10116.0,,9307,CHEMBL626357,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9308,CHEMBL626358,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9309,CHEMBL626359,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17771,10116.0,,9310,CHEMBL626360,Peak plasma concentration in rat at a dose of 3 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1628,10116.0,,9311,CHEMBL626361,Plasma concentration at 2 hr in rats was evaluated.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1628,10116.0,,9312,CHEMBL626362,Plasma concentration at 2 hr in rats was evaluated; Not available,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9313,CHEMBL626363,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,9314,CHEMBL626970,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,9315,CHEMBL626971,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4910,10116.0,,9316,CHEMBL626972,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4910,10116.0,,9317,CHEMBL626973,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4910,10116.0,,9318,CHEMBL626974,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4910,10116.0,,9319,CHEMBL874592,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,9320,CHEMBL626975,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,9321,CHEMBL626976,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,9322,CHEMBL626977,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,9323,CHEMBL626978,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16427,10116.0,,9324,CHEMBL626979,PK study was carried to determine the relative absorption ranking in rat.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4689,10116.0,,9325,CHEMBL626980,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11450,10116.0,,9326,CHEMBL626981,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11450,10116.0,,9327,CHEMBL626982,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11450,10116.0,,9328,CHEMBL626983,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11450,10116.0,,9329,CHEMBL622522,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11450,10116.0,,9330,CHEMBL622523,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11450,10116.0,,9331,CHEMBL622524,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11450,10116.0,,9332,CHEMBL622525,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11450,10116.0,,9333,CHEMBL622526,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11450,10116.0,,9334,CHEMBL619849,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11450,10116.0,,9335,CHEMBL619850,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11450,10116.0,,9336,CHEMBL623864,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11450,10116.0,,9337,CHEMBL623865,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11450,10116.0,,9338,CHEMBL623866,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11450,10116.0,,9339,CHEMBL623867,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11450,10116.0,,9340,CHEMBL877615,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11450,10116.0,,9341,CHEMBL623868,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11450,10116.0,,9342,CHEMBL623869,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11450,10116.0,,9343,CHEMBL623870,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9344,CHEMBL623871,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16434,10116.0,,9345,CHEMBL623872,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9346,CHEMBL622129,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9347,CHEMBL622130,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9348,CHEMBL622131,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9349,CHEMBL622132,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9350,CHEMBL622133,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9351,CHEMBL622134,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9352,CHEMBL622135,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,16435,10116.0,,9353,CHEMBL622136,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9354,CHEMBL622137,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9355,CHEMBL622138,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9356,CHEMBL623017,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9357,CHEMBL623018,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9358,CHEMBL623019,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9359,CHEMBL623020,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9360,CHEMBL623021,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9361,CHEMBL623022,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9362,CHEMBL623023,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9363,CHEMBL623024,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9364,CHEMBL623025,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9365,CHEMBL620545,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9366,CHEMBL620546,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9367,CHEMBL620547,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9368,CHEMBL620548,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9369,CHEMBL620549,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9370,CHEMBL620550,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9371,CHEMBL620551,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16434,10116.0,,9372,CHEMBL620552,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9373,CHEMBL620553,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9374,CHEMBL620554,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9375,CHEMBL875845,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9376,CHEMBL620555,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9377,CHEMBL620556,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,16435,10116.0,,9378,CHEMBL620557,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9379,CHEMBL620558,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9380,CHEMBL620559,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9381,CHEMBL622939,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9382,CHEMBL622940,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9383,CHEMBL622941,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9384,CHEMBL622942,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9385,CHEMBL622943,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9386,CHEMBL622944,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9387,CHEMBL622945,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9388,CHEMBL622946,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3341,10116.0,,9389,CHEMBL622947,Compound was evaluated for terminal half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3634,10116.0,,9390,CHEMBL622948,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3634,10116.0,,9391,CHEMBL622949,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4839,10116.0,,9392,CHEMBL622950,Compound was tested for its half life in rat,,1,
,,Macaca mulatta,U,1,,,BAO_0000218,Plasma,A,,22224,Intermediate,,5005,9544.0,,9393,CHEMBL622951,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,In vivo,0,1969.0
,,Rattus norvegicus,U,1,,,BAO_0000366,Plasma,A,,22224,Intermediate,,5005,10116.0,,9394,CHEMBL622952,Compound was tested for its plasma half life in Sprague Dawley rats,,0,1969.0
,,Rattus norvegicus,U,1,,,BAO_0000366,Plasma,A,,22224,Intermediate,,5005,10116.0,,9395,CHEMBL622953,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1094,10116.0,,9396,CHEMBL873818,Compound was tested for plasma half-life period in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5031,10116.0,,9397,CHEMBL622954,Elimination half life after i.v. administration of compound in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,9398,CHEMBL622955,Elimination half-life after IV dosing at 0.5 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,9399,CHEMBL875229,Elimination half-life after IV dosing at 1 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,9400,CHEMBL622956,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,9401,CHEMBL622957,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,5408,10116.0,,9402,CHEMBL622958,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5408,10116.0,,9403,CHEMBL622959,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,5408,10116.0,,9404,CHEMBL622960,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5408,10116.0,,9405,CHEMBL622961,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4687,10116.0,,9406,CHEMBL622962,Evaluated for the half life in rat (in vivo),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,9407,CHEMBL622963,Hafl life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,9408,CHEMBL622964,Hafl life rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,9409,CHEMBL622965,Hafl life rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,9410,CHEMBL622966,Hafl life rat; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,9411,CHEMBL622967,Hafl life rat; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,17411,10116.0,,9412,CHEMBL622968,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,17411,10116.0,,9413,CHEMBL622969,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,17411,10116.0,,9414,CHEMBL875327,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,9415,CHEMBL628638,Half life in rat after 1 mg/kg i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,9416,CHEMBL628639,Half life in rat after 2 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9417,CHEMBL625840,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4722,10116.0,,9418,CHEMBL625841,Half life of 10 mg/kg oral dose determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9419,CHEMBL625842,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9420,CHEMBL625843,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9421,CHEMBL625844,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9422,CHEMBL873822,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9423,CHEMBL625845,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9424,CHEMBL627059,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9425,CHEMBL627060,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,9426,CHEMBL627061,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4762,10116.0,,9427,CHEMBL627709,Half life of compound at 5 mg/kg after po administration was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5327,10116.0,,9428,CHEMBL627710,Half life of compound determined after intravenous administration to rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4847,10116.0,,9429,CHEMBL627711,Half life of compound was determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17720,10116.0,,9430,CHEMBL627712,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9431,CHEMBL627713,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9432,CHEMBL627714,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,1,
,,Macaca fascicularis,U,1,,,BAO_0000218,,A,,22224,Intermediate,,4256,9541.0,,9433,CHEMBL627889,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,4256,10116.0,,9434,CHEMBL627890,Half life determined in rat by intravenous administration,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4722,10116.0,,9435,CHEMBL627891,Half life determined in rats after iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6535,10116.0,,9436,CHEMBL627892,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6535,10116.0,,9437,CHEMBL627893,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1435,10116.0,,9438,CHEMBL627894,Half life in rat plasma was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1435,10116.0,,9439,CHEMBL627895,Half life in rat plasma was determined; NA means not applicable,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5206,10116.0,,9440,CHEMBL627896,Half life in rat was tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6080,10116.0,,9441,CHEMBL627897,Half life measured in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4449,10116.0,,9442,CHEMBL627898,Half life recorded in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,9443,CHEMBL627899,Half life was calculated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,9444,CHEMBL873823,Half life was calculated in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3747,10116.0,,9445,CHEMBL627900,Half life was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17858,10116.0,,9446,CHEMBL627901,Half life after 10 mg/kg oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9447,CHEMBL627902,Half life after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9448,CHEMBL627903,Half life after administering orally a dose of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5031,10116.0,,9449,CHEMBL627904,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4722,10116.0,,9450,CHEMBL627905,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,9451,CHEMBL627906,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,9452,CHEMBL627907,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,9453,CHEMBL876783,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,9454,CHEMBL627908,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17065,10116.0,,9455,CHEMBL627909,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1353,10116.0,,9456,CHEMBL627910,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1353,10116.0,,9457,CHEMBL627911,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1353,10116.0,,9458,CHEMBL627912,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1353,10116.0,,9459,CHEMBL627913,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1353,10116.0,,9460,CHEMBL627914,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,9461,CHEMBL627915,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,9462,CHEMBL627916,Area under the curve was evaluated after 20 uM/kg of peroral administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6062,10116.0,,9463,CHEMBL627917,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6056,10116.0,,9464,CHEMBL627918,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,9465,CHEMBL627919,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,9466,CHEMBL627920,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,9467,CHEMBL627921,Area under the curve was evaluated at an oral dose of 30 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9468,CHEMBL627922,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9469,CHEMBL876784,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9470,CHEMBL627923,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9471,CHEMBL626208,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9472,CHEMBL626209,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,9473,CHEMBL626210,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2463,10116.0,,9474,CHEMBL627994,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4709,10116.0,,9475,CHEMBL627995,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4075,10116.0,,9476,CHEMBL627996,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5394,10116.0,,9477,CHEMBL627997,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,9478,CHEMBL627998,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,9479,CHEMBL628640,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,9480,CHEMBL628641,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,9481,CHEMBL628642,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9482,CHEMBL628643,Compound was evaluated for area under the curve expressed as (h*ug/ml),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2591,10116.0,,9483,CHEMBL628644,Compound was tested for area under curve in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6567,10116.0,,9484,CHEMBL628645,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6211,10116.0,,9485,CHEMBL628646,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5529,10116.0,,9486,CHEMBL628647,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5408,10116.0,,9487,CHEMBL628648,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5408,10116.0,,9488,CHEMBL625358,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5408,10116.0,,9489,CHEMBL625359,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5408,10116.0,,9490,CHEMBL625360,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,9491,CHEMBL625361,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,9492,CHEMBL625362,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,9493,CHEMBL625363,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4796,10116.0,,9494,CHEMBL625364,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,9495,CHEMBL625365,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,9496,CHEMBL625366,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,9497,CHEMBL625367,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11450,10116.0,,9498,CHEMBL625368,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11450,10116.0,,9499,CHEMBL625369,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11450,10116.0,,9500,CHEMBL625370,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11450,10116.0,,9501,CHEMBL625371,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11450,10116.0,,9502,CHEMBL625372,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11450,10116.0,,9503,CHEMBL625373,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11450,10116.0,,9504,CHEMBL625374,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11450,10116.0,,9505,CHEMBL877593,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11450,10116.0,,9506,CHEMBL625375,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11450,10116.0,,9507,CHEMBL625376,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11450,10116.0,,9508,CHEMBL621973,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11450,10116.0,,9509,CHEMBL621974,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11450,10116.0,,9510,CHEMBL621975,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11450,10116.0,,9511,CHEMBL622166,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11450,10116.0,,9512,CHEMBL622167,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11450,10116.0,,9513,CHEMBL622168,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11450,10116.0,,9514,CHEMBL622169,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11450,10116.0,,9515,CHEMBL622170,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9516,CHEMBL622171,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9517,CHEMBL622172,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9518,CHEMBL622173,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9519,CHEMBL622174,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9520,CHEMBL622175,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9521,CHEMBL622176,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9522,CHEMBL622177,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9523,CHEMBL622178,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9524,CHEMBL622179,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9525,CHEMBL622180,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9526,CHEMBL622181,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9527,CHEMBL622182,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9528,CHEMBL622183,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9529,CHEMBL622184,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9530,CHEMBL622185,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9531,CHEMBL622186,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9532,CHEMBL622187,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9533,CHEMBL625002,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9534,CHEMBL622090,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9535,CHEMBL622091,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9536,CHEMBL622092,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9537,CHEMBL622093,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9538,CHEMBL622094,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9539,CHEMBL622095,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9540,CHEMBL622264,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9541,CHEMBL622265,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9542,CHEMBL622266,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9543,CHEMBL622267,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9544,CHEMBL622268,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9545,CHEMBL622269,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9546,CHEMBL625071,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9547,CHEMBL621621,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9548,CHEMBL621622,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9549,CHEMBL621623,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9550,CHEMBL621624,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9551,CHEMBL621625,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9552,CHEMBL621626,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9553,CHEMBL621627,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9554,CHEMBL621628,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9555,CHEMBL875328,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9556,CHEMBL621629,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9557,CHEMBL621630,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9558,CHEMBL621631,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16434,10116.0,,9559,CHEMBL621632,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9560,CHEMBL621633,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9561,CHEMBL621634,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9562,CHEMBL621635,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9563,CHEMBL621636,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9564,CHEMBL621637,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,16435,10116.0,,9565,CHEMBL621638,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9566,CHEMBL618883,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9567,CHEMBL618884,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9568,CHEMBL628627,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9569,CHEMBL628628,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9570,CHEMBL628629,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9571,CHEMBL628630,Half life after administering orally a dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9572,CHEMBL628631,Half life after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9573,CHEMBL628632,Half life after administering intravenously a dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,526,10116.0,,9574,CHEMBL628633,Half life after oral dosing in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9575,CHEMBL628634,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4368,10116.0,,9576,CHEMBL627789,Half life by intravenous administration of 3.4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3371,10116.0,,9577,CHEMBL627790,Half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6448,10116.0,,9578,CHEMBL627791,Half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6453,10116.0,,9579,CHEMBL627792,Half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4353,10116.0,,9580,CHEMBL627793,Half life in rat after intravenous administration of the compound,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4353,10116.0,,9581,CHEMBL627794,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4353,10116.0,,9582,CHEMBL627795,Half life in rat after po administration of the compound,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4353,10116.0,,9583,CHEMBL627796,Half life in rat after po administration of the compound; ND means Not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4353,10116.0,,9584,CHEMBL875335,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4353,10116.0,,9585,CHEMBL627797,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5789,10116.0,,9586,CHEMBL627798,Half life in rat i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,9587,CHEMBL627799,Half life in rat i.v. at 2 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,9588,CHEMBL627800,Half life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,484,10116.0,,9589,CHEMBL627801,Half life in rats after intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6467,10116.0,,9590,CHEMBL627802,Half life in rats at the dose of 1.0 mpk by i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,6642,10116.0,,9591,CHEMBL627803,Half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,9592,CHEMBL873820,Half life was evaluated after intravenous administration to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1369,10116.0,,9593,CHEMBL627804,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,9594,CHEMBL627805,Half life was evaluated in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6049,10116.0,,9595,CHEMBL627806,Half life was evaluated in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,9596,CHEMBL627107,Half life was evaluated in rat; Not tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16366,10116.0,,9597,CHEMBL627108,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11149,10116.0,,9598,CHEMBL627109,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11149,10116.0,,9599,CHEMBL627110,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,In vivo,1,178.0
,,Primates,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,9443.0,,9600,CHEMBL627111,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,0,
,,Primates,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,9443.0,,9601,CHEMBL627112,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,10116.0,,9602,CHEMBL627113,Half life was measured in rat at dose of 30 mg/kg by iv administration,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,10116.0,,9603,CHEMBL627114,Half life was measured in rat at dose of 30 mg/kg by po administration,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,9604,CHEMBL627115,Half life (t1/2) was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,9605,CHEMBL627116,Half life period at a dose of 10 uM/kg in rat was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,9606,CHEMBL627117,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5503,10116.0,,9607,CHEMBL627118,Half life period was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,9608,CHEMBL627119,Half life period after intravenous administration at 20 mpk in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,9609,CHEMBL627120,Half life period after intravenous administration at 20 mpk in rats; Not performed.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6109,10116.0,,9610,CHEMBL626922,Half life period after intravenous administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,9611,CHEMBL626923,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,9612,CHEMBL626924,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4755,10116.0,,9613,CHEMBL626925,Half life period in 80% rat plasma at 37 degree Centigrade,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5862,10116.0,,9614,CHEMBL626926,Half life period in SD rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9615,CHEMBL626927,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9616,CHEMBL626928,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9617,CHEMBL626929,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9618,CHEMBL626930,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5960,10116.0,,9619,CHEMBL626931,Half life period in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6103,10116.0,,9620,CHEMBL626932,Half life period in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6317,10116.0,,9621,CHEMBL626933,Half life period in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,9622,CHEMBL873826,Half life period in rat after oral administration at 10.5 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,9623,CHEMBL626934,Half life period in rat after oral administration at 11.2 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,9624,CHEMBL626935,Half life period in rat after oral administration at 13 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,9625,CHEMBL626936,Half life period in rat after oral administration at 9.7 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,9626,CHEMBL626937,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6295,10116.0,,9627,CHEMBL625906,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6296,10116.0,,9628,CHEMBL625907,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16427,10116.0,,9629,CHEMBL625908,PK study was carried to determine AUC (area under curve) value in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,9630,CHEMBL625909,Pharmacokinetic parameter AUC after intravenous administration to rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,9631,CHEMBL625910,Pharmacokinetic parameter AUC after oral administration to rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9632,CHEMBL625911,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9633,CHEMBL625912,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9634,CHEMBL626538,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9635,CHEMBL876794,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9636,CHEMBL626539,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,9637,CHEMBL626540,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5394,10116.0,,9638,CHEMBL626541,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5394,10116.0,,9639,CHEMBL626542,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,9640,CHEMBL626543,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,9641,CHEMBL626544,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,9642,CHEMBL626545,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,9643,CHEMBL626546,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,9644,CHEMBL626547,Pharmacokinetic parameter area under curve was reported,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4408,10116.0,,9645,CHEMBL626548,Pharmacokinetic property (AUC) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5983,10116.0,,9646,CHEMBL626549,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4397,10116.0,,9647,CHEMBL626550,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4397,10116.0,,9648,CHEMBL626551,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5491,10116.0,,9649,CHEMBL623777,Pharmacokinetic property was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5491,10116.0,,9650,CHEMBL623778,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5491,10116.0,,9651,CHEMBL623779,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4199,10116.0,,9652,CHEMBL623780,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4199,10116.0,,9653,CHEMBL622015,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4199,10116.0,,9654,CHEMBL622016,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5173,10116.0,,9655,CHEMBL622017,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5173,10116.0,,9656,CHEMBL622018,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5173,10116.0,,9657,CHEMBL622019,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5173,10116.0,,9658,CHEMBL622020,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16366,10116.0,,9659,CHEMBL622021,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16366,10116.0,,9660,CHEMBL622022,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5327,10116.0,,9661,CHEMBL622023,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6681,10116.0,,9662,CHEMBL622024,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12873,10116.0,,9663,CHEMBL622693,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12873,10116.0,,9664,CHEMBL622694,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,9665,CHEMBL622695,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,9666,CHEMBL622696,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,9667,CHEMBL622697,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6619,10116.0,,9668,CHEMBL622874,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6619,10116.0,,9669,CHEMBL622875,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10363,10116.0,,9670,CHEMBL622876,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4796,10116.0,,9671,CHEMBL622877,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,9672,CHEMBL622878,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4910,10116.0,,9673,CHEMBL622879,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4839,10116.0,,9674,CHEMBL877602,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9675,CHEMBL622880,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9676,CHEMBL622881,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9677,CHEMBL622882,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9678,CHEMBL622883,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9679,CHEMBL622884,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,11450,10116.0,,9680,CHEMBL622885,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,9681,CHEMBL622886,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,9682,CHEMBL622887,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8151,10116.0,,9683,CHEMBL622888,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8677,10116.0,,9684,CHEMBL622889,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8677,10116.0,,9685,CHEMBL622890,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8677,10116.0,,9686,CHEMBL622891,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8677,10116.0,,9687,CHEMBL877603,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8677,10116.0,,9688,CHEMBL622892,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8677,10116.0,,9689,CHEMBL622893,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8677,10116.0,,9690,CHEMBL622894,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8677,10116.0,,9691,CHEMBL622895,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8677,10116.0,,9692,CHEMBL622896,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8677,10116.0,,9693,CHEMBL622897,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8677,10116.0,,9694,CHEMBL622898,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8677,10116.0,,9695,CHEMBL622899,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8677,10116.0,,9696,CHEMBL622900,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8677,10116.0,,9697,CHEMBL624114,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8677,10116.0,,9698,CHEMBL624115,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8677,10116.0,,9699,CHEMBL624116,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8677,10116.0,,9700,CHEMBL624117,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8677,10116.0,,9701,CHEMBL624118,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8677,10116.0,,9702,CHEMBL624119,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8677,10116.0,,9703,CHEMBL624120,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8677,10116.0,,9704,CHEMBL624121,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8677,10116.0,,9705,CHEMBL624122,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8677,10116.0,,9706,CHEMBL624123,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8677,10116.0,,9707,CHEMBL624124,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8677,10116.0,,9708,CHEMBL624125,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8677,10116.0,,9709,CHEMBL624126,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8677,10116.0,,9710,CHEMBL624127,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8677,10116.0,,9711,CHEMBL624128,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,8677,10116.0,,9712,CHEMBL624129,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,8677,10116.0,,9713,CHEMBL624130,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,8677,10116.0,,9714,CHEMBL622340,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,8677,10116.0,,9715,CHEMBL622341,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8677,10116.0,,9716,CHEMBL622342,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8677,10116.0,,9717,CHEMBL622343,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8677,10116.0,,9718,CHEMBL622344,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8677,10116.0,,9719,CHEMBL622345,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8677,10116.0,,9720,CHEMBL622346,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8677,10116.0,,9721,CHEMBL622347,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8677,10116.0,,9722,CHEMBL622348,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8677,10116.0,,9723,CHEMBL622349,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9724,CHEMBL622350,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9725,CHEMBL622351,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9726,CHEMBL622352,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9727,CHEMBL622353,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9728,CHEMBL622354,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9729,CHEMBL622355,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9730,CHEMBL622356,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9731,CHEMBL622357,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9732,CHEMBL622358,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9733,CHEMBL622359,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9734,CHEMBL874393,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9735,CHEMBL622872,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9736,CHEMBL622873,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9737,CHEMBL623047,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9738,CHEMBL623048,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9739,CHEMBL623049,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9740,CHEMBL623050,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9741,CHEMBL623051,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9742,CHEMBL623052,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9743,CHEMBL626343,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9744,CHEMBL626344,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9745,CHEMBL626345,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9746,CHEMBL626346,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9747,CHEMBL626347,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9748,CHEMBL626348,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16434,10116.0,,9749,CHEMBL626349,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,16435,10116.0,,9750,CHEMBL626350,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9751,CHEMBL626351,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9752,CHEMBL627650,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,16435,10116.0,,9753,CHEMBL627651,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9754,CHEMBL627652,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16435,10116.0,,9755,CHEMBL627653,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9756,CHEMBL627654,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9757,CHEMBL627835,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9758,CHEMBL627836,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9759,CHEMBL627837,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9760,CHEMBL627838,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9761,CHEMBL875338,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9762,CHEMBL627839,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9763,CHEMBL627840,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9764,CHEMBL627841,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9765,CHEMBL627842,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9766,CHEMBL627843,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9767,CHEMBL627844,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9768,CHEMBL627845,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5874,10116.0,,9769,CHEMBL627846,Half life period in rat by iv administration at a dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9770,CHEMBL627847,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9771,CHEMBL873821,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9772,CHEMBL626079,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1515,10116.0,,9773,CHEMBL626080,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5491,10116.0,,9774,CHEMBL626081,Half life period was evaluated in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5491,10116.0,,9775,CHEMBL875344,Half life period was evaluated in rat plasma; Not tested,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1918,10116.0,,9776,CHEMBL626082,Half life period was evaluated in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1918,10116.0,,9777,CHEMBL626250,"Half life period was evaluated in rats, iv",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6113,10116.0,,9778,CHEMBL626251,Half life period after intravenous administration at 5 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5546,10116.0,,9779,CHEMBL626252,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5553,10116.0,,9780,CHEMBL626253,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4188,10116.0,,9781,CHEMBL626254,Half life stability of compound was evaluated in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6215,10116.0,,9782,CHEMBL626255,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6141,10116.0,,9783,CHEMBL626256,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,9784,CHEMBL626257,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,9785,CHEMBL626258,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5710,10116.0,,9786,CHEMBL626259,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5789,10116.0,,9787,CHEMBL626260,Half in rat i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6011,10116.0,,9788,CHEMBL875345,Half period in rat after intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17594,10116.0,,9789,CHEMBL626261,Half-life after repeated oral dose of compound at 1 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12357,10116.0,,9790,CHEMBL626262,Half-life measured in in vitro Cathepsin B assay in rat liver,In vitro,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5210,10116.0,,9791,CHEMBL626263,Half-life of compound was determined in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17596,10116.0,,9792,CHEMBL625270,Half-life at 10 mg/kg in rat upon intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6672,10116.0,,9793,CHEMBL625271,Half-life determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6673,10116.0,,9794,CHEMBL625272,Half-life determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,4910,10116.0,,9795,CHEMBL625273,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3741,10116.0,,9796,CHEMBL625274,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17671,10116.0,,9797,CHEMBL625275,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4910,10116.0,,9798,CHEMBL625276,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17537,10116.0,,9799,CHEMBL625277,Half-life in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4965,10116.0,,9800,CHEMBL625278,Half-life in rat plasma was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17537,10116.0,,9801,CHEMBL625279,Half-life in rat plasma; Not tested,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,6124,10116.0,,9802,CHEMBL625280,Half-life in rat serum,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,6124,10116.0,,9803,CHEMBL876797,Half-life in rat serum; na is not available,,1,1977.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,9804,CHEMBL625281,Half-life was calculated in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17668,10116.0,,9805,CHEMBL873827,Half-life was calculated in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3185,10116.0,,9806,CHEMBL625282,Half-life was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,9807,CHEMBL625283,Half-life was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2959,10116.0,,9808,CHEMBL625284,Half-life after administration of 20 mg/Kg oral dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4029,10116.0,,9809,CHEMBL625285,Half-life after administration of 3.2 mg/kg intravenously in male rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4029,10116.0,,9810,CHEMBL625286,Half-life after intravenous administration in female rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4029,10116.0,,9811,CHEMBL625287,Half-life after intravenous administration in male rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6180,10116.0,,9812,CHEMBL625288,Half-life after intravenous dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,1557,10116.0,,9813,CHEMBL625289,Half-life in a rat liver homogenate preparation,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12500,10116.0,,9814,CHEMBL625290,Half-life in plasma of rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12500,10116.0,,9815,CHEMBL876798,Half-life in plasma of rat at dose of 3-10 mgkg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5064,10116.0,,9816,CHEMBL625291,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5145,10116.0,,9817,CHEMBL625292,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5147,10116.0,,9818,CHEMBL625293,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5833,10116.0,,9819,CHEMBL622832,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6596,10116.0,,9820,CHEMBL622833,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17655,10116.0,,9821,CHEMBL622834,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,9822,CHEMBL622835,Half-life in rat after oral administration at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17538,10116.0,,9823,CHEMBL622836,Half-life in rat after po administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17538,10116.0,,9824,CHEMBL622837,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10,10116.0,,9825,CHEMBL622838,Half-life in rat at 3 mg/kg dose administered intravenously,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,17669,10116.0,,9826,CHEMBL622839,Half-life in rat brain homogenate,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17065,10116.0,,9827,CHEMBL622840,Half-life in rat plasma,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4333,10116.0,,9828,CHEMBL622841,Half-life in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6827,10116.0,,9829,CHEMBL622842,Half-life in Dawley rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,889,10116.0,,9830,CHEMBL622843,Half-life in vitro in rat plasma,In vitro,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,889,10116.0,,9831,CHEMBL622844,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,In vitro,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3747,10116.0,,9832,CHEMBL622845,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,9833,CHEMBL622846,The area under the curve of compound was measured at the dose of 100 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,9834,CHEMBL622847,The area under the curve of compound was measured at the dose of 300 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,9835,CHEMBL622848,The area under the curve of compound was measured at the dose of 30 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3360,10116.0,,9836,CHEMBL622849,Bioavailability as oral AUC in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5334,10116.0,,9837,CHEMBL622850,The plasma concentration versus time curve (AUC) was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9838,CHEMBL876807,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9839,CHEMBL622851,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9840,CHEMBL622852,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,9841,CHEMBL622853,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,9842,CHEMBL622854,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17411,10116.0,,9843,CHEMBL622855,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14941,10116.0,,9844,CHEMBL622856,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14941,10116.0,,9845,CHEMBL622857,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17538,10116.0,,9846,CHEMBL622858,AUC in rat after po administration at a dose of 10 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17752,10116.0,,9847,CHEMBL622859,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,9848,CHEMBL622860,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,9849,CHEMBL622861,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,9850,CHEMBL622862,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,9851,CHEMBL622863,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,9852,CHEMBL623817,Area under curve value 6 hr after po administration in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,9853,CHEMBL623818,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,9854,CHEMBL623819,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,9855,CHEMBL623820,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,9856,CHEMBL623821,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6642,10116.0,,9857,CHEMBL623822,AUC normalized for dose (AUCN) in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,9858,CHEMBL623823,Area under curve in rat after p.o. administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,9859,CHEMBL623824,Area under curve in rat after p.o. administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,9860,CHEMBL623825,Area under curve in rat after p.o. administration; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,9861,CHEMBL622070,Area under curve in rat after peroral administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3603,10116.0,,9862,CHEMBL622071,Area under curve (carotid artery) value of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3550,10116.0,,9863,CHEMBL622072,Bioavailability expressed as the area under curve of rat carotid artery,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,9864,CHEMBL622073,Area under curve in male SD rats was observed after intravenous administration in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17720,10116.0,,9865,CHEMBL622074,Area under curve of the compound was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5407,10116.0,,9866,CHEMBL622075,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17752,10116.0,,9867,CHEMBL622076,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17752,10116.0,,9868,CHEMBL622077,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3603,10116.0,,9869,CHEMBL622078,Area under curve (portal vein) value of the compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3550,10116.0,,9870,CHEMBL622079,Bioavailability expressed as the area under curve of rat portal vein,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17655,10116.0,,9871,CHEMBL622080,Area Under plasma concentration time curve in rat upon peroral administration,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,9872,CHEMBL877612,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,9873,CHEMBL622081,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9874,CHEMBL622082,Compound was evaluated for oral bioavailability in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9875,CHEMBL622083,Compound was evaluated for oral bioavailability in rats after iv administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9876,CHEMBL622084,Compound was evaluated for oral bioavailability in rats; 30-80,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9877,CHEMBL622085,Compound was evaluated for oral bioavailability in rats; 50-60,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9878,CHEMBL622086,Compound was evaluated for oral bioavailability in rats; no data,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17791,10116.0,,9879,CHEMBL622087,Compound was evaluated for oral bioavailability in rats; peptide,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,9880,CHEMBL622088,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,9881,CHEMBL622089,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,9882,CHEMBL623685,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,9883,CHEMBL623686,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,8677,10116.0,,9884,CHEMBL623687,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,8677,10116.0,,9885,CHEMBL623688,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,8677,10116.0,,9886,CHEMBL623689,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Stomach,A,,50597,Intermediate,,8677,10116.0,,9887,CHEMBL622485,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,945.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8677,10116.0,,9888,CHEMBL622486,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8677,10116.0,,9889,CHEMBL877613,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8677,10116.0,,9890,CHEMBL622487,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8677,10116.0,,9891,CHEMBL622488,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8677,10116.0,,9892,CHEMBL622489,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,6899,10116.0,,9893,CHEMBL622490,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,6899,10116.0,,9894,CHEMBL622491,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6899,10116.0,,9895,CHEMBL622492,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,6899,10116.0,,9896,CHEMBL622493,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,6899,10116.0,,9897,CHEMBL622494,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8677,10116.0,,9898,CHEMBL622495,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6899,10116.0,,9899,CHEMBL622496,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,6899,10116.0,,9900,CHEMBL622497,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2189,10116.0,,9901,CHEMBL622498,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,2189,10116.0,,9902,CHEMBL624918,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,2189,10116.0,,9903,CHEMBL624919,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10839,10116.0,,9904,CHEMBL624920,Biodistribution of compound in rat blood after 5 min of administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10839,10116.0,,9905,CHEMBL624921,Biodistribution of compound in rat blood after 5 min of administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10839,10116.0,,9906,CHEMBL624922,Biodistribution of compound in rat brain after 5 min of administration,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,10839,10116.0,,9907,CHEMBL624923,Biodistribution of compound in rat heart after 5 min of administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,10839,10116.0,,9908,CHEMBL624924,Biodistribution of compound in rat heart after 5 min of administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10839,10116.0,,9909,CHEMBL624925,Biodistribution of compound in rat kidney after 5 min of administration,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10839,10116.0,,9910,CHEMBL624926,Biodistribution of compound in rat kidney after 5 min of administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10839,10116.0,,9911,CHEMBL624927,Biodistribution of compound in rat liver after 5 min of administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10839,10116.0,,9912,CHEMBL874402,Biodistribution of compound in rat liver after 5 min of administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10839,10116.0,,9913,CHEMBL624928,Biodistribution of compound in rat lung after 5 min of administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10839,10116.0,,9914,CHEMBL624929,Biodistribution of compound in rat lung after 5 min of administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10839,10116.0,,9915,CHEMBL624930,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10839,10116.0,,9916,CHEMBL624931,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,4043,10116.0,,9917,CHEMBL624932,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,4043,10116.0,,9918,CHEMBL624933,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,4043,10116.0,,9919,CHEMBL624934,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,4043,10116.0,,9920,CHEMBL624935,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4043,10116.0,,9921,CHEMBL624936,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4043,10116.0,,9922,CHEMBL624937,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,4043,10116.0,,9923,CHEMBL624938,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,4043,10116.0,,9924,CHEMBL624939,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4043,10116.0,,9925,CHEMBL624940,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4043,10116.0,,9926,CHEMBL874403,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1446,10116.0,,9927,CHEMBL624941,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,9971,10116.0,,9928,CHEMBL624942,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,9971,10116.0,,9929,CHEMBL624943,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5765,10116.0,,9930,CHEMBL624944,% Bioavailability after 1 day of the drug administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5765,10116.0,,9931,CHEMBL624945,% Bioavailability after 4 day of the drug administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4257,10116.0,,9932,CHEMBL624946,Absolute bioavailability was evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9933,CHEMBL624947,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9934,CHEMBL624948,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9935,CHEMBL624949,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13091,10116.0,,9936,CHEMBL622025,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13091,10116.0,,9937,CHEMBL622026,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13091,10116.0,,9938,CHEMBL622027,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13091,10116.0,,9939,CHEMBL622028,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13091,10116.0,,9940,CHEMBL622029,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13091,10116.0,,9941,CHEMBL622208,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13091,10116.0,,9942,CHEMBL622209,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13091,10116.0,,9943,CHEMBL622210,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9944,CHEMBL622211,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9945,CHEMBL622212,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9946,CHEMBL622213,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9947,CHEMBL874404,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9948,CHEMBL620452,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9949,CHEMBL620453,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9950,CHEMBL620454,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9951,CHEMBL624067,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9952,CHEMBL624068,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,13091,10116.0,,9953,CHEMBL624069,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,13091,10116.0,,9954,CHEMBL624070,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,13091,10116.0,,9955,CHEMBL624071,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,13091,10116.0,,9956,CHEMBL624072,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,13091,10116.0,,9957,CHEMBL624073,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,13091,10116.0,,9958,CHEMBL624788,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,13091,10116.0,,9959,CHEMBL624789,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9960,CHEMBL624790,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9961,CHEMBL624791,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9962,CHEMBL624792,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13091,10116.0,,9963,CHEMBL624793,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9964,CHEMBL877491,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9965,CHEMBL624957,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9966,CHEMBL624958,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13091,10116.0,,9967,CHEMBL624959,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11977,10116.0,,9968,CHEMBL624960,Dissociation constant was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,9969,CHEMBL624961,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9970,CHEMBL624962,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,9971,CHEMBL624963,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4755,10116.0,,9972,CHEMBL624964,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,589,10116.0,,9973,CHEMBL624965,LogP value was evaluated in the in situ rat gut perfusion assay,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,9974,CHEMBL624966,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5031,10116.0,,9975,CHEMBL624967,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,9976,CHEMBL624968,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17720,10116.0,,9977,CHEMBL624969,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Expert,,2862,10116.0,,9978,CHEMBL624970,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,9979,CHEMBL624971,Half-life was evaluated after 10 uM/kg of intra arterial administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,9980,CHEMBL624972,Half-life was evaluated after 20 uM/kg of peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6005,10116.0,,9981,CHEMBL624973,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2938,10116.0,,9982,CHEMBL624974,Half-life was evaluated in plasma of rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,9983,CHEMBL624975,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,9984,CHEMBL877492,Half-life was evaluated in rats at an oral dose of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6062,10116.0,,9985,CHEMBL624976,Half-life was measured in rat after an iv dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6571,10116.0,,9986,CHEMBL624977,Half-life period of compound in rats after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3136,10116.0,,9987,CHEMBL626848,Half-life period of compound was measured in rat plasma.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3136,10116.0,,9988,CHEMBL626849,Half-life period of compound was measured in rat plasma; ND is not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3136,10116.0,,9989,CHEMBL626850,Half-life period of compound was measured in rat plasma; not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4521,10116.0,,9990,CHEMBL626851,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5871,10116.0,,9991,CHEMBL626852,Half-life period in rat by iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6077,10116.0,,9992,CHEMBL626853,Half-life period in rats following intravenous administration at 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6679,10116.0,,9993,CHEMBL626854,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5144,10116.0,,9994,CHEMBL627486,Half-life period was determined for the compound in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4498,10116.0,,9995,CHEMBL627487,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4498,10116.0,,9996,CHEMBL627488,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1908,10116.0,,9997,CHEMBL627489,Half-life value after IV dose at a dose of 5 mg/kg in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6211,10116.0,,9998,CHEMBL627490,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5529,10116.0,,9999,CHEMBL873829,Half-life was determined in rat after intravenous administration (0.5 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,10000,CHEMBL627655,Half-life was determined in rat at a dose of 1 mpk i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,10001,CHEMBL625994,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6444,10116.0,,10002,CHEMBL625995,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5207,10116.0,,10003,CHEMBL625996,Half-life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,530,10116.0,,10004,CHEMBL625850,In vitro half life in rat plasma,In vitro,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1116,10116.0,,10005,CHEMBL625851,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",In vitro,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3219,10116.0,,10006,CHEMBL625852,In vitro half life in rat,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6109,10116.0,,10007,CHEMBL625853,In vivo half life period after intravenous administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,10008,CHEMBL625854,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,10009,CHEMBL874450,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10010,CHEMBL625855,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10011,CHEMBL625856,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10012,CHEMBL625857,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10013,CHEMBL873831,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17853,10116.0,,10014,CHEMBL625858,Longer half-life in rat (i.v.) at 0.5 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17853,10116.0,,10015,CHEMBL625859,Longer half-life in rat (p.o.) at 2.0 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3457,10116.0,,10016,CHEMBL625860,Pharmacokinetic property (half life) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,10017,CHEMBL625861,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,10018,CHEMBL625862,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,10019,CHEMBL625863,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,10020,CHEMBL625864,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5739,10116.0,,10021,CHEMBL625865,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,10022,CHEMBL625866,Pharmacokinetic half time was determined intravenously in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6567,10116.0,,10023,CHEMBL625867,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2448,10116.0,,10024,CHEMBL625868,Plasma half life of hydrolysis of the compound,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5423,10116.0,,10025,CHEMBL625869,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4853,10116.0,,10026,CHEMBL874451,Plasma half life period was calculated in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4514,10116.0,,10027,CHEMBL625870,Plasma half-life in Sprague-Dawley rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4514,10116.0,,10028,CHEMBL625871,Plasma half-life in Sprague-Dawley rats; Not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1500,10116.0,,10029,CHEMBL625872,Plasma half-life in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,1500,10116.0,,10030,CHEMBL625873,Plasma half-life in rats; <MQL,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5334,10116.0,,10031,CHEMBL625874,Plasma half-life period (0-8 h) was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5334,10116.0,,10032,CHEMBL625875,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5334,10116.0,,10033,CHEMBL625876,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5334,10116.0,,10034,CHEMBL631258,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4956,10116.0,,10035,CHEMBL631259,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4956,10116.0,,10036,CHEMBL631260,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,10037,CHEMBL631261,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,10038,CHEMBL631262,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7768,10116.0,,10039,CHEMBL631263,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10040,CHEMBL631264,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10041,CHEMBL631265,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10042,CHEMBL631266,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10043,CHEMBL631267,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10044,CHEMBL631268,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10045,CHEMBL631269,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7768,10116.0,,10046,CHEMBL631270,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10047,CHEMBL631271,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10048,CHEMBL631272,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10049,CHEMBL631273,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10050,CHEMBL631274,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10051,CHEMBL631275,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10052,CHEMBL626984,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,7768,10116.0,,10053,CHEMBL626985,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10054,CHEMBL626986,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10055,CHEMBL626987,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10056,CHEMBL626988,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10057,CHEMBL626989,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10058,CHEMBL626990,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10059,CHEMBL626991,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7768,10116.0,,10060,CHEMBL626992,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10061,CHEMBL626993,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10062,CHEMBL874593,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10063,CHEMBL626994,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10064,CHEMBL626995,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10065,CHEMBL626190,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10066,CHEMBL626191,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,7768,10116.0,,10067,CHEMBL626364,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10068,CHEMBL626365,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10069,CHEMBL626366,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10070,CHEMBL626367,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10071,CHEMBL626368,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10072,CHEMBL626369,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10073,CHEMBL626370,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4498,10116.0,,10074,CHEMBL626371,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4498,10116.0,,10075,CHEMBL626372,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3603,10116.0,,10076,CHEMBL626373,Bioavailability after a dose of 10 mg/kg p.o.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6215,10116.0,,10077,CHEMBL626374,Bioavailability after peroral administration (10 mg/kg) was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5710,10116.0,,10078,CHEMBL626375,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5710,10116.0,,10079,CHEMBL626376,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5676,10116.0,,10080,CHEMBL626377,Bioavailability in rat po was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17667,10116.0,,10081,CHEMBL626378,Bioavailability of compound at 10 mg/kg in rat after oral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17667,10116.0,,10082,CHEMBL626379,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6848,10116.0,,10083,CHEMBL626380,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6848,10116.0,,10084,CHEMBL626381,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17267,10116.0,,10085,CHEMBL626382,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6362,10116.0,,10086,CHEMBL626383,Bioavailability in rat (Sprague-Dawley) (female),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17671,10116.0,,10087,CHEMBL874652,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17671,10116.0,,10088,CHEMBL626384,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4333,10116.0,,10089,CHEMBL626385,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6077,10116.0,,10090,CHEMBL626386,Bioavailability in rat at an oral dose of 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3278,10116.0,,10091,CHEMBL626387,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5964,10116.0,,10092,CHEMBL626388,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4884,10116.0,,10093,CHEMBL626389,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4905,10116.0,,10094,CHEMBL626390,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4884,10116.0,,10095,CHEMBL626391,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6850,10116.0,,10096,CHEMBL626392,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2864,10116.0,,10097,CHEMBL626393,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5780,10116.0,,10098,CHEMBL623026,Bioavailability was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1465,10116.0,,10099,CHEMBL623027,Bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5199,10116.0,,10100,CHEMBL623028,Bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5765,10116.0,,10101,CHEMBL623029,Bioavailability in rat after 1 day dosing,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5765,10116.0,,10102,CHEMBL623030,Bioavailability in rat after 4 day dosing,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,10103,CHEMBL623031,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,10104,CHEMBL623032,Bioavailability after IV dosing at 1 mg/kg in rat; no data,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,10105,CHEMBL623033,Bioavailability after oral administration at a dose of 2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6518,10116.0,,10106,CHEMBL623034,Bioavailability after oral administration at a dose of 4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2083,10116.0,,10107,CHEMBL623035,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17260,10116.0,,10108,CHEMBL623036,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4956,10116.0,,10109,CHEMBL623037,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4368,10116.0,,10110,CHEMBL623038,Bioavailability by intravenous administration of 3.4 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17752,10116.0,,10111,CHEMBL874385,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1446,10116.0,,10112,CHEMBL623039,Bioavailability in rat (Fisher) (fasted),In vivo,1,
,,Primates,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,9443.0,,10113,CHEMBL623040,Bioavailability in monkey after po administration of 10 mg/kg dose,In vivo,0,
,,Primates,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,9443.0,,10114,CHEMBL623041,Oral bioavailability in monkey (dose 10 mg/kg),In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6672,10116.0,,10115,CHEMBL623741,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6673,10116.0,,10116,CHEMBL623742,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17655,10116.0,,10117,CHEMBL623743,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,10118,CHEMBL623744,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17853,10116.0,,10119,CHEMBL623745,Bioavailability in rat (dose 2.0 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4521,10116.0,,10120,CHEMBL623746,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4940,10116.0,,10121,CHEMBL623747,Oral bioavailability in rat (dose 5 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,10116.0,,10122,CHEMBL623748,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,2891,10116.0,,10123,CHEMBL623916,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4521,10116.0,,10124,CHEMBL623917,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17686,10116.0,,10125,CHEMBL623918,Bioavailability in rat (dose 2 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,10126,CHEMBL874386,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17796,10116.0,,10127,CHEMBL623919,Bioavailability in rat; Only traces detected in rat plasma,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5064,10116.0,,10128,CHEMBL623920,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5147,10116.0,,10129,CHEMBL623148,Bioavailability upon oral administration of compound,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1916,10116.0,,10130,CHEMBL623149,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6049,10116.0,,10131,CHEMBL623150,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1445,10116.0,,10132,CHEMBL623151,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1445,10116.0,,10133,CHEMBL623152,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Expert,,2862,10116.0,,10134,CHEMBL623153,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Expert,,2862,10116.0,,10135,CHEMBL623154,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4194,10116.0,,10136,CHEMBL623155,In vitro and metabolic stability was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4194,10116.0,,10137,CHEMBL623156,In vitro metabolic stability in rat hepatocytes,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5486,10116.0,,10138,CHEMBL623157,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,Hepatocyte,50597,Intermediate,401.0,17582,10116.0,,10139,CHEMBL623158,Metabolic rate for compound was observed in rat hepatocytes,In vitro,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5600,10116.0,,10140,CHEMBL623159,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14294,10116.0,,10141,CHEMBL874390,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14294,10116.0,,10142,CHEMBL623160,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14294,10116.0,,10143,CHEMBL623161,Metabolism of compound in rat S9 microsomes; Trace,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17847,10116.0,,10144,CHEMBL623162,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10145,CHEMBL623163,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10146,CHEMBL623164,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10147,CHEMBL623165,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10148,CHEMBL623166,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10149,CHEMBL624983,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10150,CHEMBL624984,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10151,CHEMBL624985,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10152,CHEMBL622970,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10153,CHEMBL622971,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10154,CHEMBL622972,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10155,CHEMBL622973,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10156,CHEMBL622974,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10157,CHEMBL622975,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10158,CHEMBL622976,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10159,CHEMBL622977,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10160,CHEMBL624351,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10161,CHEMBL624352,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10162,CHEMBL624353,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10163,CHEMBL622397,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10164,CHEMBL622398,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10165,CHEMBL622399,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10166,CHEMBL622400,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10167,CHEMBL628428,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10168,CHEMBL628590,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10169,CHEMBL628591,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10170,CHEMBL628592,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10171,CHEMBL628593,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10172,CHEMBL875333,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10173,CHEMBL628594,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4969,10116.0,,10174,CHEMBL628595,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6737,10116.0,,10175,CHEMBL628596,Stability in rat plasma was determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,6737,10116.0,,10176,CHEMBL628597,Stability in rat plasma was determined; ND= no data,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5089,10116.0,,10177,CHEMBL628598,Tested for plasma half life period in rat (0-8 hr),,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5089,10116.0,,10178,CHEMBL628599,Tested for plasma half life period in rat (0-8 hr); Not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1466,10116.0,,10179,CHEMBL628600,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1466,10116.0,,10180,CHEMBL628601,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4950,10116.0,,10181,CHEMBL628602,Tested for the half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2412,10116.0,,10182,CHEMBL628603,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2412,10116.0,,10183,CHEMBL628604,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2412,10116.0,,10184,CHEMBL628605,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2412,10116.0,,10185,CHEMBL628606,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2412,10116.0,,10186,CHEMBL628607,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,10187,CHEMBL628608,The biological half life the compound was measured at the dose of 100 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15022,10116.0,,10188,CHEMBL628609,The biological half life the compound was measured at the dose of 30 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,406,10116.0,,10189,CHEMBL628610,The compound was evaluated for plasma half life period in rat,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,10190,CHEMBL873819,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,10191,CHEMBL628611,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5247,10116.0,,10192,CHEMBL628612,The pharmacokinetic parameter half-life period in vivo in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,10193,CHEMBL628613,"The pharmacokinetic property, Half-life was determined",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,10194,CHEMBL628614,"The pharmacokinetic property, Half-life in rat in vivo",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,10195,CHEMBL628615,"The pharmacokinetic property, Half-life was determined; ND denotes no data",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,10196,CHEMBL628616,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,3918,10116.0,,10197,CHEMBL627924,The plasma half life period in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,2906,10116.0,,10198,CHEMBL627925,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6467,10116.0,,10199,CHEMBL627926,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,10200,CHEMBL627927,t1/2 (apparent elimination)of the compound was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3788,10116.0,,10201,CHEMBL627928,t1/2 value in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17796,10116.0,,10202,CHEMBL627539,Half life in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12873,10116.0,,10203,CHEMBL876790,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5983,10116.0,,10204,CHEMBL858186,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,10205,CHEMBL627540,Half-life period in fasted rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,10206,CHEMBL627541,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,10207,CHEMBL627715,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,429,10116.0,,10208,CHEMBL627716,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17655,10116.0,,10209,CHEMBL627717,Maximum time required to achieve Cmax was determined in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10210,CHEMBL627718,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10211,CHEMBL627719,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10212,CHEMBL627720,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,10213,CHEMBL627721,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,10214,CHEMBL627722,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10215,CHEMBL627723,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10216,CHEMBL626058,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10217,CHEMBL626059,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10218,CHEMBL626060,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17720,10116.0,,10219,CHEMBL626061,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,10220,CHEMBL876791,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4723,10116.0,,10221,CHEMBL626062,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,10222,CHEMBL626063,Tmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,10223,CHEMBL626064,Tmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17720,10116.0,,10224,CHEMBL626065,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17720,10116.0,,10225,CHEMBL626066,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1466,10116.0,,10226,CHEMBL626067,tmax upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10227,CHEMBL626068,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10228,CHEMBL626069,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10229,CHEMBL626070,Percent total excretion of 3-methoxyacetaminophen glucuronide,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10230,CHEMBL626071,Percent total excretion of N-methoxyacetaminophen glucuronide,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10231,CHEMBL626072,Percent total excretion of N-methoxyacetaminophen sulfate,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10232,CHEMBL626073,Percent total excretion of acetaminophen,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7768,10116.0,,10233,CHEMBL626741,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17655,10116.0,,10234,CHEMBL626742,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17735,10116.0,,10235,CHEMBL626743,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5960,10116.0,,10236,CHEMBL876792,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17735,10116.0,,10237,CHEMBL626744,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7116,10116.0,,10238,CHEMBL626745,Compound was tested for antidiuretic activity in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,4878,10116.0,,10239,CHEMBL626746,AUC in rat after 3mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,10240,CHEMBL626747,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,10241,CHEMBL626748,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16367,10116.0,,10242,CHEMBL626749,Bioavailability administered orally at a dose of 10 mg/kg to rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16366,10116.0,,10243,CHEMBL626750,Oral Bioavailability was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,10244,CHEMBL626751,Oral bioavailability in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4426,10116.0,,10245,CHEMBL626913,Oral bioavailability in rat; Not performed.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,10246,CHEMBL626914,Bioavailability,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5041,10116.0,,10247,CHEMBL626915,Bioavailability was determined; ND denotes no data,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1500,10116.0,,10248,CHEMBL626916,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1500,10116.0,,10249,CHEMBL626917,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17409,10116.0,,10250,CHEMBL626918,Binding towards rat plasma protein at 10 uM,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17409,10116.0,,10251,CHEMBL626919,Binding towards rat plasma protein at 100 uM,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2959,10116.0,,10252,CHEMBL626920,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13501,10116.0,,10253,CHEMBL621976,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6567,10116.0,,10254,CHEMBL877599,Bioavailability in rat after 5 mg/kg oral gavage,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6571,10116.0,,10255,CHEMBL621977,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6715,10116.0,,10256,CHEMBL621978,Bioavailability in rat (dose 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6715,10116.0,,10257,CHEMBL621979,Bioavailability in rat (dose 3 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2932,10116.0,,10258,CHEMBL621980,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4171,10116.0,,10259,CHEMBL621981,Bioavailability of the compound in rats after administration of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,10260,CHEMBL621982,Bioavailability after administration of 10 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17509,10116.0,,10261,CHEMBL882953,Bioavailability after administration of 2 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4527,10116.0,,10262,CHEMBL621983,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,10263,CHEMBL621984,Bioavailability in dogs was determined; high,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6659,10116.0,,10264,CHEMBL621985,Bioavailability in monkey after intravenous administration at 1 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6659,10116.0,,10265,CHEMBL621986,Bioavailability in monkey after peroral administration at 10 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6659,10116.0,,10266,CHEMBL621987,Bioavailability in rat after intravenous administration at 1 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,6659,10116.0,,10267,CHEMBL877600,Bioavailability in rat after intravenous administration at 2 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6659,10116.0,,10268,CHEMBL621988,Bioavailability in rat after peroral administration at 30 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,6659,10116.0,,10269,CHEMBL621989,Bioavailability in rat after peroral administration at at 100 mpk,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6597,10116.0,,10270,CHEMBL621990,Bioavailability in rats was evaluated,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1202,10116.0,,10271,CHEMBL621991,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1202,10116.0,,10272,CHEMBL621992,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1202,10116.0,,10273,CHEMBL621993,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1202,10116.0,,10274,CHEMBL621994,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5207,10116.0,,10275,CHEMBL621995,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5970,10116.0,,10276,CHEMBL621996,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17538,10116.0,,10277,CHEMBL621997,Oral bioavailability in rat (dose 10 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17538,10116.0,,10278,CHEMBL621998,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1466,10116.0,,10279,CHEMBL621999,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2879,10116.0,,10280,CHEMBL622000,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2879,10116.0,,10281,CHEMBL622001,Bioavailability was measured in rat after oral administration; 2-4,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2879,10116.0,,10282,CHEMBL622002,Bioavailability was measured in rat after oral administration; 3-7,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3777,10116.0,,10283,CHEMBL622003,Bioavailability in rat (intraduodenal administration),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3777,10116.0,,10284,CHEMBL877601,Bioavailability in rat (intraduodenal administration),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3777,10116.0,,10285,CHEMBL624871,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3777,10116.0,,10286,CHEMBL622004,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5423,10116.0,,10287,CHEMBL882954,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,10288,CHEMBL622005,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16365,10116.0,,10289,CHEMBL622006,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4239,10116.0,,10290,CHEMBL622007,Bioavailability was measured in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5438,10116.0,,10291,CHEMBL622008,Bioavailability was reported,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,10292,CHEMBL622009,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,10293,CHEMBL622010,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,10294,CHEMBL622011,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,10295,CHEMBL622012,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4199,10116.0,,10296,CHEMBL622013,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4890,10116.0,,10297,CHEMBL622014,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2792,10116.0,,10298,CHEMBL624749,Bioavailability was determined at 3 mg/kg po dose in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5529,10116.0,,10299,CHEMBL624750,Oral bioavailability in rat (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,10300,CHEMBL624751,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,10301,CHEMBL624752,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6685,10116.0,,10302,CHEMBL624753,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6005,10116.0,,10303,CHEMBL624754,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,10304,CHEMBL624755,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,10305,CHEMBL624756,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6103,10116.0,,10306,CHEMBL624757,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,10307,CHEMBL624758,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6410,10116.0,,10308,CHEMBL622270,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5353,10116.0,,10309,CHEMBL622271,Bioavailability in rat (Sprague-Dawley),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,10310,CHEMBL622272,Bioavailability in rat at the dose of 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,10311,CHEMBL622273,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5809,10116.0,,10312,CHEMBL622274,Bioavailability in rat (cannulated) (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,10313,CHEMBL622275,Bioavailability value of compound in rats was determined after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3634,10116.0,,10314,CHEMBL622276,Oral bioavailability in rat (dose 20 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3341,10116.0,,10315,CHEMBL622277,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2690,10116.0,,10316,CHEMBL622278,Oral bioavailability in rat (dose 5 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3184,10116.0,,10317,CHEMBL622279,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,740,10116.0,,10318,CHEMBL622280,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1806,10116.0,,10319,CHEMBL624083,Compound was evaluated for oral bioavailability in rats; 15-27 %,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4891,10116.0,,10320,CHEMBL624084,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3634,10116.0,,10321,CHEMBL624085,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,64,10116.0,,10322,CHEMBL624086,Compound was tested for bioavailability in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4839,10116.0,,10323,CHEMBL624087,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1094,10116.0,,10324,CHEMBL624088,Oral bioavailability in rat,In vivo,1,
,,Macaca mulatta,U,1,,,BAO_0000218,,A,,22224,Intermediate,,5005,9544.0,,10325,CHEMBL624089,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Intermediate,,5005,10116.0,,10326,CHEMBL624090,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4687,10116.0,,10327,CHEMBL624091,Evaluated for the bioavailability in rat (in vivo),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17804,10116.0,,10328,CHEMBL624092,F value of compound in rats was determined after peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10329,CHEMBL624093,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10330,CHEMBL624094,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10331,CHEMBL624095,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5974,10116.0,,10332,CHEMBL624096,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1088,10116.0,,10333,CHEMBL624097,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1742,10116.0,,10334,CHEMBL624098,Maximum fall in carotid flow in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4689,10116.0,,10335,CHEMBL874392,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2463,10116.0,,10336,CHEMBL624099,Oral bioavailability in rat (dose 5 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,10337,CHEMBL624100,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5654,10116.0,,10338,CHEMBL624101,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6874,10116.0,,10339,CHEMBL624102,Oral bioavailability in rat (male Wistar),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5633,10116.0,,10340,CHEMBL624103,Oral bioavailability after administration (30 mg/kg) in rat; good,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5496,10116.0,,10341,CHEMBL624104,Oral bioavailability at the dose of 2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2358,10116.0,,10342,CHEMBL624105,Oral bioavailability determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16456,10116.0,,10343,CHEMBL624106,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5302,10116.0,,10344,CHEMBL624107,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5302,10116.0,,10345,CHEMBL623943,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5302,10116.0,,10346,CHEMBL623944,Oral bioavailability in rat (dose 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10347,CHEMBL623945,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10348,CHEMBL623946,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10349,CHEMBL623947,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10350,CHEMBL623948,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10351,CHEMBL623949,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10352,CHEMBL623950,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10353,CHEMBL874398,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10354,CHEMBL623951,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10355,CHEMBL623952,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10356,CHEMBL623953,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10357,CHEMBL623954,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10358,CHEMBL623955,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10359,CHEMBL623956,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10360,CHEMBL627807,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10361,CHEMBL627808,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10362,CHEMBL627809,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10363,CHEMBL627810,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10364,CHEMBL627811,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10365,CHEMBL627812,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10366,CHEMBL627813,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10367,CHEMBL627814,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10368,CHEMBL875336,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10369,CHEMBL627815,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10370,CHEMBL627816,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10371,CHEMBL627817,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10372,CHEMBL627818,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10373,CHEMBL627819,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10374,CHEMBL627820,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10375,CHEMBL627821,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10376,CHEMBL628464,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10377,CHEMBL626239,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10378,CHEMBL626240,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10379,CHEMBL626241,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10380,CHEMBL626242,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10381,CHEMBL626243,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10382,CHEMBL626244,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10383,CHEMBL626907,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10384,CHEMBL626908,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10385,CHEMBL626909,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10386,CHEMBL626910,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10387,CHEMBL875342,Percent total excretion of acetaminophen cysteine conjugate,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10388,CHEMBL626911,Percent total excretion of acetaminophen glucuronide,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10389,CHEMBL626912,Percent total excretion of acetaminophen sulfate,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Intermediate,,7449,10116.0,,10390,CHEMBL627065,Percent total excretion of acetaminophen-mercapturic acid,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,3172,10116.0,,10391,CHEMBL627066,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16456,10116.0,,10392,CHEMBL627067,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,1,
,,ratrat,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,10839,8656.0,,10393,CHEMBL627068,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,0,2385.0
,,ratrat,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,10839,8656.0,,10394,CHEMBL627069,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,0,2385.0
,,Ovis aries,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5334,9940.0,,10395,CHEMBL627070,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,0,
,,Ovis aries,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5334,9940.0,,10396,CHEMBL627071,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,0,
,,Ovis aries,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5334,9940.0,,10397,CHEMBL627072,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,0,
,,Ovis aries,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5334,9940.0,,10398,CHEMBL627073,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,0,
,,Ovis aries,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5334,9940.0,,10399,CHEMBL625387,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,0,
,,Ovis aries,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5334,9940.0,,10400,CHEMBL625388,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,0,
,,Ovis aries,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,5334,9940.0,,10401,CHEMBL625389,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,0,1969.0
,,Ovis aries,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,5334,9940.0,,10402,CHEMBL875343,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,0,1969.0
,,Serpentes,N,1,,,BAO_0000218,,A,,50497,Intermediate,,1735,8570.0,,10403,CHEMBL876795,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,1,
,,Serpentes,N,1,,,BAO_0000218,,A,,50497,Intermediate,,1469,8570.0,,10404,CHEMBL626552,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,1,
,,Serpentes,N,1,,,BAO_0000218,,A,,50497,Intermediate,,1336,8570.0,,10405,CHEMBL626553,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,1,
,,Homo sapiens,U,1,,,BAO_0000366,Plasma,A,,22224,Autocuration,,12403,9606.0,,10406,CHEMBL626554,The human biological plasma half life of the compound,,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8151,10116.0,,10407,CHEMBL626555,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10408,CHEMBL626556,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10409,CHEMBL626557,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10410,CHEMBL626558,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10411,CHEMBL626559,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10412,CHEMBL626560,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10413,CHEMBL876803,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10414,CHEMBL627964,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10415,CHEMBL627965,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10416,CHEMBL627966,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10417,CHEMBL627967,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10418,CHEMBL627968,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10419,CHEMBL627969,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8004,10116.0,,10420,CHEMBL627970,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8004,10116.0,,10421,CHEMBL627971,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8004,10116.0,,10422,CHEMBL627972,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,1,178.0
,,Homo sapiens,D,1,,,BAO_0000357,,B,,180,Expert,,15917,9606.0,,10423,CHEMBL856029,Dissociation constant against binding to human cyclophilin A,,9,
,,Bos taurus,H,1,,,BAO_0000019,,B,,11591,Expert,,12396,9913.0,,10424,CHEMBL627973,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,8,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7065,,,10425,CHEMBL627974,-Log C was determined by performing the electroshock minimum test,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7065,,,10426,CHEMBL627975,-Log C was determined by performing the foot shock test,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7065,,,10427,CHEMBL627976,-Log C was determined by performing the incl screen test,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7065,,,10428,CHEMBL627977,-Log C was determined by performing the maximum electroshock test,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7065,,,10429,CHEMBL627978,-Log C was determined by performing the pentylenetetrazole test,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12415,,,10430,CHEMBL627979,Tested for experimental arotinoid inhibitory dose,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10256,,,10431,CHEMBL876804,Negative log transformed activity,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7991,,,10432,CHEMBL627980,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,0,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14342,10141.0,,10433,CHEMBL627981,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14342,10141.0,,10434,CHEMBL627982,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14342,10141.0,,10435,CHEMBL627983,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,1,
,,Cavia porcellus,N,1,,,BAO_0000218,Ileum,A,,50512,Intermediate,,14342,10141.0,,10436,CHEMBL627984,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,1,2116.0
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6047,,,10437,CHEMBL627985,Solubility in water was determined; values expressed as -log,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17269,,,10438,CHEMBL627986,Ratio of Kcat to that of Km was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10026,,,10439,CHEMBL627987,Observed first order rate constant,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14583,,,10440,CHEMBL627988,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,10441,CHEMBL627989,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2661,10116.0,,10442,CHEMBL627990,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4029,10116.0,,10443,CHEMBL876805,Oral Bioavailability after administration of 10 mg/kg in male rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17735,10116.0,,10444,CHEMBL627991,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4576,10116.0,,10445,CHEMBL627992,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17582,10116.0,,10446,CHEMBL627993,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17651,10116.0,,10447,CHEMBL622817,Oral bioavailability at 1 mg/kg was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17651,10116.0,,10448,CHEMBL622818,Oral bioavailability at 10 mg/kg was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17670,10116.0,,10449,CHEMBL622819,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5045,10116.0,,10450,CHEMBL872267,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1696,10116.0,,10451,CHEMBL622820,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17764,10116.0,,10452,CHEMBL622821,Oral bioavailability after intravenous administration in rats at 24 uM/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6448,10116.0,,10453,CHEMBL622822,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6596,10116.0,,10454,CHEMBL622823,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17547,10116.0,,10455,CHEMBL622824,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17771,10116.0,,10456,CHEMBL622825,Oral bioavailability in rat at a dose of 3 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,10457,CHEMBL622901,Oral bioavailability in rat after oral administration at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4558,10116.0,,10458,CHEMBL622902,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17596,10116.0,,10459,CHEMBL621844,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6827,10116.0,,10460,CHEMBL621845,Oral bioavailability in Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4026,10116.0,,10461,CHEMBL621846,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10,10116.0,,10462,CHEMBL621847,Oral bioavailability in rat (dose 30 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10463,CHEMBL877609,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10464,CHEMBL621848,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10465,CHEMBL621849,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10466,CHEMBL622030,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4796,10116.0,,10467,CHEMBL622031,Percent oral bioavailability determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,10468,CHEMBL622032,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2137,10116.0,,10469,CHEMBL622033,The compound was evaluated for bioavailability in rats; 32-51,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2959,10116.0,,10470,CHEMBL622034,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1361,10116.0,,10471,CHEMBL622035,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4727,10116.0,,10472,CHEMBL882966,Bioavailability percent in rat at the dose of 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16423,10116.0,,10473,CHEMBL622036,Bioavailability was evaluated after 20 uM/kg of peroral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5206,10116.0,,10474,CHEMBL622037,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6448,10116.0,,10475,CHEMBL622038,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17723,10116.0,,10476,CHEMBL622039,Bioavailability in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,17738,10116.0,,10477,CHEMBL622040,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,17738,10116.0,,10478,CHEMBL622041,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,17738,10116.0,,10479,CHEMBL622042,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,17738,10116.0,,10480,CHEMBL622043,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,17738,10116.0,,10481,CHEMBL622044,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,17738,10116.0,,10482,CHEMBL622045,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,17738,10116.0,,10483,CHEMBL622046,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,17738,10116.0,,10484,CHEMBL622047,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,17738,10116.0,,10485,CHEMBL877610,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,17738,10116.0,,10486,CHEMBL622048,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,17738,10116.0,,10487,CHEMBL622049,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,17738,10116.0,,10488,CHEMBL622050,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,17738,10116.0,,10489,CHEMBL622051,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17738,10116.0,,10490,CHEMBL622052,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17738,10116.0,,10491,CHEMBL622053,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17738,10116.0,,10492,CHEMBL622054,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17738,10116.0,,10493,CHEMBL622055,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5237,10116.0,,10494,CHEMBL622056,Oral bioavailability in rats was determined; High,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5503,10116.0,,10495,CHEMBL622057,Oral bioavailability in the rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15765,10116.0,,10496,CHEMBL628008,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15660,10116.0,,10497,CHEMBL622058,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10498,CHEMBL622059,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10499,CHEMBL622060,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10500,CHEMBL622061,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5978,10116.0,,10501,CHEMBL622062,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,10502,CHEMBL622063,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,3598,10116.0,,10503,CHEMBL877611,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4216,10116.0,,10504,CHEMBL622064,Oral bioavailability of compound in Sprague Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17839,10116.0,,10505,CHEMBL622065,Oral bioavailability of compound in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6570,10116.0,,10506,CHEMBL622066,Oral bioavailability in rat (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5334,10116.0,,10507,CHEMBL622067,Oral bioavailability of compound in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6886,10116.0,,10508,CHEMBL622068,Oral bioavailability of compound in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5210,10116.0,,10509,CHEMBL622069,Oral bioavailability of compound was determined in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4170,10116.0,,10510,CHEMBL624796,Oral bioavailability at a dose of 30 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6028,10116.0,,10511,CHEMBL624797,Oral bioavailability in rat (dose 10 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6028,10116.0,,10512,CHEMBL623053,Oral bioavailability in rat (dose 10 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,10513,CHEMBL623054,Oral bioavailability evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6168,10116.0,,10514,CHEMBL623055,Oral bioavailability in fasted rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6168,10116.0,,10515,CHEMBL623056,Oral bioavailability in fed rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5160,10116.0,,10516,CHEMBL623057,Oral bioavailability in rat (mature male) (dose 30 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,10517,CHEMBL623058,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,10518,CHEMBL623059,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6535,10116.0,,10519,CHEMBL623060,Oral bioavailability in rat after administration of 10 mg/kg po,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4194,10116.0,,10520,CHEMBL623061,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6230,10116.0,,10521,CHEMBL623062,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6619,10116.0,,10522,CHEMBL623063,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17607,10116.0,,10523,CHEMBL623064,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4942,10116.0,,10524,CHEMBL623065,Oral bioavailability in ratrs,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4942,10116.0,,10525,CHEMBL623066,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6646,10116.0,,10526,CHEMBL623067,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5237,10116.0,,10527,CHEMBL623068,Oral bioavailability in rats was determined; High,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6646,10116.0,,10528,CHEMBL623069,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4449,10116.0,,10529,CHEMBL623070,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6057,10116.0,,10530,CHEMBL623071,Oral bioavailability was calculated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2552,10116.0,,10531,CHEMBL623072,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5496,10116.0,,10532,CHEMBL623073,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6484,10116.0,,10533,CHEMBL623074,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6485,10116.0,,10534,CHEMBL623075,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6616,10116.0,,10535,CHEMBL623076,Oral bioavailability after i.v. administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4969,10116.0,,10536,CHEMBL623077,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5862,10116.0,,10537,CHEMBL623078,Oral bioavailability in rat (Sprague-Dawley),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4514,10116.0,,10538,CHEMBL623079,Oral bioavailability in Sprague-Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4514,10116.0,,10539,CHEMBL623080,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4514,10116.0,,10540,CHEMBL623081,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5546,10116.0,,10541,CHEMBL623082,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6168,10116.0,,10542,CHEMBL874400,Oral bioavailability in fasted rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6168,10116.0,,10543,CHEMBL623083,Oral bioavailability in fed rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3624,10116.0,,10544,CHEMBL623084,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5213,10116.0,,10545,CHEMBL623085,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5496,10116.0,,10546,CHEMBL623086,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5553,10116.0,,10547,CHEMBL623087,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5833,10116.0,,10548,CHEMBL623088,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5836,10116.0,,10549,CHEMBL623089,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5865,10116.0,,10550,CHEMBL623090,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5960,10116.0,,10551,CHEMBL623091,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6249,10116.0,,10552,CHEMBL623092,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6448,10116.0,,10553,CHEMBL623093,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6453,10116.0,,10554,CHEMBL874401,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,10555,CHEMBL623094,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17607,10116.0,,10556,CHEMBL623095,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,10557,CHEMBL623096,Oral bioavailability in rat after peroral administration at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5939,10116.0,,10558,CHEMBL624913,Oral bioavailability in rat after peroral administration at 5 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6281,10116.0,,10559,CHEMBL624914,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5874,10116.0,,10560,CHEMBL624915,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5213,10116.0,,10561,CHEMBL624916,Oral bioavailability in rat; Not measured,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4964,10116.0,,10562,CHEMBL624917,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11020,10116.0,,10563,CHEMBL625157,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6251,10116.0,,10564,CHEMBL625158,In vitro metabolic potential in rat liver microsomes,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1568,10116.0,,10565,CHEMBL625159,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3032,10116.0,,10566,CHEMBL625160,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3748,10116.0,,10567,CHEMBL625161,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,401,10116.0,,10568,CHEMBL625162,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6512,10116.0,,10569,CHEMBL625163,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17617,10116.0,,10570,CHEMBL625164,Oral bioavailability in rats at 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6679,10116.0,,10571,CHEMBL625165,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6742,10116.0,,10572,CHEMBL625166,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,589,10116.0,,10573,CHEMBL625167,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,589,10116.0,,10574,CHEMBL625168,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3185,10116.0,,10575,CHEMBL625169,Plasma clearance of the compound,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17596,10116.0,,10576,CHEMBL626264,Plasma clearance at 10 mg/kg in rat upon intravenous administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2713,10116.0,,10577,CHEMBL626265,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12500,10116.0,,10578,CHEMBL626266,The compound was tested for plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12500,10116.0,,10579,CHEMBL626267,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2713,10116.0,,10580,CHEMBL626268,Plasma concentration upon oral administration of 1 mg/Kg in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1446,10116.0,,10581,CHEMBL626269,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6227,10116.0,,10582,CHEMBL626270,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4709,10116.0,,10583,CHEMBL626271,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,10584,CHEMBL626272,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,10585,CHEMBL626273,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,10586,CHEMBL875346,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5510,10116.0,,10587,CHEMBL626274,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4514,10116.0,,10588,CHEMBL626275,Compound was tested for protein binding in rat plasma,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2713,10116.0,,10589,CHEMBL624646,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2713,10116.0,,10590,CHEMBL624647,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,5340,10116.0,,10591,CHEMBL624648,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12058,10116.0,,10592,CHEMBL624649,Area under curve ratio was determined (po/iv) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11195,10116.0,,10593,CHEMBL624650,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11195,10116.0,,10594,CHEMBL624651,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11195,10116.0,,10595,CHEMBL624652,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6495,10116.0,,10596,CHEMBL624653,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6078,10116.0,,10597,CHEMBL624654,Ratio of AUCbrain to AUCplasma,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5656,10116.0,,10598,CHEMBL624655,Ratio of brain to plasma,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10599,CHEMBL624656,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10600,CHEMBL624657,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10601,CHEMBL624658,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10130,10116.0,,10602,CHEMBL624659,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10130,10116.0,,10603,CHEMBL624660,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10130,10116.0,,10604,CHEMBL624661,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5213,10116.0,,10605,CHEMBL624662,Steady state brain :blood ratio was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10606,CHEMBL625199,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10607,CHEMBL625200,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10608,CHEMBL625201,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4910,10116.0,,10609,CHEMBL625202,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2083,10116.0,,10610,CHEMBL625203,Percentage recovery after 3h incubation with rat hapatocytes was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2082,10116.0,,10611,CHEMBL625204,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2082,10116.0,,10612,CHEMBL625205,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6351,10116.0,,10613,CHEMBL625206,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14583,,,10614,CHEMBL625207,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14583,,,10615,CHEMBL625208,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,0,
,,Homo sapiens,N,1,,,BAO_0000218,,A,Caco-2,50587,Intermediate,495.0,4608,9606.0,,10616,CHEMBL625209,In vivo absorption in Caco-2 cell line monolayers was determined,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13668,,,10617,CHEMBL625210,Calculated partition coefficient (clogP),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,10618,CHEMBL625211,Area under curve was determine after peroral administration at 10 mpk in Rat,,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,5669,9544.0,,10619,CHEMBL625212,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,10620,CHEMBL625213,Area under curve was determine after peroral administration at 160 mpk in Rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,10621,CHEMBL625214,Area under curve was determine after peroral administration at 20 mpk in Rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,10622,CHEMBL874542,Area under curve was determine after peroral administration at 50 mpk in Rat,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6472,,,10623,CHEMBL625215,Calculated partition coefficient (clogP) (AlogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15106,,,10624,CHEMBL625216,Activated partial thromboplastin time measured,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,15207,,,10625,CHEMBL625217,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,15207,,,10626,CHEMBL625218,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13941,9615.0,,10627,CHEMBL622864,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13941,10116.0,,10628,CHEMBL622865,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13941,10116.0,,10629,CHEMBL622866,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13941,9615.0,,10630,CHEMBL622867,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,1,1969.0
,,Cavia porcellus,N,1,,,BAO_0000218,Plasma,A,,50512,Intermediate,,15240,10141.0,,10631,CHEMBL876808,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,1,1969.0
,,,U,1,,,BAO_0000019,Brain,A,,22224,Autocuration,,10655,,,10632,CHEMBL627725,AUC in brain,,0,955.0
,,,U,1,,,BAO_0000019,Serum,A,,22224,Autocuration,,10655,,,10633,CHEMBL627726,AUC in serum,,0,1977.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,6504,,,10634,CHEMBL627727,AUC was determined,,0,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,10615,,,10635,CHEMBL627728,AUC of the compound.,,0,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,10353,,,10636,CHEMBL627729,AUC value (0-4 hr),,0,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,14907,,,10637,CHEMBL627730,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,0,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,14907,,,10638,CHEMBL627731,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,0,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,14907,,,10639,CHEMBL627732,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,0,1969.0
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,14907,,,10640,CHEMBL627733,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16359,10116.0,,10641,CHEMBL627734,AUC(area under curve) was determined after intravenous administration in rats,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16359,10116.0,,10642,CHEMBL627735,AUC(area under curve) was determined after oral administration in rats,,1,1969.0
,,Cavia porcellus,N,1,,,BAO_0000218,Plasma,A,,50512,Intermediate,,15240,10141.0,,10643,CHEMBL627736,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15240,10116.0,,10644,CHEMBL876809,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,1,1969.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15469,,,10645,CHEMBL627737,Area Under Curve after oral dosing of 100 uM/Kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15469,,,10646,CHEMBL627738,Area Under Curve after oral dosing of 30 uM/Kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13520,,,10647,CHEMBL627739,Area Under Curve was measured by ploting the graph between concentration verses time,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,17025,9615.0,,10648,CHEMBL626143,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17025,314293.0,,10649,CHEMBL626144,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,17025,9986.0,,10650,CHEMBL626145,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17025,10116.0,,10651,CHEMBL626146,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12032,10116.0,,10652,CHEMBL626147,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,1,178.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10291,,,10653,CHEMBL626148,Area under curve (AUC) was determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5767,,,10654,CHEMBL626149,Area under curve (AUC) following ip administration at 1 mg/kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1434,,,10655,CHEMBL626150,Area under curve (AUC) was determined; ND is Not determined,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14925,9615.0,,10656,CHEMBL626151,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14925,9615.0,,10657,CHEMBL626152,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14925,9615.0,,10658,CHEMBL626153,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1434,,,10659,CHEMBL626154,Area under curve (AUR) was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11883,,,10660,CHEMBL626155,Area under curve at 1 uM/dg administered intravenously,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11883,,,10661,CHEMBL626156,Area under curve at 10 uM/dg administered perorally,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11883,,,10662,CHEMBL626157,Area under curve at 2 uM/dg administered intravenously,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11883,,,10663,CHEMBL626158,Area under curve at 20 uM/dg administered perorally,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15233,9615.0,,10664,CHEMBL626159,Area under curve at a peroral dose of 3 mg/kg in dog,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15233,10116.0,,10665,CHEMBL626160,Area under curve at a peroral dose of 3 mg/kg in rat,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15233,9615.0,,10666,CHEMBL626161,Area under curve at an iv dose of 1 mg/kg in dog,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15233,10116.0,,10667,CHEMBL626162,Area under curve at an iv dose of 1 mg/kg in rat,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12978,,,10668,CHEMBL626163,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12978,,,10669,CHEMBL626164,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,11355,10090.0,,10670,CHEMBL626165,Area under curve measured as conc vs time after intravenous administration to mice.,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,11355,10090.0,,10671,CHEMBL626166,Area under curve measured as conc vs time after peroral administration to mice.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12923,9615.0,,10672,CHEMBL626167,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12923,9615.0,,10673,CHEMBL626168,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12923,9615.0,,10674,CHEMBL877463,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12923,9615.0,,10675,CHEMBL626169,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,17738,10116.0,,10676,CHEMBL626170,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,17738,10116.0,,10677,CHEMBL626171,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,17738,10116.0,,10678,CHEMBL626172,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,17738,10116.0,,10679,CHEMBL626173,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,17738,10116.0,,10680,CHEMBL626174,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,17738,10116.0,,10681,CHEMBL626175,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,17738,10116.0,,10682,CHEMBL626176,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,17738,10116.0,,10683,CHEMBL626177,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,17738,10116.0,,10684,CHEMBL622499,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,17738,10116.0,,10685,CHEMBL622500,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,17738,10116.0,,10686,CHEMBL622501,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,17738,10116.0,,10687,CHEMBL622502,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,17738,10116.0,,10688,CHEMBL622503,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,17738,10116.0,,10689,CHEMBL877614,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,17738,10116.0,,10690,CHEMBL624839,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,17738,10116.0,,10691,CHEMBL624840,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,17738,10116.0,,10692,CHEMBL624841,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,17738,10116.0,,10693,CHEMBL624842,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,17738,10116.0,,10694,CHEMBL624843,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,17738,10116.0,,10695,CHEMBL624844,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,17738,10116.0,,10696,CHEMBL624845,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,17738,10116.0,,10697,CHEMBL621904,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11195,10116.0,,10698,CHEMBL621905,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11195,10116.0,,10699,CHEMBL874382,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,11195,10116.0,,10700,CHEMBL621906,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11195,10116.0,,10701,CHEMBL621907,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11195,10116.0,,10702,CHEMBL622096,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,11195,10116.0,,10703,CHEMBL622097,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11195,10116.0,,10704,CHEMBL622098,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11195,10116.0,,10705,CHEMBL622099,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,11195,10116.0,,10706,CHEMBL622100,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11195,10116.0,,10707,CHEMBL622101,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11195,10116.0,,10708,CHEMBL622102,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,11195,10116.0,,10709,CHEMBL622103,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11195,10116.0,,10710,CHEMBL622104,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11195,10116.0,,10711,CHEMBL622105,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,11195,10116.0,,10712,CHEMBL622106,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11195,10116.0,,10713,CHEMBL622107,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11195,10116.0,,10714,CHEMBL622108,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,11195,10116.0,,10715,CHEMBL622109,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11195,10116.0,,10716,CHEMBL622110,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11195,10116.0,,10717,CHEMBL622111,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11195,10116.0,,10718,CHEMBL874383,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11195,10116.0,,10719,CHEMBL622112,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11195,10116.0,,10720,CHEMBL622113,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,11195,10116.0,,10721,CHEMBL622114,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11195,10116.0,,10722,CHEMBL622115,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,11195,10116.0,,10723,CHEMBL622116,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6193,10116.0,,10724,CHEMBL622117,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6803,10116.0,,10725,CHEMBL622118,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6647,10116.0,,10726,CHEMBL622119,Oral bioavailability in rats at 6 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6647,10116.0,,10727,CHEMBL622120,Oral bioavailability in rat (dose 6 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6647,10116.0,,10728,CHEMBL622121,Oral bioavailability in rats at 6 mg/kg dose; Not tested,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6640,10116.0,,10729,CHEMBL622122,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,10730,CHEMBL622123,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6641,10116.0,,10731,CHEMBL622124,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6642,10116.0,,10732,CHEMBL622125,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,10733,CHEMBL622126,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6141,10116.0,,10734,CHEMBL620455,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4390,10116.0,,10735,CHEMBL620456,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,10736,CHEMBL620457,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5472,10116.0,,10737,CHEMBL620458,Oral bioavailability was evaluated; Not tested,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5438,10116.0,,10738,CHEMBL620459,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4883,10116.0,,10739,CHEMBL620460,Oral bioavailability in rat by oral dosing,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1908,10116.0,,10740,CHEMBL620461,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10741,CHEMBL620462,Oral bioavailability in rat (Sprague-Dawley),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10742,CHEMBL620463,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10743,CHEMBL620464,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10744,CHEMBL620465,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10745,CHEMBL620466,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10746,CHEMBL620467,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4853,10116.0,,10747,CHEMBL620468,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12873,10116.0,,10748,CHEMBL620469,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12873,10116.0,,10749,CHEMBL620470,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3169,10116.0,,10750,CHEMBL620471,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6305,10116.0,,10751,CHEMBL620472,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4762,10116.0,,10752,CHEMBL620473,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17847,10116.0,,10753,CHEMBL620474,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6211,10116.0,,10754,CHEMBL620475,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6011,10116.0,,10755,CHEMBL620476,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6317,10116.0,,10756,CHEMBL620477,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,10757,CHEMBL620478,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,10758,CHEMBL618768,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,10759,CHEMBL618769,Oral bioavailability in rat after oral administration at 13 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6644,10116.0,,10760,CHEMBL618770,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6113,10116.0,,10761,CHEMBL618771,Oral bioavailability (dose 20 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5937,10116.0,,10762,CHEMBL618772,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5711,10116.0,,10763,CHEMBL618773,Oral bioavailability in rat at 10 mg/kg of the compound,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10764,CHEMBL875842,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10765,CHEMBL618774,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10766,CHEMBL618775,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17717,10116.0,,10767,CHEMBL618776,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4722,10116.0,,10768,CHEMBL618777,Percent bioavailability (F) in rats after iv administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4722,10116.0,,10769,CHEMBL618778,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4353,10116.0,,10770,CHEMBL618779,Bioavailability in rat (dose 5 uM/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15662,10116.0,,10771,CHEMBL618780,Oral bioavailability,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,10772,CHEMBL618781,Bioavailability in rat (dose 2 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,4756,10116.0,,10773,CHEMBL618782,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3436,10116.0,,10774,CHEMBL618783,Oral bioavailability in rat (dose 20 mg/kg),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17800,10116.0,,10775,CHEMBL618784,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15762,10116.0,,10776,CHEMBL618785,Percent oral bioavailability evaluated in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5089,10116.0,,10777,CHEMBL618786,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5089,10116.0,,10778,CHEMBL618787,Percent oral bioavailability in rat; Not determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3185,10116.0,,10779,CHEMBL618788,Oral bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5145,10116.0,,10780,CHEMBL618789,Bioavailability in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3457,10116.0,,10781,CHEMBL618790,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3457,10116.0,,10782,CHEMBL618791,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5983,10116.0,,10783,CHEMBL875843,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5739,10116.0,,10784,CHEMBL618792,Oral bioavailability in rat (dose 20 mg/kg p.o.),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,3579,10116.0,,10785,CHEMBL623395,Cmax at a dose of 30 mg/kg in rat,In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17788,314293.0,,10786,CHEMBL623396,Cmax in monkeys at a dose of 1 mg/kg,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14956,10116.0,,10787,CHEMBL623397,Cmax in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17788,10116.0,,10788,CHEMBL623398,Cmax in rats at a dose of 1 mg/kg,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9750,10090.0,,10789,CHEMBL623399,Cmax was measured in mice after an oral dose of 50 mg/kg.,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12767,,,10790,CHEMBL623400,"Cmax value at a dose of 12.7 uM/kg, po",In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12767,,,10791,CHEMBL623401,"Cmax value at a dose of 6.3 uM/kg, iv",In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12767,,,10792,CHEMBL623402,"Cmax value at a dose of 7.1 uM/kg, iv",In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12703,,,10793,CHEMBL623403,Cmax value of compound was determined after 1 hr,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15778,,,10794,CHEMBL623404,Cmax value of the compound,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12818,10116.0,,10795,CHEMBL625997,Cmax value administered intraintestinal in rats.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14964,10116.0,,10796,CHEMBL625998,Cmax value administered perorally was determined in rat; Not determined,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15808,,,10797,CHEMBL625999,Cmax value at the dose of 2.3 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15808,,,10798,CHEMBL626000,Cmax value at the dose of 5 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15778,,,10799,CHEMBL626001,Cmax value in the period of 8 hr after dosing. ,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3715,,,10800,CHEMBL626002,Cmax value at a oral dose of 20 mg/kg; Not tested,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3715,,,10801,CHEMBL626003,Cmax value at a oral dose of 20 mg/kg,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,1446,10116.0,,10802,CHEMBL626004,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,15240,10141.0,,10803,CHEMBL626005,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15240,10116.0,,10804,CHEMBL626006,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14810,10116.0,,10805,CHEMBL626007,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14239,10090.0,,10806,CHEMBL626008,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Liver,A,,50588,Intermediate,,12555,9615.0,,10807,CHEMBL626009,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,In vivo,1,2107.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,10754,9615.0,,10808,CHEMBL626010,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,10809,CHEMBL626011,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,10810,CHEMBL626012,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,10811,CHEMBL626013,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,10812,CHEMBL626014,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,10754,10090.0,,10813,CHEMBL877496,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,F,,50588,Intermediate,,14600,9615.0,,10814,CHEMBL626015,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,F,,50588,Intermediate,,14600,9615.0,,10815,CHEMBL626016,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,F,,50588,Intermediate,,14600,9615.0,,10816,CHEMBL626017,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13543,9615.0,,10817,CHEMBL626018,Bioavailability as maximal plasma concentration in dogs,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13543,9615.0,,10818,CHEMBL626692,Bioavailability as maximal plasma concentration in dogs,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13543,10116.0,,10819,CHEMBL626693,Bioavailability as maximal plasma concentration in rats,In vivo,1,1969.0
,,Rattus norvegicus,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13543,10116.0,,10820,CHEMBL626694,Bioavailability as maximal plasma concentration in rats,In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,14600,9615.0,,10821,CHEMBL626695,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,14600,9615.0,,10822,CHEMBL626696,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,14600,9615.0,,10823,CHEMBL626697,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,14600,9615.0,,10824,CHEMBL626859,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,14600,9615.0,,10825,CHEMBL626860,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,14600,9615.0,,10826,CHEMBL626861,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14681,10116.0,,10827,CHEMBL626296,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15905,,,10828,CHEMBL626297,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,15905,,,10829,CHEMBL626298,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13304,10116.0,,10830,CHEMBL626299,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,10831,CHEMBL626300,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,10832,CHEMBL626301,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,10833,CHEMBL626962,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,10834,CHEMBL626963,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,10835,CHEMBL626964,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,In vivo,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,14839,9541.0,,10836,CHEMBL626965,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14839,10090.0,,10837,CHEMBL626966,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14839,10090.0,,10838,CHEMBL626967,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,14839,9541.0,,10839,CHEMBL626968,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10840,CHEMBL626969,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10841,CHEMBL627126,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10842,CHEMBL631276,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10843,CHEMBL631277,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10844,CHEMBL631278,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10845,CHEMBL874457,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10846,CHEMBL631279,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10847,CHEMBL631280,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10848,CHEMBL631281,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10849,CHEMBL631968,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10850,CHEMBL631969,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10851,CHEMBL631970,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10852,CHEMBL631971,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10853,CHEMBL631972,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10854,CHEMBL630435,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10855,CHEMBL630436,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10856,CHEMBL630437,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10857,CHEMBL630438,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8418,10116.0,,10858,CHEMBL630439,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10859,CHEMBL630440,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10860,CHEMBL630441,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10861,CHEMBL630442,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10862,CHEMBL625234,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10863,CHEMBL625235,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10864,CHEMBL625236,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10865,CHEMBL625237,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10866,CHEMBL626125,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10867,CHEMBL626126,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10868,CHEMBL626127,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10869,CHEMBL626128,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10870,CHEMBL626129,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10871,CHEMBL626130,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10872,CHEMBL626131,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10873,CHEMBL626132,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10874,CHEMBL626752,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10875,CHEMBL626753,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10876,CHEMBL626754,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8418,10116.0,,10877,CHEMBL626755,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,10878,CHEMBL626756,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,10879,CHEMBL626757,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,10880,CHEMBL626758,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,10881,CHEMBL626759,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,10882,CHEMBL626760,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,1,2107.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10883,CHEMBL626394,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10884,CHEMBL626395,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10885,CHEMBL626396,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10886,CHEMBL626397,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10887,CHEMBL626398,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10888,CHEMBL626399,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10889,CHEMBL874653,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10890,CHEMBL626400,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10891,CHEMBL626401,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10892,CHEMBL626402,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10893,CHEMBL626403,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10894,CHEMBL626404,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10895,CHEMBL626405,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10896,CHEMBL625529,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10897,CHEMBL625530,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10898,CHEMBL625531,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10899,CHEMBL625532,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10900,CHEMBL625533,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10901,CHEMBL875474,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10902,CHEMBL625534,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10903,CHEMBL625535,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10904,CHEMBL625536,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10905,CHEMBL625537,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10906,CHEMBL625538,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10907,CHEMBL625539,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10908,CHEMBL625540,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10909,CHEMBL625541,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10910,CHEMBL625542,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10911,CHEMBL625543,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,10912,CHEMBL625544,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10913,CHEMBL625545,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10914,CHEMBL625546,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10915,CHEMBL625547,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10916,CHEMBL625548,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10917,CHEMBL625549,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10918,CHEMBL625550,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10919,CHEMBL625551,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10920,CHEMBL875475,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10921,CHEMBL625552,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10922,CHEMBL625553,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10923,CHEMBL625554,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10924,CHEMBL625555,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10925,CHEMBL625556,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10926,CHEMBL624986,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10927,CHEMBL624987,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,10928,CHEMBL624988,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10929,CHEMBL624989,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10930,CHEMBL624990,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10931,CHEMBL874391,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10932,CHEMBL624991,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10933,CHEMBL624992,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10934,CHEMBL624993,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10935,CHEMBL624994,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10936,CHEMBL624995,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10937,CHEMBL624996,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10938,CHEMBL624997,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10939,CHEMBL624998,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10940,CHEMBL624999,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10941,CHEMBL882955,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10942,CHEMBL625000,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10943,CHEMBL625001,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10944,CHEMBL625089,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10945,CHEMBL625090,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10946,CHEMBL625091,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10947,CHEMBL625092,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10948,CHEMBL625093,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10949,CHEMBL625094,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,10950,CHEMBL625095,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,In vivo,1,1637.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,2249,9615.0,,10951,CHEMBL625096,Compound was evaluated for its bioavailability in the dogs,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2249,10116.0,,10952,CHEMBL625097,Compound was evaluated for its bioavailability in the rats,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17515,,,10953,CHEMBL882956,Compound was evaluated for oral bioavailability,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14541,10116.0,,10954,CHEMBL625098,Compound was evaluated for percentage of Oral bioavailability in rats,In vivo,1,
,,Cavia porcellus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12797,10141.0,,10955,CHEMBL625099,Bioavailability in guinea pig,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12797,10116.0,,10956,CHEMBL625100,Compound was evaluated for the oral bioavailability in rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12797,9615.0,,10957,CHEMBL625101,Compound was evaluated for the oral bioavailability in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12797,10116.0,,10958,CHEMBL874396,Compound was evaluated for the oral bioavailability in rat,In vivo,1,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,F,,22224,Autocuration,,11727,9615.0,,10959,CHEMBL625102,Bioavailability in dog (dosed i.v.),In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13249,9615.0,,10960,CHEMBL625103,Compound was tested for in vivo bioavailability in dog,In vivo,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,13249,10026.0,,10961,CHEMBL625104,Compound was tested for in vivo bioavailability in hamsters,In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13249,314293.0,,10962,CHEMBL625105,Compound was tested for in vivo bioavailability in monkey,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13249,10116.0,,10963,CHEMBL625106,Compound was tested for in vivo bioavailability in rat,In vivo,1,
,,Mus musculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9552,10090.0,,10964,CHEMBL625107,Oral bioavailability in mouse,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9552,10090.0,,10965,CHEMBL625108,Compound was tested for percent of oral bioavailability in mice; 56-74,In vivo,1,
,,Mus musculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14839,10090.0,,10966,CHEMBL625109,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),In vivo,0,
,,Macaca fascicularis,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14839,9541.0,,10967,CHEMBL625110,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),In vivo,0,
,,Macaca fascicularis,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14839,9541.0,,10968,CHEMBL625111,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,10969,CHEMBL625112,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,10970,CHEMBL875334,Oral bioavailability in nude mice,In vivo,1,
,,Primates,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11219,9443.0,,10971,CHEMBL628617,Bioavailability in monkey (i.d. dosing),In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9552,10116.0,,10972,CHEMBL628618,Bioavailability in rat,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,10973,CHEMBL628619,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,10974,CHEMBL628620,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,In vivo,0,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,10975,CHEMBL628621,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,10976,CHEMBL628622,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14839,9541.0,,10977,CHEMBL628623,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,14839,9541.0,,10978,CHEMBL628624,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14839,10090.0,,10979,CHEMBL628625,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,14839,9541.0,,10980,CHEMBL628626,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14839,10090.0,,10981,CHEMBL627041,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14839,10090.0,,10982,CHEMBL627042,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14839,10090.0,,10983,CHEMBL627043,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13932,,,10984,CHEMBL627044,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,In vivo,0,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,11637,10090.0,,10985,CHEMBL627045,Cmax in mouse plasma,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,11637,,,10986,CHEMBL627046,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13960,10116.0,,10987,CHEMBL627047,Maximal plasma concentration in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15905,10116.0,,10988,CHEMBL627048,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,10989,CHEMBL627049,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,10990,CHEMBL627050,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,10991,CHEMBL627051,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,10992,CHEMBL627052,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,10993,CHEMBL627053,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,10994,CHEMBL627054,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,10995,CHEMBL627055,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,10996,CHEMBL627056,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,10997,CHEMBL627057,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,10998,CHEMBL627058,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,10999,CHEMBL626211,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,10291,,,11000,CHEMBL626212,Maximum Concentration of the compound.,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,11001,CHEMBL626213,Maximum Concentration was measured after iv administration into Beagle dog,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,11002,CHEMBL626214,Maximum Concentration was measured after iv administration into Beagle dog.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,11003,CHEMBL626215,Maximum Concentration was measured after po administration into Beagle dog,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14599,9615.0,,11004,CHEMBL626216,Maximum Concentration was measured after po administration into Beagle dog.,In vivo,1,
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12767,,,11005,CHEMBL626217,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12767,,,11006,CHEMBL626218,Maximum blood level reached after an iv dose of 12.2 uM/kg,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12767,,,11007,CHEMBL626219,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12767,,,11008,CHEMBL626220,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12767,,,11009,CHEMBL626221,Maximum blood level reached after an oral dose of 5.0 mg/kg,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12767,,,11010,CHEMBL626222,Maximum blood level reached at dose of 10.6 uM/kg orally,In vivo,0,178.0
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14706,10141.0,,11011,CHEMBL626223,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,In vivo,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14706,10141.0,,11012,CHEMBL626224,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14793,10116.0,,11013,CHEMBL626225,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14793,10116.0,,11014,CHEMBL626226,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14793,10116.0,,11015,CHEMBL626227,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14793,10116.0,,11016,CHEMBL626228,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,11017,CHEMBL626229,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,11018,CHEMBL626921,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,11019,CHEMBL876793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14793,10116.0,,11020,CHEMBL625309,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,In vivo,1,
,,Bacillus subtilis,N,1,,,BAO_0000218,,A,,50278,Intermediate,,10524,1423.0,,11021,CHEMBL625310,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11871,314293.0,,11022,CHEMBL625311,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11871,10116.0,,11023,CHEMBL625312,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3437,,,11024,CHEMBL625313,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12038,10090.0,,11025,CHEMBL625314,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12038,10116.0,,11026,CHEMBL625315,Maximum concentration in male rats after iv administration of 20 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11027,CHEMBL625316,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11028,CHEMBL625317,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11029,CHEMBL625318,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11030,CHEMBL625319,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11031,CHEMBL625320,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11032,CHEMBL625321,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11033,CHEMBL625322,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11034,CHEMBL876801,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11035,CHEMBL625323,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11036,CHEMBL625324,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11037,CHEMBL625325,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11038,CHEMBL625326,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11039,CHEMBL625327,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8418,10116.0,,11040,CHEMBL625328,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11041,CHEMBL625329,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11042,CHEMBL625330,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11043,CHEMBL627774,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11044,CHEMBL627775,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11045,CHEMBL627949,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11046,CHEMBL627950,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11047,CHEMBL627951,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11048,CHEMBL627952,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11049,CHEMBL627953,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11050,CHEMBL627954,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11051,CHEMBL627955,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11052,CHEMBL627956,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11053,CHEMBL876802,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11054,CHEMBL627957,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11055,CHEMBL627958,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11056,CHEMBL627959,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11057,CHEMBL627960,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11058,CHEMBL627961,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8418,10116.0,,11059,CHEMBL627962,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9796,10116.0,,11060,CHEMBL627963,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9796,10116.0,,11061,CHEMBL624759,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9796,10116.0,,11062,CHEMBL624760,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9796,10116.0,,11063,CHEMBL624761,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9796,10116.0,,11064,CHEMBL877607,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9796,10116.0,,11065,CHEMBL624762,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9796,10116.0,,11066,CHEMBL624763,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9796,10116.0,,11067,CHEMBL624764,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9796,10116.0,,11068,CHEMBL624765,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9796,10116.0,,11069,CHEMBL624766,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,2107.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11070,CHEMBL624767,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11071,CHEMBL624768,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11072,CHEMBL624769,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11073,CHEMBL624770,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11074,CHEMBL624771,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11075,CHEMBL624772,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11076,CHEMBL624773,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11077,CHEMBL624774,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11078,CHEMBL624775,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11079,CHEMBL624776,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11080,CHEMBL624777,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11081,CHEMBL624778,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11082,CHEMBL624779,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11083,CHEMBL624780,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11084,CHEMBL624781,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11085,CHEMBL877608,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11086,CHEMBL624782,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11087,CHEMBL624783,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11088,CHEMBL624784,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11089,CHEMBL624785,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11090,CHEMBL624786,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11091,CHEMBL624787,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11092,CHEMBL628676,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11093,CHEMBL621842,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11094,CHEMBL621843,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11095,CHEMBL623873,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11096,CHEMBL623874,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11097,CHEMBL623875,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,11098,CHEMBL623876,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11099,CHEMBL623877,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11100,CHEMBL623878,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11101,CHEMBL623879,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11102,CHEMBL623880,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11103,CHEMBL623881,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11104,CHEMBL623957,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11105,CHEMBL623958,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11106,CHEMBL623959,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11107,CHEMBL623960,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11108,CHEMBL623961,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11109,CHEMBL623962,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11110,CHEMBL624676,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11111,CHEMBL624677,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11112,CHEMBL624678,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11113,CHEMBL624679,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11114,CHEMBL624680,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,11115,CHEMBL624849,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,11116,CHEMBL624850,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,11117,CHEMBL874399,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,11118,CHEMBL624851,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11732,,,11119,CHEMBL624852,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13359,10116.0,,11120,CHEMBL624853,Oral bioavailability in rat (dose 10 mg/kg),In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16618,10116.0,,11121,CHEMBL624854,Oral bioavailability in rat (Sprague-Dawley),In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13960,10116.0,,11122,CHEMBL624855,Oral bioavailability in rat,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13917,10116.0,,11123,CHEMBL624856,Oral bioavailability in rats was determined in vivo,In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14266,9615.0,,11124,CHEMBL882957,Oral bioavailability in dog,In vivo,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12359,314293.0,,11125,CHEMBL624857,Oral bioavailability of compound in monkey,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12359,10116.0,,11126,CHEMBL622202,Oral bioavailability of compound in rat,In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12359,10116.0,,11127,CHEMBL622203,Bioavailability in rat of PMEA prodrug,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12359,10116.0,,11128,CHEMBL625522,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,In vivo,1,
,,Macaca mulatta,U,1,,,BAO_0000218,,A,,22224,Autocuration,,10791,9544.0,,11129,CHEMBL622868,Serum conc at 3 hours following 25 mg/kg dose,In vivo,0,
,,Macaca mulatta,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,10791,9544.0,,11130,CHEMBL622869,Urine conc 0-5 hours following 25 mg/kg dose,In vivo,0,1088.0
,,Macaca mulatta,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,10791,9544.0,,11131,CHEMBL622870,Urine conc 0-24 hours following 25 mg/kg dose,In vivo,0,1088.0
,,Chlorocebus aethiops,U,1,,,BAO_0000218,,A,,22224,Autocuration,,138,9534.0,,11132,CHEMBL622871,Oral bioavailability in African green monkeys; 20-25,In vivo,0,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14521,9541.0,,11133,CHEMBL620560,Oral bioavailability in cynomolgus monkey.,In vivo,1,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13953,9615.0,,11134,CHEMBL620561,Oral bioavailability in dog,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12836,9615.0,,11135,CHEMBL620562,Oral bioavailability in dog at 10 mg/kg oral dose,In vivo,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,12836,10026.0,,11136,CHEMBL620563,Oral bioavailability in hamster at 10 mg/kg oral dose,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12836,10116.0,,11137,CHEMBL620564,Oral bioavailability in rat at 10 mg/kg oral dose,In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14521,10116.0,,11138,CHEMBL872265,Oral bioavailability in rat,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13953,10116.0,,11139,CHEMBL620565,Oral bioavailability in rat,In vivo,0,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6799,9347.0,,11140,CHEMBL620566,Oral bioavailability,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11311,,,11141,CHEMBL620567,Oral bioavailability was determined; range 49-102%,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,4013,9615.0,,11142,CHEMBL620568,Oral bioavailability was determined in dogs,In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4013,10116.0,,11143,CHEMBL620569,Oral bioavailability in rat,In vivo,0,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17591,9347.0,,11144,CHEMBL620570,Oral bioavailability,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17591,,,11145,CHEMBL620571,Oral bioavailability was determined; Not orally available,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15011,10090.0,,11146,CHEMBL620572,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,1,
,,Mus musculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15011,10090.0,,11147,CHEMBL620573,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),In vivo,0,
,,Mus musculus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15011,10090.0,,11148,CHEMBL620574,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,In vivo,0,
,,Macaca mulatta,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9552,9544.0,,11149,CHEMBL620575,Oral bioavailability in Rhesus monkey,In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9552,9615.0,,11150,CHEMBL620576,Oral bioavailability in dog (female mongrel),In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3639,,,11151,CHEMBL875846,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13397,9615.0,,11152,CHEMBL620577,Oral bioavailability in dog,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3031,,,11153,CHEMBL620578,Percentage Bioavailability was evaluated.,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12818,10116.0,,11154,CHEMBL620579,Bioavailability in rat administered i.d.,In vivo,0,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4847,9347.0,,11155,CHEMBL621248,Bioavailability,In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12421,9615.0,,11156,CHEMBL625390,Bioavailability in dog (male Beagle) i.v. administration,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11966,10116.0,,11157,CHEMBL625391,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",In vivo,0,
,,Primates,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11218,9443.0,,11158,CHEMBL872266,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13129,10116.0,,11159,CHEMBL625392,Oral bioavailability in rat (Sprague-Dawley) (male),In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12350,10116.0,,11160,CHEMBL625393,The oral bioavailability was measured on rats after oral administration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2231,10116.0,,11161,CHEMBL625394,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,2231,9544.0,,11162,CHEMBL625395,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,10116.0,,11163,CHEMBL625396,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12421,9615.0,,11164,CHEMBL625397,Bioavailability in dog (male Beagle) i.v. administration,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11165,CHEMBL625398,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,13256,10090.0,,11166,CHEMBL625399,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Cerebellum,A,,50594,Intermediate,,13256,10090.0,,11167,CHEMBL626074,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2037.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11168,CHEMBL626075,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2231,10116.0,,11169,CHEMBL626076,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,1,1969.0
,,Macaca mulatta,N,1,,,BAO_0000218,Plasma,A,,50797,Intermediate,,2231,9544.0,,11170,CHEMBL626077,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12178,10116.0,,11171,CHEMBL626078,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,1,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12178,,,11172,CHEMBL625846,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,12178,,,11173,CHEMBL625847,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),In vivo,0,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,15633,10116.0,,11174,CHEMBL625848,Maximum concentration observed in rats at an oral dose of 50 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14258,10116.0,,11175,CHEMBL625849,Maximum concentration of compound in plasma administered orally to rats,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,11176,CHEMBL626023,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,11177,CHEMBL626024,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,11178,CHEMBL626025,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",In vivo,1,1969.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5566,,,11179,CHEMBL626026,Maximum concentration after 10 mg/kg by oral administration,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16935,,,11180,CHEMBL626027,Maximum concentration at a dose of 1.5 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16935,,,11181,CHEMBL626028,Maximum concentration at a dose of 2.0 mg/kg,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,11182,CHEMBL626029,Maximum concentration in dog plasma,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,12536,,,11183,CHEMBL626030,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,12536,,,11184,CHEMBL626031,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,12536,,,11185,CHEMBL626032,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,12536,,,11186,CHEMBL626033,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,12536,,,11187,CHEMBL626034,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,9994,9615.0,,11188,CHEMBL626035,Maximum concentration in plasma after oral administration in dog (25 mg/kg),In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,1434,,,11189,CHEMBL626036,Maximum concentration in plasma at Tmax,In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Expert,,12836,9615.0,,11190,CHEMBL626037,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,In vivo,1,1969.0
,,Cricetinae,N,1,,,BAO_0000218,Plasma,A,,100712,Intermediate,,12836,10026.0,,11191,CHEMBL626038,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12836,10116.0,,11192,CHEMBL626039,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12545,10116.0,,11193,CHEMBL626040,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,In vivo,1,1969.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Plasma,A,,50592,Intermediate,,13856,9986.0,,11194,CHEMBL626041,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3550,,,11195,CHEMBL626042,Maximum concentration was calculated,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,2632,,,11196,CHEMBL626043,Maximum concentration was calculated.,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5566,,,11197,CHEMBL626044,Maximum concentration at a peroral dose of 10 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11883,,,11198,CHEMBL626045,Maximum concentration of the drug at 10 uM/dg administered perorally,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11883,,,11199,CHEMBL626046,Maximum concentration of the drug at 2 uM/dg administered intravenously,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14122,9615.0,,11200,CHEMBL626047,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",In vivo,1,1969.0
,,Cricetinae,N,1,,,BAO_0000218,Plasma,A,,100712,Intermediate,,14122,10026.0,,11201,CHEMBL626048,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14122,10116.0,,11202,CHEMBL626049,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12542,10116.0,,11203,CHEMBL626050,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,12542,9615.0,,11204,CHEMBL874541,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,In vivo,1,1969.0
,,Cricetinae,N,1,,,BAO_0000218,Plasma,A,,100712,Intermediate,,12542,10026.0,,11205,CHEMBL622826,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,In vivo,1,1969.0
,,Cricetinae,N,1,,,BAO_0000218,Plasma,A,,100712,Intermediate,,12542,10026.0,,11206,CHEMBL622827,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12542,10116.0,,11207,CHEMBL622828,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14080,10116.0,,11208,CHEMBL622829,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11911,10116.0,,11209,CHEMBL876806,Maximum concentration reached following intravenous administration in male rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13204,9615.0,,11210,CHEMBL622830,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13204,10116.0,,11211,CHEMBL622831,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14346,9615.0,,11212,CHEMBL626794,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,11213,CHEMBL626795,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,11214,CHEMBL626796,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14346,10116.0,,11215,CHEMBL626797,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14127,10116.0,,11216,CHEMBL626798,Maximum drug concentration is determined after oral dosing in rats.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14339,9615.0,,11217,CHEMBL626799,Maximum observed concentration in oral (5 mg/kg) fasted dogs,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14339,9615.0,,11218,CHEMBL626800,Maximum observed concentration in oral (5 mg/kg) fed dogs,In vivo,1,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13494,,,11219,CHEMBL626801,Maximum plasma concentration,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14925,10116.0,,11220,CHEMBL876816,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14474,10116.0,,11221,CHEMBL626802,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14474,9615.0,,11222,CHEMBL626803,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13917,,,11223,CHEMBL626804,Maximum plasma concentration following oral administration of 30 umol/kg,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9796,10116.0,,11224,CHEMBL626805,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9796,10116.0,,11225,CHEMBL626309,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9796,10116.0,,11226,CHEMBL626310,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9796,10116.0,,11227,CHEMBL626311,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9796,10116.0,,11228,CHEMBL626312,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,9796,10116.0,,11229,CHEMBL626313,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,9796,10116.0,,11230,CHEMBL626314,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,9796,10116.0,,11231,CHEMBL626315,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,9796,10116.0,,11232,CHEMBL626316,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,9796,10116.0,,11233,CHEMBL626317,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11234,CHEMBL626318,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11235,CHEMBL626319,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11236,CHEMBL626320,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11237,CHEMBL875053,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11238,CHEMBL626321,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11239,CHEMBL626322,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11240,CHEMBL626323,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11241,CHEMBL626324,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11242,CHEMBL626325,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11243,CHEMBL626326,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11244,CHEMBL626327,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8363,10116.0,,11245,CHEMBL626328,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11246,CHEMBL626329,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11247,CHEMBL626330,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11248,CHEMBL626331,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11249,CHEMBL626332,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11250,CHEMBL626333,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11251,CHEMBL626334,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11252,CHEMBL626335,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8684,10116.0,,11253,CHEMBL624798,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11254,CHEMBL624799,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11255,CHEMBL624800,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11256,CHEMBL624801,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11257,CHEMBL624802,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11258,CHEMBL624803,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11259,CHEMBL624804,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11260,CHEMBL624805,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,8684,10116.0,,11261,CHEMBL624806,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11262,CHEMBL624807,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11263,CHEMBL624808,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11264,CHEMBL624809,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11265,CHEMBL624810,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11266,CHEMBL877618,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11267,CHEMBL624811,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11268,CHEMBL624812,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11269,CHEMBL624813,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11270,CHEMBL624814,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11271,CHEMBL624815,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11272,CHEMBL624816,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11273,CHEMBL624817,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11274,CHEMBL624818,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11275,CHEMBL624819,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11276,CHEMBL624820,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11277,CHEMBL624821,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11278,CHEMBL624822,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,11279,CHEMBL624823,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,1,
,,Escherichia coli,N,1,,,BAO_0000218,,A,,50212,Intermediate,,15599,562.0,,11280,CHEMBL624824,Observed diffusion coefficient in organic solvent for Escherichia coli,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9614,10116.0,,11281,CHEMBL624825,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9614,10116.0,,11282,CHEMBL624826,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cardiac atrium,A,,50597,Intermediate,,9614,10116.0,,11283,CHEMBL876817,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,2081.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cardiac atrium,A,,50597,Intermediate,,9614,10116.0,,11284,CHEMBL624827,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,2081.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9614,10116.0,,11285,CHEMBL624828,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9614,10116.0,,11286,CHEMBL624829,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9614,10116.0,,11287,CHEMBL624830,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9614,10116.0,,11288,CHEMBL624831,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cardiac atrium,A,,50597,Intermediate,,9614,10116.0,,11289,CHEMBL624832,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,2081.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cardiac atrium,A,,50597,Intermediate,,9614,10116.0,,11290,CHEMBL624833,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,2081.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9614,10116.0,,11291,CHEMBL624834,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9614,10116.0,,11292,CHEMBL624835,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9614,10116.0,,11293,CHEMBL624836,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,9614,10116.0,,11294,CHEMBL624837,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9071,10116.0,,11295,CHEMBL624838,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9071,10116.0,,11296,CHEMBL622188,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9071,10116.0,,11297,CHEMBL622189,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9071,10116.0,,11298,CHEMBL622190,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9071,10116.0,,11299,CHEMBL625170,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9071,10116.0,,11300,CHEMBL625171,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9071,10116.0,,11301,CHEMBL625172,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,9071,10116.0,,11302,CHEMBL625173,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9071,10116.0,,11303,CHEMBL625174,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9071,10116.0,,11304,CHEMBL625175,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9071,10116.0,,11305,CHEMBL625176,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9071,10116.0,,11306,CHEMBL625177,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9071,10116.0,,11307,CHEMBL625178,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9071,10116.0,,11308,CHEMBL625179,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9071,10116.0,,11309,CHEMBL625180,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,1,2048.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,10677,,,11310,CHEMBL625181,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,0,
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,9750,10090.0,,11311,CHEMBL625182,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11312,CHEMBL625183,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11313,CHEMBL875848,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11314,CHEMBL622260,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11315,CHEMBL622261,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11316,CHEMBL622262,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11317,CHEMBL622263,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11318,CHEMBL622418,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8319,10116.0,,11319,CHEMBL622419,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11320,CHEMBL623388,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,13256,10090.0,,11321,CHEMBL623389,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11322,CHEMBL623390,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11323,CHEMBL623391,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,13256,10090.0,,11324,CHEMBL623392,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Cerebellum,A,,50594,Intermediate,,13256,10090.0,,11325,CHEMBL623393,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2037.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11326,CHEMBL623394,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11327,CHEMBL618885,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,13256,10090.0,,11328,CHEMBL618886,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11329,CHEMBL618887,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11330,CHEMBL619535,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,13256,10090.0,,11331,CHEMBL619536,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Cerebellum,A,,50594,Intermediate,,13256,10090.0,,11332,CHEMBL619537,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2037.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11333,CHEMBL619705,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11334,CHEMBL619706,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,13256,10090.0,,11335,CHEMBL619707,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11336,CHEMBL619708,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11337,CHEMBL625219,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,13256,10090.0,,11338,CHEMBL625220,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Cerebellum,A,,50594,Intermediate,,13256,10090.0,,11339,CHEMBL625221,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2037.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11340,CHEMBL625222,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11341,CHEMBL625223,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,13256,10090.0,,11342,CHEMBL625224,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13256,10090.0,,11343,CHEMBL625225,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8829,10116.0,,11344,CHEMBL625226,Biodistribution in Rat blood after 24 hours of iv administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8829,10116.0,,11345,CHEMBL625227,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8829,10116.0,,11346,CHEMBL625228,Biodistribution in Rat blood after 30 minutes of iv administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8829,10116.0,,11347,CHEMBL875354,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8829,10116.0,,11348,CHEMBL625229,Biodistribution in Rat blood after 5 minutes of iv administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8829,10116.0,,11349,CHEMBL625230,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8829,10116.0,,11350,CHEMBL625231,Biodistribution in Rat heart after 24 hours of iv administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8829,10116.0,,11351,CHEMBL625900,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8829,10116.0,,11352,CHEMBL625901,Biodistribution in Rat heart after 30 minutes of iv administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8829,10116.0,,11353,CHEMBL625902,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8829,10116.0,,11354,CHEMBL625903,Biodistribution in Rat heart after 5 minutes of iv administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8829,10116.0,,11355,CHEMBL625904,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11356,CHEMBL625905,Biodistribution in Rat liver after 24 hours of iv administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11357,CHEMBL627861,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11358,CHEMBL627862,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11359,CHEMBL627863,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11360,CHEMBL627769,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,1,2107.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13249,9615.0,,11361,CHEMBL627770,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,In vivo,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,13622,9541.0,,11362,CHEMBL627771,Cmax in cynomolgus monkey (PO dose),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13622,10116.0,,11363,CHEMBL627772,Cmax in rat (PO dose),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13622,10116.0,,11364,CHEMBL627773,Cmax in rat (PO dose),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13494,10116.0,,11365,CHEMBL621922,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12170,10116.0,,11366,CHEMBL621923,Cmax in rat plasma after oral dose (10 mg/kg),In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,12170,,,11367,CHEMBL621924,Cmax in plasma after oral dose (10 mg/kg),In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17025,9615.0,,11368,CHEMBL621925,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,In vivo,1,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,17025,314293.0,,11369,CHEMBL621926,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,In vivo,0,1969.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Plasma,A,,50592,Intermediate,,17025,9986.0,,11370,CHEMBL621927,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17025,10116.0,,11371,CHEMBL621928,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14187,10116.0,,11372,CHEMBL621929,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14816,10090.0,,11373,CHEMBL621930,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17820,10116.0,,11374,CHEMBL621931,Maximum plasma concentration after oral dosing in rat,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11375,CHEMBL621932,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11376,CHEMBL621933,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14691,9615.0,,11377,CHEMBL621934,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14691,9615.0,,11378,CHEMBL621935,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13375,10116.0,,11379,CHEMBL621936,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,6236,,,11380,CHEMBL621937,Maximum plasma concentration was determined,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11381,CHEMBL621938,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11382,CHEMBL621939,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11383,CHEMBL621940,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11384,CHEMBL621941,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11385,CHEMBL621942,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11386,CHEMBL626178,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11387,CHEMBL626179,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14380,,,11388,CHEMBL626180,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13622,10116.0,,11389,CHEMBL626181,Plasma Cmax in rat (PO dose),In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,11390,CHEMBL626182,Maximum serum concentration after po dose of 5.22 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,11391,CHEMBL626183,Maximum serum concentration after po dose of 5.46 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,11392,CHEMBL626184,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15372,10116.0,,11393,CHEMBL626185,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14925,9615.0,,11394,CHEMBL626186,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14925,9615.0,,11395,CHEMBL877589,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11883,,,11396,CHEMBL626187,Maximum concentration of the drug at 1 uM/dg administered intravenously,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11883,,,11397,CHEMBL626188,Maximum concentration of the drug at 20 uM/dg administered perorally,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13391,,,11398,CHEMBL626189,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13391,,,11399,CHEMBL626855,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13391,,,11400,CHEMBL623781,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13391,,,11401,CHEMBL623782,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,0,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16360,10116.0,,11402,CHEMBL623783,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,3673,9615.0,,11403,CHEMBL623784,Cmax in dog plasma after 1mg/kg oral dose,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14431,9615.0,,11404,CHEMBL623785,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14431,10116.0,,11405,CHEMBL623786,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14964,10116.0,,11406,CHEMBL623787,Oral maximum concentration in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14964,10116.0,,11407,CHEMBL623788,Oral maximum concentration in rat,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,14209,10090.0,,11408,CHEMBL623789,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,11355,10090.0,,11409,CHEMBL623790,Peak concentration in blood after intravenous administration to mice,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,11355,10090.0,,11410,CHEMBL623791,Peak concentration in blood after peroral administration to mice,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,11966,10116.0,,11411,CHEMBL623792,Peak concentration in rat plasma was determined,In vivo,1,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,8918,314293.0,,11412,CHEMBL623793,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,0,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,8918,10090.0,,11413,CHEMBL623794,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,8918,10116.0,,11414,CHEMBL623795,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11415,CHEMBL623796,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11416,CHEMBL623797,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11417,CHEMBL623798,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11418,CHEMBL623799,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11419,CHEMBL624490,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11420,CHEMBL624491,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11421,CHEMBL624492,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11422,CHEMBL624493,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11423,CHEMBL877595,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11424,CHEMBL624494,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11425,CHEMBL624495,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,8684,10116.0,,11426,CHEMBL624681,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11427,CHEMBL624682,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11428,CHEMBL624683,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11429,CHEMBL624684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11430,CHEMBL624685,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11431,CHEMBL624686,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11432,CHEMBL624687,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11433,CHEMBL624688,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11434,CHEMBL627161,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11435,CHEMBL622127,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11436,CHEMBL622128,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11437,CHEMBL874384,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11438,CHEMBL624898,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11439,CHEMBL624899,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11440,CHEMBL624900,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11441,CHEMBL624901,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11442,CHEMBL624902,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11443,CHEMBL624903,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11444,CHEMBL624904,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11445,CHEMBL624905,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11446,CHEMBL624906,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11447,CHEMBL624907,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11448,CHEMBL624908,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11449,CHEMBL624909,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11450,CHEMBL624910,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11451,CHEMBL624911,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11452,CHEMBL874388,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11453,CHEMBL624912,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11454,CHEMBL622930,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11455,CHEMBL623121,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11456,CHEMBL623122,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11457,CHEMBL623123,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,8684,10116.0,,11458,CHEMBL623124,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11459,CHEMBL623125,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11460,CHEMBL623126,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11461,CHEMBL623127,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11462,CHEMBL623128,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11463,CHEMBL623129,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11464,CHEMBL623130,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11465,CHEMBL623131,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11466,CHEMBL623132,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8319,10116.0,,11467,CHEMBL623133,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11468,CHEMBL623134,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11469,CHEMBL874389,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11470,CHEMBL623135,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11471,CHEMBL623136,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11472,CHEMBL623137,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11473,CHEMBL623138,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11474,CHEMBL623139,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11475,CHEMBL623140,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8319,10116.0,,11476,CHEMBL623141,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8319,10116.0,,11477,CHEMBL623142,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11478,CHEMBL623143,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,14571,10090.0,,11479,CHEMBL623144,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,14571,10116.0,,11480,CHEMBL623405,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11481,CHEMBL624074,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11482,CHEMBL624075,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11483,CHEMBL624076,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11484,CHEMBL624077,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11485,CHEMBL624078,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11486,CHEMBL624079,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11487,CHEMBL624261,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11488,CHEMBL624262,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11489,CHEMBL624263,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11490,CHEMBL624264,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11491,CHEMBL624265,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11492,CHEMBL624266,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11493,CHEMBL624267,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11494,CHEMBL624268,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11495,CHEMBL875227,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11496,CHEMBL624269,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8319,10116.0,,11497,CHEMBL624270,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11498,CHEMBL624271,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11499,CHEMBL624272,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8319,10116.0,,11500,CHEMBL624273,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12064,10116.0,,11501,CHEMBL624274,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12064,10116.0,,11502,CHEMBL624275,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12064,10116.0,,11503,CHEMBL624276,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12038,10116.0,,11504,CHEMBL624277,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,1,1088.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14314,,,11505,CHEMBL624278,% dose converted to 2-amino-5-chlorophenyl sulfate,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14314,,,11506,CHEMBL624279,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,11488,10116.0,,11507,CHEMBL624280,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,11488,10116.0,,11508,CHEMBL624281,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,11488,10116.0,,11509,CHEMBL622933,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,11488,10116.0,,11510,CHEMBL622934,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11511,CHEMBL622935,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11512,CHEMBL622936,Biodistribution in Rat liver after 5 minutes of iv administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8829,10116.0,,11513,CHEMBL875228,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8829,10116.0,,11514,CHEMBL622937,Biodistribution in Rat lung after 24 hours of iv administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8829,10116.0,,11515,CHEMBL622938,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8829,10116.0,,11516,CHEMBL619736,Biodistribution in Rat lung after 30 minutes of iv administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8829,10116.0,,11517,CHEMBL625117,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8829,10116.0,,11518,CHEMBL625118,Biodistribution in Rat lung after 5 minutes of iv administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8829,10116.0,,11519,CHEMBL625119,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14972,10116.0,,11520,CHEMBL625120,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14972,10116.0,,11521,CHEMBL625121,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Thalamus,A,,50597,Intermediate,,14972,10116.0,,11522,CHEMBL625122,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",In vivo,1,10000006.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14608,10116.0,,11523,CHEMBL622204,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14608,10116.0,,11524,CHEMBL877503,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14608,10116.0,,11525,CHEMBL627127,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,178.0
,,,U,1,,,BAO_0000218,Hippocampus,A,,22224,Autocuration,,14608,,,11526,CHEMBL627128,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,0,10000000.0
,,,U,1,,,BAO_0000218,Hippocampus,A,,22224,Autocuration,,14608,,,11527,CHEMBL627129,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,0,10000000.0
,,,U,1,,,BAO_0000218,Hippocampus,A,,22224,Autocuration,,14608,,,11528,CHEMBL627130,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,0,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14608,10116.0,,11529,CHEMBL627131,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14608,10116.0,,11530,CHEMBL627132,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14608,10116.0,,11531,CHEMBL627133,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14608,10116.0,,11532,CHEMBL627134,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14608,10116.0,,11533,CHEMBL627135,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14608,10116.0,,11534,CHEMBL627136,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14608,10116.0,,11535,CHEMBL628435,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14608,10116.0,,11536,CHEMBL628436,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14608,10116.0,,11537,CHEMBL628437,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14608,10116.0,,11538,CHEMBL628438,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14608,10116.0,,11539,CHEMBL628439,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14608,10116.0,,11540,CHEMBL628440,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,14608,10116.0,,11541,CHEMBL628441,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,14608,10116.0,,11542,CHEMBL628442,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,14608,10116.0,,11543,CHEMBL628443,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14608,10116.0,,11544,CHEMBL628444,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14608,10116.0,,11545,CHEMBL628445,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14608,10116.0,,11546,CHEMBL877504,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14608,10116.0,,11547,CHEMBL628446,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14608,10116.0,,11548,CHEMBL626874,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14608,10116.0,,11549,CHEMBL626875,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14608,10116.0,,11550,CHEMBL626876,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14608,10116.0,,11551,CHEMBL626877,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14608,10116.0,,11552,CHEMBL626878,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14608,10116.0,,11553,CHEMBL626879,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2385.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,8918,314293.0,,11554,CHEMBL626880,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,0,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,8918,10090.0,,11555,CHEMBL626881,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,8918,10116.0,,11556,CHEMBL626882,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14470,9615.0,,11557,CHEMBL626883,Peak plasma concentration was measured in dogs,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,11558,CHEMBL626884,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14886,10116.0,,11559,CHEMBL626885,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14886,10116.0,,11560,CHEMBL626886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14886,10116.0,,11561,CHEMBL626887,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,11562,CHEMBL626888,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13465,9615.0,,11563,CHEMBL626889,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13465,314293.0,,11564,CHEMBL626761,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13465,9615.0,,11565,CHEMBL626762,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13465,9615.0,,11566,CHEMBL626763,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13465,10116.0,,11567,CHEMBL626764,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13465,10116.0,,11568,CHEMBL626765,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13465,9615.0,,11569,CHEMBL626766,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13465,10116.0,,11570,CHEMBL626767,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13465,10116.0,,11571,CHEMBL626768,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13465,9615.0,,11572,CHEMBL626769,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13465,9615.0,,11573,CHEMBL874463,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13465,314293.0,,11574,CHEMBL626770,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,In vivo,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13465,314293.0,,11575,CHEMBL626771,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13465,10116.0,,11576,CHEMBL626772,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14731,9541.0,,11577,CHEMBL626773,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14731,10090.0,,11578,CHEMBL626774,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13376,9615.0,,11579,CHEMBL626775,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13376,9615.0,,11580,CHEMBL626776,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14443,10116.0,,11581,CHEMBL626777,Maximum concentration (Cmax) in rat when administered orally,In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13465,314293.0,,11582,CHEMBL626778,Maximal concentration in monkey plasma after 25 mg/kg oral dose,In vivo,0,1969.0
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16359,10116.0,,11583,CHEMBL626779,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16359,10116.0,,11584,CHEMBL626780,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",In vivo,0,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,15618,,,11585,CHEMBL626781,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14554,10116.0,,11586,CHEMBL632164,Pharmacokinetic profile Cmax was evaluated in rats,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,11537,9615.0,,11587,CHEMBL632165,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,11537,10090.0,,11588,CHEMBL632166,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,11537,9615.0,,11589,CHEMBL632167,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,11537,10090.0,,11590,CHEMBL632168,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,2021,10116.0,,11591,CHEMBL632169,Cmax in rat plasma,In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,5932,9615.0,,11592,CHEMBL632170,Cmax in dog plasma after 30mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5932,10116.0,,11593,CHEMBL632171,Cmax in rat plasma after 30mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17320,10116.0,,11594,CHEMBL632172,Plasma level in rats at 30 mg/kg,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,15831,10090.0,,11595,CHEMBL632173,Tested for maximum plasma concentration in mice,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,11596,CHEMBL632174,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,11597,CHEMBL632175,The Cmax values in female wistar rats.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,15343,9615.0,,11598,CHEMBL632176,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15343,10116.0,,11599,CHEMBL632177,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14856,10116.0,,11600,CHEMBL632178,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13129,10116.0,,11601,CHEMBL632179,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13098,10116.0,,11602,CHEMBL632180,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13098,10116.0,,11603,CHEMBL632181,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13098,10116.0,,11604,CHEMBL632182,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,In vivo,1,178.0
,,Mus musculus,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,15478,10090.0,,11605,CHEMBL632183,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,In vivo,0,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15341,9615.0,,11606,CHEMBL632184,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,11607,CHEMBL874470,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11608,CHEMBL631302,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11609,CHEMBL631303,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11610,CHEMBL631304,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11611,CHEMBL631305,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11612,CHEMBL631306,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11613,CHEMBL631307,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11614,CHEMBL631308,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8684,10116.0,,11615,CHEMBL625557,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11616,CHEMBL625558,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11617,CHEMBL625559,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11618,CHEMBL625560,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11619,CHEMBL625561,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11620,CHEMBL625562,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11621,CHEMBL875320,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11622,CHEMBL625563,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,8684,10116.0,,11623,CHEMBL625564,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11624,CHEMBL625565,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11625,CHEMBL625566,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11626,CHEMBL625567,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11627,CHEMBL625568,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11628,CHEMBL628217,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11629,CHEMBL628218,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11630,CHEMBL628219,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8684,10116.0,,11631,CHEMBL628220,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,1,995.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11632,CHEMBL628221,Distribution in the blood after 120 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11633,CHEMBL628222,Distribution in the blood after 15 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11634,CHEMBL628223,Distribution in the blood after 30 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11635,CHEMBL628224,Distribution in the blood after 5 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11636,CHEMBL628225,Distribution in the blood after 60 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11637,CHEMBL628226,Distribution in the blood after 90 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11638,CHEMBL628227,Distribution in the bone after 120 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11639,CHEMBL875481,Distribution in the bone after 15 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11640,CHEMBL628228,Distribution in the bone after 30 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11641,CHEMBL628229,Distribution in the bone after 5 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11642,CHEMBL628230,Distribution in the bone after 60 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11643,CHEMBL628231,Distribution in the bone after 90 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11644,CHEMBL628232,Distribution in the heart after 120 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11645,CHEMBL628233,Distribution in the heart after 15 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11646,CHEMBL628234,Distribution in the heart after 30 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11647,CHEMBL628235,Distribution in the heart after 5 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11648,CHEMBL628236,Distribution in the heart after 60 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11649,CHEMBL628237,Distribution in the heart after 90 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11650,CHEMBL628238,Distribution in the kidneys after 120 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11651,CHEMBL628239,Distribution in the kidneys after 15 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11652,CHEMBL628240,Distribution in the kidneys after 30 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11653,CHEMBL628241,Distribution in the kidneys after 5 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11654,CHEMBL628242,Distribution in the kidneys after 60 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11655,CHEMBL875482,Distribution in the kidneys after 90 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11656,CHEMBL628243,Distribution in the liver after 120 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11657,CHEMBL628244,Distribution in the liver after 15 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11658,CHEMBL628245,Distribution in the liver after 30 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11659,CHEMBL628246,Distribution in the liver after 5 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11660,CHEMBL628247,Distribution in the liver after 60 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11661,CHEMBL628248,Distribution in the liver after 90 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11662,CHEMBL628249,Distribution in the lung after 120 min of intravenous administration,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,11663,CHEMBL625452,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,11664,CHEMBL625453,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,11665,CHEMBL625454,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14839,10090.0,,11666,CHEMBL623844,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12178,10116.0,,11667,CHEMBL623845,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12178,10116.0,,11668,CHEMBL623846,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12178,,,11669,CHEMBL623847,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,0,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,11670,CHEMBL623848,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,11671,CHEMBL623849,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,11672,CHEMBL623850,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,11673,CHEMBL623851,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,11674,CHEMBL623852,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,0,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,12187,9669.0,,11675,CHEMBL624551,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,12187,9669.0,,11676,CHEMBL624552,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,11677,CHEMBL624553,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,11678,CHEMBL624554,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12187,10116.0,,11679,CHEMBL624555,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12187,10116.0,,11680,CHEMBL624741,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14122,9615.0,,11681,CHEMBL624742,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,14122,10026.0,,11682,CHEMBL624743,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14122,10116.0,,11683,CHEMBL877606,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13391,,,11684,CHEMBL624744,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,0,
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13391,,,11685,CHEMBL624745,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13391,,,11686,CHEMBL624746,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13391,,,11687,CHEMBL624747,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,0,178.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,16360,,,11688,CHEMBL624748,Oral absorption expressed as Area under curve was determined,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,3673,9615.0,,11689,CHEMBL622504,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14122,9615.0,,11690,CHEMBL622505,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,14122,10026.0,,11691,CHEMBL622506,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,14122,10026.0,,11692,CHEMBL622507,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14122,10116.0,,11693,CHEMBL622508,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13889,,,11694,CHEMBL622509,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,11695,CHEMBL622510,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17279,10116.0,,11696,CHEMBL622511,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14548,9541.0,,11697,CHEMBL622512,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14548,9541.0,,11698,CHEMBL622513,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14548,9541.0,,11699,CHEMBL622514,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14548,9615.0,,11700,CHEMBL622515,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14548,9615.0,,11701,CHEMBL622516,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14548,10116.0,,11702,CHEMBL622517,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14548,10116.0,,11703,CHEMBL622518,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14548,10116.0,,11704,CHEMBL622519,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14608,10116.0,,11705,CHEMBL622520,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14608,10116.0,,11706,CHEMBL622521,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,14608,10090.0,,11707,CHEMBL625113,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,14608,10116.0,,11708,CHEMBL625114,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,14608,10116.0,,11709,CHEMBL874397,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14608,10116.0,,11710,CHEMBL625115,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14608,10116.0,,11711,CHEMBL625116,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14608,10116.0,,11712,CHEMBL623932,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,14608,10116.0,,11713,CHEMBL623933,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,14608,10116.0,,11714,CHEMBL623934,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,14608,10116.0,,11715,CHEMBL623935,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,14608,10116.0,,11716,CHEMBL623936,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,14608,10116.0,,11717,CHEMBL623937,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,14608,10116.0,,11718,CHEMBL623938,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,1,2046.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11719,CHEMBL623939,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11720,CHEMBL623940,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11721,CHEMBL623941,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11722,CHEMBL627216,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11723,CHEMBL623942,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,15383,10090.0,,11724,CHEMBL618793,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,15383,10090.0,,11725,CHEMBL618794,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,15383,10090.0,,11726,CHEMBL618795,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11727,CHEMBL618796,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11728,CHEMBL618797,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15383,10090.0,,11729,CHEMBL618798,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15383,10090.0,,11730,CHEMBL618799,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15383,10090.0,,11731,CHEMBL618800,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15383,10090.0,,11732,CHEMBL618801,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15383,10090.0,,11733,CHEMBL618802,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15383,10090.0,,11734,CHEMBL618803,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15383,10090.0,,11735,CHEMBL618804,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15383,10090.0,,11736,CHEMBL618805,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15383,10090.0,,11737,CHEMBL618806,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15383,10090.0,,11738,CHEMBL618807,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15383,10090.0,,11739,CHEMBL618808,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15383,10090.0,,11740,CHEMBL618809,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,15383,10090.0,,11741,CHEMBL618810,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,15383,10090.0,,11742,CHEMBL618811,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,15383,10090.0,,11743,CHEMBL875844,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,15383,10090.0,,11744,CHEMBL618812,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,15383,10090.0,,11745,CHEMBL618813,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11746,CHEMBL618814,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11747,CHEMBL618815,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11748,CHEMBL618816,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11749,CHEMBL618817,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11750,CHEMBL620544,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,11751,CHEMBL626230,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,11752,CHEMBL626231,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,11753,CHEMBL626232,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14906,9615.0,,11754,CHEMBL626233,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14906,10116.0,,11755,CHEMBL626234,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14906,10116.0,,11756,CHEMBL875341,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,In vivo,1,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,14215,9606.0,,11757,CHEMBL626235,The maximum plasma concentration (100 mg/kg) administered orally in human,In vivo,1,1969.0
,,Callithrix,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14215,9481.0,,11758,CHEMBL626236,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,In vivo,0,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14215,314293.0,,11759,CHEMBL626237,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,In vivo,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14215,9615.0,,11760,CHEMBL626238,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,In vivo,1,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,14215,9606.0,,11761,CHEMBL622412,The maximum plasma concentration (200 mg/kg) administered orally in human,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14215,10116.0,,11762,CHEMBL623114,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,In vivo,1,1969.0
,,Callithrix,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14215,9481.0,,11763,CHEMBL623115,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,In vivo,0,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14215,314293.0,,11764,CHEMBL623116,The maximum plasma concentration (25 mg/kg) administered orally in monkey,In vivo,0,1969.0
,,Canis lupus familiaris,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14215,9615.0,,11765,CHEMBL623117,The maximum plasma concentration (30 mg/kg) administered orally in dog,In vivo,0,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,14215,9606.0,,11766,CHEMBL623118,The maximum plasma concentration (400 mg/kg) administered orally in human,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14215,10116.0,,11767,CHEMBL623119,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14215,10116.0,,11768,CHEMBL623120,The maximum plasma concentration (50 mg/kg) administered orally in rat,In vivo,1,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,14215,9606.0,,11769,CHEMBL623286,The maximum plasma concentration (800 mg/kg) administered orally in human,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14067,10116.0,,11770,CHEMBL623287,The maximum plasma concentration was measured on rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12350,10116.0,,11771,CHEMBL623288,The maximum plasma concentration was measured on rats after oral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14813,10116.0,,11772,CHEMBL623289,Plasma drug Cmax in rat (PO dose),In vivo,1,1969.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12536,,,11773,CHEMBL623290,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14169,9615.0,,11774,CHEMBL623291,maximum Plasma concentration in Dog was determined after Peroral administration,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14169,10116.0,,11775,CHEMBL623292,maximum Plasma concentration in Rats was determined after Peroral administration,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,15604,9615.0,,11776,CHEMBL623293,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,In vivo,1,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,15604,314293.0,,11777,CHEMBL623294,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15604,10116.0,,11778,CHEMBL623295,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,In vivo,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14387,10090.0,,11779,CHEMBL623296,maximum concentration was measured when administered through oral route in mice,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15115,10090.0,,11780,CHEMBL875349,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,1,
,,Simiiformes,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15115,314293.0,,11781,CHEMBL623297,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,0,
,,Simiiformes,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15115,314293.0,,11782,CHEMBL623298,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,0,
,,Simiiformes,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15115,314293.0,,11783,CHEMBL623299,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16359,10116.0,,11784,CHEMBL623300,Pharmacokinetic parameter was evaluated in rats,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12829,10090.0,,11785,CHEMBL623301,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12829,10090.0,,11786,CHEMBL623302,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12829,10090.0,,11787,CHEMBL623303,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12829,10090.0,,11788,CHEMBL623304,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12829,10090.0,,11789,CHEMBL623305,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,11790,CHEMBL623306,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,11791,CHEMBL623307,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15137,10116.0,,11792,CHEMBL623308,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,15137,10090.0,,11793,CHEMBL623309,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13509,10090.0,,11794,CHEMBL623310,Plasma Concentration after 120 min of oral administration to mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13509,10090.0,,11795,CHEMBL623311,Plasma Concentration after 30 min of oral administration to mice,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,13509,9541.0,,11796,CHEMBL623312,Plasma Concentration after 60 min of oral administration to mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13509,10090.0,,11797,CHEMBL875350,Plasma Concentration after 60 min of oral administration to mice; Not determined,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13509,10090.0,,11798,CHEMBL628635,Plasma Concentration after 90 min of oral administration to mice,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12064,10116.0,,11799,CHEMBL628636,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12064,10116.0,,11800,CHEMBL628637,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12064,10116.0,,11801,CHEMBL628058,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11802,CHEMBL628059,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11803,CHEMBL628060,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11804,CHEMBL628061,Distribution in the lung after 15 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11805,CHEMBL628062,Distribution in the lung after 30 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11806,CHEMBL628063,Distribution in the lung after 5 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11807,CHEMBL628064,Distribution in the lung after 60 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8926,,,11808,CHEMBL628065,Distribution in the lung after 90 min of intravenous administration,,0,
,,,U,1,,,BAO_0000019,Muscle tissue,A,,22224,Autocuration,,8926,,,11809,CHEMBL628066,Distribution in the muscle after 120 min of intravenous administration,,0,2385.0
,,,U,1,,,BAO_0000019,Muscle tissue,A,,22224,Autocuration,,8926,,,11810,CHEMBL628067,Distribution in the muscle after 15 min of intravenous administration,,0,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Muscle tissue,A,,50594,Intermediate,,8926,10090.0,,11811,CHEMBL874646,Distribution in the muscle after 30 min of intravenous administration,,1,2385.0
,,,U,1,,,BAO_0000019,Muscle tissue,A,,22224,Autocuration,,8926,,,11812,CHEMBL628068,Distribution in the muscle after 5 min of intravenous administration,,0,2385.0
,,,U,1,,,BAO_0000019,Muscle tissue,A,,22224,Autocuration,,8926,,,11813,CHEMBL628069,Distribution in the muscle after 60 min of intravenous administration,,0,2385.0
,,,U,1,,,BAO_0000019,Muscle tissue,A,,22224,Autocuration,,8926,,,11814,CHEMBL628070,Distribution in the muscle after 90 min of intravenous administration,,0,2385.0
,,,U,1,,,BAO_0000019,Spleen,A,,22224,Autocuration,,8926,,,11815,CHEMBL628071,Distribution in the spleen after 120 min of intravenous administration,,0,2106.0
,,,U,1,,,BAO_0000019,Spleen,A,,22224,Autocuration,,8926,,,11816,CHEMBL628072,Distribution in the spleen after 15 min of intravenous administration,,0,2106.0
,,,U,1,,,BAO_0000019,Spleen,A,,22224,Autocuration,,8926,,,11817,CHEMBL628073,Distribution in the spleen after 30 min of intravenous administration,,0,2106.0
,,,U,1,,,BAO_0000019,Spleen,A,,22224,Autocuration,,8926,,,11818,CHEMBL628074,Distribution in the spleen after 5 min of intravenous administration,,0,2106.0
,,,U,1,,,BAO_0000019,Spleen,A,,22224,Autocuration,,8926,,,11819,CHEMBL628075,Distribution in the spleen after 60 min of intravenous administration,,0,2106.0
,,,U,1,,,BAO_0000019,Spleen,A,,22224,Autocuration,,8926,,,11820,CHEMBL628076,Distribution in the spleen after 90 min of intravenous administration,,0,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal cortex,A,,50597,Intermediate,,7570,10116.0,,11821,CHEMBL628077,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,1,1235.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7570,10116.0,,11822,CHEMBL628078,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7570,10116.0,,11823,CHEMBL628079,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,7570,10116.0,,11824,CHEMBL628080,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7570,10116.0,,11825,CHEMBL628081,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal cortex,A,,50597,Intermediate,,7570,10116.0,,11826,CHEMBL628082,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,1,1235.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7570,10116.0,,11827,CHEMBL874647,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7570,10116.0,,11828,CHEMBL626406,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,7570,10116.0,,11829,CHEMBL626407,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,7570,10116.0,,11830,CHEMBL626408,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11831,CHEMBL626409,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11832,CHEMBL626410,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11833,CHEMBL626411,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11834,CHEMBL626412,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11835,CHEMBL626413,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11836,CHEMBL626414,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11837,CHEMBL626415,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11838,CHEMBL626416,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11839,CHEMBL627062,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11840,CHEMBL627063,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11841,CHEMBL627064,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11842,CHEMBL627227,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11843,CHEMBL627228,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11844,CHEMBL627229,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11845,CHEMBL625792,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11846,CHEMBL625793,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11847,CHEMBL625794,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8608,10116.0,,11848,CHEMBL625795,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13792,10090.0,,11849,CHEMBL625796,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13376,9615.0,,11850,CHEMBL625797,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13376,9615.0,,11851,CHEMBL625798,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11852,CHEMBL875613,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11853,CHEMBL625799,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11854,CHEMBL625800,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11855,CHEMBL625801,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11856,CHEMBL625802,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11857,CHEMBL625803,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14380,,,11858,CHEMBL625804,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14380,,,11859,CHEMBL622530,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11860,CHEMBL622531,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11861,CHEMBL622532,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11862,CHEMBL623176,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11863,CHEMBL623177,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11864,CHEMBL623178,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11865,CHEMBL623179,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11866,CHEMBL623180,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11867,CHEMBL623181,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11868,CHEMBL624131,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11869,CHEMBL624132,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11870,CHEMBL624133,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11871,CHEMBL624846,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11872,CHEMBL624847,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11873,CHEMBL624848,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11874,CHEMBL625012,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11875,CHEMBL625013,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11876,CHEMBL625014,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11877,CHEMBL625015,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11878,CHEMBL625016,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11879,CHEMBL625017,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11880,CHEMBL625018,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11881,CHEMBL625019,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11882,CHEMBL625020,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,11883,CHEMBL625021,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,11884,CHEMBL625022,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14731,10090.0,,11885,CHEMBL625023,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14731,9541.0,,11886,CHEMBL625024,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14731,9541.0,,11887,CHEMBL627626,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,1,
,,,U,1,,,BAO_0000218,Brain,A,,22224,Autocuration,,13758,,,11888,CHEMBL627627,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,0,955.0
,,,U,1,,,BAO_0000218,Serum,A,,22224,Autocuration,,13758,,,11889,CHEMBL627628,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,0,1977.0
,,,U,1,,,BAO_0000218,Brain,A,,22224,Autocuration,,13758,,,11890,CHEMBL627629,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,0,955.0
,,,U,1,,,BAO_0000218,Serum,A,,22224,Autocuration,,13758,,,11891,CHEMBL627630,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,0,1977.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,16359,,,11892,CHEMBL627631,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16359,,,11893,CHEMBL629515,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,0,
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,15383,10090.0,,11894,CHEMBL629516,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,15383,10090.0,,11895,CHEMBL629517,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,15383,10090.0,,11896,CHEMBL629518,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11897,CHEMBL877499,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11898,CHEMBL629519,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11899,CHEMBL629520,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,15383,10090.0,,11900,CHEMBL629521,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11901,CHEMBL629522,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11902,CHEMBL629523,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11903,CHEMBL629524,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11904,CHEMBL629525,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11905,CHEMBL629526,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11906,CHEMBL629527,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11907,CHEMBL629528,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11908,CHEMBL629529,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11909,CHEMBL629530,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11910,CHEMBL629531,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11911,CHEMBL628656,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,11912,CHEMBL628657,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11913,CHEMBL628658,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11914,CHEMBL628659,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11915,CHEMBL877500,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11916,CHEMBL628660,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11917,CHEMBL628661,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11918,CHEMBL628662,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11919,CHEMBL628663,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,11920,CHEMBL628664,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11921,CHEMBL628665,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11922,CHEMBL628666,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11923,CHEMBL628667,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11924,CHEMBL628668,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11925,CHEMBL628669,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11926,CHEMBL628670,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13751,10116.0,,11927,CHEMBL628671,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,13751,10116.0,,11928,CHEMBL628672,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,13751,10116.0,,11929,CHEMBL630300,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,13751,10116.0,,11930,CHEMBL629787,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,13751,10116.0,,11931,CHEMBL629788,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,11932,CHEMBL629789,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,11933,CHEMBL629790,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,11934,CHEMBL629791,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,11935,CHEMBL629792,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,11936,CHEMBL629793,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,11937,CHEMBL629794,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11938,CHEMBL874459,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11939,CHEMBL629795,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11940,CHEMBL629796,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11941,CHEMBL629797,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10677,10116.0,,11942,CHEMBL629798,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal gland,A,,50597,Intermediate,,10911,10116.0,,11943,CHEMBL629799,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2369.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal gland,A,,50597,Intermediate,,10911,10116.0,,11944,CHEMBL629800,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2369.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal gland,A,,50597,Intermediate,,10911,10116.0,,11945,CHEMBL629801,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2369.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal gland,A,,50597,Intermediate,,10911,10116.0,,11946,CHEMBL629802,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,In vivo,1,2369.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Adrenal gland,A,,50597,Intermediate,,10911,10116.0,,11947,CHEMBL629803,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2369.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10911,10116.0,,11948,CHEMBL629804,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10911,10116.0,,11949,CHEMBL629805,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10911,10116.0,,11950,CHEMBL629806,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10911,10116.0,,11951,CHEMBL629807,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,10911,10116.0,,11952,CHEMBL629808,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10911,10116.0,,11953,CHEMBL629809,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10911,10116.0,,11954,CHEMBL629810,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10911,10116.0,,11955,CHEMBL629811,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10911,10116.0,,11956,CHEMBL629812,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10911,10116.0,,11957,CHEMBL629813,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,10911,10116.0,,11958,CHEMBL874460,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10911,10116.0,,11959,CHEMBL629814,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10911,10116.0,,11960,CHEMBL629815,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10911,10116.0,,11961,CHEMBL629816,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10911,10116.0,,11962,CHEMBL629817,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10911,10116.0,,11963,CHEMBL626643,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10911,10116.0,,11964,CHEMBL626644,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10911,10116.0,,11965,CHEMBL626806,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,10911,10116.0,,11966,CHEMBL626807,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10911,10116.0,,11967,CHEMBL627261,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10911,10116.0,,11968,CHEMBL627262,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10911,10116.0,,11969,CHEMBL627263,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,10911,10116.0,,11970,CHEMBL627264,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10911,10116.0,,11971,CHEMBL627265,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10911,10116.0,,11972,CHEMBL627266,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10911,10116.0,,11973,CHEMBL627267,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,10911,10116.0,,11974,CHEMBL627268,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10911,10116.0,,11975,CHEMBL627269,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10911,10116.0,,11976,CHEMBL627270,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11977,CHEMBL627271,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11978,CHEMBL627946,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11979,CHEMBL875472,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11980,CHEMBL627947,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11981,CHEMBL627948,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11982,CHEMBL628113,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11983,CHEMBL628114,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11984,CHEMBL628115,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11985,CHEMBL628116,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11986,CHEMBL628117,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11987,CHEMBL628118,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11988,CHEMBL628119,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11989,CHEMBL628120,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11990,CHEMBL628121,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11991,CHEMBL628122,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11992,CHEMBL627297,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11993,CHEMBL627298,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11994,CHEMBL627299,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11995,CHEMBL627300,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11996,CHEMBL627301,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11997,CHEMBL627302,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11998,CHEMBL627303,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,11999,CHEMBL627304,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12000,CHEMBL627305,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12001,CHEMBL627306,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12002,CHEMBL623982,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12003,CHEMBL623983,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12004,CHEMBL623984,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12005,CHEMBL623985,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12006,CHEMBL623986,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12007,CHEMBL623987,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12008,CHEMBL623988,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12009,CHEMBL623989,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12010,CHEMBL622215,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12011,CHEMBL622216,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8608,10116.0,,12012,CHEMBL877481,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16359,,,12013,CHEMBL622217,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13701,10090.0,,12014,CHEMBL622218,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14554,10116.0,,12015,CHEMBL622219,Pharmacokinetic profile AUC was evaluated in rats,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6241,,,12016,CHEMBL622220,Pharmacokinetic property (Area under curve),,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,11537,9615.0,,12017,CHEMBL622221,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,11537,10090.0,,12018,CHEMBL622222,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,11537,9615.0,,12019,CHEMBL622223,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,11537,10090.0,,12020,CHEMBL622224,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,12021,CHEMBL622225,Plasma concentration (AUC) was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,12022,CHEMBL622226,Plasma concentration (AUC) was determined; Not detectable,,0,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,9562,10141.0,,12023,CHEMBL624154,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10363,10116.0,,12024,CHEMBL624155,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10363,10116.0,,12025,CHEMBL624156,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10363,10116.0,,12026,CHEMBL624157,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10363,10116.0,,12027,CHEMBL624158,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,12028,CHEMBL624159,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,12029,CHEMBL624160,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,12030,CHEMBL624161,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,12031,CHEMBL624162,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13317,9615.0,,12032,CHEMBL624163,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,12033,CHEMBL624164,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,12034,CHEMBL624165,The AUC(0-infinity) values in female wistar rats.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,12035,CHEMBL624166,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,12036,CHEMBL624167,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,12037,CHEMBL624168,The AUC(0-t)values in female wistar rats.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14067,10116.0,,12038,CHEMBL624169,The Area under the concentration time curve of compound was measured on rats,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,14215,9606.0,,12039,CHEMBL624170,The area under curve (100 mg/kg) administered orally in humans,,1,
,,Callithrix,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14215,9481.0,,12040,CHEMBL624171,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14215,314293.0,,12041,CHEMBL624172,The area under curve (12.5 mg/kg) administered intravenously in monkey,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14215,9615.0,,12042,CHEMBL624173,The area under curve (15 mg/kg) administered intravenously in dog,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,14215,9606.0,,12043,CHEMBL877488,The area under curve (200 mg/kg) administered orally in humans,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14215,10116.0,,12044,CHEMBL624174,The area under curve (25 mg/kg) administered intravenously in rat,,1,
,,Callithrix,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14215,9481.0,,12045,CHEMBL624175,The area under curve (25 mg/kg) administered orally in marmoset,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14215,314293.0,,12046,CHEMBL624176,The area under curve (25 mg/kg) administered orally in monkey,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14215,9615.0,,12047,CHEMBL624177,The area under curve (30 mg/kg) administered orally in dog,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,14215,9606.0,,12048,CHEMBL624178,The area under curve (400 mg/kg) administered orally in humans,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14215,10116.0,,12049,CHEMBL624179,The area under curve (50 mg/kg) administered orally in fasted rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14215,10116.0,,12050,CHEMBL627689,The area under curve (50 mg/kg) administered orally in rat,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,14215,9606.0,,12051,CHEMBL627690,The area under curve (800 mg/kg) administered orally in humans,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11324,,,12052,CHEMBL627691,The compound was evaluated for area under the curve,,0,
,,Callithrix,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11324,9481.0,,12053,CHEMBL627692,The compound was evaluated for area under the curve in marmosets,,0,
,,Callithrix,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11324,9481.0,,12054,CHEMBL627693,The compound was evaluated for area under the curve in marmosets,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13875,10116.0,,12055,CHEMBL627694,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13875,10116.0,,12056,CHEMBL627695,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13875,,,12057,CHEMBL627696,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13875,10116.0,,12058,CHEMBL627697,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13875,10116.0,,12059,CHEMBL627698,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13875,10116.0,,12060,CHEMBL627699,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13807,10116.0,,12061,CHEMBL627700,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14127,10116.0,,12062,CHEMBL627701,Total drug exposure is determined after oral dosing in rats.,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15116,,,12063,CHEMBL627702,Total drug exposure (5 mg/kg) when administered intravenously,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15116,,,12064,CHEMBL627703,Total drug exposure (5 mg/kg) when administered orally,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15604,314293.0,,12065,CHEMBL626873,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15604,10116.0,,12066,CHEMBL629583,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15604,9615.0,,12067,CHEMBL629584,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15604,9615.0,,12068,CHEMBL629585,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,12069,CHEMBL629586,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13751,10116.0,,12070,CHEMBL629587,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12071,CHEMBL629588,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12072,CHEMBL629589,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12073,CHEMBL629590,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12074,CHEMBL629591,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12075,CHEMBL629592,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12076,CHEMBL629593,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12077,CHEMBL629594,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12078,CHEMBL629595,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12079,CHEMBL630290,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12080,CHEMBL627137,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12081,CHEMBL627138,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12082,CHEMBL627139,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12083,CHEMBL627140,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13751,10116.0,,12084,CHEMBL627141,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12085,CHEMBL627142,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12086,CHEMBL627143,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12087,CHEMBL874449,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12088,CHEMBL627144,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12089,CHEMBL627145,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12090,CHEMBL627146,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13751,10116.0,,12091,CHEMBL627147,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12092,CHEMBL627148,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12093,CHEMBL627149,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12094,CHEMBL632160,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12095,CHEMBL632161,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12096,CHEMBL632162,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12097,CHEMBL632163,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12098,CHEMBL874469,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13751,10116.0,,12099,CHEMBL627182,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12100,CHEMBL627183,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12101,CHEMBL627184,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12102,CHEMBL627185,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12103,CHEMBL627186,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12104,CHEMBL627187,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12105,CHEMBL627188,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13751,10116.0,,12106,CHEMBL627189,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13751,10116.0,,12107,CHEMBL627190,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12108,CHEMBL627191,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12109,CHEMBL627192,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12110,CHEMBL627193,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10911,10116.0,,12111,CHEMBL874590,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10911,10116.0,,12112,CHEMBL627194,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10911,10116.0,,12113,CHEMBL627195,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,10911,10116.0,,12114,CHEMBL627196,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,10911,10116.0,,12115,CHEMBL627197,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,10911,10116.0,,12116,CHEMBL627198,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,10911,10116.0,,12117,CHEMBL627199,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,In vivo,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Female gonad,A,,50597,Intermediate,,10911,10116.0,,12118,CHEMBL627200,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,992.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,10911,10116.0,,12119,CHEMBL627201,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,10911,10116.0,,12120,CHEMBL627202,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,10911,10116.0,,12121,CHEMBL627203,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,10911,10116.0,,12122,CHEMBL627204,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10911,10116.0,,12123,CHEMBL627205,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10911,10116.0,,12124,CHEMBL627206,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10911,10116.0,,12125,CHEMBL627207,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,10911,10116.0,,12126,CHEMBL627208,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10911,10116.0,,12127,CHEMBL627209,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10911,10116.0,,12128,CHEMBL627210,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10911,10116.0,,12129,CHEMBL627211,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,10911,10116.0,,12130,CHEMBL627212,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,10911,10116.0,,12131,CHEMBL627213,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,10911,10116.0,,12132,CHEMBL626599,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,10911,10116.0,,12133,CHEMBL626600,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,10911,10116.0,,12134,CHEMBL626601,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,1,995.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8081,,,12135,CHEMBL627484,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,0,
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,17248,9541.0,,12136,CHEMBL627485,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,17248,9541.0,,12137,CHEMBL628147,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,17248,9541.0,,12138,CHEMBL628148,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17248,9615.0,,12139,CHEMBL628149,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17248,9615.0,,12140,CHEMBL628150,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17248,9615.0,,12141,CHEMBL628318,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17248,9615.0,,12142,CHEMBL628319,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15592,9615.0,,12143,CHEMBL875609,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12144,CHEMBL628320,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12145,CHEMBL628321,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12146,CHEMBL628322,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12147,CHEMBL628323,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12148,CHEMBL628324,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12149,CHEMBL628325,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7040,,,12150,CHEMBL628326,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal medulla,A,,50588,Intermediate,,9614,9615.0,,12151,CHEMBL628327,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,1,1236.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal medulla,A,,50588,Intermediate,,9614,9615.0,,12152,CHEMBL628328,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,1,1236.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,9614,9615.0,,12153,CHEMBL628329,"Concentration of compound in blood of dog 1, after administering intravenously",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12154,CHEMBL628330,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12155,CHEMBL628331,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12156,CHEMBL628332,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12157,CHEMBL628333,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12158,CHEMBL628334,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12159,CHEMBL628335,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12160,CHEMBL628336,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12161,CHEMBL628337,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12162,CHEMBL628338,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12163,CHEMBL875610,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12164,CHEMBL628339,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12165,CHEMBL628340,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12166,CHEMBL628341,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12167,CHEMBL622214,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12168,CHEMBL623167,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12169,CHEMBL623168,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12170,CHEMBL623169,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8608,10116.0,,12171,CHEMBL623170,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12172,CHEMBL627224,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12173,CHEMBL875634,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12174,CHEMBL627225,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12175,CHEMBL627226,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12176,CHEMBL626083,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12177,CHEMBL626084,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12178,CHEMBL626085,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12179,CHEMBL626086,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12180,CHEMBL626087,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12181,CHEMBL626088,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12182,CHEMBL626089,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12183,CHEMBL626090,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12184,CHEMBL626091,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12185,CHEMBL626092,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12186,CHEMBL626093,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12187,CHEMBL626094,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12188,CHEMBL626095,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8608,10116.0,,12189,CHEMBL626096,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,1,2048.0
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15604,314293.0,,12190,CHEMBL626097,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15604,10116.0,,12191,CHEMBL626098,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,1,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,1806,,,12192,CHEMBL626099,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,1806,,,12193,CHEMBL626100,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,0,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17237,9615.0,,12194,CHEMBL626101,AUC 0-inf in dog,,1,1969.0
,,Cavia porcellus,N,1,,,BAO_0000218,Plasma,A,,50512,Intermediate,,17237,10141.0,,12195,CHEMBL626102,AUC 0-inf in guinea pig,,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,17237,9615.0,,12196,CHEMBL626103,AUC 0-t in dog,,1,1969.0
,,Cavia porcellus,N,1,,,BAO_0000218,Plasma,A,,50512,Intermediate,,17237,10141.0,,12197,CHEMBL628391,AUC 0-t in guinea pig,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15194,10116.0,,12198,CHEMBL628392,The compound was tested for brain to plasma partition in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15194,10116.0,,12199,CHEMBL628393,The compound was tested for brain to plasma partition in rat.,,1,
,,,U,1,,,BAO_0000019,Blood,A,,22224,Autocuration,,8787,,,12200,CHEMBL628394,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,0,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,17025,9615.0,,12201,CHEMBL628395,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17025,314293.0,,12202,CHEMBL628396,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,17025,9986.0,,12203,CHEMBL628397,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17025,10116.0,,12204,CHEMBL628398,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,4236,9544.0,,12205,CHEMBL628399,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15343,9615.0,,12206,CHEMBL628400,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15343,10116.0,,12207,CHEMBL874907,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17720,,,12208,CHEMBL628401,Area under curve of the compound was determined,,0,
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,17788,314293.0,,12209,CHEMBL628402,AUC in monkeys at a dose of 1 mg/kg,,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,17788,10116.0,,12210,CHEMBL628403,AUC in rats at a dose of 1 mg/kg,,1,1969.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8778,,,12211,CHEMBL628404,Compound was evaluated for the overall absorbance loss at pH of 2,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8778,,,12212,CHEMBL628405,Compound was evaluated for the overall absorbance loss at pH of 4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8778,,,12213,CHEMBL628406,Compound was evaluated for the overall absorbance loss at pH of 7,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,2249,10116.0,,12214,CHEMBL628407,Compound was evaluated for its absorption in the rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8881,10116.0,,12215,CHEMBL628408,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8881,10116.0,,12216,CHEMBL629171,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8881,10116.0,,12217,CHEMBL629172,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8881,10116.0,,12218,CHEMBL629173,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12219,CHEMBL629174,In vitro percent permeability into rat ileum,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12220,CHEMBL629175,In vitro percent permeability into rat ileum; Range is 10-17,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12221,CHEMBL629176,In vitro percent permeability into rat ileum; Range is 10-18,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12222,CHEMBL629177,In vitro percent permeability into rat ileum; Range is 10-19,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12223,CHEMBL629178,In vitro percent permeability into rat ileum; Range is 12-15,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12224,CHEMBL631869,In vitro percent permeability into rat ileum; Range is 13-19,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12225,CHEMBL631870,In vitro percent permeability into rat ileum; Range is 14-17,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12226,CHEMBL631871,In vitro percent permeability into rat ileum; Range is 15-18,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12227,CHEMBL631872,In vitro percent permeability into rat ileum; Range is 2-5,,1,
,,,U,1,,,BAO_0000221,Ileum,A,,22224,Autocuration,,15286,,,12228,CHEMBL875775,In vitro percent permeability into rat ileum; Range is 23-42,,0,2116.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12229,CHEMBL631873,In vitro percent permeability into rat ileum; Range is 28-36,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12230,CHEMBL631874,In vitro percent permeability into rat ileum; Range is 29-35,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12231,CHEMBL631875,In vitro percent permeability into rat ileum; Range is 46-66,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12232,CHEMBL631876,In vitro percent permeability into rat ileum; Range is 50-68,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12233,CHEMBL631877,In vitro percent permeability into rat ileum; Range is 78-81,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12234,CHEMBL631878,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12235,CHEMBL631879,In vitro percent permeability into rat ileum; nd indicates not detected,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12236,CHEMBL631880,In vitro percent permeability into rat ileum; nt indicates not detected,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15286,10116.0,,12237,CHEMBL631881,In vitro percent permeability into rat ileum; nt indicates not tested,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13770,10116.0,,12238,CHEMBL631882,Compound was tested for oral absorption in bile-duct cannulated rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13770,10116.0,,12239,CHEMBL630749,Compound was tested for oral absorption in bile-duct cannulated rats.,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,5202,9606.0,,12240,CHEMBL630750,Oral absorption using Caco-2 cell monolayers.,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,14920,9606.0,,12241,CHEMBL630253,Percent of the drug absorbed after administration to humans was determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12242,CHEMBL630254,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12243,CHEMBL630255,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12244,CHEMBL630256,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12245,CHEMBL875781,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12246,CHEMBL630257,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13751,10116.0,,12247,CHEMBL630258,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15807,10116.0,,12248,CHEMBL630259,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,15807,10116.0,,12249,CHEMBL630260,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,15807,10116.0,,12250,CHEMBL630261,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12251,CHEMBL630262,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12252,CHEMBL630263,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12253,CHEMBL630264,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12254,CHEMBL630265,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12255,CHEMBL630266,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14950,10116.0,,12256,CHEMBL630267,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14950,10116.0,,12257,CHEMBL630268,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12258,CHEMBL630269,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12259,CHEMBL630270,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14950,10116.0,,12260,CHEMBL630141,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14950,10116.0,,12261,CHEMBL630142,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14950,10116.0,,12262,CHEMBL630143,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14950,10116.0,,12263,CHEMBL630144,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Prostate gland,A,,50597,Intermediate,,14950,10116.0,,12264,CHEMBL630145,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,1,2367.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Prostate gland,A,,50597,Intermediate,,14950,10116.0,,12265,CHEMBL630146,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,1,2367.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12266,CHEMBL630147,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12267,CHEMBL630148,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12268,CHEMBL630149,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14950,10116.0,,12269,CHEMBL630150,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14950,10116.0,,12270,CHEMBL630151,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,14950,10116.0,,12271,CHEMBL632031,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,14950,10116.0,,12272,CHEMBL632032,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12273,CHEMBL632033,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12274,CHEMBL632034,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14950,10116.0,,12275,CHEMBL632035,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14950,10116.0,,12276,CHEMBL632036,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,14950,10116.0,,12277,CHEMBL632037,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12278,CHEMBL632038,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12279,CHEMBL632039,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12280,CHEMBL632040,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12281,CHEMBL632041,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Blood,A,,50588,Intermediate,,9614,9615.0,,12282,CHEMBL632042,"Concentration of compound in blood of dog 2, after administering intravenously",,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9614,9615.0,,12283,CHEMBL632043,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9614,9615.0,,12284,CHEMBL632044,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Liver,A,,50588,Intermediate,,9614,9615.0,,12285,CHEMBL632045,"Concentration of compound in liver of dog 1, after administering intravenously",,1,2107.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Liver,A,,50588,Intermediate,,9614,9615.0,,12286,CHEMBL632046,"Concentration of compound in liver of dog 2, after administering intravenously",,1,2107.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Lung,A,,50588,Intermediate,,9614,9615.0,,12287,CHEMBL632047,"Concentration of compound in lung of dog 1, after administering intravenously",,1,2048.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Lung,A,,50588,Intermediate,,9614,9615.0,,12288,CHEMBL632048,"Concentration of compound in lung of dog 2, after administering intravenously",,1,2048.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Muscle tissue,A,,50588,Intermediate,,9614,9615.0,,12289,CHEMBL632049,"Concentration of compound in muscle of dog 1, after administering intravenously",,1,2385.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Muscle tissue,A,,50588,Intermediate,,9614,9615.0,,12290,CHEMBL876418,"Concentration of compound in muscle of dog 2, after administering intravenously",,1,2385.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Spleen,A,,50588,Intermediate,,9614,9615.0,,12291,CHEMBL632050,"Concentration of compound in spleen of dog 1,after administering intravenously",,1,2106.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Spleen,A,,50588,Intermediate,,9614,9615.0,,12292,CHEMBL632051,"Concentration of compound in spleen of dog 2, after administering intravenously",,1,2106.0
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,10353,,,12293,CHEMBL632052,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,0,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,10353,,,12294,CHEMBL632053,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,10353,,,12295,CHEMBL632054,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,0,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,10353,,,12296,CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,0,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,10353,,,12297,CHEMBL631181,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12298,CHEMBL631182,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12299,CHEMBL631183,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12300,CHEMBL631184,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12301,CHEMBL629774,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12302,CHEMBL629775,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12303,CHEMBL876549,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12304,CHEMBL628172,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12305,CHEMBL628173,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12306,CHEMBL628174,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12307,CHEMBL628175,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12308,CHEMBL628176,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12309,CHEMBL628177,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12310,CHEMBL628178,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12311,CHEMBL628179,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12312,CHEMBL628180,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12313,CHEMBL628181,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12314,CHEMBL628182,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12315,CHEMBL628183,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12316,CHEMBL628184,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12317,CHEMBL628185,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12318,CHEMBL875617,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12319,CHEMBL628186,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12320,CHEMBL628187,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12321,CHEMBL628188,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12322,CHEMBL628189,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12323,CHEMBL628190,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12324,CHEMBL628191,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12325,CHEMBL626513,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12326,CHEMBL626514,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12327,CHEMBL626515,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12328,CHEMBL626516,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12329,CHEMBL626517,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12330,CHEMBL626518,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12331,CHEMBL626519,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12332,CHEMBL626520,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12333,CHEMBL626521,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12334,CHEMBL626522,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12335,CHEMBL626523,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12336,CHEMBL626524,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12337,CHEMBL626688,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12338,CHEMBL626689,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12339,CHEMBL626690,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12340,CHEMBL626691,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12341,CHEMBL627319,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12342,CHEMBL624052,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8608,10116.0,,12343,CHEMBL624053,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8085,10116.0,,12344,CHEMBL624054,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8085,10116.0,,12345,CHEMBL624055,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8085,10116.0,,12346,CHEMBL624056,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12347,CHEMBL624057,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12348,CHEMBL622281,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12349,CHEMBL622282,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12350,CHEMBL622283,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12351,CHEMBL622284,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12352,CHEMBL622285,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,8085,10116.0,,12353,CHEMBL622286,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,1,995.0
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,7657,,,12354,CHEMBL622287,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8935,10090.0,,12355,CHEMBL622288,Partition coefficient (logD7.4),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13792,10090.0,,12356,CHEMBL622289,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,12357,CHEMBL622290,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13792,10090.0,,12358,CHEMBL622291,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,12359,CHEMBL622292,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13792,10090.0,,12360,CHEMBL622293,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,12361,CHEMBL622294,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13792,10090.0,,12362,CHEMBL622295,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13792,10116.0,,12363,CHEMBL622296,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12364,CHEMBL874409,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12365,CHEMBL622297,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12366,CHEMBL622298,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12367,CHEMBL622299,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12368,CHEMBL622300,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12369,CHEMBL622301,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12370,CHEMBL622302,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12371,CHEMBL622303,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12372,CHEMBL622304,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12373,CHEMBL622305,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12374,CHEMBL622306,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12375,CHEMBL626864,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12376,CHEMBL626865,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12377,CHEMBL626866,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12378,CHEMBL626867,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12379,CHEMBL626868,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12380,CHEMBL626869,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12381,CHEMBL626870,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12382,CHEMBL626871,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12383,CHEMBL626872,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12384,CHEMBL632185,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14103,10116.0,,12385,CHEMBL632186,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,1,1969.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12904,,,12386,CHEMBL629310,Amount of acetic acid produced by the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12904,,,12387,CHEMBL629311,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9663,10116.0,,12388,CHEMBL629312,Log of (Cbrain/Cblood) in rats,,1,
,,,U,1,,,BAO_0000221,,A,,22224,Autocuration,,7652,,,12389,CHEMBL629313,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000221,,A,,22224,Autocuration,,7652,,,12390,CHEMBL629314,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000221,,A,,22224,Autocuration,,7652,,,12391,CHEMBL629315,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000219,,B,,22224,Autocuration,,7652,,,12392,CHEMBL629316,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000221,,A,,22224,Autocuration,,7652,,,12393,CHEMBL629317,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12394,CHEMBL629318,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12395,CHEMBL877497,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12396,CHEMBL629319,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12397,CHEMBL629320,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12398,CHEMBL629496,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12399,CHEMBL629497,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12400,CHEMBL629498,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12401,CHEMBL629499,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12402,CHEMBL629500,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12403,CHEMBL629501,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7652,,,12404,CHEMBL629502,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,0,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,8267,,,12405,CHEMBL629503,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8267,9615.0,,12406,CHEMBL629504,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14479,,,12407,CHEMBL629505,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17515,,,12408,CHEMBL629506,Compound was evaluated for total body clearance,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17515,,,12409,CHEMBL629507,Compound was evaluated for volume of distribution at steady state,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8142,,,12410,CHEMBL877498,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14849,,,12411,CHEMBL629508,Percentage of the diamine which is monoprotonated at pH 7.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7653,,,12412,CHEMBL629509,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12413,CHEMBL629510,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12414,CHEMBL629511,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12415,CHEMBL629512,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12416,CHEMBL629513,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12417,CHEMBL629514,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12418,CHEMBL628447,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12419,CHEMBL628448,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12420,CHEMBL628449,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12421,CHEMBL631119,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12422,CHEMBL631120,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12423,CHEMBL631121,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12424,CHEMBL874458,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12425,CHEMBL631122,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12426,CHEMBL631123,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12427,CHEMBL631124,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12428,CHEMBL631125,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12429,CHEMBL631290,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12430,CHEMBL631291,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12431,CHEMBL631292,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12432,CHEMBL631293,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12433,CHEMBL631294,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12434,CHEMBL631295,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12435,CHEMBL631296,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8631,10116.0,,12436,CHEMBL631297,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,1,178.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,10263,,,12437,CHEMBL631298,Maximum biodistribution (Bmax) was determined.,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12364,10090.0,,12438,CHEMBL631299,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12364,10090.0,,12439,CHEMBL631300,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12364,10090.0,,12440,CHEMBL631301,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12364,10090.0,,12441,CHEMBL630291,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12442,CHEMBL630292,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12443,CHEMBL630293,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12444,CHEMBL630294,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12445,CHEMBL630295,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12446,CHEMBL630296,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12447,CHEMBL626782,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12448,CHEMBL626783,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12449,CHEMBL626784,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12450,CHEMBL626785,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12451,CHEMBL626786,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12452,CHEMBL626787,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12453,CHEMBL626788,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12454,CHEMBL625927,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12455,CHEMBL625928,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12456,CHEMBL625929,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12457,CHEMBL625930,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12458,CHEMBL625931,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12459,CHEMBL627230,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12460,CHEMBL627231,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12461,CHEMBL627232,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12462,CHEMBL627233,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12463,CHEMBL875470,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12464,CHEMBL627234,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12465,CHEMBL627235,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12466,CHEMBL627236,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12467,CHEMBL627237,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12468,CHEMBL627238,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12469,CHEMBL627239,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12470,CHEMBL627240,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12471,CHEMBL627241,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12472,CHEMBL627242,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12473,CHEMBL627243,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12474,CHEMBL627244,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12475,CHEMBL627245,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12476,CHEMBL627246,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12477,CHEMBL627247,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12478,CHEMBL627248,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12479,CHEMBL627249,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12480,CHEMBL625569,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12481,CHEMBL625570,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12482,CHEMBL625571,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12483,CHEMBL625572,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12484,CHEMBL625573,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12485,CHEMBL625574,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12486,CHEMBL626245,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12487,CHEMBL626246,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12488,CHEMBL626247,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12489,CHEMBL626248,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12490,CHEMBL626249,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12491,CHEMBL626420,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12492,CHEMBL626421,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12493,CHEMBL626422,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12494,CHEMBL626423,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12495,CHEMBL626424,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12023,9615.0,,12496,CHEMBL626425,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12023,10116.0,,12497,CHEMBL875476,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12023,9541.0,,12498,CHEMBL626426,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,1,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,10580,,,12499,CHEMBL626427,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,10580,,,12500,CHEMBL626428,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,16032,,,12501,CHEMBL626429,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,0,
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,16032,,,12502,CHEMBL625025,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12503,CHEMBL625026,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12504,CHEMBL625027,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12505,CHEMBL874410,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12506,CHEMBL625028,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12507,CHEMBL625029,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12508,CHEMBL625030,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12509,CHEMBL625031,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12510,CHEMBL625032,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12511,CHEMBL625033,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12512,CHEMBL625034,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12513,CHEMBL624872,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12514,CHEMBL624873,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12515,CHEMBL624874,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12516,CHEMBL624875,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12517,CHEMBL624876,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12518,CHEMBL624877,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12519,CHEMBL624878,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12520,CHEMBL624879,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12521,CHEMBL624880,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12522,CHEMBL624881,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12523,CHEMBL624882,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12524,CHEMBL624883,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12525,CHEMBL624884,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12526,CHEMBL624885,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12527,CHEMBL624886,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12528,CHEMBL624887,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12529,CHEMBL624888,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12530,CHEMBL624889,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12531,CHEMBL624890,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12532,CHEMBL621964,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12533,CHEMBL621965,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12534,CHEMBL621966,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12535,CHEMBL621967,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12536,CHEMBL622164,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,2107.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7653,,,12537,CHEMBL623097,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7653,,,12538,CHEMBL623098,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7653,,,12539,CHEMBL623099,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7653,,,12540,CHEMBL623100,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12541,CHEMBL628673,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12542,CHEMBL628674,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12543,CHEMBL628675,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12544,CHEMBL627644,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12545,CHEMBL627645,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12546,CHEMBL627646,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12547,CHEMBL627647,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9104,10116.0,,12548,CHEMBL627648,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12902,10116.0,,12549,CHEMBL627649,Free level in rat plasma,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6614,,,12550,CHEMBL628313,Level reaching in blood plasma of rat or human was determined,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9663,10116.0,,12551,CHEMBL628314,Log (Cbrain/Cblood) in rats,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17658,,,12552,CHEMBL628315,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17658,,,12553,CHEMBL628316,Mean percentage of compound transport through membrane; expressed as membrane transport,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14314,,,12554,CHEMBL628317,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7385,,,12555,CHEMBL628473,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7385,,,12556,CHEMBL628474,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7385,,,12557,CHEMBL628475,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1329,,,12558,CHEMBL628476,Net water uptake by a carrier mediated transport (%cm) mechanism,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,12559,CHEMBL628477,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,0,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,12187,9669.0,,12560,CHEMBL628478,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,12187,9669.0,,12561,CHEMBL628479,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,12562,CHEMBL628480,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,12563,CHEMBL628481,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12187,10116.0,,12564,CHEMBL628482,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12187,10116.0,,12565,CHEMBL628483,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9278,10116.0,,12566,CHEMBL628484,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9278,10116.0,,12567,CHEMBL628485,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,9278,9541.0,,12568,CHEMBL628486,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,1,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,9278,9606.0,,12569,CHEMBL628487,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9278,10116.0,,12570,CHEMBL628488,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9278,10116.0,,12571,CHEMBL628489,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,9278,10116.0,,12572,CHEMBL628490,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,12573,CHEMBL628491,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,12574,CHEMBL877507,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12186,,,12575,CHEMBL628492,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,0,
,,Simiiformes,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12041,314293.0,,12576,CHEMBL628493,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,0,
,,Simiiformes,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12041,314293.0,,12577,CHEMBL628494,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,0,
,,Simiiformes,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12041,314293.0,,12578,CHEMBL628495,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,0,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,6737,9606.0,,12579,CHEMBL628496,Permeability in Caco-2 assay at 10E-6,,1,
,,,U,1,,,BAO_0000218,Brain,A,,22224,Autocuration,,13758,,,12580,CHEMBL628497,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,0,955.0
,,,U,1,,,BAO_0000218,Brain,A,,22224,Autocuration,,13758,,,12581,CHEMBL628498,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,0,955.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5676,,,12582,CHEMBL628499,Plasma protein binding was determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12583,CHEMBL627656,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12584,CHEMBL627657,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12585,CHEMBL626808,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12586,CHEMBL626809,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12587,CHEMBL626810,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12588,CHEMBL626811,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12589,CHEMBL874465,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12590,CHEMBL626812,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12591,CHEMBL626813,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,,,12592,CHEMBL626814,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14000,,,12593,CHEMBL626815,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5948,,,12594,CHEMBL628566,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13824,,,12595,CHEMBL628567,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,10778,,,12596,CHEMBL628568,Calculated partition coefficient (clogP),,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,17237,9615.0,,12597,CHEMBL628569,C max in dog,In vivo,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,17237,10141.0,,12598,CHEMBL628570,C max in guinea pig,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,2809,,,12599,CHEMBL628571,C max value was evaluated,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12600,CHEMBL628572,Cmax value after oral dose of 0.1 mg//kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12601,CHEMBL628573,Cmax value after oral dose of 0.3 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12602,CHEMBL628574,Cmax value after oral dose of 1 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12603,CHEMBL628575,Cmax value after oral dose of 10 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12604,CHEMBL628576,Cmax value after oral dose of 23.4 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12605,CHEMBL628577,Cmax value after oral dose of 3 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,12606,CHEMBL628578,Cmax value after oral dose of 3.87 mg/kg,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12768,9615.0,,12607,CHEMBL874466,Cmax value in female Beagle dogs,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12768,10116.0,,12608,CHEMBL628579,Cmax value in male rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,12780,10116.0,,12609,CHEMBL628580,Cmax value in rat plasma when administered 20 mg/kg perorally,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,15592,9615.0,,12610,CHEMBL628581,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,15592,9615.0,,12611,CHEMBL628582,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,17025,9615.0,,12612,CHEMBL628583,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17025,314293.0,,12613,CHEMBL625782,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,17025,9986.0,,12614,CHEMBL625783,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17025,10116.0,,12615,CHEMBL625784,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,1,
,,Macaca mulatta,N,1,,,BAO_0000218,Plasma,A,,50797,Intermediate,,4236,9544.0,,12616,CHEMBL625785,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15791,10116.0,,12617,CHEMBL625786,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11149,,,12618,CHEMBL874467,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15592,9615.0,,12619,CHEMBL625787,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,1,
,,Human immunodeficiency virus,N,1,,,BAO_0000218,,A,,50677,Intermediate,,15778,12721.0,,12620,CHEMBL625964,cytotoxicity against HIV protease enzyme.,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,12621,CHEMBL625965,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12745,10090.0,,12622,CHEMBL625966,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13941,9615.0,,12623,CHEMBL625967,The plasma clearance in dog.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13941,10116.0,,12624,CHEMBL625968,The plasma clearance in rat.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,16449,10116.0,,12625,CHEMBL625969,Clearance from plasma in male Sprague-Dawley rats,In vivo,1,1969.0
,,Macaca fascicularis,N,1,,,BAO_0000218,Plasma,A,,100710,Intermediate,,16449,9541.0,,12626,CHEMBL625970,Clearance from plasma in male cynomolgus monkeys,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,12627,CHEMBL625971,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,12628,CHEMBL625972,Clearance of compound in dog plasma,In vivo,1,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,14224,9606.0,,12629,CHEMBL625973,Clearance of compound in human plasma,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14317,9615.0,,12630,CHEMBL625974,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14317,9615.0,,12631,CHEMBL625975,Clearance of compound when administered intravenously as an individual dose to a single dog.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14224,9615.0,,12632,CHEMBL625976,"Clearance (10 mg/kg, intravenously) in dog plasma",In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,17237,9615.0,,12633,CHEMBL625977,Clearance value in dog,In vivo,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,17237,10141.0,,12634,CHEMBL625978,Clearance value in guinea pig,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14187,10116.0,,12635,CHEMBL874468,Clearance values in rats after iv administration.,In vivo,1,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,4806,,,12636,CHEMBL625421,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,In vivo,0,1969.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,15025,9986.0,,12637,CHEMBL625422,In vivo clearance (5 mg/kg) was determined in rabbits,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13197,10116.0,,12638,CHEMBL625423,Plasma Clearance rate was determined for the compound in rats,In vivo,1,
,,Saimiri,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13197,9520.0,,12639,CHEMBL625424,Plasma Clearance rate was determined for the compound in squirrel monkeys,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13960,10116.0,,12640,CHEMBL625425,Plasma clearance in rat,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17820,,,12641,CHEMBL625426,Plasma clearance of the compound,In vivo,0,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14706,10141.0,,12642,CHEMBL625427,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,In vivo,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,14706,10141.0,,12643,CHEMBL625428,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6504,,,12644,CHEMBL625429,Plasma clearance was determined,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14925,9615.0,,12645,CHEMBL625430,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13197,10116.0,,12646,CHEMBL625431,Plasma clearance rate was determined for the compound in rats,In vivo,1,
,,Saimiri,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13197,9520.0,,12647,CHEMBL627307,Plasma clearance rate was determined for the compound in squirrel monkeys,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,3437,,,12648,CHEMBL627308,Slow clearance (CL) was determined,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12649,CHEMBL627309,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12650,CHEMBL627310,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12651,CHEMBL627311,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12652,CHEMBL627312,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12653,CHEMBL627313,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12654,CHEMBL627314,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12655,CHEMBL627315,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12656,CHEMBL627316,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12657,CHEMBL627317,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12658,CHEMBL627318,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12659,CHEMBL627999,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12660,CHEMBL628000,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12661,CHEMBL628001,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12662,CHEMBL628002,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12663,CHEMBL625610,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12664,CHEMBL625611,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12665,CHEMBL625612,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12666,CHEMBL625613,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12667,CHEMBL875479,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12668,CHEMBL625614,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12669,CHEMBL625615,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9196,,,12670,CHEMBL626302,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12671,CHEMBL626303,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8374,10116.0,,12672,CHEMBL627420,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12673,CHEMBL627421,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12674,CHEMBL625695,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12675,CHEMBL625696,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,10009,10090.0,,12676,CHEMBL875606,Distribution of compound in mice brain was measured after 1 hr,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,10009,10090.0,,12677,CHEMBL625697,Distribution of compound in mice brain was measured after 24 hr r,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,10009,10090.0,,12678,CHEMBL625698,Distribution of compound in mice brain was measured after 2 hr,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,10009,10090.0,,12679,CHEMBL625699,Distribution of compound in mice brain was measured after 3 hr,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,10009,10090.0,,12680,CHEMBL625700,Distribution of compound in mice brain was measured after 6 hr,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,12681,CHEMBL625701,Distribution of compound in mice liver was measured after 1 hr,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,12682,CHEMBL625702,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,12683,CHEMBL625703,Distribution of compound in mice liver was measured after 2 hr,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,12684,CHEMBL625704,Distribution of compound in mice liver was measured after 3 hr,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,12685,CHEMBL625705,Distribution of compound in mice liver was measured after 6 hr,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal medulla,A,,50588,Intermediate,,8170,9615.0,,12686,CHEMBL625706,Distribution in dog adrenal medulla 30 min after administration.,,1,1236.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal medulla,A,,50588,Intermediate,,8170,9615.0,,12687,CHEMBL625707,Distribution in dog adrenal medulla 72 hours after administration.,,1,1236.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12688,CHEMBL625708,Distribution in female dog Ovary 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12689,CHEMBL625709,Distribution in female dog Ovary 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12690,CHEMBL624180,Distribution in female dog adipose 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12691,CHEMBL624181,Distribution in female dog adipose 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal cortex,A,,50588,Intermediate,,8170,9615.0,,12692,CHEMBL624182,Distribution in female dog adrenal cortex 72 hours after administration.,,1,1235.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal cortex,A,,50588,Intermediate,,8170,9615.0,,12693,CHEMBL624183,Distribution in female dog adrenal cortex 72 hours after administration.,,1,1235.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12694,CHEMBL624184,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12695,CHEMBL877489,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12696,CHEMBL624185,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12697,CHEMBL624186,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12698,CHEMBL624187,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12699,CHEMBL624188,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12700,CHEMBL624189,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12701,CHEMBL624190,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12702,CHEMBL624191,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12703,CHEMBL624192,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12704,CHEMBL624193,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12705,CHEMBL624194,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12706,CHEMBL624891,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12707,CHEMBL624892,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12708,CHEMBL624893,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12709,CHEMBL627632,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12710,CHEMBL627633,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12711,CHEMBL627634,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12712,CHEMBL627635,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12713,CHEMBL627636,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12714,CHEMBL626816,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12715,CHEMBL626817,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12716,CHEMBL626818,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12717,CHEMBL626819,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12718,CHEMBL626820,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12719,CHEMBL626821,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12720,CHEMBL626822,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12721,CHEMBL626823,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12722,CHEMBL626824,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12723,CHEMBL626825,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12724,CHEMBL626826,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12725,CHEMBL626827,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12726,CHEMBL626828,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12727,CHEMBL626829,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12728,CHEMBL626830,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12729,CHEMBL627150,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12730,CHEMBL627151,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12731,CHEMBL627152,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12732,CHEMBL627153,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12904,,,12733,CHEMBL627154,Rate of acetate production by the compound was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12904,,,12734,CHEMBL627155,Rate of acetate production by the compound was determined; Not determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3730,,,12735,CHEMBL627156,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3627,,,12736,CHEMBL627157,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,13799,9986.0,,12737,CHEMBL627158,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Plasma,A,,50592,Intermediate,,13799,9986.0,,12738,CHEMBL627159,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,1,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13799,10090.0,,12739,CHEMBL627160,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13799,10116.0,,12740,CHEMBL628540,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13799,10116.0,,12741,CHEMBL628541,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13799,10116.0,,12742,CHEMBL628542,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,1,1969.0
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6629,,,12743,CHEMBL628543,Solubility after at a pH 1.2,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6629,,,12744,CHEMBL628544,Solubility after at pH 1.2,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6629,,,12745,CHEMBL628545,Solubility after injection of water,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14000,,,12746,CHEMBL628546,Statistical significance of IC 50 values; Expressed as R value,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8267,,,12747,CHEMBL874455,Systemic availability with respect to methyldopa was determined,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13799,10116.0,,12748,CHEMBL628547,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,13799,10116.0,,12749,CHEMBL628548,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,1,1969.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12750,CHEMBL628549,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12751,CHEMBL628550,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12752,CHEMBL628551,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12753,CHEMBL628552,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12754,CHEMBL628553,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12755,CHEMBL628554,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12756,CHEMBL628555,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12757,CHEMBL628556,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Kidney,A,,50592,Intermediate,,7132,9986.0,,12758,CHEMBL628557,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,1,2113.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12759,CHEMBL628558,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12760,CHEMBL628559,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12761,CHEMBL628560,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12762,CHEMBL874456,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12763,CHEMBL628561,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12764,CHEMBL628562,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12765,CHEMBL628563,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12766,CHEMBL628564,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12767,CHEMBL628565,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12768,CHEMBL631248,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,12769,CHEMBL631249,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Kidney,A,,50592,Intermediate,,7132,9986.0,,12770,CHEMBL627214,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,1,2113.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12771,CHEMBL874591,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12772,CHEMBL627215,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,12773,CHEMBL625471,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,7132,9986.0,,12774,CHEMBL625472,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,7132,9986.0,,12775,CHEMBL625473,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13317,9615.0,,12776,CHEMBL625474,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15341,9615.0,,12777,CHEMBL625475,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,12778,CHEMBL625476,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,12779,CHEMBL625477,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15341,10116.0,,12780,CHEMBL625478,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,esophageal tunica muscularis mucosae,A,,50597,Intermediate,,12801,10116.0,,12781,CHEMBL625479,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,esophageal tunica muscularis mucosae,A,,50597,Intermediate,,12801,10116.0,,12782,CHEMBL625480,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,In vitro,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14856,10116.0,,12783,CHEMBL625481,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,12784,CHEMBL625482,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,12785,CHEMBL625483,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,12786,CHEMBL625484,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14062,10116.0,,12787,CHEMBL625485,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14346,9615.0,,12788,CHEMBL625486,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14346,10116.0,,12789,CHEMBL625487,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14346,10116.0,,12790,CHEMBL625488,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14346,10116.0,,12791,CHEMBL625489,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14346,10116.0,,12792,CHEMBL625490,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14346,9615.0,,12793,CHEMBL625491,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14346,10116.0,,12794,CHEMBL625492,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,1,1969.0
,,Homo sapiens,N,1,,,BAO_0000218,Plasma,A,,50587,Intermediate,,15711,9606.0,,12795,CHEMBL625493,plasma clearance in human,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14886,10116.0,,12796,CHEMBL625494,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14886,10116.0,,12797,CHEMBL625495,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14886,10116.0,,12798,CHEMBL625496,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,4115,,,12799,CHEMBL625497,1-Octanol/water partition coefficient measured at 7.4,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13733,,,12800,CHEMBL625498,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12102,,,12801,CHEMBL625499,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12676,,,12802,CHEMBL625500,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13733,,,12803,CHEMBL625501,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13740,,,12804,CHEMBL625502,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12766,,,12805,CHEMBL625503,Calculated partition coefficient (clogP) (relative to BAY K 8644),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,2764,,,12806,CHEMBL625504,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12355,,,12807,CHEMBL625505,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,11314,,,12808,CHEMBL625506,Calculated partition coefficient of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12706,,,12809,CHEMBL625507,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12645,,,12810,CHEMBL625508,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13668,,,12811,CHEMBL625509,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12819,,,12812,CHEMBL625510,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13668,,,12813,CHEMBL883125,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13017,,,12814,CHEMBL625511,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2448,,,12815,CHEMBL874650,Partition coefficient of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11526,,,12816,CHEMBL625512,Partition coefficient of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12426,,,12817,CHEMBL625513,Partition coefficient of compound was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2448,,,12818,CHEMBL625514,Partition coefficient was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12001,,,12819,CHEMBL625515,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12426,,,12820,CHEMBL625516,partition coefficient of compound was determined,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13204,9615.0,,12821,CHEMBL625517,The total body administered intravenously in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13204,10116.0,,12822,CHEMBL625518,The total body administered intravenously in rats,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13889,10090.0,,12823,CHEMBL625519,Time taken for the administration to female NIH mice weighing 25-30 g.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13889,,,12824,CHEMBL625520,Time taken for the administration,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,17025,9615.0,,12825,CHEMBL874651,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,In vivo,1,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17025,314293.0,,12826,CHEMBL625521,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,In vivo,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,17025,9986.0,,12827,CHEMBL623171,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,17025,10116.0,,12828,CHEMBL623853,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,In vivo,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15067,,,12829,CHEMBL623854,Plasma clearance for the compound was determined.,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,3091,,,12830,CHEMBL874405,CLog P value of the compound,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15592,,,12831,CHEMBL623855,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14738,,,12832,CHEMBL623856,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14738,,,12833,CHEMBL623857,ClogP value of the compound; nd ='no data',,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14738,,,12834,CHEMBL623858,ClogP value of the compound; nd ='not determined',,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,6076,,,12835,CHEMBL623859,CLog P was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,17840,,,12836,CHEMBL839829,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13589,,,12837,CHEMBL623860,CLogP was calculated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17655,,,12838,CHEMBL623861,CLogP value was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5867,,,12839,CHEMBL623862,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,5867,,,12840,CHEMBL874406,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,10783,,,12841,CHEMBL623863,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14849,,,12842,CHEMBL624021,Calculated partition coefficient (clogP),,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal medulla,A,,50588,Intermediate,,8170,9615.0,,12843,CHEMBL624022,Distribution in female dog adrenal medulla 24 hours after administration.,,1,1236.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Adrenal medulla,A,,50588,Intermediate,,8170,9615.0,,12844,CHEMBL624023,Distribution in female dog adrenal medulla 72 hours after administration.,,1,1236.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12845,CHEMBL624024,Distribution in female dog bile 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12846,CHEMBL624025,Distribution in female dog bile 72 hr after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12847,CHEMBL624026,Distribution in female dog blood 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12848,CHEMBL624027,Distribution in female dog blood 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12849,CHEMBL624028,Distribution in female dog heart 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12850,CHEMBL624029,Distribution in female dog heart 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12851,CHEMBL624030,Distribution in female dog kidney 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12852,CHEMBL624031,Distribution in female dog kidney 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Intestine,A,,50588,Intermediate,,8170,9615.0,,12853,CHEMBL624032,Distribution in female dog large intestine 24 hours after administration.,,1,160.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Intestine,A,,50588,Intermediate,,8170,9615.0,,12854,CHEMBL874407,Distribution in female dog large intestine 72 hours after administration.,,1,160.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12855,CHEMBL624033,Distribution in female dog liver 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12856,CHEMBL624034,Distribution in female dog liver 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12857,CHEMBL624035,Distribution in female dog lung 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12858,CHEMBL624036,Distribution in female dog lung 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Muscle tissue,A,,50588,Intermediate,,8170,9615.0,,12859,CHEMBL624037,Distribution in female dog muscle 24 hours after administration.,,1,2385.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Muscle tissue,A,,50588,Intermediate,,8170,9615.0,,12860,CHEMBL624038,Distribution in female dog muscle 72 hours after administration.,,1,2385.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12861,CHEMBL624039,Distribution in female dog pancreas 24 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8170,9615.0,,12862,CHEMBL624040,Distribution in female dog pancreas 72 hours after administration.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Intestine,A,,50588,Intermediate,,8170,9615.0,,12863,CHEMBL624041,Distribution in female dog small intestine 24 hours after administration.,,1,160.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Intestine,A,,50588,Intermediate,,8170,9615.0,,12864,CHEMBL624042,Distribution in female dog small intestine 72 hours after administration.,,1,160.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Spleen,A,,50588,Intermediate,,8170,9615.0,,12865,CHEMBL624043,Distribution in female dog spleen 24 hours after administration.,,1,2106.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Spleen,A,,50588,Intermediate,,8170,9615.0,,12866,CHEMBL624044,Distribution in female dog spleen 72 hours after administration.,,1,2106.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Stomach,A,,50588,Intermediate,,8170,9615.0,,12867,CHEMBL624045,Distribution in female dog stomach 24 hours after administration.,,1,945.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Stomach,A,,50588,Intermediate,,8170,9615.0,,12868,CHEMBL624046,Distribution in female dog stomach 72 hours after administration.,,1,945.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Thyroid gland,A,,50588,Intermediate,,8170,9615.0,,12869,CHEMBL624047,Distribution in female dog thyroid 24 hours after administration.,,1,2046.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Thyroid gland,A,,50588,Intermediate,,8170,9615.0,,12870,CHEMBL624048,Distribution in female dog thyroid 72 hours after administration.,,1,2046.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8170,9615.0,,12871,CHEMBL874408,Distribution in female dog urine 24 hours after administration.,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8170,9615.0,,12872,CHEMBL624049,Distribution in female dog urine 72 hr after administration.,,1,1088.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14283,,,12873,CHEMBL624050,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,0,1969.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5623,,,12874,CHEMBL624051,Plasma concentration at 7 hr after intravenous dosing,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12875,CHEMBL623278,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12876,CHEMBL623279,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12877,CHEMBL623280,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12878,CHEMBL623963,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12879,CHEMBL623964,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12880,CHEMBL623965,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12881,CHEMBL623966,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12882,CHEMBL874415,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12883,CHEMBL623967,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12884,CHEMBL623968,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12885,CHEMBL623969,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12886,CHEMBL628409,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12887,CHEMBL628410,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12888,CHEMBL628411,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,12889,CHEMBL628412,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12553,,,12890,CHEMBL628413,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,0,
,,,U,1,,,BAO_0000019,Plasma,A,,22224,Autocuration,,14548,,,12891,CHEMBL628414,The concentration in plasmat; Not determined,,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,12892,CHEMBL628415,Tissue level at 10 mg/kg/po in wistar rats in blood,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,12893,CHEMBL628416,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,12894,CHEMBL628417,Tissue level at 10 mg/kg/po in wistar rats in heart,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14393,10116.0,,12895,CHEMBL874908,Tissue level at 10 mg/kg/po in wistar rats in liver,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,12896,CHEMBL628418,Tissue level at 10 mg/kg/po in wistar rats in plasma,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14393,10116.0,,12897,CHEMBL628419,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,12898,CHEMBL628420,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1629,,,12899,CHEMBL628421,Water solubility at 37 degree C.,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,12900,CHEMBL626726,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,12901,CHEMBL626727,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12902,CHEMBL626728,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12903,CHEMBL626729,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12904,CHEMBL626730,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12905,CHEMBL626731,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8594,10116.0,,12906,CHEMBL626732,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12907,CHEMBL626733,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12908,CHEMBL626734,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12909,CHEMBL626735,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12910,CHEMBL874909,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,8594,10116.0,,12911,CHEMBL626736,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12912,CHEMBL626737,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12913,CHEMBL630999,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12914,CHEMBL631000,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12915,CHEMBL631001,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,8594,10116.0,,12916,CHEMBL631002,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12917,CHEMBL631003,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12918,CHEMBL631004,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12919,CHEMBL631005,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12920,CHEMBL631006,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,8594,10116.0,,12921,CHEMBL631007,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12922,CHEMBL631008,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12923,CHEMBL631009,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12924,CHEMBL631010,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12925,CHEMBL631011,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,8594,10116.0,,12926,CHEMBL631012,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12927,CHEMBL630271,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12928,CHEMBL630272,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12929,CHEMBL630273,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12930,CHEMBL630274,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,8594,10116.0,,12931,CHEMBL630275,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12932,CHEMBL875782,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12933,CHEMBL630276,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12934,CHEMBL630277,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12935,CHEMBL630278,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8594,10116.0,,12936,CHEMBL630279,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8151,,,12937,CHEMBL630280,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8151,,,12938,CHEMBL630281,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,7132,9986.0,,12939,CHEMBL630282,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,7132,9986.0,,12940,CHEMBL630283,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5797,,,12941,CHEMBL630284,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7849,,,12942,CHEMBL630285,Alkylating activity was determined,,0,
,,,U,1,Microsomes,,BAO_0000251,,A,,22224,Autocuration,,14220,,,12943,CHEMBL630286,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,0,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,8650,9986.0,,12944,CHEMBL630069,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,8650,9986.0,,12945,CHEMBL630070,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,8650,9986.0,,12946,CHEMBL630071,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,8650,9986.0,,12947,CHEMBL630072,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,8650,9986.0,,12948,CHEMBL875110,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7116,10116.0,,12949,CHEMBL630073,Compound was tested for antidiuretic activity in rats,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14131,,,12950,CHEMBL630074,Compound was tested for inactivation kinetic values,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,7415,,,12951,CHEMBL630075,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,In vivo,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13178,,,12952,CHEMBL630076,Dissociation rate calculated from the first-order equation using the t1/2 value,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8815,,,12953,CHEMBL630077,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,1450,,,12954,CHEMBL630078,Aqueous solubility was measured,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,1450,,,12955,CHEMBL630079,Aqueous solubility was measured at a pH 4,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,1450,,,12956,CHEMBL630080,Aqueous solubility (pH 7),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,1450,,,12957,CHEMBL630081,Aqueous solubility was measured at a pH 9,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12711,,,12958,CHEMBL630082,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12711,,,12959,CHEMBL630083,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12711,,,12960,CHEMBL630084,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15032,,,12961,CHEMBL629198,Aqueous solubility of the compound,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,9964,,,12962,CHEMBL629199,Aqueous solubility at 37 degree Celsius at pH 7.38,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14962,,,12963,CHEMBL629200,Aqueous solubility in pH 7.4 phosphate buffer,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12487,9615.0,,12964,CHEMBL629201,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12487,9615.0,,12965,CHEMBL629202,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10026,9606.0,,12966,CHEMBL875111,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10026,9606.0,,12967,CHEMBL629203,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10026,9606.0,,12968,CHEMBL629204,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10026,9606.0,,12969,CHEMBL629205,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10026,9606.0,,12970,CHEMBL629206,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10026,,,12971,CHEMBL631185,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7415,10116.0,,12972,CHEMBL631186,Compound was evaluated for the average bile flow rat in rats,,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,17025,9986.0,,12973,CHEMBL631187,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,17025,9986.0,,12974,CHEMBL631188,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10184,,,12975,CHEMBL876419,Average half life period was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10184,,,12976,CHEMBL631189,Average half life period was determined,,0,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12977,CHEMBL631190,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12978,CHEMBL631191,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12979,CHEMBL631192,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12980,CHEMBL632400,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12981,CHEMBL630564,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12982,CHEMBL630565,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12983,CHEMBL630566,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12984,CHEMBL631229,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,12985,CHEMBL631230,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6030,,,12986,CHEMBL876428,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6147,,,12987,CHEMBL631231,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14556,,,12988,CHEMBL631232,Calculated partition coefficient (clogP) (MacLogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,768,,,12989,CHEMBL631233,Hydrophilicity was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14452,,,12990,CHEMBL631234,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5237,,,12991,CHEMBL883126,Increased absorption was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14378,,,12992,CHEMBL631235,Lipophilicity value was evaluated,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14418,,,12993,CHEMBL631236,Log P value of the compound.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5249,,,12994,CHEMBL631237,Partition coefficient of compound was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14621,,,12995,CHEMBL631238,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12542,,,12996,CHEMBL876429,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12542,,,12997,CHEMBL631414,Partition coefficient was measured by medchem software; Not calculated,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,12542,,,12998,CHEMBL631415,Partition coefficient was measured by octanol-water using standard shake-flask method,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15462,,,12999,CHEMBL631416,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14884,,,13000,CHEMBL631417,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,16526,,,13001,CHEMBL631418,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13693,,,13002,CHEMBL631419,The Octanol/Water partition coefficient CLogP,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13693,,,13003,CHEMBL631420,The pharmacokinetic parameter C Log p was reported,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13779,,,13004,CHEMBL631421,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14772,,,13005,CHEMBL631422,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14393,,,13006,CHEMBL631423,Calculated partition coefficient (clogP),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,13007,CHEMBL876430,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,13008,CHEMBL631424,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13744,9615.0,,13009,CHEMBL631425,Compound was administered intravenously in dog to evaluate plasma clearance values,In vivo,1,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,13744,314293.0,,13010,CHEMBL631426,Compound was administered intravenously in monkey to evaluate plasma clearance values,In vivo,0,1969.0
,,Mus musculus,N,1,,,BAO_0000218,Plasma,A,,50594,Intermediate,,13744,10090.0,,13011,CHEMBL631427,Compound was administered intravenously in mouse to evaluate plasma clearance values,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,13207,9615.0,,13012,CHEMBL631428,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,In vivo,1,1969.0
,,Macaca mulatta,N,1,Microsomes,,BAO_0000218,Liver,A,,50797,Intermediate,,5669,9544.0,,13013,CHEMBL631429,Intrinsic clearance in Rhesus liver microsome,In vitro,1,2107.0
,,Canis lupus familiaris,N,1,Microsomes,,BAO_0000218,Liver,A,,50588,Intermediate,,5669,9615.0,,13014,CHEMBL631430,Intrinsic clearance in dog liver microsome,In vitro,1,2107.0
,,Rattus norvegicus,N,1,Microsomes,,BAO_0000218,Liver,A,,50597,Intermediate,,5669,10116.0,,13015,CHEMBL631431,Intrinsic clearance in rat liver microsome,In vitro,1,2107.0
,,Macaca mulatta,N,1,,,BAO_0000218,Plasma,A,,50797,Intermediate,,4853,9544.0,,13016,CHEMBL631432,Low plasma clearance was calculated in rhesus monkey,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,16452,9615.0,,13017,CHEMBL631433,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,13018,CHEMBL631434,Plasma clearance after intravenous dose of 0.3 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,13019,CHEMBL631435,Plasma clearance after intravenous dose of 1 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,13020,CHEMBL631436,Plasma clearance after intravenous dose of 3 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11954,,,13021,CHEMBL631437,Plasma clearance after intravenous dose of 3.87 mg/kg,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,13022,CHEMBL631438,Plasma clearance after peroral administration at 10 mpk in Rat,In vivo,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,5669,9544.0,,13023,CHEMBL876431,Plasma clearance after peroral administration at 10 mpk in Rhesus,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,5669,9615.0,,13024,CHEMBL631439,Plasma clearance after peroral administration at 10 mpk in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13662,10116.0,,13025,CHEMBL631440,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,In vivo,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8272,,,13026,CHEMBL631441,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13410,,,13027,CHEMBL631442,Critical Micellar concentration was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13410,,,13028,CHEMBL626525,Critical Micellar concentration of the compound. was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12628,,,13029,CHEMBL627168,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9675,,,13030,CHEMBL875618,Critical micellar concentration was measured in water by the dye solubilization method,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,12628,,,13031,CHEMBL626612,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12766,,,13032,CHEMBL626613,CMR value (relative to BAY K 8644),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7849,,,13033,CHEMBL626614,Carbamoylating activity was determined,,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,13034,CHEMBL626615,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2040,,,13035,CHEMBL626616,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2040,,,13036,CHEMBL626617,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,14180,9615.0,,13037,CHEMBL626618,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14180,10116.0,,13038,CHEMBL626619,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14474,9615.0,,13039,CHEMBL626620,"Clearance rate at 0.46 mg/kg, iv, in dogs",In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14474,10116.0,,13040,CHEMBL626621,"Clearance rate at 5.5 mg/kg, iv, in rat",In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14548,9541.0,,13041,CHEMBL626622,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14548,9541.0,,13042,CHEMBL626623,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,14548,9615.0,,13043,CHEMBL626624,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14548,10116.0,,13044,CHEMBL626625,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6125,10116.0,,13045,CHEMBL626626,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,1,2107.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6874,,,13046,CHEMBL626627,Tested for the total clearance of the compound,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15343,9615.0,,13047,CHEMBL626628,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,6236,,,13048,CHEMBL626629,Total body clearance was determined,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13049,CHEMBL626630,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13050,CHEMBL626631,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,13051,CHEMBL626632,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,13052,CHEMBL626633,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,13053,CHEMBL626634,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,13054,CHEMBL626635,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,13055,CHEMBL626636,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8194,,,13056,CHEMBL626637,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,0,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13057,CHEMBL626638,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13058,CHEMBL626639,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13059,CHEMBL626640,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13060,CHEMBL626641,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13061,CHEMBL627272,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13062,CHEMBL627273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13063,CHEMBL627441,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13064,CHEMBL628355,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13065,CHEMBL628356,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13066,CHEMBL628357,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13067,CHEMBL628358,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,1,
,,Pneumocystis carinii,N,1,,,BAO_0000218,,A,,50339,Intermediate,,13273,4754.0,,13068,CHEMBL622307,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,13069,CHEMBL622527,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,13070,CHEMBL622528,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,13071,CHEMBL622529,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,13072,CHEMBL622992,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,13073,CHEMBL622993,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13118,,,13074,CHEMBL622994,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10633,10116.0,,13075,CHEMBL622995,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10633,10116.0,,13076,CHEMBL622996,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10633,10116.0,,13077,CHEMBL622997,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10633,10116.0,,13078,CHEMBL622998,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5767,,,13079,CHEMBL622999,Cp max following ip administration at 1 mg/kg,,0,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,3302,,,13080,CHEMBL623000,Maximum concentration in plasma was reported at 0.5 hour,In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,3302,,,13081,CHEMBL623001,Maximum concentration in plasma was reported at 2 hour,In vivo,0,1969.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12467,10090.0,,13082,CHEMBL623002,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,11778,,,13083,CHEMBL623003,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,4321,,,13084,CHEMBL623004,Steady state concentration was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14884,,,13085,CHEMBL623005,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15234,,,13086,CHEMBL623006,Partition coefficient (logD7.4),,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14198,10116.0,,13087,CHEMBL623007,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,14198,10116.0,,13088,CHEMBL623008,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14198,10116.0,,13089,CHEMBL876654,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13090,CHEMBL623009,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13091,CHEMBL623010,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14198,10116.0,,13092,CHEMBL623011,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,14198,10116.0,,13093,CHEMBL623012,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,1,160.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8151,,,13094,CHEMBL623013,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8151,,,13095,CHEMBL623014,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,0,
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,8151,,,13096,CHEMBL623015,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,8151,,,13097,CHEMBL623016,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,8151,,,13098,CHEMBL624858,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,13099,CHEMBL624859,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,13100,CHEMBL624860,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,13101,CHEMBL624861,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,13102,CHEMBL624862,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,13103,CHEMBL624863,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8151,10116.0,,13104,CHEMBL876655,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13105,CHEMBL624864,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13106,CHEMBL624865,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13107,CHEMBL624866,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,F,,50588,Expert,,6996,9615.0,,13108,CHEMBL624867,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13109,CHEMBL624868,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13110,CHEMBL628450,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13111,CHEMBL628451,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13112,CHEMBL628452,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13113,CHEMBL628453,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13114,CHEMBL628454,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13115,CHEMBL628455,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13116,CHEMBL628456,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13117,CHEMBL628457,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13118,CHEMBL877505,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13119,CHEMBL628458,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13120,CHEMBL628459,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13121,CHEMBL628460,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13122,CHEMBL628461,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,1,
,,,U,1,,,BAO_0000218,,B,,22224,Autocuration,,6996,,,13123,CHEMBL628462,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13124,CHEMBL628463,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,F,,50597,Expert,,6996,10116.0,,13125,CHEMBL625666,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,1,
,,,U,1,,,BAO_0000218,,B,,22224,Autocuration,,6996,,,13126,CHEMBL625667,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Expert,,6996,10116.0,,13127,CHEMBL625668,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13128,CHEMBL625669,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7114,,,13129,CHEMBL625670,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7114,10116.0,,13130,CHEMBL625671,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13131,CHEMBL625672,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13132,CHEMBL625673,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13133,CHEMBL625674,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13134,CHEMBL625675,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13135,CHEMBL627637,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13136,CHEMBL627638,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13137,CHEMBL627639,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13138,CHEMBL627640,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13139,CHEMBL627641,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13140,CHEMBL627642,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,13141,CHEMBL877506,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8613,10090.0,,13142,CHEMBL627275,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13143,CHEMBL627643,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13144,CHEMBL631246,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13145,CHEMBL631247,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13146,CHEMBL629532,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13147,CHEMBL629533,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13148,CHEMBL629534,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,1,
,,Mustela putorius furo,N,1,,,BAO_0000218,,A,,50506,Intermediate,,11219,9669.0,,13149,CHEMBL629535,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14837,,,13150,CHEMBL625932,Pharmacokinetic parameter :drug bound to plasma was reported,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14837,,,13151,CHEMBL625933,compound was evaluated for drug bound in plasma,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15343,10116.0,,13152,CHEMBL625934,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,1,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13761,9347.0,,13153,CHEMBL625935,Bioavailability,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14810,10116.0,,13154,CHEMBL625936,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14810,10116.0,,13155,CHEMBL625937,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13249,9615.0,,13156,CHEMBL625938,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Bile,A,,50597,Intermediate,,9267,10116.0,,13157,CHEMBL625939,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,1,1970.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bile,A,,50597,Intermediate,,9267,10116.0,,13158,CHEMBL625940,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,1,1970.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bile,A,,50597,Intermediate,,9267,10116.0,,13159,CHEMBL874464,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,1,1970.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bile,A,,50597,Intermediate,,9267,10116.0,,13160,CHEMBL625941,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,1,1970.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bile,A,,50597,Intermediate,,9267,10116.0,,13161,CHEMBL625942,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,1,1970.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bile,A,,50597,Intermediate,,9267,10116.0,,13162,CHEMBL625943,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,1,1970.0
,,Homo sapiens,N,1,,,BAO_0000218,Serum,A,,50587,Intermediate,,15549,9606.0,,13163,CHEMBL625944,In vitro protein binding in human serum at 5 ug/ml,,1,1977.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10929,,,13164,CHEMBL625945,Serum protein binding ability was measured,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15444,,,13165,CHEMBL625946,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12860,9615.0,,13166,CHEMBL625947,Oral bioavailability in dog,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12170,10116.0,,13167,CHEMBL625948,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13168,CHEMBL625949,Absolute oral bioavailability at an iv dose of 14 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13169,CHEMBL625950,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,In vivo,0,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,9347.0,,13170,CHEMBL625951,Oral bioavailability (dose 15 mg/kg i.v.),In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13171,CHEMBL625952,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13172,CHEMBL625953,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13173,CHEMBL625954,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13174,CHEMBL882959,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,11767,9615.0,,13175,CHEMBL625955,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,In vivo,1,
,,Mustela putorius furo,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11219,9669.0,,13176,CHEMBL625956,Bioavailability in ferret,In vivo,0,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,12186,9541.0,,13177,CHEMBL625957,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13178,CHEMBL625958,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13179,CHEMBL625959,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13180,CHEMBL626642,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13181,CHEMBL631330,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13182,CHEMBL631331,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13183,CHEMBL631332,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13184,CHEMBL631333,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13185,CHEMBL632018,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13186,CHEMBL632019,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13187,CHEMBL632020,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13188,CHEMBL632021,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13189,CHEMBL632022,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13190,CHEMBL632023,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13191,CHEMBL632024,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13192,CHEMBL874472,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13193,CHEMBL632025,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13194,CHEMBL632026,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13195,CHEMBL632027,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13196,CHEMBL632028,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13197,CHEMBL626430,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13198,CHEMBL626431,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13199,CHEMBL626432,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13200,CHEMBL626433,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13201,CHEMBL626434,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13202,CHEMBL627280,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13203,CHEMBL627281,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13204,CHEMBL627282,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7199,,,13205,CHEMBL627283,Total body clearance was measured at given dose,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,7199,,,13206,CHEMBL627284,Total body clearance was measured at given dose.,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7095,10116.0,,13207,CHEMBL627285,Metabolic clearance from the body in rat,,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,7095,,,13208,CHEMBL627286,Renal clearance from the body,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7095,10116.0,,13209,CHEMBL875477,Renal clearance from the body in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12528,10116.0,,13210,CHEMBL627287,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12528,9615.0,,13211,CHEMBL627288,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7095,10116.0,,13212,CHEMBL627289,Total clearance from the body in rat,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14223,10116.0,,13213,CHEMBL627290,Clearance into cortex from rat plasma or PBS,In vivo,1,1969.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13569,,,13214,CHEMBL627291,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13569,,,13215,CHEMBL627292,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13569,,,13216,CHEMBL627293,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13569,,,13217,CHEMBL627294,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13569,,,13218,CHEMBL875478,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13979,,,13219,CHEMBL627295,Clearance was determined,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14315,10090.0,,13220,CHEMBL627296,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,In vivo,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,,A,,50592,Intermediate,,14315,9986.0,,13221,CHEMBL626119,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14315,10116.0,,13222,CHEMBL626120,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12174,10116.0,,13223,CHEMBL626121,Clearance in rat after iv dose (100 ug/kg),In vivo,1,
,,Cavia porcellus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12797,10141.0,,13224,CHEMBL626122,Clearance in guinea pig,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12797,10116.0,,13225,CHEMBL626123,Compound was evaluated for clearance in rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12797,9615.0,,13226,CHEMBL623456,Compound was evaluated for the clearance in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12797,10116.0,,13227,CHEMBL623457,Compound was evaluated for the clearance in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11500,10116.0,,13228,CHEMBL623458,Compound was tested in vivo for clearance after iv administration in the rat,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13229,CHEMBL623459,IV clearance determined at an iv dose of 14 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13230,CHEMBL875484,IV clearance determined at an iv dose of 15.2 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13231,CHEMBL623460,IV clearance determined at an iv dose of 15 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13232,CHEMBL623461,IV clearance determined at an peroral dose of 30 mg/kg.,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13233,CHEMBL623462,IV clearance determined at an peroral dose of 30.2 mg/kg.,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13234,CHEMBL627386,IV clearance determined at an peroral dose of 30.3 mg/kg.,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14198,10116.0,,13235,CHEMBL627387,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14198,10116.0,,13236,CHEMBL627388,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14198,10116.0,,13237,CHEMBL627389,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14198,10116.0,,13238,CHEMBL627390,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14198,10116.0,,13239,CHEMBL627391,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13240,CHEMBL627392,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14198,10116.0,,13241,CHEMBL627393,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Trachea,A,,50597,Intermediate,,14198,10116.0,,13242,CHEMBL627394,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,1,3126.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,14198,10116.0,,13243,CHEMBL627395,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14198,10116.0,,13244,CHEMBL875485,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13245,CHEMBL627396,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13246,CHEMBL627397,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14198,10116.0,,13247,CHEMBL627398,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,14198,10116.0,,13248,CHEMBL627399,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14198,10116.0,,13249,CHEMBL627400,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14198,10116.0,,13250,CHEMBL627401,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14198,10116.0,,13251,CHEMBL627402,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14198,10116.0,,13252,CHEMBL627403,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14198,10116.0,,13253,CHEMBL627404,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13254,CHEMBL623101,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14198,10116.0,,13255,CHEMBL877480,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Trachea,A,,50597,Intermediate,,14198,10116.0,,13256,CHEMBL623102,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,1,3126.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,14198,10116.0,,13257,CHEMBL623103,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14198,10116.0,,13258,CHEMBL623104,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13259,CHEMBL623105,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13260,CHEMBL623106,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14198,10116.0,,13261,CHEMBL623107,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,14198,10116.0,,13262,CHEMBL623108,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14198,10116.0,,13263,CHEMBL623109,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,14198,10116.0,,13264,CHEMBL623110,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14198,10116.0,,13265,CHEMBL623111,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14198,10116.0,,13266,CHEMBL625060,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14198,10116.0,,13267,CHEMBL625061,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13268,CHEMBL625062,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14198,10116.0,,13269,CHEMBL625063,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Trachea,A,,50597,Intermediate,,14198,10116.0,,13270,CHEMBL625064,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,1,3126.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Bone,A,,50597,Intermediate,,14198,10116.0,,13271,CHEMBL625065,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,1,10000001.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,14198,10116.0,,13272,CHEMBL625066,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13273,CHEMBL625067,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13274,CHEMBL625068,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,14198,10116.0,,13275,CHEMBL622159,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Intestine,A,,50597,Intermediate,,14198,10116.0,,13276,CHEMBL622160,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,In vivo,1,160.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,14198,10116.0,,13277,CHEMBL622161,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,14198,10116.0,,13278,CHEMBL622162,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,14198,10116.0,,13279,CHEMBL622163,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14198,10116.0,,13280,CHEMBL622313,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14198,10116.0,,13281,CHEMBL622314,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,14198,10116.0,,13282,CHEMBL622315,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Trachea,A,,50597,Intermediate,,14198,10116.0,,13283,CHEMBL622316,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,1,3126.0
,,Escherichia coli,N,1,,,BAO_0000218,,A,,50212,Intermediate,,15599,562.0,,13284,CHEMBL877486,Normal diffusion coefficient in water for Escherichia coli,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8204,,,13285,CHEMBL622317,Average max percent decrease in RVR (renal vascular resistance) was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8204,,,13286,CHEMBL622318,Average max percent decrease in RVR (renal vascular resistance) was determined.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13287,CHEMBL622319,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13288,CHEMBL622320,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13289,CHEMBL622321,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13290,CHEMBL622322,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7114,,,13291,CHEMBL622323,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7114,10116.0,,13292,CHEMBL622324,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13293,CHEMBL622325,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13294,CHEMBL622326,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13295,CHEMBL877487,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13296,CHEMBL622327,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13297,CHEMBL622328,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13298,CHEMBL622329,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13299,CHEMBL622330,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13300,CHEMBL622331,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13301,CHEMBL622332,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13302,CHEMBL622333,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,1,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13303,CHEMBL627658,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13304,CHEMBL630428,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13305,CHEMBL630429,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13306,CHEMBL630430,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13307,CHEMBL630431,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13308,CHEMBL630432,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13309,CHEMBL630433,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13310,CHEMBL630434,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13311,CHEMBL629372,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13312,CHEMBL629553,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13313,CHEMBL629554,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13314,CHEMBL874447,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13315,CHEMBL629555,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13316,CHEMBL629556,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13317,CHEMBL629557,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13318,CHEMBL629558,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13319,CHEMBL629559,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13320,CHEMBL629560,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13321,CHEMBL629561,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13322,CHEMBL629562,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13323,CHEMBL629563,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13324,CHEMBL629564,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13325,CHEMBL629565,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13326,CHEMBL629566,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13327,CHEMBL629567,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13328,CHEMBL629568,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13329,CHEMBL629569,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13330,CHEMBL629570,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,1,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13331,CHEMBL629571,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,0,1088.0
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12170,10116.0,,13332,CHEMBL629572,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12170,10116.0,,13333,CHEMBL629573,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,0,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4985,9347.0,,13334,CHEMBL629574,Bioavailability (dose 20 mg/kg),In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15145,9615.0,,13335,CHEMBL629575,Bioavailability in dog,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14080,10116.0,,13336,CHEMBL874448,Bioavailability in rat (Sprague-Dawley) (male),In vivo,0,
,,Primates,U,1,,,BAO_0000218,,A,,22224,Autocuration,,11219,9443.0,,13337,CHEMBL629576,Bioavailability in monkey (dose 10 mg/kg i.d.),In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15145,10116.0,,13338,CHEMBL629577,Bioavailability in rat,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15145,10116.0,,13339,CHEMBL629578,Bioavailability in rat,In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,1202,9615.0,,13340,CHEMBL629579,Bioavailability in dog (dose 3.0 mg/kg p.o.),In vivo,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,1202,9615.0,,13341,CHEMBL882958,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,In vivo,0,
,,Pan troglodytes,N,1,,,BAO_0000218,,A,,50505,Intermediate,,1202,9598.0,,13342,CHEMBL629580,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,In vivo,1,
,,Eutheria,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4026,9347.0,,13343,CHEMBL629581,Bioavailability,In vivo,0,
,,Saimiri,U,1,,,BAO_0000218,,A,,22224,Autocuration,,1492,9520.0,,13344,CHEMBL629582,Bioavailability in squirrel monkey,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,12793,9615.0,,13345,CHEMBL628522,Bioavailability was evaluated in dog,In vivo,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,12793,10026.0,,13346,CHEMBL625432,Bioavailability was evaluated in hamster,In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12793,10116.0,,13347,CHEMBL625433,Bioavailability in rat,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,13348,CHEMBL625434,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,14793,10116.0,,13349,CHEMBL625435,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,In vivo,1,1969.0
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14793,10116.0,,13350,CHEMBL625436,Bioavailability in rat (dose 10 mg/kg p.o.),In vivo,0,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,14731,9541.0,,13351,CHEMBL874588,Bioavailability was measured in cynomolgus monkeys.,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14731,10090.0,,13352,CHEMBL625437,Bioavailability was measured in nude mice.,In vivo,1,
,,Mustela putorius furo,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,9669.0,,13353,CHEMBL625438,Bioavailability in ferret (dose 10 mg/kg i.d.),In vivo,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,13354,CHEMBL625439,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),In vivo,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,13355,CHEMBL625440,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",In vivo,0,
,,Simiiformes,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,314293.0,,13356,CHEMBL625441,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12187,10116.0,,13357,CHEMBL625442,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12187,10116.0,,13358,CHEMBL625443,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,17431,,,13359,CHEMBL625444,Bioavailability was determined; extremely poor,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13318,10090.0,,13360,CHEMBL625445,% bioavailability in mice after oral administration of prodrug,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13361,CHEMBL625446,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13362,CHEMBL882960,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13363,CHEMBL625447,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13364,CHEMBL625448,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13365,CHEMBL625449,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13366,CHEMBL874589,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13367,CHEMBL625450,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13368,CHEMBL625451,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13369,CHEMBL626584,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13370,CHEMBL626585,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13371,CHEMBL626586,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13372,CHEMBL626587,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13373,CHEMBL626588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13374,CHEMBL626589,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13375,CHEMBL626590,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13376,CHEMBL626591,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13377,CHEMBL627181,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13378,CHEMBL628083,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,15173,,,13379,CHEMBL628084,IV clearance determined at an peroral dose of 15 mg/kg.,In vivo,0,
,,Hymenolepis nana,N,1,,,BAO_0000218,,F,,50064,Expert,,7732,102285.0,,13380,CHEMBL628085,Mouse oral clearance was measured against Hymenolepiasis nana.,In vivo,1,
,,Heligmosomoides polygyrus,N,1,,,BAO_0000218,,F,,50545,Expert,,7732,6339.0,,13381,CHEMBL628086,Mouse oral clearance was measured against Nematospiroides dubius,In vivo,1,
,,,U,1,,,BAO_0000218,,F,,22224,Autocuration,,7732,,,13382,CHEMBL628087,Mouse oral clearance was measured against N. dubius; NT is Not Tested,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,7732,10090.0,,13383,CHEMBL628088,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,1,
,,,U,1,,,BAO_0000218,,B,,22224,Autocuration,,7732,,,13384,CHEMBL628089,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13385,CHEMBL628090,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13386,CHEMBL628091,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13387,CHEMBL628092,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13388,CHEMBL628093,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13389,CHEMBL875607,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13390,CHEMBL625710,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13391,CHEMBL625711,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13392,CHEMBL625712,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,8328,,,13393,CHEMBL625713,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,13376,9615.0,,13394,CHEMBL625714,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,In vivo,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,13477,9544.0,,13395,CHEMBL625715,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,13396,CHEMBL625716,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13477,10116.0,,13397,CHEMBL625717,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13313,10116.0,,13398,CHEMBL625718,Plasma clearance was determined for the compound in rats,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,13399,CHEMBL625719,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,13400,CHEMBL625720,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,13401,CHEMBL625721,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12504,10116.0,,13402,CHEMBL625722,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13129,10116.0,,13403,CHEMBL625723,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,1,
,,Heligmosomoides polygyrus,N,1,,,BAO_0000218,,A,,50545,Intermediate,,7732,6339.0,,13404,CHEMBL625724,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,In vivo,1,
,,Heligmosomoides polygyrus,N,1,,,BAO_0000218,,A,,50545,Intermediate,,7732,6339.0,,13405,CHEMBL625725,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,In vivo,1,
,,Heligmosomoides polygyrus,N,1,,,BAO_0000218,,A,,50545,Intermediate,,7732,6339.0,,13406,CHEMBL625726,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,In vivo,1,
,,Heligmosomoides polygyrus,N,1,,,BAO_0000218,,A,,50545,Intermediate,,7732,6339.0,,13407,CHEMBL875608,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,In vivo,1,
,,Heligmosomoides polygyrus,N,1,,,BAO_0000218,,A,,50545,Intermediate,,7732,6339.0,,13408,CHEMBL625727,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,In vivo,1,
,,Rattus norvegicus,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,9278,10116.0,,13409,CHEMBL625728,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,In vivo,0,1088.0
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9278,10116.0,,13410,CHEMBL625729,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,9278,10116.0,,13411,CHEMBL625730,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,9278,10116.0,,13412,CHEMBL625731,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,0,1088.0
,,Rattus norvegicus,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,9278,10116.0,,13413,CHEMBL626417,Urinary clearance was determined in rat at 25 mg/kg os dosage,In vivo,0,1088.0
,,Homo sapiens,N,1,,,BAO_0000218,Urine,A,,50587,Intermediate,,9278,9606.0,,13414,CHEMBL626418,Urinary clearance was determined at 100 mg/kg oral dosage in human,In vivo,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,9278,9615.0,,13415,CHEMBL626419,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,In vivo,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,5932,9615.0,,13416,CHEMBL626592,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,5932,10116.0,,13417,CHEMBL626593,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5182,10116.0,,13418,CHEMBL626594,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,10499,9615.0,,13419,CHEMBL625035,Clearance rate in dogs,In vivo,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6051,,,13420,CHEMBL625036,Compound was measured for intrinsic clearance,In vitro,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,17508,,,13421,CHEMBL625037,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6228,,,13422,CHEMBL625038,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6231,,,13423,CHEMBL625039,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,17740,,,13424,CHEMBL625040,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6495,,,13425,CHEMBL625041,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,2171,,,13426,CHEMBL625042,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3255,,,13427,CHEMBL874411,Partition coefficient of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6821,,,13428,CHEMBL625043,Permeability,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,2685,,,13429,CHEMBL625044,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17584,,,13430,CHEMBL625045,Partition coefficient (logD),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13824,,,13431,CHEMBL625046,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13824,,,13432,CHEMBL625047,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,16479,,,13433,CHEMBL625048,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,11997,,,13434,CHEMBL625049,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,2988,,,13435,CHEMBL625050,Calculated logarithm of partition coefficient (P) was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,931,,,13436,CHEMBL625051,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,4381,,,13437,CHEMBL874412,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,4397,,,13438,CHEMBL625052,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,5889,,,13439,CHEMBL625053,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13440,CHEMBL623250,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13441,CHEMBL623251,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13442,CHEMBL623252,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13443,CHEMBL623253,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13444,CHEMBL623254,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6154,,,13445,CHEMBL623255,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6887,,,13446,CHEMBL626831,Percent degradation of compound at a pH of 1 over a 18 hr period,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6887,,,13447,CHEMBL877494,Percent degradation of compound at pH of 1 over an 18 hr period,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14116,,,13448,CHEMBL626832,Delta Logarithm of Partition Coefficient value was determined.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11137,,,13449,CHEMBL626833,Delta logPoct-cyc,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,7230,,,13450,CHEMBL626834,Lipophilicity estimated on reversed phase TLC,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15741,,,13451,CHEMBL626835,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9663,,,13452,CHEMBL626836,Delta logPoct-cyc,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,9663,,,13453,CHEMBL626837,Change in logarithm of partition coefficient of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13807,,,13454,CHEMBL626838,Delta logD (pH 6.5),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,13807,,,13455,CHEMBL626839,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17425,,,13456,CHEMBL626840,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12143,,,13457,CHEMBL626841,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,0,
,,,U,1,,,BAO_0000219,,A,,22224,Autocuration,,12608,,,13458,CHEMBL626842,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,0,
,,,U,1,,,BAO_0000219,,A,,22224,Autocuration,,12608,,,13459,CHEMBL626843,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13460,CHEMBL626844,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13461,CHEMBL877495,Amount of deuterium retained was reported after normal workup in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13462,CHEMBL626845,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13463,CHEMBL626846,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13464,CHEMBL626847,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13465,CHEMBL628677,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8649,10116.0,,13466,CHEMBL628678,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9659,,,13467,CHEMBL628679,Compound was subjected to electrochemical oxidation,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9659,,,13468,CHEMBL628680,Compound was subjected to photochemical oxidation,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9659,,,13469,CHEMBL628681,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9659,,,13470,CHEMBL628682,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9659,,,13471,CHEMBL628683,Oxidation of compound by methemoglobin in presence of hydroperoxide,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9607,10116.0,,13472,CHEMBL628684,Percent diffusion through fuzzy rat skin after 48 h of incubation,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,7057,,,13473,CHEMBL877501,Dissociation constant (pKa),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,7057,,,13474,CHEMBL628685,Dissociation constant value of the compound; ND means not determined.,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7911,10116.0,,13475,CHEMBL628686,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,7911,10116.0,,13476,CHEMBL628687,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7911,10116.0,,13477,CHEMBL628688,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7911,10116.0,,13478,CHEMBL628689,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7911,10116.0,,13479,CHEMBL628690,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,7911,10116.0,,13480,CHEMBL629363,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,7911,10116.0,,13481,CHEMBL629364,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,7911,10116.0,,13482,CHEMBL629365,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7911,10116.0,,13483,CHEMBL629366,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,7911,10116.0,,13484,CHEMBL629367,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,7911,10116.0,,13485,CHEMBL629368,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,7911,10116.0,,13486,CHEMBL877502,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Cerebellum,A,,50594,Intermediate,,13792,10090.0,,13487,CHEMBL629369,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,1,2037.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,13488,CHEMBL629370,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,1,955.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13489,CHEMBL629371,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13490,CHEMBL626276,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13491,CHEMBL626277,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13492,CHEMBL631250,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13493,CHEMBL631251,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13494,CHEMBL631252,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13495,CHEMBL631253,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13496,CHEMBL631254,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13497,CHEMBL631255,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13498,CHEMBL631256,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13499,CHEMBL631257,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13500,CHEMBL628009,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13501,CHEMBL628010,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13502,CHEMBL628011,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13503,CHEMBL628012,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13504,CHEMBL628013,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13505,CHEMBL628014,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13506,CHEMBL628015,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13507,CHEMBL628016,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13508,CHEMBL874461,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13509,CHEMBL628017,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13510,CHEMBL628018,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13511,CHEMBL628019,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13512,CHEMBL628020,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13513,CHEMBL628021,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13514,CHEMBL628022,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,8133,9615.0,,13515,CHEMBL628023,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,1,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13516,CHEMBL628024,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13517,CHEMBL628025,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13518,CHEMBL628026,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13519,CHEMBL628027,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,0,1088.0
,,Simiiformes,U,1,,,BAO_0000218,Urine,A,,22224,Autocuration,,8133,314293.0,,13520,CHEMBL628028,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13521,CHEMBL628029,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13522,CHEMBL628030,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13523,CHEMBL628031,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13524,CHEMBL628032,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13525,CHEMBL628033,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13526,CHEMBL628034,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13527,CHEMBL628035,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13528,CHEMBL628036,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13529,CHEMBL874462,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13530,CHEMBL628037,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13531,CHEMBL628123,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13532,CHEMBL628124,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13533,CHEMBL628125,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13534,CHEMBL628126,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13535,CHEMBL628127,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13536,CHEMBL628128,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13537,CHEMBL628129,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13538,CHEMBL628130,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13539,CHEMBL628131,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13540,CHEMBL628132,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13541,CHEMBL628133,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13542,CHEMBL628134,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13543,CHEMBL628135,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13544,CHEMBL628136,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13545,CHEMBL628137,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13546,CHEMBL628138,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13547,CHEMBL628139,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13548,CHEMBL628140,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13549,CHEMBL628141,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13550,CHEMBL628142,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13551,CHEMBL628143,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13552,CHEMBL628144,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13553,CHEMBL628145,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13554,CHEMBL628146,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13555,CHEMBL625355,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13556,CHEMBL625356,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13557,CHEMBL625357,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13558,CHEMBL625527,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13559,CHEMBL875473,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,9025,9615.0,,13560,CHEMBL625528,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,9025,10116.0,,13561,CHEMBL626304,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Artery,A,,50588,Intermediate,,9025,9615.0,,13562,CHEMBL624138,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,In vivo,1,1637.0
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6448,,,13563,CHEMBL624139,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,17221,,,13564,CHEMBL624140,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6545,,,13565,CHEMBL624141,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,577,,,13566,CHEMBL624142,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6285,,,13567,CHEMBL624143,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6500,,,13568,CHEMBL624144,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6716,,,13569,CHEMBL624145,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,13658,,,13570,CHEMBL624146,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6549,,,13571,CHEMBL624147,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,14685,,,13572,CHEMBL883123,Calculated partition coefficient (clogP) (MacLogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6893,,,13573,CHEMBL624148,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3687,,,13574,CHEMBL874416,Kinetic parameter was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,4207,,,13575,CHEMBL624149,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,4626,,,13576,CHEMBL624150,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,1021,,,13577,CHEMBL624151,Lipophilicity was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,3777,,,13578,CHEMBL624152,Lipophilicity was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,17533,,,13579,CHEMBL622139,Lipophilicity was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6524,,,13580,CHEMBL622140,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,17533,,,13581,CHEMBL622141,Lipophilicity was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,6480,,,13582,CHEMBL622142,Lipophilicity in octanol-water,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,17606,,,13583,CHEMBL622143,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6863,,,13584,CHEMBL622144,Octanol-water partition coefficient was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1356,,,13585,CHEMBL877473,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,3326,,,13586,CHEMBL622145,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1356,,,13587,CHEMBL622146,Partition coefficient was determined; ND means not determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,12984,,,13588,CHEMBL622147,Calculated partition coefficient (clogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17363,,,13589,CHEMBL622148,Partition coefficient of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,6827,,,13590,CHEMBL883124,Permeability was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,261,,,13591,CHEMBL622149,The compound was evaluated for the partition coefficient,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2685,,,13592,CHEMBL622150,Partition coefficient (logP),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,414,,,13593,CHEMBL622151,The lipophilicity was reported,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15769,,,13594,CHEMBL622152,logarithm of the octanol-water partition coefficient for the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17248,,,13595,CHEMBL622153,Clogp value was determined,,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16935,,,13596,CHEMBL877474,Clp at a dose of 1.5 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16935,,,13597,CHEMBL622154,Clp at a dose of 2.0 mg/kg,In vivo,0,
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14832,,,13598,CHEMBL622155,"Clp, plasma clearance at a dose of 10 mg/kg",In vivo,0,1969.0
,,,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,14832,,,13599,CHEMBL622156,"Clp, plasma clearance at a dose of 50 mg/kg",In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2399,10116.0,,13600,CHEMBL622157,Compound was tested for plasma clearance in rat,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,2399,10116.0,,13601,CHEMBL622158,Compound was tested for plasma clearance in rat; Not determined,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6227,10116.0,,13602,CHEMBL622807,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,In vivo,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,6227,9544.0,,13603,CHEMBL622808,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,5623,,,13604,CHEMBL622809,Plasma clearance by iv administration at a dose 0.003 ug/mL,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4854,,,13605,CHEMBL622810,Plasma clearance determined,In vivo,0,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,4493,10026.0,,13606,CHEMBL876653,Plasma clearance after iv administration at 3 mg/kg in hamster,In vivo,1,
,,Cricetinae,N,1,,,BAO_0000218,,A,,100712,Intermediate,,4493,10026.0,,13607,CHEMBL622811,Plasma clearance after iv administration at 4 mg/kg in hamster,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14956,10116.0,,13608,CHEMBL622986,Rate of clearance in rat was determined,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15372,10116.0,,13609,CHEMBL622987,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15372,10116.0,,13610,CHEMBL622988,Total plasma clearance after iv dose of 5.10 mg/kg in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15372,10116.0,,13611,CHEMBL622989,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15372,10116.0,,13612,CHEMBL622990,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,In vivo,1,1969.0
,,Simiiformes,U,1,,,BAO_0000218,Plasma,A,,22224,Autocuration,,15604,314293.0,,13613,CHEMBL622991,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,In vivo,0,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15604,10116.0,,13614,CHEMBL622227,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,In vivo,1,1969.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,15604,9615.0,,13615,CHEMBL622228,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14964,10116.0,,13616,CHEMBL622229,Clpl value in rat,In vivo,1,
,,Cavia porcellus,N,1,,,BAO_0000218,,A,,50512,Intermediate,,15240,10141.0,,13617,CHEMBL622230,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16449,10116.0,,13618,CHEMBL622231,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,In vivo,1,
,,Macaca fascicularis,N,1,,,BAO_0000218,,A,,100710,Intermediate,,16449,9541.0,,13619,CHEMBL622232,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13620,CHEMBL622233,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13621,CHEMBL622234,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13622,CHEMBL622235,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13623,CHEMBL622236,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13624,CHEMBL622237,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13625,CHEMBL877482,Cmax in minutes at a po dose of 10.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13626,CHEMBL622238,Cmax in minutes at a po dose of 20.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,12902,,,13627,CHEMBL622239,Cmax in minutes at a po dose of 40.0(pmol/g/h).,In vivo,0,
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,11149,,,13628,CHEMBL622240,Cmax was calculated as maximum concentration reached in the blood,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,11149,,,13629,CHEMBL622241,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,In vivo,0,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,13630,CHEMBL631013,Cmax was determine after peroral administration at 10 mpk in Rat,In vivo,1,
,,Macaca mulatta,N,1,,,BAO_0000218,,A,,50797,Intermediate,,5669,9544.0,,13631,CHEMBL631014,Cmax was determine after peroral administration at 10 mpk in Rhesus,In vivo,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,5669,9615.0,,13632,CHEMBL631015,Cmax was determine after peroral administration at 10 mpk in dog,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,13633,CHEMBL631016,Cmax was determine after peroral administration at 160 mpk in Rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,13634,CHEMBL631017,Cmax was determine after peroral administration at 20 mpk in Rat,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,5669,10116.0,,13635,CHEMBL631018,Cmax was determine after peroral administration at 50 mpk in Rat,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,4236,,,13636,CHEMBL631019,Cmax was determined,In vivo,0,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,13637,CHEMBL875761,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,13638,CHEMBL631020,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,13639,CHEMBL631669,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,13792,10090.0,,13640,CHEMBL631670,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Striatum,A,,50594,Intermediate,,13792,10090.0,,13641,CHEMBL631671,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13642,CHEMBL631672,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13643,CHEMBL631673,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13644,CHEMBL631856,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13645,CHEMBL631857,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13646,CHEMBL631858,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13647,CHEMBL631859,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13648,CHEMBL631860,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13649,CHEMBL631861,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13650,CHEMBL631862,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13651,CHEMBL631863,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13652,CHEMBL631864,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13653,CHEMBL631865,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13654,CHEMBL631866,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13655,CHEMBL629360,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13656,CHEMBL629361,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13657,CHEMBL629362,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13658,CHEMBL630740,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13659,CHEMBL630741,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,8418,10116.0,,13660,CHEMBL630742,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13661,CHEMBL630743,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13662,CHEMBL630744,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13663,CHEMBL630745,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13664,CHEMBL630746,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13665,CHEMBL630747,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13666,CHEMBL630748,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13667,CHEMBL632056,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13668,CHEMBL632057,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13669,CHEMBL632058,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13670,CHEMBL632059,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13671,CHEMBL632060,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13672,CHEMBL632061,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13673,CHEMBL629207,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13674,CHEMBL629208,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13675,CHEMBL629209,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13676,CHEMBL629210,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13677,CHEMBL629211,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13678,CHEMBL629212,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8418,10116.0,,13679,CHEMBL629213,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13680,CHEMBL629214,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13681,CHEMBL629215,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,8133,10116.0,,13682,CHEMBL635154,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13683,CHEMBL629216,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13684,CHEMBL629217,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13685,CHEMBL629218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13686,CHEMBL629219,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13687,CHEMBL629220,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13688,CHEMBL629221,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13689,CHEMBL631127,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13690,CHEMBL631128,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13691,CHEMBL631129,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13692,CHEMBL631130,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13693,CHEMBL631131,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13694,CHEMBL631132,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13695,CHEMBL631133,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13696,CHEMBL631134,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13697,CHEMBL875120,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13698,CHEMBL631135,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13699,CHEMBL631136,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13700,CHEMBL631137,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13701,CHEMBL631138,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13702,CHEMBL631139,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13703,CHEMBL631140,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13704,CHEMBL631141,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13705,CHEMBL631142,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13706,CHEMBL631143,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6996,10116.0,,13707,CHEMBL631144,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13708,CHEMBL631145,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13709,CHEMBL631146,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13710,CHEMBL631147,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13711,CHEMBL631148,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13712,CHEMBL631149,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13713,CHEMBL631150,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13714,CHEMBL631151,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13715,CHEMBL631152,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13716,CHEMBL631443,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13717,CHEMBL631444,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13718,CHEMBL631445,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13719,CHEMBL631446,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13720,CHEMBL631447,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13721,CHEMBL631448,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13722,CHEMBL631449,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13723,CHEMBL631450,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,6996,9615.0,,13724,CHEMBL629724,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,1,
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,9716,10090.0,,13725,CHEMBL629725,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Zone of skin,A,,50594,Intermediate,,9716,10090.0,,13726,CHEMBL629726,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,14.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,9716,10090.0,,13727,CHEMBL629727,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,9716,10090.0,,13728,CHEMBL630404,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,9716,10090.0,,13729,CHEMBL630405,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,9716,10090.0,,13730,CHEMBL630406,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Stomach,A,,50594,Intermediate,,9716,10090.0,,13731,CHEMBL630407,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,945.0
,,Mus musculus,N,1,,,BAO_0000218,Stomach,A,,50594,Intermediate,,9716,10090.0,,13732,CHEMBL630573,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,945.0
,,Mus musculus,N,1,,,BAO_0000218,Stomach,A,,50594,Intermediate,,9716,10090.0,,13733,CHEMBL630574,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,945.0
,,Mus musculus,N,1,,,BAO_0000218,Stomach,A,,50594,Intermediate,,9716,10090.0,,13734,CHEMBL630575,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,945.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9716,10090.0,,13735,CHEMBL630576,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9716,10090.0,,13736,CHEMBL630577,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9716,10090.0,,13737,CHEMBL630578,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,9716,10090.0,,13738,CHEMBL630579,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,12192,10090.0,,13739,CHEMBL630580,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,12192,10090.0,,13740,CHEMBL630581,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,12192,10090.0,,13741,CHEMBL630582,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13742,CHEMBL630583,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13743,CHEMBL630584,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13744,CHEMBL630585,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13745,CHEMBL630586,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13746,CHEMBL630587,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13747,CHEMBL630588,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13748,CHEMBL630589,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,12192,10090.0,,13749,CHEMBL630590,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,1,
,,,U,1,,,BAO_0000019,Feces,A,,22224,Autocuration,,12192,,,13750,CHEMBL630591,Removal of 238-Plutonium(IV) in feces at 24 h,,0,1988.0
,,,U,1,,,BAO_0000019,Feces,A,,22224,Autocuration,,12192,,,13751,CHEMBL630592,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,0,1988.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12192,,,13752,CHEMBL630593,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12192,,,13753,CHEMBL630594,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,0,
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13754,CHEMBL630595,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13755,CHEMBL630596,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13756,CHEMBL630597,Removal of 238-Plutonium(IV) in urine after 0-24 h,,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13757,CHEMBL630598,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13758,CHEMBL630599,Removal of 238-Plutonium(IV) in urine after 0-4 h,,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13759,CHEMBL630600,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13760,CHEMBL630601,Removal of 238-Plutonium(IV) in urine after 4-24 h,,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13761,CHEMBL630602,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13762,CHEMBL630603,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,0,1088.0
,,,U,1,,,BAO_0000019,Urine,A,,22224,Autocuration,,12192,,,13763,CHEMBL630604,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,13764,CHEMBL624869,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,13765,CHEMBL624870,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,13766,CHEMBL623189,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,13767,CHEMBL623190,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,13768,CHEMBL623191,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13769,CHEMBL623192,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13770,CHEMBL623193,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13771,CHEMBL623194,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13772,CHEMBL623195,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13773,CHEMBL623196,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11836,10116.0,,13774,CHEMBL623197,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11836,10116.0,,13775,CHEMBL623198,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11836,10116.0,,13776,CHEMBL623199,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13777,CHEMBL623200,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13778,CHEMBL623201,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13779,CHEMBL623202,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13780,CHEMBL623203,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13781,CHEMBL623204,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13782,CHEMBL623205,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13783,CHEMBL623206,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13784,CHEMBL623207,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13785,CHEMBL623208,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13786,CHEMBL623209,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,11836,10116.0,,13787,CHEMBL623210,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11836,10116.0,,13788,CHEMBL623211,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,11836,10116.0,,13789,CHEMBL623212,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,1,995.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12640,,,13790,CHEMBL623213,Tested in vitro for intrinsic activity relative to quinpirole,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14218,,,13791,CHEMBL623214,"Relative ion enhancement, determined in pulsed ultrafiltration",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11296,,,13792,CHEMBL623215,% ionization at the pH 7.4 at 37 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10929,,,13793,CHEMBL623216,Percentage ionization was measured,,0,
,,Bos taurus,N,1,,,BAO_0000218,,A,,50591,Intermediate,,13841,9913.0,,13794,CHEMBL623217,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10431,,,13795,CHEMBL623218,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10431,,,13796,CHEMBL623913,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10431,,,13797,CHEMBL623914,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8826,,,13798,CHEMBL623915,Compound was evaluated for the partition coefficient in octanol/water,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8826,,,13799,CHEMBL624080,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9884,,,13800,CHEMBL624081,Equilibrium constant measured by the pulse radiolysis at pH 7,,0,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,9827,9606.0,,13801,CHEMBL624082,In vitro hydrolytic rate constant determined in human blood,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10009,9606.0,,13802,CHEMBL625054,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10009,,,13803,CHEMBL877485,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,13804,CHEMBL625055,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,13805,CHEMBL625056,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,10009,9606.0,,13806,CHEMBL625057,In vitro oxidation of compound in presence of human plasma,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10009,,,13807,CHEMBL625058,In vitro oxidation of compound in presence of hydrogen peroxide,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,13808,CHEMBL625059,In vitro oxidation of compound in presence of mouse brain homogenate,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,10009,10090.0,,13809,CHEMBL629536,In vitro oxidation of compound in presence of mouse liver homogenate,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13810,CHEMBL629537,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13811,CHEMBL629538,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13812,CHEMBL629539,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13813,CHEMBL874445,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13814,CHEMBL629540,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13815,CHEMBL629541,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13816,CHEMBL629542,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13817,CHEMBL630243,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13818,CHEMBL630244,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13819,CHEMBL630245,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13820,CHEMBL630246,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13821,CHEMBL630247,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13822,CHEMBL630248,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13100,10116.0,,13823,CHEMBL630249,Biodistribution in rat blood at 240 minutes after dose administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13100,10116.0,,13824,CHEMBL630250,Biodistribution in rat blood at 30 minutes after dose administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13100,10116.0,,13825,CHEMBL630251,Biodistribution in rat blood at 360 minutes after dose administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13100,10116.0,,13826,CHEMBL630252,Biodistribution in rat blood at 3 hr after dose administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13100,10116.0,,13827,CHEMBL630408,Biodistribution in rat blood at 60 minutes after dose administration.,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13828,CHEMBL630409,Biodistribution in rat cerebellum at 120 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13829,CHEMBL874446,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13830,CHEMBL630410,Biodistribution in rat cerebellum at 15 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13831,CHEMBL630411,Biodistribution in rat cerebellum at 240 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13832,CHEMBL630412,Biodistribution in rat cerebellum at 30 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13833,CHEMBL630413,Biodistribution in rat cerebellum at 360 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13834,CHEMBL630414,Biodistribution in rat cerebellum at 3 hr after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,13100,10116.0,,13835,CHEMBL630415,Biodistribution in rat cerebellum at 60 minutes after dose administration.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13836,CHEMBL630416,Biodistribution in rat cortex at 120 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13837,CHEMBL630417,Biodistribution in rat cortex at 1440 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13838,CHEMBL630418,Biodistribution in rat cortex at 15 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13839,CHEMBL630419,Biodistribution in rat cortex at 240 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13840,CHEMBL630420,Biodistribution in rat cortex at 30 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13841,CHEMBL630421,Biodistribution in rat cortex at 360 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13842,CHEMBL630422,Biodistribution in rat cortex at 3 hr after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,13843,CHEMBL630423,Biodistribution in rat cortex at 60 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13844,CHEMBL630424,Biodistribution in rat heart at 120 minutes after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13845,CHEMBL630425,Biodistribution in rat heart at 15 minutes after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13846,CHEMBL629462,Biodistribution in rat heart at 240 minutes after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13847,CHEMBL630426,Biodistribution in rat heart at 30 minutes after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13848,CHEMBL630427,Biodistribution in rat heart at 360 minutes after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13849,CHEMBL625877,Biodistribution in rat heart at 3 hr after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13100,10116.0,,13850,CHEMBL625878,Biodistribution in rat heart at 60 minutes after dose administration.,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13100,10116.0,,13851,CHEMBL625879,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13100,10116.0,,13852,CHEMBL625880,Biodistribution in rat hippocampus at 240 minutes after dose administration.,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13100,10116.0,,13853,CHEMBL625881,Biodistribution in rat hippocampus at 30 minutes after dose administration.,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13100,10116.0,,13854,CHEMBL625882,Biodistribution in rat hippocampus at 360 minutes after dose administration.,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,13100,10116.0,,13855,CHEMBL625883,Biodistribution in rat hippocampus at 15 minutes after dose administration.,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13856,CHEMBL625884,Biodistribution in rat kidney at 120 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13857,CHEMBL625885,Biodistribution in rat kidney at 1440 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13858,CHEMBL628649,Biodistribution in rat kidney at 15 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13859,CHEMBL628650,Biodistribution in rat kidney at 240 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13860,CHEMBL628651,Biodistribution in rat kidney at 30 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13861,CHEMBL628652,Biodistribution in rat kidney at 360 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13100,10116.0,,13862,CHEMBL628653,Biodistribution in rat kidney at 60 minutes after dose administration.,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13863,CHEMBL628654,Biodistribution in rat liver at 120 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13864,CHEMBL628655,Biodistribution in rat liver at 1440 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13865,CHEMBL625238,Biodistribution in rat liver at 15 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13866,CHEMBL625239,Biodistribution in rat liver at 240 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13867,CHEMBL625240,Biodistribution in rat liver at 30 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13868,CHEMBL625241,Biodistribution in rat liver at 360 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13100,10116.0,,13869,CHEMBL625242,Biodistribution in rat liver at 60 minutes after dose administration.,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,13870,CHEMBL874587,Biodistribution in rat lung at 120 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,13871,CHEMBL625405,Biodistribution in rat lung at 1440 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,13872,CHEMBL625406,Biodistribution in rat lung at 15 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,13873,CHEMBL625407,Biodistribution in rat lung at 240 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,13874,CHEMBL625408,Biodistribution in rat lung at 30 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,13875,CHEMBL625409,Biodistribution in rat lung at 360 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13876,CHEMBL625410,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13877,CHEMBL625411,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13878,CHEMBL625412,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13879,CHEMBL625413,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13880,CHEMBL625414,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13881,CHEMBL625415,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thoracic aorta,A,,50597,Intermediate,,12361,10116.0,,13882,CHEMBL625416,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,1,1515.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12712,10116.0,,13883,CHEMBL625417,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,7415,10116.0,,13884,CHEMBL625418,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,7415,10116.0,,13885,CHEMBL625419,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7415,10116.0,,13886,CHEMBL625420,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7415,10116.0,,13887,CHEMBL626996,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,7415,10116.0,,13888,CHEMBL626997,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,7415,10116.0,,13889,CHEMBL626998,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7415,10116.0,,13890,CHEMBL626999,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8050,10090.0,,13891,CHEMBL627000,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8050,10090.0,,13892,CHEMBL627001,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8050,10090.0,,13893,CHEMBL627002,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8050,10090.0,,13894,CHEMBL627003,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,1,
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13895,CHEMBL627004,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13896,CHEMBL627005,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13897,CHEMBL874594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13898,CHEMBL627006,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13899,CHEMBL627007,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13900,CHEMBL627884,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13901,CHEMBL627885,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13902,CHEMBL627886,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13903,CHEMBL627887,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13904,CHEMBL627888,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13905,CHEMBL628057,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,1,1088.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,8050,10090.0,,13906,CHEMBL627405,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13907,CHEMBL627406,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13908,CHEMBL627407,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13909,CHEMBL627408,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13910,CHEMBL627409,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13911,CHEMBL875486,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13912,CHEMBL627410,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13913,CHEMBL627411,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13914,CHEMBL627412,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13915,CHEMBL627413,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13916,CHEMBL627414,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13917,CHEMBL627415,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13918,CHEMBL627416,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13919,CHEMBL627417,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13920,CHEMBL627418,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13921,CHEMBL627419,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13922,CHEMBL627320,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,13923,CHEMBL627321,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,13924,CHEMBL627322,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,13925,CHEMBL627323,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,13926,CHEMBL627491,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,13927,CHEMBL627492,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,13928,CHEMBL627493,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,13929,CHEMBL627494,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,13930,CHEMBL627495,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,13931,CHEMBL627496,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,13932,CHEMBL627497,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,13933,CHEMBL627498,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,13934,CHEMBL627499,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,13935,CHEMBL627500,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,13936,CHEMBL627501,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,13937,CHEMBL625616,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,13938,CHEMBL625617,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,13939,CHEMBL625618,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,13940,CHEMBL625619,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,13941,CHEMBL625620,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,13942,CHEMBL625621,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,13943,CHEMBL625622,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13944,CHEMBL625788,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13945,CHEMBL625789,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13946,CHEMBL625790,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13947,CHEMBL625791,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13948,CHEMBL622334,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,12017,10116.0,,13949,CHEMBL622335,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,12017,10116.0,,13950,CHEMBL622336,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,12017,10116.0,,13951,CHEMBL622337,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,12017,10116.0,,13952,CHEMBL622338,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,12017,10116.0,,13953,CHEMBL622339,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13954,CHEMBL624153,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13955,CHEMBL628430,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13956,CHEMBL628431,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13957,CHEMBL628432,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,13958,CHEMBL628433,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13959,CHEMBL628434,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13960,CHEMBL626789,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13961,CHEMBL626790,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13962,CHEMBL626791,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13963,CHEMBL626792,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,13964,CHEMBL626793,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13965,CHEMBL627436,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13966,CHEMBL627437,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13967,CHEMBL627438,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13968,CHEMBL627439,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13969,CHEMBL627440,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13970,CHEMBL627602,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13971,CHEMBL627603,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13972,CHEMBL627604,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13973,CHEMBL627605,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13974,CHEMBL627606,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13975,CHEMBL627607,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13976,CHEMBL627608,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13977,CHEMBL627609,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13978,CHEMBL627610,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13979,CHEMBL627611,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,13980,CHEMBL627612,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,8362,,,13981,CHEMBL627613,Octanol:water partition coefficient is evaluated,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,8257,,,13982,CHEMBL627614,Partition coefficient in 1-octanol/water system,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,8257,,,13983,CHEMBL627615,Partition coefficient in 1-octanol/water system measured using radio active compounds,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,9468,,,13984,CHEMBL627616,Partition coefficient in octanol/water system was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,9468,,,13985,CHEMBL627617,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10568,,,13986,CHEMBL627618,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10568,,,13987,CHEMBL627619,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15359,,,13988,CHEMBL627620,Pseudo-first-order rate constant of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15359,,,13989,CHEMBL627621,Pseudo-first-order rate constant with 1-min time point,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15359,,,13990,CHEMBL627622,Pseudo-first-order rate constant without 1-min time point,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10431,,,13991,CHEMBL627623,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10431,,,13992,CHEMBL627624,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10431,,,13993,CHEMBL627625,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15704,,,13994,CHEMBL628523,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15287,,,13995,CHEMBL628524,The alkaline hydrolysis second order rate constant(K OH) of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7516,,,13996,CHEMBL628525,The efflux rate constant of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12973,,,13997,CHEMBL625732,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12973,,,13998,CHEMBL625733,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,
,,,U,1,,,BAO_0000019,,F,,22224,Autocuration,,12973,,,13999,CHEMBL625734,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12973,,,14000,CHEMBL625913,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8696,,,14001,CHEMBL625914,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15052,,,14002,CHEMBL625915,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15052,,,14003,CHEMBL625916,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10503,,,14004,CHEMBL625917,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14005,CHEMBL625918,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14006,CHEMBL625919,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14007,CHEMBL625920,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14008,CHEMBL874453,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14009,CHEMBL625921,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10503,,,14010,CHEMBL625922,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14011,CHEMBL625923,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14012,CHEMBL625924,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14013,CHEMBL625925,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14014,CHEMBL625926,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13100,10116.0,,14015,CHEMBL627704,Biodistribution in rat lung at 60 minutes after dose administration.,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,14016,CHEMBL627705,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,14017,CHEMBL627706,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,14018,CHEMBL627707,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,14019,CHEMBL627708,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,14020,CHEMBL628361,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13100,10116.0,,14021,CHEMBL628362,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14022,CHEMBL628363,Biodistribution in rat striatum at 120 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14023,CHEMBL628364,Biodistribution in rat striatum at 1440 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14024,CHEMBL628365,Biodistribution in rat striatum at 15 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14025,CHEMBL874454,Biodistribution in rat striatum at 240 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14026,CHEMBL628531,Biodistribution in rat striatum at 30 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14027,CHEMBL628532,Biodistribution in rat striatum at 360 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14028,CHEMBL628533,Biodistribution in rat striatum at 3 hr after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Striatum,A,,50597,Intermediate,,13100,10116.0,,14029,CHEMBL628534,Biodistribution in rat striatum at 60 minutes after dose administration.,In vivo,1,2435.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14030,CHEMBL628535,Biodistribution in rat thyroid at 120 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14031,CHEMBL628536,Biodistribution in rat thyroid at 1440 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14032,CHEMBL628537,Biodistribution in rat thyroid at 15 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14033,CHEMBL628538,Biodistribution in rat thyroid at 240 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14034,CHEMBL628539,Biodistribution in rat thyroid at 30 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14035,CHEMBL630297,Biodistribution in rat thyroid at 360 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,13100,10116.0,,14036,CHEMBL630298,Biodistribution in rat thyroid at 60 minutes after dose administration.,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14037,CHEMBL630299,Biodistribution in rest of brain of rat 120 minutes after dose administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14038,CHEMBL628094,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14039,CHEMBL628095,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14040,CHEMBL874648,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14041,CHEMBL628096,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14042,CHEMBL628097,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13100,10116.0,,14043,CHEMBL628098,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,In vivo,1,955.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14044,CHEMBL628099,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14045,CHEMBL628100,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14046,CHEMBL628101,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14047,CHEMBL628102,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14048,CHEMBL628103,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14049,CHEMBL628104,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14050,CHEMBL628105,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13331,,,14051,CHEMBL628106,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,10086,10116.0,,14052,CHEMBL628107,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,1,1088.0
,,,U,1,,,BAO_0000218,Urine,F,,22224,Autocuration,,10086,,,14053,CHEMBL628108,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,10086,10116.0,,14054,CHEMBL628109,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,1,1088.0
,,,U,1,,,BAO_0000218,Urine,F,,22224,Autocuration,,10086,,,14055,CHEMBL625299,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,0,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,10086,10116.0,,14056,CHEMBL625300,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,10086,10116.0,,14057,CHEMBL625301,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,10086,10116.0,,14058,CHEMBL625302,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,10086,10116.0,,14059,CHEMBL874649,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13248,10116.0,,14060,CHEMBL625303,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13248,10116.0,,14061,CHEMBL625463,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,1,
,,Homo sapiens,N,1,,,BAO_0000218,Liver,A,,50587,Intermediate,,14527,9606.0,,14062,CHEMBL625464,In vitro metabolism in human liver microsomes,,1,2107.0
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,3008,9606.0,,14063,CHEMBL625465,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14064,CHEMBL625466,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14065,CHEMBL625467,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14066,CHEMBL625468,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14067,CHEMBL625469,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14068,CHEMBL625470,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14069,CHEMBL632418,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14070,CHEMBL627250,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14071,CHEMBL627251,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14072,CHEMBL627252,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14073,CHEMBL627253,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14074,CHEMBL627254,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14075,CHEMBL875471,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14076,CHEMBL627255,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14077,CHEMBL627256,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14078,CHEMBL627257,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14079,CHEMBL627258,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14080,CHEMBL627259,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14081,CHEMBL627260,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14082,CHEMBL623256,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14083,CHEMBL874413,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14084,CHEMBL623257,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14085,CHEMBL623258,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14086,CHEMBL623259,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14087,CHEMBL623260,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14088,CHEMBL623261,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14089,CHEMBL623262,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14090,CHEMBL623263,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14091,CHEMBL623264,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14092,CHEMBL623265,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14093,CHEMBL623266,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14094,CHEMBL623267,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14095,CHEMBL623268,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14096,CHEMBL623269,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14097,CHEMBL623270,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14098,CHEMBL623271,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14099,CHEMBL623272,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14100,CHEMBL623273,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14101,CHEMBL623274,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14102,CHEMBL874414,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14103,CHEMBL623275,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14104,CHEMBL629150,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14105,CHEMBL623276,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14106,CHEMBL623277,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14107,CHEMBL623112,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14108,CHEMBL623113,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14109,CHEMBL623800,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14110,CHEMBL623801,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14111,CHEMBL623802,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,12017,10116.0,,14112,CHEMBL623803,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,12017,10116.0,,14113,CHEMBL623970,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Uterus,A,,50597,Intermediate,,12017,10116.0,,14114,CHEMBL623971,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,995.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14045,10116.0,,14115,CHEMBL623972,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14045,10116.0,,14116,CHEMBL623973,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14045,10116.0,,14117,CHEMBL623974,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,14045,10116.0,,14118,CHEMBL623975,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14045,10116.0,,14119,CHEMBL623976,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14045,10116.0,,14120,CHEMBL623977,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14045,10116.0,,14121,CHEMBL623978,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,14045,10116.0,,14122,CHEMBL623979,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14045,10116.0,,14123,CHEMBL623980,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14045,10116.0,,14124,CHEMBL623981,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14045,10116.0,,14125,CHEMBL626278,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14045,10116.0,,14126,CHEMBL626279,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14127,CHEMBL626280,Biodistribution in mice bladder plus excreted urine was determined,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14128,CHEMBL626281,"Percentage biodistribution in mouse blood, 10 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14129,CHEMBL626282,"Percentage biodistribution in mouse blood, 30 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14130,CHEMBL626283,"Percentage biodistribution in mouse blood, 5 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14131,CHEMBL626284,"Percentage biodistribution in mouse blood, 60 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,14045,10090.0,,14132,CHEMBL626285,"Percentage biodistribution in mouse brain, 10 minutes post injection",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,14045,10090.0,,14133,CHEMBL626286,"Percentage biodistribution in mouse brain, 30 minutes post injection",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,14045,10090.0,,14134,CHEMBL626287,"Percentage biodistribution in mouse brain, 5 minutes post injection",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,Brain,A,,50594,Intermediate,,14045,10090.0,,14135,CHEMBL626288,"Percentage biodistribution in mouse brain, 60 minutes post injection",,1,955.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14136,CHEMBL626289,"Percentage biodistribution in mouse heart, 10 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14137,CHEMBL626290,"Percentage biodistribution in mouse heart, 30 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14138,CHEMBL626291,"Percentage biodistribution in mouse heart, 5 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14139,CHEMBL839888,"Percentage biodistribution in mouse heart, 60 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,Intestine,A,,50594,Intermediate,,14045,10090.0,,14140,CHEMBL626292,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,1,160.0
,,Mus musculus,N,1,,,BAO_0000218,Intestine,A,,50594,Intermediate,,14045,10090.0,,14141,CHEMBL626293,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,1,160.0
,,Mus musculus,N,1,,,BAO_0000218,Intestine,A,,50594,Intermediate,,14045,10090.0,,14142,CHEMBL626294,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,1,160.0
,,Mus musculus,N,1,,,BAO_0000218,Intestine,A,,50594,Intermediate,,14045,10090.0,,14143,CHEMBL626295,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,1,160.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,14045,10090.0,,14144,CHEMBL627659,"Percentage biodistribution in mouse liver, 10 minutes post injection",,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,14045,10090.0,,14145,CHEMBL627660,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,14045,10090.0,,14146,CHEMBL627661,"Percentage biodistribution in mouse liver, 5 minutes post injection",,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,14045,10090.0,,14147,CHEMBL627662,Biodistribution in mice liver at 60 minutes of post injection,In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,14045,10090.0,,14148,CHEMBL627663,Biodistribution in mice lungs at 10 min of post injection,In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14149,CHEMBL627664,"Percentage biodistribution in mouse lung, 30 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14045,10090.0,,14150,CHEMBL627665,"Percentage biodistribution in mousee lung, 5 minutes post injection",,1,
,,Mus musculus,N,1,,,BAO_0000218,Lung,A,,50594,Intermediate,,14045,10090.0,,14151,CHEMBL627666,Biodistribution in mice lungs at 60 min of post injection,In vivo,1,2048.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,14045,10090.0,,14152,CHEMBL627667,Percentage biodistribution in mouse spleen,,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Stomach,A,,50594,Intermediate,,14045,10090.0,,14153,CHEMBL627668,Percentage biodistribution in mouse stomach,,1,945.0
,,Mus musculus,N,1,,,BAO_0000218,Urine,A,,50594,Intermediate,,11745,10090.0,,14154,CHEMBL627669,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,1,1088.0
,,,U,1,,,BAO_0000218,Urinary bladder,A,,22224,Autocuration,,13257,,,14155,CHEMBL627670,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,In vivo,0,1255.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13257,,,14156,CHEMBL627671,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Bone element,A,,22224,Autocuration,,13257,,,14157,CHEMBL627672,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,In vivo,0,1474.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14158,CHEMBL627673,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,In vivo,0,
,,,U,1,,,BAO_0000218,Kidney,A,,22224,Autocuration,,13257,,,14159,CHEMBL627674,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,In vivo,0,2113.0
,,,U,1,,,BAO_0000218,Liver,A,,22224,Autocuration,,13257,,,14160,CHEMBL627675,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,In vivo,0,2107.0
,,,U,1,,,BAO_0000218,Lung,A,,22224,Autocuration,,13257,,,14161,CHEMBL627676,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,In vivo,0,2048.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14162,CHEMBL627677,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14163,CHEMBL627678,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,7095,10116.0,,14164,CHEMBL627679,Affinity for protein binding expressed as association constant in fresh rat serum,,1,1977.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12185,,,14165,CHEMBL627680,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12185,,,14166,CHEMBL627681,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12185,,,14167,CHEMBL627682,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12185,,,14168,CHEMBL627683,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12686,,,14169,CHEMBL627684,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12686,,,14170,CHEMBL874441,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12686,,,14171,CHEMBL627685,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12686,,,14172,CHEMBL627686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8057,,,14173,CHEMBL627687,Apparent rate constant Koff for inactivation of dTMP synthase.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15778,,,14174,CHEMBL627688,The irreversible inhibitor activity by second order rate equation.,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12375,10116.0,,14175,CHEMBL628038,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12375,10116.0,,14176,CHEMBL628039,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12375,10116.0,,14177,CHEMBL628040,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13588,,,14178,CHEMBL628041,Dissociation rate calculated from the first-order equation using t1/2 value,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15039,,,14179,CHEMBL630226,The compound was tested for Binding constant against DNA,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9500,,,14180,CHEMBL628042,First order rate constant for cyclization of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10014,,,14181,CHEMBL625232,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10014,,,14182,CHEMBL625233,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14183,CHEMBL625979,Hydrolysis rate constant was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10026,,,14184,CHEMBL625980,Observed first order rate constant,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10281,,,14185,CHEMBL625981,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10281,,,14186,CHEMBL625982,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14187,CHEMBL625983,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14188,CHEMBL625984,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14189,CHEMBL625985,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14190,CHEMBL625986,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14191,CHEMBL625987,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14192,CHEMBL625988,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14193,CHEMBL625989,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14194,CHEMBL625990,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14195,CHEMBL625991,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14196,CHEMBL625992,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14197,CHEMBL625993,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14198,CHEMBL631973,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14199,CHEMBL632143,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14200,CHEMBL632144,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14201,CHEMBL632145,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14202,CHEMBL632146,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14203,CHEMBL632147,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14204,CHEMBL632148,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14205,CHEMBL632149,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14206,CHEMBL632150,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14207,CHEMBL632151,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,3008,9606.0,,14208,CHEMBL632152,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,4509,9606.0,,14209,CHEMBL632153,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,4509,9606.0,,14210,CHEMBL632154,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14211,CHEMBL632155,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14212,CHEMBL632156,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14213,CHEMBL632157,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14214,CHEMBL632158,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14215,CHEMBL632159,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14216,CHEMBL626305,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14217,CHEMBL626306,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14218,CHEMBL626307,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14219,CHEMBL626308,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14220,CHEMBL626479,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,1,
,,Human herpesvirus 1,N,1,,,BAO_0000218,,A,,50602,Intermediate,,8613,10298.0,,14221,CHEMBL626480,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,6021,,,14222,CHEMBL626481,Calculated partition coefficient (clogP) (MlogP),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9348,,,14223,CHEMBL626482,Equipotent potent ratio relative to carbachol (nicotinic activity),,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15592,9615.0,,14224,CHEMBL626483,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,15592,9615.0,,14225,CHEMBL626484,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,1,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15592,,,14226,CHEMBL626485,Solubility at pH 7.4 in micro g/mL;NA denotes available,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15592,,,14227,CHEMBL626486,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15592,,,14228,CHEMBL626487,Solubility at pH 7.4 in ug/mL;NA denotes not available,,0,
,,Canis lupus familiaris,N,1,,,BAO_0000218,Plasma,A,,50588,Intermediate,,15592,9615.0,,14229,CHEMBL626488,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Serum,A,,50597,Intermediate,,7095,10116.0,,14230,CHEMBL626489,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,1,1977.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,16618,,,14231,CHEMBL626490,Area under the MAP curve measured over 5 min; ND means Not determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,16835,,,14232,CHEMBL626491,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,15284,,,14233,CHEMBL626492,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15750,,,14234,CHEMBL626493,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16618,10116.0,,14235,CHEMBL626494,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16618,,,14236,CHEMBL626495,Half life after oral tested,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15812,10116.0,,14237,CHEMBL626496,Half life was determined in plasma of rat; NT indicates not tested,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,16618,10116.0,,14238,CHEMBL626497,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,1,
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16618,,,14239,CHEMBL626498,Oral bioavailability after oral tested,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13098,10116.0,,14240,CHEMBL626499,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13098,10116.0,,14241,CHEMBL626500,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15812,10116.0,,14242,CHEMBL626501,half life was determined in plasma of rat; NT indicates not tested,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Plasma,A,,50597,Intermediate,,15812,10116.0,,14243,CHEMBL626502,half life was determined in plasma of rat; NT means not tested,,1,1969.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14244,CHEMBL626503,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14245,CHEMBL626504,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14246,CHEMBL626505,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14247,CHEMBL626506,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14248,CHEMBL626507,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14249,CHEMBL626508,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14250,CHEMBL626509,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14251,CHEMBL875480,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14252,CHEMBL626510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14253,CHEMBL626511,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14254,CHEMBL626512,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14255,CHEMBL628208,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14256,CHEMBL628209,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14257,CHEMBL628210,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14258,CHEMBL628211,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14259,CHEMBL628212,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14260,CHEMBL628213,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14261,CHEMBL628214,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14262,CHEMBL628215,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14263,CHEMBL628216,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14264,CHEMBL626595,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14265,CHEMBL626596,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14266,CHEMBL626597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14267,CHEMBL626598,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14268,CHEMBL622242,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14269,CHEMBL622243,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14270,CHEMBL622244,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14271,CHEMBL622245,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14272,CHEMBL622246,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14273,CHEMBL622247,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14274,CHEMBL622248,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14275,CHEMBL877483,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14276,CHEMBL622249,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14277,CHEMBL622250,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14278,CHEMBL622251,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14279,CHEMBL622252,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14280,CHEMBL622253,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14281,CHEMBL622254,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14282,CHEMBL622255,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14283,CHEMBL622256,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14284,CHEMBL622257,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14285,CHEMBL622258,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14286,CHEMBL622259,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14287,CHEMBL622927,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14288,CHEMBL622928,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14289,CHEMBL622929,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14290,CHEMBL623182,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14291,CHEMBL623183,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14292,CHEMBL623184,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14293,CHEMBL623185,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14294,CHEMBL877484,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14295,CHEMBL627274,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14296,CHEMBL623186,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14297,CHEMBL623187,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14298,CHEMBL623188,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14299,CHEMBL628055,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14300,CHEMBL628056,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14301,CHEMBL628200,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14302,CHEMBL628201,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14303,CHEMBL628202,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14304,CHEMBL628203,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14305,CHEMBL628204,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14306,CHEMBL628205,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14307,CHEMBL628206,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,1,1088.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14308,CHEMBL628207,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14309,CHEMBL627220,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14310,CHEMBL627221,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14311,CHEMBL627222,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14312,CHEMBL627223,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,In vivo,0,
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14313,CHEMBL632062,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Spleen,A,,22224,Autocuration,,13257,,,14314,CHEMBL632063,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,In vivo,0,2106.0
,,,U,1,,,BAO_0000218,Urinary bladder,A,,22224,Autocuration,,13257,,,14315,CHEMBL632064,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,In vivo,0,1255.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13257,,,14316,CHEMBL632065,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Bone element,A,,22224,Autocuration,,13257,,,14317,CHEMBL632066,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,In vivo,0,1474.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14318,CHEMBL632067,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,In vivo,0,
,,,U,1,,,BAO_0000218,Kidney,A,,22224,Autocuration,,13257,,,14319,CHEMBL629188,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,In vivo,0,2113.0
,,,U,1,,,BAO_0000218,Liver,A,,22224,Autocuration,,13257,,,14320,CHEMBL629189,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,In vivo,0,2107.0
,,,U,1,,,BAO_0000218,Lung,A,,22224,Autocuration,,13257,,,14321,CHEMBL629190,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,In vivo,0,2048.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14322,CHEMBL629191,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14323,CHEMBL629192,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14324,CHEMBL629193,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14325,CHEMBL629194,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14326,CHEMBL629195,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,In vivo,0,
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14327,CHEMBL629373,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Spleen,A,,22224,Autocuration,,13257,,,14328,CHEMBL629374,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,In vivo,0,2106.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14329,CHEMBL629375,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Urinary bladder,A,,22224,Autocuration,,13257,,,14330,CHEMBL629376,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,In vivo,0,1255.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13257,,,14331,CHEMBL629377,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Bone element,A,,22224,Autocuration,,13257,,,14332,CHEMBL629378,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,In vivo,0,1474.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14333,CHEMBL629379,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,In vivo,0,
,,,U,1,,,BAO_0000218,Kidney,A,,22224,Autocuration,,13257,,,14334,CHEMBL629151,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,In vivo,0,2113.0
,,,U,1,,,BAO_0000218,Liver,A,,22224,Autocuration,,13257,,,14335,CHEMBL629152,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,In vivo,0,2107.0
,,,U,1,,,BAO_0000218,Lung,A,,22224,Autocuration,,13257,,,14336,CHEMBL629153,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,In vivo,0,2048.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14337,CHEMBL629154,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14338,CHEMBL629155,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14339,CHEMBL629156,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14340,CHEMBL629157,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14341,CHEMBL629158,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14342,CHEMBL629159,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,In vivo,0,
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14343,CHEMBL629160,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Spleen,A,,22224,Autocuration,,13257,,,14344,CHEMBL629161,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,In vivo,0,2106.0
,,,U,1,,,BAO_0000218,Urinary bladder,A,,22224,Autocuration,,13257,,,14345,CHEMBL629162,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,In vivo,0,1255.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13257,,,14346,CHEMBL629163,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Bone element,A,,22224,Autocuration,,13257,,,14347,CHEMBL629164,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,In vivo,0,1474.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14348,CHEMBL629165,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,In vivo,0,
,,,U,1,,,BAO_0000218,Liver,A,,22224,Autocuration,,13257,,,14349,CHEMBL629166,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,In vivo,0,2107.0
,,,U,1,,,BAO_0000218,Lung,A,,22224,Autocuration,,13257,,,14350,CHEMBL629167,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,In vivo,0,2048.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14351,CHEMBL629168,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2193,,,14352,CHEMBL629169,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2193,,,14353,CHEMBL629170,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2193,,,14354,CHEMBL631153,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2193,,,14355,CHEMBL875121,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2193,,,14356,CHEMBL631154,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2193,,,14357,CHEMBL631155,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14358,CHEMBL631156,Hydrolysis rate constant was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14359,CHEMBL631157,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14360,CHEMBL631158,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14361,CHEMBL631159,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10026,,,14362,CHEMBL631160,Observed second order rate constant,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10281,,,14363,CHEMBL631161,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10014,,,14364,CHEMBL631162,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10014,,,14365,CHEMBL630313,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14366,CHEMBL630314,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14367,CHEMBL630315,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14368,CHEMBL630316,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14369,CHEMBL630986,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14370,CHEMBL630987,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14371,CHEMBL630988,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14372,CHEMBL630989,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14373,CHEMBL630990,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14374,CHEMBL630991,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14375,CHEMBL630992,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14376,CHEMBL630993,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13028,,,14377,CHEMBL630994,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,10014,10116.0,,14378,CHEMBL630995,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9962,,,14379,CHEMBL629252,Association constant for compound at 31 degree C was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12029,,,14380,CHEMBL629253,Calculated antagonist equilibrium dissociation constant of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12029,,,14381,CHEMBL629944,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,0,
,,Cavia porcellus,N,1,,,BAO_0000218,Trachea,A,,50512,Intermediate,,10583,10141.0,,14382,CHEMBL629945,Dissociation constants vs LTE4 on guinea pig trachea,,1,3126.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14383,CHEMBL629946,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14384,CHEMBL629947,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14385,CHEMBL629948,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14386,CHEMBL856024,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7493,,,14387,CHEMBL629949,Affinity constant KD value was derived from TMP,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8371,,,14388,CHEMBL629950,Apparent dissociation (binding) rate constant was evaluated,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,13114,,,14389,CHEMBL630127,Dissociation constant (KD) of the compound,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,15515,,,14390,CHEMBL630128,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,522,,,14391,CHEMBL630129,Dissociation constant from ESR titration experiments,,0,
,,,U,1,,,BAO_0000019,,,,22224,Autocuration,,13888,,,14392,CHEMBL630130,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,2616,,,14393,CHEMBL875234,Dissociation constant was evaluated.,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,3798,,,14394,CHEMBL630131,Dissociation constant was reported,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,8731,10116.0,,14395,CHEMBL630132,Dissociation constant was determined in rat pituitary cells.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11892,,,14396,CHEMBL630133,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11892,,,14397,CHEMBL630134,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2582,,,14398,CHEMBL630135,Equilibrium dissociation constant of the compound,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11892,,,14399,CHEMBL630136,Equilibrium dissociation constant was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13396,,,14400,CHEMBL630137,Kinetic constant KD was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,603,,,14401,CHEMBL630138,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15673,,,14402,CHEMBL630139,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10368,,,14403,CHEMBL630140,Rate constant for hydrolysis in aqueous acetone.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14228,,,14404,CHEMBL875235,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14405,CHEMBL876439,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14406,CHEMBL630605,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14407,CHEMBL630606,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14408,CHEMBL630607,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14409,CHEMBL630608,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14410,CHEMBL630609,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14411,CHEMBL630610,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14412,CHEMBL630611,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14413,CHEMBL629552,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14414,CHEMBL629733,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14415,CHEMBL629734,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14416,CHEMBL629735,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14417,CHEMBL629736,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14418,CHEMBL629737,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14419,CHEMBL629738,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14420,CHEMBL629739,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14421,CHEMBL629740,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14422,CHEMBL629741,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14423,CHEMBL629742,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14424,CHEMBL629743,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14425,CHEMBL629744,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14426,CHEMBL629745,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14427,CHEMBL629746,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14428,CHEMBL629747,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14429,CHEMBL629748,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14430,CHEMBL629749,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14431,CHEMBL629750,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14432,CHEMBL629751,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14433,CHEMBL629752,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14434,CHEMBL629753,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14435,CHEMBL629754,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14436,CHEMBL629755,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14437,CHEMBL629756,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14438,CHEMBL629757,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14439,CHEMBL629758,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14440,CHEMBL629759,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14441,CHEMBL629760,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11510,10116.0,,14442,CHEMBL876443,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8310,9615.0,,14443,CHEMBL629761,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8310,9615.0,,14444,CHEMBL629762,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14445,CHEMBL629763,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14446,CHEMBL629764,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14447,CHEMBL629765,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14448,CHEMBL629766,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14449,CHEMBL629767,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8310,9615.0,,14450,CHEMBL629768,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14451,CHEMBL629769,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8310,9615.0,,14452,CHEMBL629770,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,1,
,,Canis lupus familiaris,N,1,,,BAO_0000218,,A,,50588,Intermediate,,8310,9615.0,,14453,CHEMBL629771,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14454,CHEMBL629772,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14455,CHEMBL629773,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14456,CHEMBL625455,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14457,CHEMBL625456,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,8310,10090.0,,14458,CHEMBL625457,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14459,CHEMBL625458,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14460,CHEMBL625459,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14461,CHEMBL875483,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14462,CHEMBL634779,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14463,CHEMBL625460,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14464,CHEMBL626117,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14465,CHEMBL626118,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14466,CHEMBL628342,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14467,CHEMBL628343,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14468,CHEMBL628344,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14469,CHEMBL628345,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14470,CHEMBL628346,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14471,CHEMBL628347,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14472,CHEMBL628348,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14473,CHEMBL628349,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14474,CHEMBL875611,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14475,CHEMBL628350,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14476,CHEMBL628351,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14477,CHEMBL628352,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14478,CHEMBL628353,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14479,CHEMBL628354,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14480,CHEMBL626667,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14481,CHEMBL626668,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14482,CHEMBL626669,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14483,CHEMBL626670,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14484,CHEMBL626671,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14485,CHEMBL626672,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14486,CHEMBL626673,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14487,CHEMBL626674,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14488,CHEMBL626675,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14489,CHEMBL626676,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14490,CHEMBL626677,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14491,CHEMBL626678,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14492,CHEMBL626679,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14493,CHEMBL875612,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14494,CHEMBL626680,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14495,CHEMBL626681,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14496,CHEMBL626682,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14497,CHEMBL626683,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14498,CHEMBL626684,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14499,CHEMBL626685,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14500,CHEMBL626686,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14501,CHEMBL626687,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14502,CHEMBL624978,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14503,CHEMBL624979,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14504,CHEMBL624980,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14505,CHEMBL624981,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14506,CHEMBL624982,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,1,1088.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14507,CHEMBL627564,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14508,CHEMBL627565,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14509,CHEMBL627566,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,In vivo,0,
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14510,CHEMBL627567,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Spleen,A,,22224,Autocuration,,13257,,,14511,CHEMBL627568,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,In vivo,0,2106.0
,,,U,1,,,BAO_0000218,Kidney,A,,22224,Autocuration,,13257,,,14512,CHEMBL627569,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,In vivo,0,2113.0
,,,U,1,,,BAO_0000218,Urinary bladder,A,,22224,Autocuration,,13257,,,14513,CHEMBL627570,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,In vivo,0,1255.0
,,,U,1,,,BAO_0000218,Blood,A,,22224,Autocuration,,13257,,,14514,CHEMBL627571,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,In vivo,0,178.0
,,,U,1,,,BAO_0000218,Bone element,A,,22224,Autocuration,,13257,,,14515,CHEMBL627572,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,In vivo,0,1474.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14516,CHEMBL627573,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,In vivo,0,
,,,U,1,,,BAO_0000218,Kidney,A,,22224,Autocuration,,13257,,,14517,CHEMBL627574,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,In vivo,0,2113.0
,,,U,1,,,BAO_0000218,Liver,A,,22224,Autocuration,,13257,,,14518,CHEMBL627575,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,In vivo,0,2107.0
,,,U,1,,,BAO_0000218,Lung,A,,22224,Autocuration,,13257,,,14519,CHEMBL627576,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,In vivo,0,2048.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14520,CHEMBL627577,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14521,CHEMBL627578,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14522,CHEMBL627579,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14523,CHEMBL627580,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14524,CHEMBL627581,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),In vivo,0,2367.0
,,,U,1,,,BAO_0000218,,A,,22224,Autocuration,,13257,,,14525,CHEMBL627582,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,In vivo,0,
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14526,CHEMBL627583,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,In vivo,0,2385.0
,,,U,1,,,BAO_0000218,Spleen,A,,22224,Autocuration,,13257,,,14527,CHEMBL627584,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,In vivo,0,2106.0
,,,U,1,,,BAO_0000218,Prostate gland,A,,22224,Autocuration,,13257,,,14528,CHEMBL627585,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,In vivo,0,2367.0
,,,U,1,,,BAO_0000218,Muscle tissue,A,,22224,Autocuration,,13257,,,14529,CHEMBL627586,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,In vivo,0,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14530,CHEMBL627587,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14531,CHEMBL627588,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14532,CHEMBL628250,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14533,CHEMBL628251,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14534,CHEMBL628252,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14535,CHEMBL628253,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14536,CHEMBL628254,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14537,CHEMBL877493,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14538,CHEMBL628255,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14539,CHEMBL628256,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14540,CHEMBL628257,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14541,CHEMBL628258,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14542,CHEMBL628259,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14543,CHEMBL628429,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14544,CHEMBL626862,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14545,CHEMBL626863,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,15413,10116.0,,14546,CHEMBL625886,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,15413,10116.0,,14547,CHEMBL625887,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14548,CHEMBL625888,Biodistribution of the [11C]-radiolabeled compound in rat cortex,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14549,CHEMBL625889,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14550,CHEMBL625890,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14551,CHEMBL625891,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14552,CHEMBL625892,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14553,CHEMBL625893,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Cerebellum,A,,50597,Intermediate,,15413,10116.0,,14554,CHEMBL625894,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,In vivo,1,2037.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15413,10116.0,,14555,CHEMBL625895,Biodistribution of the [18F]-radiolabeled compound in rat cortex,In vivo,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12404,,,14556,CHEMBL625896,Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14557,CHEMBL625897,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14558,CHEMBL625898,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,568,,,14559,CHEMBL625899,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12404,,,14560,CHEMBL626124,Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,
,,Escherichia coli,N,1,,,BAO_0000218,,A,,50212,Intermediate,,7624,562.0,,14561,CHEMBL628500,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7624,10116.0,,14562,CHEMBL857856,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7624,10116.0,,14563,CHEMBL628501,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,4643,,,14564,CHEMBL628502,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11532,,,14565,CHEMBL628503,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11018,,,14566,CHEMBL628504,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14567,CHEMBL628505,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14568,CHEMBL874452,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14569,CHEMBL628506,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14570,CHEMBL628507,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14571,CHEMBL628508,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8949,,,14572,CHEMBL628509,Michaelis constant (KM) was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12404,,,14573,CHEMBL628510,Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,7625,,,14574,CHEMBL628511,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,7625,,,14575,CHEMBL628512,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,7625,,,14576,CHEMBL628513,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,7625,,,14577,CHEMBL628514,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,12908,,,14578,CHEMBL628515,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10368,,,14579,CHEMBL628516,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13108,,,14580,CHEMBL628517,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13108,,,14581,CHEMBL628518,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15217,,,14582,CHEMBL628519,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15217,,,14583,CHEMBL628520,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10933,,,14584,CHEMBL628521,Binding constant was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2363,,,14585,CHEMBL630443,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2363,,,14586,CHEMBL630444,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14587,CHEMBL857732,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14915,,,14588,CHEMBL630445,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8847,,,14589,CHEMBL630446,Catalytic rate constant of the compound,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,15357,,,14590,CHEMBL630447,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2869,,,14591,CHEMBL630448,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3484,,,14592,CHEMBL630449,Catalytic rate constant against phospholipase A2 was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,1373,,,14593,CHEMBL630450,"Compound was evaluated for catalytic constant, Kcat",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8142,,,14594,CHEMBL630451,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14131,,,14595,CHEMBL630452,Kcat calculated from 0.693/T1/2,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17269,,,14596,CHEMBL630453,Kcat was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3485,,,14597,CHEMBL630454,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3485,,,14598,CHEMBL630455,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3485,,,14599,CHEMBL631487,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,5962,,,14600,CHEMBL631488,Kcat value was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3133,,,14601,CHEMBL876440,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3133,,,14602,CHEMBL631489,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14603,CHEMBL857742,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14604,CHEMBL631490,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14605,CHEMBL631491,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14606,CHEMBL631492,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14607,CHEMBL631493,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,4892,,,14608,CHEMBL631494,Kinetic parameter for rate of conversion to PABA was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3133,,,14609,CHEMBL631495,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Feces,A,,50597,Intermediate,,11488,10116.0,,14610,CHEMBL631496,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,1,1988.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,11488,10116.0,,14611,CHEMBL631497,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,11488,10116.0,,14612,CHEMBL631498,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,11488,10116.0,,14613,CHEMBL629776,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,11488,10116.0,,14614,CHEMBL629777,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,11488,10116.0,,14615,CHEMBL629778,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14616,CHEMBL630456,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14617,CHEMBL630457,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14618,CHEMBL630458,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14619,CHEMBL630459,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14620,CHEMBL630460,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14621,CHEMBL876550,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14622,CHEMBL630461,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14623,CHEMBL630462,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14624,CHEMBL630463,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14625,CHEMBL630464,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14626,CHEMBL630465,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14627,CHEMBL630466,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14628,CHEMBL630467,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14629,CHEMBL630633,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14630,CHEMBL630634,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14631,CHEMBL630635,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14632,CHEMBL630636,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,11488,10116.0,,14633,CHEMBL630637,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,1,
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14634,CHEMBL630638,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14635,CHEMBL630639,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14636,CHEMBL630640,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14637,CHEMBL876551,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14638,CHEMBL630641,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14639,CHEMBL630642,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14640,CHEMBL630643,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14641,CHEMBL630644,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14642,CHEMBL630645,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14643,CHEMBL625599,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14644,CHEMBL625600,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14645,CHEMBL625601,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Feces,A,,50592,Intermediate,,7132,9986.0,,14646,CHEMBL625602,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,1,1988.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14647,CHEMBL627470,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14648,CHEMBL627471,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14649,CHEMBL627472,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14650,CHEMBL627473,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,1,1088.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Urine,A,,50592,Intermediate,,7132,9986.0,,14651,CHEMBL627474,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13925,10116.0,,14652,CHEMBL627475,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,13925,10116.0,,14653,CHEMBL627476,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,178.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14654,CHEMBL627477,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14655,CHEMBL627478,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14656,CHEMBL627479,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14657,CHEMBL627480,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14658,CHEMBL627481,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14659,CHEMBL627482,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14660,CHEMBL627483,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14661,CHEMBL875636,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14662,CHEMBL625764,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14663,CHEMBL625765,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14664,CHEMBL625766,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14665,CHEMBL625767,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14666,CHEMBL625768,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14667,CHEMBL625769,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14668,CHEMBL625770,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14669,CHEMBL625771,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14670,CHEMBL625772,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,1,1088.0
,,Canis lupus familiaris,N,1,,,BAO_0000218,Urine,A,,50588,Intermediate,,12582,9615.0,,14671,CHEMBL625773,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14672,CHEMBL625774,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14673,CHEMBL625775,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14674,CHEMBL625776,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14675,CHEMBL625777,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14676,CHEMBL625778,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14677,CHEMBL625779,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14678,CHEMBL625780,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14679,CHEMBL625781,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14680,CHEMBL875637,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14681,CHEMBL626473,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14682,CHEMBL626474,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14683,CHEMBL626475,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14684,CHEMBL626476,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14685,CHEMBL634397,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14686,CHEMBL626477,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14687,CHEMBL631069,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14688,CHEMBL631070,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14689,CHEMBL631071,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14690,CHEMBL631072,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14691,CHEMBL631073,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14692,CHEMBL631074,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14693,CHEMBL631075,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14694,CHEMBL631725,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14695,CHEMBL631726,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14696,CHEMBL631727,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14697,CHEMBL631728,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14698,CHEMBL631729,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14699,CHEMBL631730,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14700,CHEMBL631731,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14701,CHEMBL631910,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hippocampus,A,,50597,Intermediate,,15413,10116.0,,14702,CHEMBL631911,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,In vivo,1,10000000.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14703,CHEMBL631912,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Hypothalamus,A,,50597,Intermediate,,15413,10116.0,,14704,CHEMBL631913,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,In vivo,1,1898.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14705,CHEMBL631914,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14706,CHEMBL631915,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14707,CHEMBL875778,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14708,CHEMBL631916,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14709,CHEMBL631917,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14710,CHEMBL631918,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14711,CHEMBL631919,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14712,CHEMBL631920,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14713,CHEMBL631921,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14714,CHEMBL631922,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,12017,10116.0,,14715,CHEMBL631923,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14716,CHEMBL631924,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14717,CHEMBL630234,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14718,CHEMBL630235,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14719,CHEMBL630236,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14720,CHEMBL630237,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14721,CHEMBL630238,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14722,CHEMBL630239,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14723,CHEMBL630303,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14724,CHEMBL630304,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,12017,10116.0,,14725,CHEMBL630305,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14726,CHEMBL630306,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14727,CHEMBL630307,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14728,CHEMBL630308,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14729,CHEMBL630309,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14730,CHEMBL629309,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14731,CHEMBL629993,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14732,CHEMBL629994,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14733,CHEMBL629995,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14734,CHEMBL631993,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14735,CHEMBL631994,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,12017,10116.0,,14736,CHEMBL631995,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14737,CHEMBL631996,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14738,CHEMBL631997,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14739,CHEMBL631998,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14740,CHEMBL631999,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14741,CHEMBL632000,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14742,CHEMBL632001,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14743,CHEMBL874424,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14744,CHEMBL632002,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14745,CHEMBL632003,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3133,,,14746,CHEMBL632004,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14747,CHEMBL632005,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14748,CHEMBL632006,Compound was tested for amidase rate in the presence of N62C screen enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14749,CHEMBL632007,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14750,CHEMBL632008,Compound was tested for amidase rate in the presence of S166C screen enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14751,CHEMBL632009,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14752,CHEMBL632010,Compound was tested for esterase rate in the presence of N62C screen enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14753,CHEMBL857750,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2742,,,14754,CHEMBL632011,Compound was tested for esterase rate in the presence of S166C screen enzyme,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14755,CHEMBL632012,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14756,CHEMBL632013,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14757,CHEMBL632014,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14758,CHEMBL629622,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14759,CHEMBL629623,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14760,CHEMBL629624,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17269,,,14761,CHEMBL629625,Ratio of Kcat to that of Km was determined,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14762,CHEMBL629626,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2276,,,14763,CHEMBL629627,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,15917,,,14764,CHEMBL629628,"Compound was evaluated for constant, Kd",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10933,,,14765,CHEMBL629629,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10933,,,14766,CHEMBL629630,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14293,,,14767,CHEMBL856030,Dissociation Constant of compound determined,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,6698,,,14768,CHEMBL629631,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,0,
,,,U,1,,,BAO_0000019,,B,,22224,Autocuration,,6698,,,14769,CHEMBL629632,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,4318,,,14770,CHEMBL629633,Dissociation constant of compound with Fructose was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,4318,,,14771,CHEMBL629634,Dissociation constant of compound with Fructose was determined; Not determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,4318,,,14772,CHEMBL629635,Dissociation constant of compound with Lactulose was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,4318,,,14773,CHEMBL629636,Dissociation constant of compound with Lactulose was determined; Not determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14959,,,14774,CHEMBL629637,Dissociation constant of the Compound,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,5913,,,14775,CHEMBL629638,Dissociation constant by non-linear regression analysis,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,14218,,,14776,CHEMBL629639,Dissociation constant was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,10689,,,14777,CHEMBL629640,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,13925,,,14778,CHEMBL629641,Dissociation constant was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,16359,,,14779,CHEMBL631344,Dissociation constant was determined,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10944,10116.0,,14780,CHEMBL631345,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,1,2385.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11080,,,14781,CHEMBL631346,The dissociation constant determined by fluorescence displacement assay,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,17805,,,14782,CHEMBL631524,kd value surface plasmon resonance (SPR) method,,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,10944,10116.0,,14783,CHEMBL631525,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,1,2385.0
,,,U,1,,,BAO_0000019,,F,,22224,Autocuration,,16645,,,14784,CHEMBL631526,First dissociation constant of the binding of compound to V30M TTR,,0,
,,,U,1,,,BAO_0000019,,F,,22224,Autocuration,,16645,,,14785,CHEMBL631527,Second dissociation constant of the binding of compound to V30M TTR,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7793,,,14786,CHEMBL631528,"Compound was evaluated for equilibrium constant, Ke",,0,
,,,U,1,,,BAO_0000019,Hypothalamus,A,,22224,Autocuration,,12199,,,14787,CHEMBL631529,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,0,1898.0
,,,U,1,,,BAO_0000019,Hypothalamus,A,,22224,Autocuration,,12199,,,14788,CHEMBL631530,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,0,1898.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14789,CHEMBL631531,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14790,CHEMBL631532,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,9680,,,14791,CHEMBL631533,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14792,CHEMBL876552,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14793,CHEMBL631534,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14794,CHEMBL631535,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14795,CHEMBL631536,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14796,CHEMBL631537,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14797,CHEMBL631538,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14798,CHEMBL631539,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,13758,10090.0,,14799,CHEMBL631540,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,14800,CHEMBL625637,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14393,10116.0,,14801,CHEMBL625638,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,15078,10116.0,,14802,CHEMBL625639,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13925,10116.0,,14803,CHEMBL625640,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,13925,10116.0,,14804,CHEMBL625641,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13925,10116.0,,14805,CHEMBL625642,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,13925,10116.0,,14806,CHEMBL625643,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13925,10116.0,,14807,CHEMBL625644,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Kidney,A,,50597,Intermediate,,13925,10116.0,,14808,CHEMBL625645,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2113.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13925,10116.0,,14809,CHEMBL625646,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,13925,10116.0,,14810,CHEMBL625647,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13925,10116.0,,14811,CHEMBL625648,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,13925,10116.0,,14812,CHEMBL625649,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13925,10116.0,,14813,CHEMBL625650,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,13925,10116.0,,14814,CHEMBL625651,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,13925,10116.0,,14815,CHEMBL625652,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Zone of skin,A,,50597,Intermediate,,13925,10116.0,,14816,CHEMBL625653,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,14.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13925,10116.0,,14817,CHEMBL625654,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,13925,10116.0,,14818,CHEMBL625655,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9712,10116.0,,14819,CHEMBL625656,Biodistribution of Compound in rat blood after 15 minutes of administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Blood,A,,50597,Intermediate,,9712,10116.0,,14820,CHEMBL625657,Biodistribution of Compound in rat blood after 2 minutes of administration,In vivo,1,178.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,9712,10116.0,,14821,CHEMBL625658,Biodistribution of Compound in rat brain after 15 minutes of administration,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Brain,A,,50597,Intermediate,,9712,10116.0,,14822,CHEMBL625659,Biodistribution of Compound in rat brain after 2 minutes of administration,In vivo,1,955.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9712,10116.0,,14823,CHEMBL625660,Biodistribution of Compound in rat heart after 15 minutes of administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Heart,A,,50597,Intermediate,,9712,10116.0,,14824,CHEMBL625661,Biodistribution of Compound in rat heart after 2 minutes of administration,In vivo,1,948.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9712,10116.0,,14825,CHEMBL625662,Biodistribution of Compound in rat liver after 15 minutes of administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,9712,10116.0,,14826,CHEMBL625663,Biodistribution of Compound in rat liver after 2 minutes of administration,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9712,10116.0,,14827,CHEMBL875621,Biodistribution of Compound in rat lung after 15 minutes of administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,9712,10116.0,,14828,CHEMBL628382,Biodistribution of Compound in rat lung after 2 minutes of administration,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9712,10116.0,,14829,CHEMBL628383,Biodistribution of Compound in rat muscle after 15 minutes of administration,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,9712,10116.0,,14830,CHEMBL628384,Biodistribution of Compound in rat muscle after 2 minutes of administration,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13925,10116.0,,14831,CHEMBL628385,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13925,10116.0,,14832,CHEMBL875753,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,13925,10116.0,,14833,CHEMBL628386,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14834,CHEMBL628387,Organ distribution in rat blood 2 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14835,CHEMBL628388,Organ distribution in rat blood 2 hr after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14836,CHEMBL628389,Organ distribution in rat blood 30 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14837,CHEMBL632756,Organ distribution in rat blood 30 min after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14838,CHEMBL628390,Organ distribution in rat brain 2 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14839,CHEMBL631811,Organ distribution in rat brain 2 hr after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14840,CHEMBL631812,Organ distribution in rat brain 30 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14841,CHEMBL631813,Organ distribution in rat heart 2 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14842,CHEMBL631814,Organ distribution in rat heart 2 hr after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14843,CHEMBL631815,Organ distribution in rat heart 30 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14844,CHEMBL631816,Organ distribution in rat kidney 2 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14845,CHEMBL875758,Organ distribution in rat kidney 2 hr after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14846,CHEMBL631817,Organ distribution in rat kidney 30 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6941,10116.0,,14847,CHEMBL631818,Organ distribution in rat liver 2 minutes after intravenous injection,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6941,10116.0,,14848,CHEMBL631819,Organ distribution in rat liver 2 hr after intravenous injection,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,6941,10116.0,,14849,CHEMBL631820,Organ distribution in rat liver 30 minutes after intravenous injection,,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14850,CHEMBL631821,Organ distribution in rat lung 2 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14851,CHEMBL631822,Organ distribution in rat lung 2 hr after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,6941,10116.0,,14852,CHEMBL631823,Organ distribution in rat lung 30 minutes after intravenous injection,,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,6941,10116.0,,14853,CHEMBL631824,Organ distribution in rat muscle 2 minutes after intravenous injection,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,6941,10116.0,,14854,CHEMBL631825,Organ distribution in rat muscle 2 hr after intravenous injection,,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,6941,10116.0,,14855,CHEMBL631826,Organ distribution in rat muscle 30 minutes after intravenous injection,,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,14856,CHEMBL631827,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,14857,CHEMBL631828,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,14858,CHEMBL631829,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),In vivo,1,
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14859,CHEMBL875759,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14860,CHEMBL631830,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14861,CHEMBL631831,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14862,CHEMBL631832,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14863,CHEMBL631833,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14864,CHEMBL631834,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14865,CHEMBL631835,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14866,CHEMBL631836,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14867,CHEMBL631837,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14868,CHEMBL631838,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14869,CHEMBL631839,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14870,CHEMBL631840,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14871,CHEMBL631841,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14872,CHEMBL631842,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14873,CHEMBL631843,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14874,CHEMBL631844,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14875,CHEMBL631845,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14876,CHEMBL631846,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14877,CHEMBL875760,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14878,CHEMBL632199,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14879,CHEMBL631847,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14880,CHEMBL631848,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14881,CHEMBL628707,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14882,CHEMBL628708,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14883,CHEMBL628709,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14884,CHEMBL628710,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14885,CHEMBL628711,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14886,CHEMBL628712,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14887,CHEMBL628713,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Urine,A,,50597,Intermediate,,12582,10116.0,,14888,CHEMBL628714,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,1,1088.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,7415,10116.0,,14889,CHEMBL628715,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7313,,,14890,CHEMBL629179,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7313,,,14891,CHEMBL629180,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7313,,,14892,CHEMBL875108,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,0,
,,,U,1,,,BAO_0000019,Adrenal cortex,A,,22224,Autocuration,,7570,,,14893,CHEMBL629181,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,0,1235.0
,,,U,1,,,BAO_0000019,Adrenal cortex,A,,22224,Autocuration,,7570,,,14894,CHEMBL629182,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,0,1235.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14895,CHEMBL629183,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14896,CHEMBL629184,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,Adrenal cortex,A,,22224,Autocuration,,7570,,,14897,CHEMBL629185,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,0,1235.0
,,,U,1,,,BAO_0000019,Adrenal cortex,A,,22224,Autocuration,,7570,,,14898,CHEMBL629186,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,0,1235.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14899,CHEMBL629187,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14900,CHEMBL629887,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14901,CHEMBL629888,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14902,CHEMBL629889,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,Adrenal cortex,A,,22224,Autocuration,,7570,,,14903,CHEMBL629890,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,0,1235.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14904,CHEMBL629891,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14905,CHEMBL629892,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,Adrenal cortex,A,,22224,Autocuration,,7570,,,14906,CHEMBL629893,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,0,1235.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14907,CHEMBL629894,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,7570,,,14908,CHEMBL629895,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,0,
,,Canis lupus familiaris,U,1,,,BAO_0000218,,A,,22224,Autocuration,,14122,9615.0,,14909,CHEMBL875109,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",In vivo,0,
,,Macaca fascicularis,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16449,9541.0,,14910,CHEMBL629896,Absolute bioavailability in male cynomolgus monkeys,In vivo,0,
,,Rattus norvegicus,U,1,,,BAO_0000218,,A,,22224,Autocuration,,16449,10116.0,,14911,CHEMBL629897,Absolute bioavailability in maleSprague-Dawley rats,In vivo,0,
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14912,CHEMBL629898,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14913,CHEMBL630057,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Liver,A,,50597,Intermediate,,12017,10116.0,,14914,CHEMBL630058,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2107.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14915,CHEMBL630059,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14916,CHEMBL630060,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14917,CHEMBL630061,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14918,CHEMBL630062,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14919,CHEMBL630063,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14920,CHEMBL630064,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14921,CHEMBL630065,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14922,CHEMBL630066,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14923,CHEMBL630067,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Lung,A,,50597,Intermediate,,12017,10116.0,,14924,CHEMBL630068,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2048.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14925,CHEMBL631113,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14926,CHEMBL631114,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14927,CHEMBL631115,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14928,CHEMBL631116,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14929,CHEMBL630528,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14930,CHEMBL630529,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14931,CHEMBL630530,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14932,CHEMBL630531,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14933,CHEMBL630532,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Muscle tissue,A,,50597,Intermediate,,12017,10116.0,,14934,CHEMBL630533,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2385.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,15045,10090.0,,14935,CHEMBL630534,Biodistribution in normal mice blood after 120 hr,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,15045,10090.0,,14936,CHEMBL630535,Biodistribution in normal mice blood after 24 hr,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Blood,A,,50594,Intermediate,,15045,10090.0,,14937,CHEMBL630536,Biodistribution in normal mice blood after 4 hr,In vivo,1,178.0
,,Mus musculus,N,1,,,BAO_0000218,Bone,A,,50594,Intermediate,,15045,10090.0,,14938,CHEMBL630537,Biodistribution in normal mice bone after 120 hr,In vivo,1,10000001.0
,,Mus musculus,N,1,,,BAO_0000218,Bone,A,,50594,Intermediate,,15045,10090.0,,14939,CHEMBL630538,Biodistribution in normal mice bone after 24 hr,In vivo,1,10000001.0
,,Mus musculus,N,1,,,BAO_0000218,Bone,A,,50594,Intermediate,,15045,10090.0,,14940,CHEMBL630539,Biodistribution in normal mice bone after 4 hr,In vivo,1,10000001.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,15045,10090.0,,14941,CHEMBL630540,Biodistribution in normal mice heart after 120 hr,In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,15045,10090.0,,14942,CHEMBL630541,Biodistribution in normal mice heart after 24 hr,In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Heart,A,,50594,Intermediate,,15045,10090.0,,14943,CHEMBL630542,Biodistribution in normal mice heart after 4 hr,In vivo,1,948.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15045,10090.0,,14944,CHEMBL630543,Biodistribution in normal mice kidney after 120 hr,In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15045,10090.0,,14945,CHEMBL630544,Biodistribution in normal mice kidney after 24 hr,In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Kidney,A,,50594,Intermediate,,15045,10090.0,,14946,CHEMBL630545,Biodistribution in normal mice kidney after 4 hr,In vivo,1,2113.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15045,10090.0,,14947,CHEMBL630546,Biodistribution in normal mice liver after 120 hr,In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15045,10090.0,,14948,CHEMBL630547,Biodistribution in normal mice liver after 24 hr,In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Liver,A,,50594,Intermediate,,15045,10090.0,,14949,CHEMBL630548,Biodistribution in normal mice liver after 4 hr,In vivo,1,2107.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,15045,10090.0,,14950,CHEMBL630549,Biodistribution in normal mice spleen after 120 hr,In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,15045,10090.0,,14951,CHEMBL630550,Biodistribution in normal mice spleen after 24 hr,In vivo,1,2106.0
,,Mus musculus,N,1,,,BAO_0000218,Spleen,A,,50594,Intermediate,,15045,10090.0,,14952,CHEMBL876426,Biodistribution in normal mice spleen after 4 hr,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14953,CHEMBL630551,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14954,CHEMBL630552,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14955,CHEMBL630553,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14956,CHEMBL630554,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14957,CHEMBL630555,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14958,CHEMBL630556,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14959,CHEMBL630557,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14960,CHEMBL630558,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14961,CHEMBL630559,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Spleen,A,,50597,Intermediate,,12017,10116.0,,14962,CHEMBL630560,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2106.0
,,Rattus norvegicus,N,1,,,BAO_0000218,Thyroid gland,A,,50597,Intermediate,,12017,10116.0,,14963,CHEMBL876427,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,1,2046.0
,,Rattus norvegicus,N,1,,,BAO_0000218,,A,,50597,Intermediate,,14941,10116.0,,14964,CHEMBL630561,The Kel values in female wistar rats.,,1,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,4646,,,14965,CHEMBL630562,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8847,,,14966,CHEMBL630563,Hydrolysis rate constant of the compound,,0,
,,,U,1,,,BAO_0000100,,P,,22229,Autocuration,,11778,,,14967,CHEMBL629673,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2363,,,14968,CHEMBL629674,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2363,,,14969,CHEMBL629675,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2363,,,14970,CHEMBL629676,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2363,,,14971,CHEMBL629677,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8371,,,14972,CHEMBL629678,Apparent inactivation rate constant was evaluated,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14883,,,14973,CHEMBL629679,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,14883,,,14974,CHEMBL629680,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,4643,,,14975,CHEMBL629681,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,3519,,,14976,CHEMBL629682,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,10600,,,14977,CHEMBL629683,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,0,
,,,U,1,,,BAO_0000019,,F,,22224,Autocuration,,8501,,,14978,CHEMBL629684,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,8505,,,14979,CHEMBL629685,Dissociation constant was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,9778,,,14980,CHEMBL629686,Dissociation constant was determined,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,9778,,,14981,CHEMBL872932,Dissociation constant at pH 7.4,,0,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,9778,,,14982,CHEMBL629687,Dissociation constant in presence of 1 mM dithiothreitol,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13007,,,14983,CHEMBL872931,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13007,,,14984,CHEMBL628151,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13007,,,14985,CHEMBL628152,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,13007,,,14986,CHEMBL628153,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11482,,,14987,CHEMBL628154,Kinetic constant for aromatization of androstenedione,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11482,,,14988,CHEMBL628155,Kinetic constant for aromatization of testosterone,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,2303,,,14989,CHEMBL628156,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11964,,,14990,CHEMBL628157,Local inhibition constant was determined,,0,
,,Saccharomyces cerevisiae,N,1,,,BAO_0000218,,A,,50347,Intermediate,,3140,4932.0,,14991,CHEMBL857533,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,1,
,,,U,1,,,BAO_0000100,,P,,22224,Autocuration,,10650,,,14992,CHEMBL628158,Dissociation constant value of the compound,,0,
,,,U,1,,,BAO_0000019,Cornea,A,,22224,Autocuration,,4667,,,14993,CHEMBL628159,In vitro permeability through cornea without epithelium,,0,964.0
,,,U,1,,,BAO_0000019,Cornea,A,,22224,Autocuration,,4667,,,14994,CHEMBL875616,In vitro permeability through intact cornea,,0,964.0
,,Oryctolagus cuniculus,N,1,,,BAO_0000218,Cornea,A,,50592,Intermediate,,9199,9986.0,,14995,CHEMBL628160,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,1,964.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,11966,,,14996,CHEMBL628161,Rate of enzyme inactivation for the compound was determined,,0,
,,,U,1,,,BAO_0000019,Cornea,A,,22224,Autocuration,,4667,,,14997,CHEMBL628162,In vitro permeability through cornea without epithelium,,0,964.0
,,,U,1,,,BAO_0000019,Cornea,A,,22224,Autocuration,,4667,,,14998,CHEMBL628163,In vitro permeability through intact cornea,,0,964.0
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,14999,CHEMBL628164,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15000,CHEMBL628165,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15001,CHEMBL628166,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15002,CHEMBL628167,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15003,CHEMBL628168,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15004,CHEMBL628169,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15005,CHEMBL628170,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15006,CHEMBL628171,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15007,CHEMBL627434,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15008,CHEMBL627435,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15009,CHEMBL628110,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15010,CHEMBL628111,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15011,CHEMBL628112,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15012,CHEMBL628260,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,,U,1,,,BAO_0000019,,A,,22224,Autocuration,,8354,,,15013,CHEMBL628261,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15014,CHEMBL628262,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),In vivo,1,
,,Homo sapiens,N,1,,,BAO_0000218,,A,,50587,Intermediate,,14439,9606.0,,15015,CHEMBL628263,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15016,CHEMBL628264,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15017,CHEMBL628265,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15018,CHEMBL628266,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15019,CHEMBL628267,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15020,CHEMBL628268,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15021,CHEMBL628269,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15022,CHEMBL628270,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15023,CHEMBL628271,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),In vivo,1,
,,Mus musculus,N,1,,,BAO_0000218,,A,,50594,Intermediate,,14439,10090.0,,15024,CHEMBL628272,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),In vivo,1,
